data_6u46_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6u46 _Structure_validation_residue.Date_analyzed 2020-08-21 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.495 1.796 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.4 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 63.5 m -129.29 125.03 35.87 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.267 -0.896 . . . . 0.0 110.309 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.77 -136.72 44.09 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.6 m -42.18 -35.46 0.95 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.691 -0.888 . . . . 0.0 110.624 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.4 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 0.8 OUTLIER -59.74 -35.34 74.37 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.821 -1.174 . . . . 0.0 108.851 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 8' ' ' GLY . 10.5 tp -71.89 -50.1 32.25 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.3 t -59.88 -61.2 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.5 mt-10 -45.06 -29.48 0.88 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.851 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.1 -60.82 1.93 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.157 -0.964 . . . . 0.0 109.715 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.5 mt -47.3 -36.97 10.0 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.028 -1.045 . . . . 0.0 109.562 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -50.72 -40.22 53.76 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.496 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -78.54 -50.67 11.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 108.754 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.1 t -50.19 -54.18 9.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-O 121.555 0.693 . . . . 0.0 109.282 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.4 m -78.71 -22.42 46.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.561 -0.712 . . . . 0.0 110.646 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.69 -113.35 3.44 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -85.68 -29.22 24.15 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.191 -1.182 . . . . 0.0 110.842 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -54.35 -36.72 64.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.884 -1.135 . . . . 0.0 109.412 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.53 167.16 17.5 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.249 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' A' ' 24' ' ' PHE . 8.5 p90 -138.1 173.63 11.42 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.536 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 18.8 p90 -109.0 121.09 44.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 110.36 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.2 t80 . . . . . 0 N--CA 1.5 2.06 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.209 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.52 -35.12 20.84 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.88 -50.32 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.546 -0.973 . . . . 0.0 109.908 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.501 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.4 t -69.47 -65.04 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.53 -1.356 . . . . 0.0 111.329 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 46' ' ' ARG . 69.5 mm-40 -58.64 -47.04 85.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.795 -1.191 . . . . 0.0 110.475 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.504 ' NE2' HE21 ' A' ' 53' ' ' GLN . 19.2 tt0 -48.75 -50.07 35.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.687 -1.258 . . . . 0.0 109.577 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 47' ' ' SER . 84.8 m -81.99 -53.35 6.2 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.165 -0.959 . . . . 0.0 109.851 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.401 ' N ' ' O ' ' A' ' 41' ' ' VAL . 53.2 t -60.04 -50.99 71.55 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.958 -1.089 . . . . 0.0 109.952 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -68.5 -35.74 77.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.082 -1.011 . . . . 0.0 110.049 -179.323 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 44' ' ' CYS . 58.4 m -136.78 148.4 47.19 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.029 -1.045 . . . . 0.0 109.562 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.3 mt -68.6 99.53 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.989 -1.069 . . . . 0.0 109.573 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.7 p -84.2 139.65 32.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 109.026 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 m -71.78 160.67 32.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 109.815 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.3 mt -54.11 -32.55 55.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.344 -0.847 . . . . 0.0 109.191 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -48.75 -46.28 40.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.891 . . . . 0.0 109.306 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.525 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 21.9 mt-30 -69.57 -49.76 51.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.319 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.8 mt -56.25 -33.78 65.75 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.152 -0.967 . . . . 0.0 108.598 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.03 -8.88 57.76 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -79.64 -22.11 43.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.512 -0.743 . . . . 0.0 110.933 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.525 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.1 m-85 -99.99 -7.32 25.24 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.089 -1.007 . . . . 0.0 110.321 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 82.4 m -60.9 98.55 0.07 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.293 -0.88 . . . . 0.0 109.64 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.267 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.503 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 mp . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.6 m -128.67 125.09 37.32 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.243 -0.91 . . . . 0.0 110.335 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.29 -137.52 45.36 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -42.26 -34.19 0.74 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.587 -0.949 . . . . 0.0 110.575 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -59.33 -35.74 74.39 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.954 -1.091 . . . . 0.0 108.764 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 8' ' ' GLY . 9.4 tp -71.18 -53.09 15.66 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 13' ' ' GLU . 66.3 t -57.53 -59.95 2.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.494 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 26.7 mt-10 -44.01 -29.92 0.66 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.715 -0.616 . . . . 0.0 110.039 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.7 -60.92 1.88 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 109.523 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.2 mt -46.6 -36.2 6.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.14 -0.975 . . . . 0.0 109.641 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -52.22 -42.06 63.25 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.429 -0.794 . . . . 0.0 108.858 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.494 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -76.94 -51.18 11.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 108.873 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -50.17 -54.24 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.646 -0.659 . . . . 0.0 109.249 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.3 m -78.44 -22.32 47.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.54 -0.725 . . . . 0.0 110.371 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 56.71 -118.44 11.84 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -84.95 -23.63 28.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.148 -1.207 . . . . 0.0 110.034 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.4 mtp180 -54.63 -37.4 65.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.985 -1.072 . . . . 0.0 109.124 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.25 163.97 12.7 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 120.071 -1.062 . . . . 0.0 110.869 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 24' ' ' PHE . 8.7 p90 -138.54 173.1 11.95 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.52 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.4 p90 -110.19 124.38 51.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.092 -1.005 . . . . 0.0 109.39 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.8 t80 . . . . . 0 N--CA 1.499 2.015 0 O-C-N 121.073 -1.017 . . . . 0.0 109.497 179.875 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.1 -30.15 35.5 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.517 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -101.38 -52.73 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.52 -0.988 . . . . 0.0 110.185 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.517 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 5.7 t -69.49 -64.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.528 -1.358 . . . . 0.0 111.595 -178.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 46' ' ' ARG . 54.2 mt-10 -57.25 -54.24 48.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.847 -1.158 . . . . 0.0 110.569 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.617 ' NE2' ' NE2' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -44.65 -50.59 9.75 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.874 -1.141 . . . . 0.0 110.096 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.441 ' O ' ' O ' ' A' ' 47' ' ' SER . 99.4 m -79.43 -51.28 9.58 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.903 -1.123 . . . . 0.0 110.126 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.2 t -60.36 -53.25 59.81 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.099 -1.0 . . . . 0.0 110.62 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 42' ' ' GLU . 17.8 tpt180 -71.52 -38.53 71.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.87 -1.144 . . . . 0.0 109.9 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 44' ' ' CYS . 2.1 m -124.51 145.09 49.75 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.115 -0.99 . . . . 0.0 109.893 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.2 mt -69.46 99.35 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.004 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.411 ' CB ' HE22 ' A' ' 43' ' ' GLN . 24.8 p -86.37 142.25 28.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.304 -0.872 . . . . 0.0 109.467 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.7 m -72.22 159.82 33.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.722 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.9 mt -54.86 -31.69 59.94 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.35 -0.844 . . . . 0.0 108.849 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -47.49 -54.67 10.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.363 -0.835 . . . . 0.0 109.352 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.617 ' NE2' ' NE2' ' A' ' 43' ' ' GLN . 48.7 mt-30 -60.09 -49.85 76.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.233 -0.917 . . . . 0.0 109.197 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 98.1 mt -55.57 -34.58 64.9 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.161 -0.962 . . . . 0.0 108.688 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.403 ' CD ' ' O ' ' A' ' 55' ' ' GLU . 5.0 tm-20 -73.45 -9.25 58.5 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.677 0.751 . . . . 0.0 109.059 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -79.67 -21.74 44.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.373 -0.829 . . . . 0.0 111.239 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.508 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.3 m-85 -100.17 -6.31 26.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.087 -1.008 . . . . 0.0 110.534 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 71.4 m -60.9 98.72 0.07 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.17 -0.956 . . . . 0.0 109.695 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.314 0 CA-C-O 117.94 -1.478 . . . . 0.0 109.583 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.408 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 58.9 m -129.75 124.85 34.47 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.289 -0.882 . . . . 0.0 110.2 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 61.43 -136.54 47.45 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -41.93 -34.04 0.63 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.693 -0.886 . . . . 0.0 110.767 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.408 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 1.7 t-80 -62.06 -34.69 76.74 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.757 -1.214 . . . . 0.0 108.808 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 8' ' ' GLY . 11.3 tp -71.7 -49.08 42.78 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.7 t -59.28 -61.46 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.497 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 25.1 mt-10 -44.31 -29.64 0.7 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.346 -0.541 . . . . 0.0 109.949 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.35 -61.23 1.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.164 -0.96 . . . . 0.0 109.74 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.0 mt -46.68 -36.91 7.61 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.123 -0.986 . . . . 0.0 109.613 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -51.11 -41.34 59.95 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.404 -0.81 . . . . 0.0 108.871 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.497 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -77.51 -50.91 11.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.93 . . . . 0.0 108.847 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.2 t -50.18 -54.41 8.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.57 0.7 . . . . 0.0 109.142 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.3 m -79.39 -20.83 46.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.595 -0.69 . . . . 0.0 110.328 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.42 -117.11 6.56 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -84.73 -22.22 29.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.152 -1.205 . . . . 0.0 109.622 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.585 ' CG ' HH21 ' A' ' 22' ' ' ARG . 3.2 mtt-85 -54.59 -38.14 66.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.19 -0.944 . . . . 0.0 109.157 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.95 162.05 9.31 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.078 -1.058 . . . . 0.0 110.501 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.518 ' CD1' ' N ' ' A' ' 24' ' ' PHE . 8.0 p90 -137.97 172.57 12.74 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.527 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.1 p90 -111.02 121.76 46.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.33 -0.856 . . . . 0.0 108.977 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.1 t80 . . . . . 0 N--CA 1.495 1.785 0 O-C-N 120.972 -1.08 . . . . 0.0 108.962 -179.953 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.336 0.588 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.48 -40.39 9.99 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.509 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.43 -51.15 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.316 -1.108 . . . . 0.0 110.291 -178.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.509 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.9 t -66.41 -64.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 120.627 -1.296 . . . . 0.0 111.775 -178.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 46' ' ' ARG . 81.9 mt-10 -56.06 -54.14 48.51 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.904 -1.122 . . . . 0.0 111.209 -178.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.682 HE21 HE22 ' A' ' 53' ' ' GLN . 0.0 OUTLIER -45.7 -48.68 15.09 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.849 -1.157 . . . . 0.0 110.141 -178.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.47 ' O ' ' O ' ' A' ' 47' ' ' SER . 85.2 m -82.3 -53.58 5.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.062 -1.024 . . . . 0.0 110.042 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.2 t -60.61 -51.91 67.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.999 -1.063 . . . . 0.0 109.987 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 42' ' ' GLU . 3.7 tmt_? -67.04 -36.62 82.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.186 -0.946 . . . . 0.0 110.025 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 44' ' ' CYS . 68.4 m -136.46 148.17 47.57 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.168 -0.958 . . . . 0.0 109.398 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.6 mt -68.46 99.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.12 -0.988 . . . . 0.0 109.512 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.4 p -83.14 140.48 32.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.407 -0.808 . . . . 0.0 109.217 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 m -70.61 160.96 31.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.208 -0.932 . . . . 0.0 109.527 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.9 mt -55.48 -31.32 61.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.233 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -49.51 -51.97 32.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 109.216 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.682 HE22 HE21 ' A' ' 43' ' ' GLN . 18.3 mt-30 -62.32 -50.28 72.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.209 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.3 mt -56.68 -33.18 66.16 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.101 -0.999 . . . . 0.0 108.462 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -74.25 -8.96 58.03 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -79.99 -21.97 43.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.44 -0.787 . . . . 0.0 110.932 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.466 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 8.0 m-85 -99.46 -7.18 26.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.069 -1.019 . . . . 0.0 110.514 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.4 m -60.73 99.14 0.08 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.188 -0.945 . . . . 0.0 109.6 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.271 0 CA-C-O 118.022 -1.432 . . . . 0.0 109.562 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 N--CA 1.496 1.851 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.4 m -130.29 125.29 34.38 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.22 -0.925 . . . . 0.0 110.633 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 61.56 -136.5 47.15 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.424 ' O ' ' OE2' ' A' ' 13' ' ' GLU . 57.4 m -43.66 -28.74 0.43 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.518 -0.989 . . . . 0.0 110.548 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -66.61 -32.13 73.27 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.815 -1.178 . . . . 0.0 108.814 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 8' ' ' GLY . 9.7 tp -72.48 -51.58 19.5 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.4 t -58.0 -60.42 2.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.485 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.6 mt-10 -43.77 -29.24 0.5 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.748 -0.595 . . . . 0.0 110.106 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.2 -59.94 2.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.648 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.6 mt -46.94 -37.22 8.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.125 -0.984 . . . . 0.0 109.488 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -50.86 -42.02 58.51 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.485 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -76.88 -50.04 14.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 108.786 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.2 t -50.36 -55.08 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.648 0.737 . . . . 0.0 109.039 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.0 m -78.87 -22.32 46.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.559 -0.713 . . . . 0.0 110.426 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.84 -116.05 6.74 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 2.6 mp0 -85.21 -23.91 28.08 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.191 -1.182 . . . . 0.0 110.062 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.557 HH21 ' CG ' ' A' ' 22' ' ' ARG . 4.7 mtt-85 -54.78 -37.55 66.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.098 -1.001 . . . . 0.0 109.356 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.13 164.14 12.46 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.962 -1.114 . . . . 0.0 110.329 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.529 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 7.3 p90 -138.42 172.75 12.43 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.53 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.7 p90 -111.1 122.56 48.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 109.253 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.8 t80 . . . . . 0 N--CA 1.496 1.827 0 O-C-N 120.908 -1.12 . . . . 0.0 108.662 179.739 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.42 HH21 ' HG3' ' A' ' 38' ' ' ARG . 4.2 ptm180 . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.64 -34.0 23.41 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.951 -1.659 . . . . 0.0 108.951 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -101.64 -52.49 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.441 -1.035 . . . . 0.0 110.096 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 3.2 t -67.85 -64.03 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 120.663 -1.273 . . . . 0.0 111.813 -178.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' ARG . 67.2 mm-40 -57.34 -54.85 42.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.824 -1.172 . . . . 0.0 111.339 -177.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.548 ' CD ' HE22 ' A' ' 53' ' ' GLN . 0.0 OUTLIER -45.76 -45.86 14.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.553 -1.342 . . . . 0.0 110.012 -178.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' A' ' 47' ' ' SER . 95.1 m -84.44 -53.2 5.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.964 -1.085 . . . . 0.0 110.103 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.406 ' N ' ' O ' ' A' ' 41' ' ' VAL . 53.7 t -63.05 -44.51 95.65 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.984 -1.072 . . . . 0.0 110.332 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 42' ' ' GLU . 3.5 tmt_? -72.21 -36.37 69.15 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.793 -1.192 . . . . 0.0 109.605 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 44' ' ' CYS . 69.5 m -138.03 153.1 49.4 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.203 -0.935 . . . . 0.0 109.946 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.0 mt -68.97 99.15 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 108.857 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.6 p -83.39 148.46 27.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 109.313 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.8 m -78.76 162.61 26.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.261 -0.9 . . . . 0.0 110.063 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.8 mt -57.13 -33.18 67.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.557 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -48.95 -45.42 41.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.184 -0.948 . . . . 0.0 109.163 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.548 HE22 ' CD ' ' A' ' 43' ' ' GLN . 21.5 mt-30 -69.34 -52.76 24.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.369 -0.832 . . . . 0.0 109.191 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 99.2 mt -55.86 -32.47 63.67 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.029 -1.044 . . . . 0.0 108.654 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -76.08 -9.04 58.3 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.595 0.712 . . . . 0.0 109.225 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -79.85 -21.82 43.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.419 -0.801 . . . . 0.0 110.836 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.531 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.6 m-85 -99.27 -6.91 27.18 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.172 -0.955 . . . . 0.0 110.487 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 71.2 m -60.63 100.96 0.12 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.136 -0.978 . . . . 0.0 109.624 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.299 0 CA-C-O 118.048 -1.418 . . . . 0.0 109.581 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 mp . . . . . 0 N--CA 1.496 1.852 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 82.3 m -129.3 125.2 36.23 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.21 -0.931 . . . . 0.0 110.648 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.74 -137.26 44.25 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 m -42.83 -32.24 0.59 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.599 -0.942 . . . . 0.0 110.576 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -61.83 -34.23 75.58 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.852 -1.155 . . . . 0.0 108.877 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 8' ' ' GLY . 10.0 tp -71.76 -52.24 18.65 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.0 t -58.52 -60.06 2.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.5 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 51.5 mt-10 -44.5 -28.98 0.64 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.726 -0.609 . . . . 0.0 109.97 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.15 -61.14 1.82 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.599 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.8 mt -46.47 -36.93 7.12 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.167 -0.958 . . . . 0.0 109.581 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -51.13 -40.82 59.39 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.5 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.1 -50.9 11.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -0.869 . . . . 0.0 108.808 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.1 t -50.26 -54.8 7.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.543 0.687 . . . . 0.0 109.317 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.8 m -77.47 -22.22 51.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.57 -0.707 . . . . 0.0 110.634 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.88 -115.65 5.79 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -85.23 -24.16 27.93 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.194 -1.18 . . . . 0.0 110.077 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.585 ' CG ' HH21 ' A' ' 22' ' ' ARG . 3.4 mtt-85 -54.43 -37.99 65.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.046 -1.034 . . . . 0.0 109.367 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.53 164.02 10.88 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 24' ' ' PHE . 7.9 p90 -138.2 172.71 12.51 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.543 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 17.0 p90 -109.11 122.01 46.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -0.925 . . . . 0.0 109.554 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.9 t80 . . . . . 0 N--CA 1.498 1.968 0 O-C-N 121.208 -0.933 . . . . 0.0 108.863 179.67 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.632 0.729 . . . . 0.0 109.037 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.78 -36.87 14.59 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.494 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.58 -50.21 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.547 -0.972 . . . . 0.0 109.928 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.494 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.5 t -67.58 -65.09 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.61 -1.306 . . . . 0.0 111.455 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 46' ' ' ARG . 13.9 mm-40 -57.58 -48.84 78.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.847 -1.158 . . . . 0.0 110.426 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.47 ' CD ' ' NE2' ' A' ' 53' ' ' GLN . 23.0 tt0 -46.83 -49.41 20.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.776 -1.202 . . . . 0.0 109.86 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.483 ' O ' ' O ' ' A' ' 47' ' ' SER . 94.9 m -84.58 -53.5 5.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 110.172 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.416 ' N ' ' O ' ' A' ' 41' ' ' VAL . 54.1 t -60.93 -46.17 91.76 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.929 -1.107 . . . . 0.0 110.008 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.505 ' CG ' HH21 ' A' ' 46' ' ' ARG . 0.0 OUTLIER -69.87 -38.38 76.37 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.876 -1.14 . . . . 0.0 109.576 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.483 ' O ' ' O ' ' A' ' 44' ' ' CYS . 13.9 m -138.08 153.19 49.31 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.151 -0.968 . . . . 0.0 109.72 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.2 mt -68.6 99.68 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.109 -0.995 . . . . 0.0 109.837 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.7 p -83.34 140.56 32.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 108.918 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.2 m -70.36 157.51 37.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.182 -0.949 . . . . 0.0 109.885 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 48.2 mt -53.54 -33.28 54.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.41 -0.806 . . . . 0.0 109.247 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -50.07 -49.03 52.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 108.968 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.519 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 37.3 mt-30 -63.52 -50.33 70.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.853 . . . . 0.0 108.932 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.3 mt -56.78 -32.8 66.01 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.178 -0.951 . . . . 0.0 108.455 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -74.71 -8.85 57.67 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -80.35 -22.21 41.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.523 -0.735 . . . . 0.0 110.961 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.519 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.4 m-85 -98.87 -7.46 27.25 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.066 -1.021 . . . . 0.0 110.332 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 73.4 m -60.51 99.19 0.08 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.249 -0.907 . . . . 0.0 109.813 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.327 0 CA-C-O 118.002 -1.443 . . . . 0.0 109.517 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 N--CA 1.499 1.98 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.41 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 58.6 m -128.64 125.03 37.26 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.346 -0.846 . . . . 0.0 110.331 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 60.59 -135.21 49.65 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.2 m -42.77 -35.14 1.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.619 -0.93 . . . . 0.0 110.645 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.41 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 2.6 t-80 -60.54 -34.04 73.55 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.906 -1.121 . . . . 0.0 108.646 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 8' ' ' GLY . 13.4 tp -73.67 -49.1 27.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 t -59.64 -61.85 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.503 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.5 mt-10 -44.8 -29.1 0.73 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.022 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.31 -60.18 2.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.066 -1.021 . . . . 0.0 109.723 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.9 mt -48.1 -37.09 14.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.935 -1.103 . . . . 0.0 109.441 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -50.62 -40.48 53.09 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.503 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -78.42 -51.51 9.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.933 . . . . 0.0 108.815 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 t -50.03 -53.99 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-O 121.531 0.681 . . . . 0.0 109.202 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.4 m -78.92 -21.98 46.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.594 -0.691 . . . . 0.0 110.205 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.23 -115.44 5.19 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.649 -1.781 . . . . 0.0 108.649 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -85.32 -23.64 28.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.161 -1.199 . . . . 0.0 109.964 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 59' ' ' GLY . 89.2 mtt180 -54.62 -37.89 66.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.976 -1.077 . . . . 0.0 109.175 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.83 164.35 11.91 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 24' ' ' PHE . 9.7 p90 -139.75 173.07 11.9 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.511 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 17.4 p90 -111.04 125.41 53.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.243 -0.911 . . . . 0.0 109.343 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.6 t80 . . . . . 0 N--CA 1.499 1.99 0 O-C-N 121.038 -1.038 . . . . 0.0 109.094 179.918 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.584 ' CG ' HH21 ' A' ' 38' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.32 -26.66 46.9 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.52 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -102.01 -53.9 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.435 -1.038 . . . . 0.0 110.337 -179.577 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.52 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 8.6 t -71.32 -65.17 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.554 -1.341 . . . . 0.0 111.271 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 46' ' ' ARG . 67.9 mt-10 -57.09 -50.65 72.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.921 -1.112 . . . . 0.0 110.369 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.703 HE21 HE22 ' A' ' 53' ' ' GLN . 0.4 OUTLIER -48.46 -53.55 17.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.735 -1.228 . . . . 0.0 109.8 -179.504 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.48 ' O ' ' O ' ' A' ' 47' ' ' SER . 97.6 m -75.7 -52.14 11.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.009 -1.057 . . . . 0.0 110.077 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.4 t -60.61 -52.77 63.72 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.913 -1.117 . . . . 0.0 110.229 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 42' ' ' GLU . 1.9 tmm_? -66.27 -36.49 83.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 0.0 110.027 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 44' ' ' CYS . 15.6 m -135.17 145.17 47.49 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.244 -0.91 . . . . 0.0 109.15 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.7 mt -68.24 99.6 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.134 -0.979 . . . . 0.0 109.472 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.4 p -82.98 141.91 31.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.44 -0.788 . . . . 0.0 109.333 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.7 m -70.19 157.04 38.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.701 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 43.8 mt -52.13 -32.36 35.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.374 -0.829 . . . . 0.0 108.978 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -48.43 -55.48 10.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.835 . . . . 0.0 109.314 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.703 HE22 HE21 ' A' ' 43' ' ' GLN . 22.4 mt-30 -57.79 -50.14 74.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.892 . . . . 0.0 109.188 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.0 mt -55.63 -35.48 65.94 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.115 -0.991 . . . . 0.0 108.675 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -72.41 -8.92 57.54 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.462 0.648 . . . . 0.0 109.322 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -80.04 -21.45 43.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.502 -0.749 . . . . 0.0 111.035 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.527 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.6 m-85 -100.76 -7.15 24.0 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.157 -0.965 . . . . 0.0 110.458 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 77.0 m -60.46 97.59 0.05 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.719 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.417 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 64.1 m -128.54 125.09 37.61 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.272 -0.893 . . . . 0.0 110.675 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 60.34 -136.16 49.6 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.8 m -42.17 -33.97 0.68 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.752 -0.852 . . . . 0.0 110.624 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.417 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 1.0 OUTLIER -61.68 -34.99 76.71 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.841 -1.162 . . . . 0.0 108.83 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 8' ' ' GLY . 12.1 tp -71.26 -49.74 40.02 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.5 t -58.6 -59.8 3.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.5 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 74.2 mt-10 -45.38 -30.15 1.26 Allowed 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.304 -0.559 . . . . 0.0 109.909 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.13 -60.87 1.91 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.152 -0.968 . . . . 0.0 109.694 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 mt -47.27 -36.33 8.99 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.004 -1.06 . . . . 0.0 109.64 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.86 -40.94 61.42 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.429 -0.795 . . . . 0.0 108.857 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.5 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -77.98 -51.71 9.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.164 -0.96 . . . . 0.0 108.871 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.3 t -49.91 -53.76 9.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.7 m -80.39 -22.32 41.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.617 -0.677 . . . . 0.0 110.297 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.84 -116.31 5.32 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.487 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 24.7 mp0 -84.48 -22.02 30.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -1.192 . . . . 0.0 109.699 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -54.96 -37.82 66.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.163 -0.961 . . . . 0.0 109.126 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.1 161.22 8.79 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.511 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 9.1 p90 -138.31 173.31 11.74 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.531 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 6.9 p90 -108.94 123.57 49.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.134 -0.979 . . . . 0.0 109.889 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.3 t80 . . . . . 0 N--CA 1.5 2.037 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.133 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.583 ' CG ' HH21 ' A' ' 38' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 121.681 0.753 . . . . 0.0 109.081 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.01 -31.77 22.45 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.521 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.4 -53.84 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.418 -1.048 . . . . 0.0 110.712 -178.425 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.521 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 4.3 t -69.65 -64.09 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 120.392 -1.443 . . . . 0.0 111.012 -178.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -56.16 -51.15 69.01 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.176 -0.952 . . . . 0.0 110.287 -178.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.534 ' NE2' ' OE1' ' A' ' 53' ' ' GLN . 40.9 tt0 -48.77 -53.96 16.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.633 -1.292 . . . . 0.0 110.063 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 47' ' ' SER . 87.3 m -74.83 -52.81 10.41 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.133 -0.98 . . . . 0.0 109.89 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 54.1 t -60.36 -52.47 65.13 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.062 -1.024 . . . . 0.0 110.341 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 42' ' ' GLU . 2.6 tmm_? -69.15 -34.59 75.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.926 -1.109 . . . . 0.0 110.185 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 44' ' ' CYS . 51.3 m -135.24 146.13 48.31 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.09 -1.006 . . . . 0.0 109.323 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.1 mt -68.66 99.64 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.0 -1.063 . . . . 0.0 109.706 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.5 p -83.77 138.41 33.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.319 -0.863 . . . . 0.0 109.09 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.4 m -69.61 160.2 32.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.264 -0.897 . . . . 0.0 110.162 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.0 mt -53.72 -32.86 53.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.504 -0.748 . . . . 0.0 109.133 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -49.71 -49.58 47.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 108.97 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.534 ' OE1' ' NE2' ' A' ' 43' ' ' GLN . 61.7 mt-30 -63.12 -52.53 62.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.358 -0.839 . . . . 0.0 109.095 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.5 mt -54.92 -35.32 64.06 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.292 -0.88 . . . . 0.0 108.718 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -73.13 -8.87 57.69 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.524 0.678 . . . . 0.0 109.303 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -80.16 -21.68 42.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.437 -0.789 . . . . 0.0 110.926 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.511 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.0 m-85 -100.38 -6.33 25.91 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.172 -0.955 . . . . 0.0 110.474 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.4 m -61.19 97.32 0.06 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.114 -0.991 . . . . 0.0 109.507 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.268 0 CA-C-O 117.993 -1.449 . . . . 0.0 109.517 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.497 1.911 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 68.9 m -129.39 125.06 35.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.255 -0.903 . . . . 0.0 110.377 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.99 -137.78 43.89 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.0 m -42.68 -34.87 0.97 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.648 -0.913 . . . . 0.0 110.412 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -58.1 -35.66 71.75 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.94 -1.1 . . . . 0.0 108.56 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 8' ' ' GLY . 11.0 tp -71.5 -52.49 18.04 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 75.2 t -58.87 -58.95 4.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.493 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 30.2 mt-10 -44.85 -28.75 0.69 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.74 -0.6 . . . . 0.0 109.909 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.8 -61.31 1.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -0.962 . . . . 0.0 109.52 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.5 mt -46.23 -36.58 6.24 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.171 -0.956 . . . . 0.0 109.713 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -51.97 -41.12 61.87 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.387 -0.821 . . . . 0.0 108.807 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.493 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -77.77 -50.95 11.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 0.0 108.863 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.5 t -50.16 -54.66 7.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.2 m -78.61 -22.01 47.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.601 -0.687 . . . . 0.0 110.258 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.92 -116.74 6.44 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 5.1 mp0 -84.77 -21.65 29.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.072 -1.252 . . . . 0.0 109.676 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -54.94 -38.1 67.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.163 -0.961 . . . . 0.0 109.286 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.14 162.11 9.8 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.497 ' CD1' ' N ' ' A' ' 24' ' ' PHE . 8.0 p90 -139.26 172.42 12.85 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.519 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 19.3 p90 -109.1 123.45 49.2 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.4 t80 . . . . . 0 N--CA 1.496 1.86 0 O-C-N 120.939 -1.101 . . . . 0.0 109.839 -179.355 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.603 ' CG ' HH21 ' A' ' 38' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.569 0.699 . . . . 0.0 109.183 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.6 -28.72 38.12 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.9 -51.25 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.442 -1.034 . . . . 0.0 110.18 -179.275 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.5 t -69.73 -65.0 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.521 -1.362 . . . . 0.0 111.237 -178.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 46' ' ' ARG . 61.5 mm-40 -57.5 -47.53 81.66 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.897 -1.127 . . . . 0.0 110.38 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -48.66 -53.65 17.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.682 -1.262 . . . . 0.0 109.565 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.468 ' O ' ' O ' ' A' ' 47' ' ' SER . 96.6 m -78.16 -53.65 7.13 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.211 -0.93 . . . . 0.0 109.965 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.7 t -59.96 -52.49 65.19 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.9 -1.125 . . . . 0.0 110.056 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -68.69 -33.13 73.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -0.952 . . . . 0.0 110.362 -179.172 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 44' ' ' CYS . 7.7 m -136.28 144.93 45.02 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.105 -0.997 . . . . 0.0 109.387 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.412 HD12 HG22 ' A' ' 48' ' ' ILE . 55.0 mt -68.43 99.48 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.013 -1.055 . . . . 0.0 109.272 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.6 p -85.5 141.81 29.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.417 -0.802 . . . . 0.0 109.343 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.3 m -73.04 160.56 31.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.634 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 43.8 mt -53.06 -33.01 50.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 109.342 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -48.43 -56.96 6.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -0.9 . . . . 0.0 109.31 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.517 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 17.0 mt-30 -56.47 -50.53 71.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.209 -0.932 . . . . 0.0 109.018 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.8 mt -56.07 -33.97 65.52 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.136 -0.977 . . . . 0.0 108.543 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -73.85 -9.02 58.23 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -79.98 -21.73 43.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.498 -0.751 . . . . 0.0 111.092 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.517 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.6 m-85 -100.64 -6.14 25.62 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.11 -0.994 . . . . 0.0 110.352 -178.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 73.6 m -62.08 97.05 0.08 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.193 -0.942 . . . . 0.0 109.805 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.304 0 CA-C-O 117.98 -1.456 . . . . 0.0 109.515 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.411 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 57.9 m -130.77 125.23 33.25 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.293 -0.879 . . . . 0.0 110.425 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 61.05 -137.03 48.25 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.3 m -42.36 -31.67 0.43 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.613 -0.934 . . . . 0.0 110.695 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.411 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 6.7 t-160 -64.39 -34.5 78.32 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.777 -1.202 . . . . 0.0 108.665 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 8' ' ' GLY . 9.6 tp -71.09 -49.72 41.42 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 t -57.71 -60.46 2.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 25.7 mt-10 -44.5 -29.93 0.79 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.068 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.6 -60.55 1.99 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.086 -1.009 . . . . 0.0 109.578 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.7 mt -47.05 -37.34 9.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.055 -1.028 . . . . 0.0 109.745 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -50.89 -40.76 57.4 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.496 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -77.82 -50.6 11.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 108.746 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.7 t -50.26 -55.29 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.4 m -79.17 -22.19 45.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.6 -0.687 . . . . 0.0 110.304 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.72 -116.57 6.13 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -85.01 -22.67 28.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.128 -1.219 . . . . 0.0 109.76 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -54.77 -38.35 67.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.15 -0.969 . . . . 0.0 108.843 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.2 162.69 10.61 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 120.094 -1.051 . . . . 0.0 110.747 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 24' ' ' PHE . 7.0 p90 -137.43 172.58 12.76 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.533 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 15.7 p90 -110.89 122.21 47.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 0.0 108.995 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.1 t80 . . . . . 0 N--CA 1.497 1.924 0 O-C-N 120.863 -1.148 . . . . 0.0 108.787 179.9 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.32 -36.09 15.63 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.87 -50.79 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.407 -1.054 . . . . 0.0 110.039 -179.255 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.49 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.3 t -67.73 -64.9 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.57 -1.331 . . . . 0.0 111.802 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 46' ' ' ARG . 31.5 mm-40 -55.72 -53.0 61.99 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.934 -1.104 . . . . 0.0 111.377 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -47.44 -50.13 23.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.651 -1.28 . . . . 0.0 109.973 -178.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 47' ' ' SER . 94.6 m -81.17 -54.4 5.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.995 -1.066 . . . . 0.0 110.186 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 54.0 t -61.51 -47.87 83.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.872 -1.142 . . . . 0.0 110.074 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 42' ' ' GLU . 1.0 OUTLIER -69.79 -36.32 75.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.999 -1.063 . . . . 0.0 109.722 -179.469 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 44' ' ' CYS . 6.9 m -137.27 150.33 47.74 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.062 -1.024 . . . . 0.0 109.733 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.5 mt -68.64 99.74 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.145 -0.972 . . . . 0.0 109.272 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.1 p -83.27 146.21 28.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.388 -0.82 . . . . 0.0 109.817 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.1 m -79.54 166.28 22.09 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.305 -0.872 . . . . 0.0 109.516 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.0 mt -56.49 -31.99 64.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.484 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -48.31 -48.62 35.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.14 -0.975 . . . . 0.0 109.47 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.522 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 19.9 mt-30 -69.16 -53.38 20.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.343 -0.848 . . . . 0.0 109.633 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 98.0 mt -55.12 -35.44 64.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.142 -0.974 . . . . 0.0 109.021 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -73.91 -9.36 58.56 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -78.83 -22.03 46.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.387 -0.82 . . . . 0.0 110.839 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.522 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.2 m-85 -100.28 -6.45 25.92 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.185 -0.947 . . . . 0.0 110.443 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 74.6 m -62.71 96.51 0.09 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.1 -1.0 . . . . 0.0 109.536 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.283 0 CA-C-O 117.984 -1.453 . . . . 0.0 109.523 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 68.0 m -129.74 125.17 35.26 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.189 -0.945 . . . . 0.0 110.65 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 60.66 -139.22 48.1 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 8' ' ' GLY . 70.6 m -39.64 -33.34 0.18 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.856 -0.791 . . . . 0.0 110.71 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -60.91 -39.77 90.62 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.878 -1.139 . . . . 0.0 108.699 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.455 ' N ' ' O ' ' A' ' 8' ' ' GLY . 9.2 tp -65.34 -53.96 35.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.408 -0.807 . . . . 0.0 109.109 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.2 t -55.4 -59.75 2.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.493 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 32.5 mt-10 -44.59 -28.77 0.63 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.698 -0.626 . . . . 0.0 110.126 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.77 -60.51 1.97 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.118 -0.989 . . . . 0.0 109.485 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.3 mt -46.96 -35.76 6.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.102 -0.999 . . . . 0.0 109.552 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -52.36 -40.85 62.52 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.493 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.02 -51.13 10.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 108.867 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.6 t -50.15 -54.1 9.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.3 m -78.44 -22.13 48.11 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.634 -0.666 . . . . 0.0 110.32 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.06 -115.04 4.14 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.519 -1.832 . . . . 0.0 108.519 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -85.41 -23.4 27.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.11 -1.229 . . . . 0.0 109.931 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 59' ' ' GLY . 37.2 mtp180 -54.76 -37.79 66.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -0.982 . . . . 0.0 109.286 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.82 162.73 9.76 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.562 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 24' ' ' PHE . 9.5 p90 -138.85 173.8 11.19 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.548 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 18.5 p90 -110.7 122.15 47.1 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.173 -0.954 . . . . 0.0 110.273 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.1 t80 . . . . . 0 N--CA 1.5 2.052 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.906 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.403 ' HG3' HH21 ' A' ' 38' ' ' ARG . 1.6 ptm180 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.59 -32.45 27.52 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.513 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.77 -51.42 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.479 -1.012 . . . . 0.0 110.121 -179.418 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.513 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 4.1 t -68.79 -64.34 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.649 -1.282 . . . . 0.0 111.409 -178.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 46' ' ' ARG . 68.2 mm-40 -58.26 -53.04 62.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.791 -1.193 . . . . 0.0 110.257 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.473 ' CD ' ' NE2' ' A' ' 53' ' ' GLN . 12.2 tt0 -43.85 -47.48 8.22 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.972 -1.08 . . . . 0.0 110.187 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.451 ' O ' ' O ' ' A' ' 47' ' ' SER . 95.3 m -84.05 -50.47 7.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.036 -1.04 . . . . 0.0 109.933 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.9 t -61.79 -53.12 60.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.243 -0.911 . . . . 0.0 110.472 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 42' ' ' GLU . 7.9 tpp180 -69.68 -39.45 76.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.918 -1.114 . . . . 0.0 109.708 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 44' ' ' CYS . 15.6 m -126.41 144.78 50.72 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.11 -0.993 . . . . 0.0 109.584 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.5 mt -69.38 99.38 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.173 -0.954 . . . . 0.0 109.24 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.5 p -83.85 143.34 29.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.327 -0.858 . . . . 0.0 109.533 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.0 m -73.35 161.25 30.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.86 . . . . 0.0 109.805 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 42.3 mt -55.52 -34.18 64.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.852 . . . . 0.0 109.342 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -48.63 -53.73 17.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.129 -0.982 . . . . 0.0 109.031 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.52 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 38.1 mt-30 -58.69 -51.75 68.6 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.331 -0.856 . . . . 0.0 108.939 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.4 mt -56.69 -30.77 63.78 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -76.29 -8.86 58.0 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -80.51 -22.85 40.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.533 -0.729 . . . . 0.0 110.869 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.52 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 5.7 m-85 -99.35 -7.43 26.27 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.111 -0.993 . . . . 0.0 110.048 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 91.5 m -61.35 93.98 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.386 -0.821 . . . . 0.0 109.722 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.344 0 CA-C-O 118.029 -1.428 . . . . 0.0 109.568 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.493 1.677 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 76.2 m -128.22 125.07 38.24 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.99 0.9 . . . . 0.0 110.839 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.73 -136.85 48.78 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.4 m -42.65 -31.49 0.47 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.605 -0.938 . . . . 0.0 110.484 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.403 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 1.7 t-160 -62.26 -34.0 75.7 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.944 -1.097 . . . . 0.0 108.758 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.0 tp -72.97 -52.57 13.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.438 -0.789 . . . . 0.0 109.015 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.9 t -56.44 -59.64 2.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.484 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.6 mt-10 -44.25 -28.96 0.58 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.804 -0.56 . . . . 0.0 110.222 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.96 -59.8 2.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.132 -0.98 . . . . 0.0 109.602 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 mt -47.21 -36.77 9.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.164 -0.96 . . . . 0.0 109.513 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.32 -41.13 60.34 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.484 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -77.74 -50.09 13.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 108.856 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.5 t -50.44 -54.55 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-O 121.65 0.738 . . . . 0.0 109.029 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.1 m -79.51 -22.77 43.53 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.696 -0.628 . . . . 0.0 110.506 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 50.09 -109.65 0.7 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.48 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 8.9 mp0 -85.48 -25.58 26.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.213 -1.169 . . . . 0.0 110.269 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.429 HH21 ' HG2' ' A' ' 22' ' ' ARG . 31.7 mtt-85 -54.66 -38.68 67.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.955 -1.091 . . . . 0.0 109.309 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.34 161.54 8.02 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 24' ' ' PHE . 9.5 p90 -138.4 173.59 11.44 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.469 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 4.9 p90 -106.25 128.53 54.03 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.209 -0.932 . . . . 0.0 110.012 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.5 t80 . . . . . 0 N--CA 1.506 2.33 0 O-C-N 121.343 -0.848 . . . . 0.0 109.069 179.691 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.485 HH21 ' HG2' ' A' ' 38' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.06 -28.63 40.62 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.514 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -101.1 -54.13 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.475 -1.015 . . . . 0.0 110.283 -179.288 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.514 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.2 t -66.73 -64.83 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.358 -1.464 . . . . 0.0 111.21 -178.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 46' ' ' ARG . 52.5 mm-40 -56.24 -48.55 76.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.919 -1.113 . . . . 0.0 110.08 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -46.98 -55.87 7.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.739 -1.226 . . . . 0.0 109.991 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 47' ' ' SER . 93.6 m -76.94 -52.66 9.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.246 -0.909 . . . . 0.0 110.062 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.8 t -59.47 -52.93 63.48 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.867 -1.145 . . . . 0.0 109.97 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 42' ' ' GLU . 2.7 tmt_? -66.82 -36.3 82.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.289 -0.882 . . . . 0.0 110.235 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 44' ' ' CYS . 16.2 m -134.43 145.25 48.7 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.124 -0.985 . . . . 0.0 109.362 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 57.5 mt -68.21 99.62 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.036 -1.04 . . . . 0.0 109.331 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.8 p -84.93 150.01 25.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.417 -0.802 . . . . 0.0 109.421 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.7 m -88.41 166.17 14.42 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.262 -0.899 . . . . 0.0 110.026 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.1 mt -52.17 -34.25 44.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.421 -0.8 . . . . 0.0 109.519 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -47.52 -43.1 24.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.246 -0.909 . . . . 0.0 109.57 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.512 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 41.8 mt-30 -77.47 -52.33 9.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.374 -0.829 . . . . 0.0 109.792 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 98.7 mt -54.45 -38.08 65.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.031 -1.043 . . . . 0.0 109.007 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -71.0 -9.27 57.72 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 121.544 0.688 . . . . 0.0 109.286 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -78.91 -22.36 45.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 0.0 111.033 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.512 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.7 m-85 -99.98 -8.04 24.39 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.078 -1.013 . . . . 0.0 110.272 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 87.5 m -60.53 94.86 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.511 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 mp . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 86.0 m -128.5 124.98 37.44 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.31 -0.869 . . . . 0.0 110.388 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.56 -137.01 44.63 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 m -42.31 -35.63 1.04 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.707 -0.878 . . . . 0.0 110.568 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -58.49 -35.12 71.71 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.919 -1.113 . . . . 0.0 108.892 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 8' ' ' GLY . 12.7 tp -72.03 -52.52 16.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.332 -0.855 . . . . 0.0 108.826 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 75.1 t -58.44 -59.25 3.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.499 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 85.7 mt-10 -45.12 -29.0 0.82 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.727 -0.608 . . . . 0.0 109.895 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.53 -60.9 1.86 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -0.939 . . . . 0.0 109.559 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.6 mt -46.87 -36.55 7.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.166 -0.958 . . . . 0.0 109.555 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.7 -41.96 61.86 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.408 -0.808 . . . . 0.0 108.842 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.499 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -76.38 -51.84 11.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 108.735 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 t -49.97 -53.78 9.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.547 0.689 . . . . 0.0 109.203 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 m -79.84 -22.38 43.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.471 -0.768 . . . . 0.0 110.471 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.86 -114.22 3.41 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.744 -1.743 . . . . 0.0 108.744 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -85.29 -23.98 27.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.2 -1.176 . . . . 0.0 110.125 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -54.6 -37.69 65.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.966 -1.084 . . . . 0.0 109.359 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.83 162.24 9.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' A' ' 24' ' ' PHE . 9.3 p90 -138.41 173.51 11.52 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 3.8 p90 -107.72 125.41 51.36 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.086 -1.008 . . . . 0.0 110.231 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.5 t80 . . . . . 0 N--CA 1.502 2.165 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.045 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.568 ' CG ' HH21 ' A' ' 38' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.23 -33.05 24.15 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.502 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -101.29 -53.88 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.159 -1.201 . . . . 0.0 110.837 -178.749 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.502 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.7 t -65.93 -63.65 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.454 -1.404 . . . . 0.0 111.402 -177.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' ARG . 71.4 mt-10 -55.46 -51.59 66.43 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.868 -1.145 . . . . 0.0 111.056 -178.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.474 ' NE2' HE22 ' A' ' 53' ' ' GLN . 0.4 OUTLIER -48.21 -52.05 22.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.622 -1.299 . . . . 0.0 110.044 -179.128 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 47' ' ' SER . 85.4 m -78.01 -53.77 7.04 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.962 -1.086 . . . . 0.0 110.013 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 54.0 t -59.86 -52.18 66.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.89 -1.131 . . . . 0.0 109.939 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -67.03 -35.58 80.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 0.0 110.303 -179.396 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 44' ' ' CYS . 26.4 m -136.67 147.2 46.7 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.059 -1.026 . . . . 0.0 109.307 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.9 mt -68.32 99.71 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.045 -1.034 . . . . 0.0 109.554 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.4 p -85.29 138.77 32.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.364 -0.835 . . . . 0.0 109.175 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.0 m -70.1 163.06 27.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.27 -0.894 . . . . 0.0 109.68 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.1 mt -56.61 -31.0 63.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.337 -0.852 . . . . 0.0 108.892 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -48.91 -51.95 27.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 109.177 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.49 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 56.8 mt-30 -62.99 -50.35 71.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.223 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.8 mt -55.09 -36.01 65.2 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.2 -0.938 . . . . 0.0 108.768 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -71.81 -8.98 57.57 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.485 0.659 . . . . 0.0 109.254 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -79.81 -22.5 42.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.422 -0.798 . . . . 0.0 110.958 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.49 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.8 m-85 -100.04 -8.15 24.16 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.069 -1.019 . . . . 0.0 110.209 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 81.6 m -60.39 93.03 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.357 -0.839 . . . . 0.0 109.44 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.284 0 CA-C-O 117.985 -1.453 . . . . 0.0 109.555 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.406 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 63.0 m -130.73 124.57 31.77 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.321 -0.862 . . . . 0.0 109.872 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 63.95 -138.1 41.66 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.6 m -41.69 -35.17 0.72 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.715 -0.873 . . . . 0.0 110.764 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.406 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 7.3 t-160 -59.29 -35.68 74.2 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.878 -1.139 . . . . 0.0 108.89 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 8' ' ' GLY . 8.4 tp -70.18 -52.73 21.12 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.6 t -58.12 -60.38 2.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.489 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 70.9 mt-10 -44.01 -30.17 0.69 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.818 -0.551 . . . . 0.0 110.022 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.9 -61.15 1.85 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.254 -0.904 . . . . 0.0 109.71 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.2 mt -46.1 -36.9 6.22 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.245 -0.909 . . . . 0.0 109.629 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -51.85 -40.43 60.53 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.489 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -78.37 -50.65 11.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 108.761 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.2 t -50.12 -55.02 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.523 0.678 . . . . 0.0 109.362 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.6 m -77.29 -22.34 52.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.556 -0.715 . . . . 0.0 110.615 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.32 -112.59 2.11 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 2.6 mp0 -85.32 -25.11 27.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.226 -1.161 . . . . 0.0 109.972 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -54.44 -38.3 66.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.065 -1.022 . . . . 0.0 109.486 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.15 162.71 8.73 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 24' ' ' PHE . 9.2 p90 -138.48 173.33 11.71 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.544 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 18.8 p90 -111.96 121.68 45.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 109.643 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 13.7 t80 . . . . . 0 N--CA 1.498 1.953 0 O-C-N 121.026 -1.046 . . . . 0.0 108.798 179.27 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.55 -31.01 31.42 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.516 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -101.13 -52.49 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.706 -0.879 . . . . 0.0 110.137 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.516 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.9 t -68.97 -64.76 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.514 -1.366 . . . . 0.0 111.473 -178.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 46' ' ' ARG . 97.4 mt-10 -58.23 -49.32 77.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.913 -1.117 . . . . 0.0 110.534 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -46.75 -49.47 19.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.82 -1.175 . . . . 0.0 109.899 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.486 ' O ' ' O ' ' A' ' 47' ' ' SER . 86.4 m -84.16 -51.84 6.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 110.248 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.3 t -61.57 -48.29 81.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.813 -1.179 . . . . 0.0 109.79 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.542 ' CG ' HH21 ' A' ' 46' ' ' ARG . 0.0 OUTLIER -66.25 -39.11 89.26 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.99 -1.069 . . . . 0.0 109.703 -179.718 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 44' ' ' CYS . 68.8 m -138.61 152.84 48.48 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.143 -0.973 . . . . 0.0 109.719 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.4 mt -68.53 99.46 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.012 -1.055 . . . . 0.0 109.381 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.3 p -80.87 141.28 34.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 0.0 108.891 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 m -70.39 158.87 35.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -0.951 . . . . 0.0 109.912 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 43.3 mt -53.02 -32.25 45.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.442 -0.786 . . . . 0.0 109.187 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -49.5 -52.09 31.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.257 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.492 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 45.7 mt-30 -62.41 -51.32 68.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 109.326 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.8 mt -56.5 -33.23 65.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.093 -1.004 . . . . 0.0 108.437 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -74.37 -8.95 58.01 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -79.65 -22.22 43.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.452 -0.78 . . . . 0.0 110.897 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.492 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.4 m-85 -100.27 -8.17 23.78 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.187 -0.946 . . . . 0.0 110.056 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 93.4 m -60.63 96.2 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.59 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.499 1.994 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.414 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 62.7 m -128.95 124.86 36.19 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.212 -0.93 . . . . 0.0 110.163 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.14 -136.45 45.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -42.01 -35.44 0.89 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.719 -0.871 . . . . 0.0 110.584 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.414 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 0.8 OUTLIER -59.4 -36.28 75.53 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.9 -1.125 . . . . 0.0 108.751 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 8' ' ' GLY . 10.7 tp -70.97 -50.16 37.48 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.9 t -59.36 -60.83 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.498 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.7 mt-10 -44.71 -29.73 0.82 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.919 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.2 -61.11 1.85 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.726 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.2 mt -46.72 -36.95 7.73 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.142 -0.974 . . . . 0.0 109.706 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -51.37 -40.43 59.18 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.498 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.34 -50.74 11.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 108.759 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.487 ' O ' ' NH1' ' A' ' 22' ' ' ARG . 21.1 t -49.98 -54.94 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.7 m -79.81 -22.39 43.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.62 -0.675 . . . . 0.0 110.113 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.74 -115.69 5.19 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.769 -1.733 . . . . 0.0 108.769 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 8.9 mp0 -84.6 -22.14 30.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.187 -1.184 . . . . 0.0 109.67 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.487 ' NH1' ' O ' ' A' ' 18' ' ' VAL . 78.5 mtm180 -55.02 -37.84 67.15 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.152 -0.968 . . . . 0.0 109.253 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.85 160.14 7.59 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.48 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 8.6 p90 -137.77 172.63 12.66 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.523 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 9.2 p90 -109.86 124.81 51.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 109.335 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.7 t80 . . . . . 0 N--CA 1.497 1.918 0 O-C-N 121.045 -1.034 . . . . 0.0 108.703 179.378 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.616 0.722 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.36 -35.74 51.7 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.487 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -101.12 -51.5 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.244 -1.151 . . . . 0.0 110.467 -179.149 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.487 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.5 t -69.56 -64.63 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 120.463 -1.398 . . . . 0.0 111.994 -177.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -55.45 -53.82 51.56 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.849 -1.157 . . . . 0.0 111.028 -177.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.551 HE21 ' C ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -47.19 -49.42 22.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.824 -1.172 . . . . 0.0 109.876 -178.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 47' ' ' SER . 95.1 m -81.14 -54.44 5.53 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.931 -1.105 . . . . 0.0 109.897 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.6 t -60.95 -52.06 66.63 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.922 -1.111 . . . . 0.0 110.102 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -68.89 -33.78 74.34 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.218 -0.926 . . . . 0.0 110.402 -179.031 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 44' ' ' CYS . 25.4 m -136.48 147.63 47.27 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.071 -1.018 . . . . 0.0 109.404 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.5 mt -69.14 99.36 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.088 -1.008 . . . . 0.0 109.125 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.1 p -85.41 146.68 26.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.376 -0.827 . . . . 0.0 109.297 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.3 m -77.62 162.94 26.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.891 . . . . 0.0 109.69 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.5 mt -56.09 -31.76 63.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 0.0 108.969 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -46.9 -54.4 10.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 0.0 109.533 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.534 HE22 ' CD ' ' A' ' 43' ' ' GLN . 16.1 mt-30 -62.36 -50.46 71.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.388 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.3 mt -55.71 -34.14 64.85 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.078 -1.014 . . . . 0.0 108.686 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.487 ' OE2' ' NH2' ' A' ' 22' ' ' ARG . 4.2 tm-20 -74.42 -9.38 58.53 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -79.52 -21.79 44.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.386 -0.822 . . . . 0.0 110.99 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.525 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.9 m-85 -99.17 -7.4 26.63 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.078 -1.014 . . . . 0.0 110.626 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.436 ' O ' ' OXT' ' A' ' 59' ' ' GLY . 78.4 m -59.01 102.17 0.11 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.004 -1.06 . . . . 0.0 109.066 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.492 2.426 0 CA-C-O 117.911 -1.494 . . . . 0.0 109.945 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 mp . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 58.6 m -130.11 124.99 34.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.177 -0.952 . . . . 0.0 110.516 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.82 -137.27 44.08 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.3 m -43.31 -30.95 0.56 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.54 -0.977 . . . . 0.0 110.419 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -63.18 -33.6 75.83 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.97 -1.081 . . . . 0.0 108.811 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 8' ' ' GLY . 9.2 tp -72.12 -51.65 20.42 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 13' ' ' GLU . 76.5 t -58.12 -60.98 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.49 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 29.2 mt-10 -43.55 -29.35 0.46 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.821 -0.549 . . . . 0.0 109.975 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.77 -61.11 1.83 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.435 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.8 mt -46.15 -37.13 6.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.201 -0.937 . . . . 0.0 109.707 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.52 -42.42 61.72 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.407 -0.808 . . . . 0.0 108.842 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.49 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -75.66 -51.23 13.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.281 -0.887 . . . . 0.0 108.763 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.0 t -50.37 -55.1 6.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-O 121.516 0.674 . . . . 0.0 109.337 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.6 m -78.01 -22.31 49.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.481 -0.762 . . . . 0.0 110.613 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.22 -118.38 13.21 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -85.37 -24.9 27.38 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.135 -1.215 . . . . 0.0 110.329 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.586 ' CG ' HH21 ' A' ' 22' ' ' ARG . 2.8 mtt-85 -54.3 -36.66 63.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.946 -1.096 . . . . 0.0 109.303 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.33 166.84 19.98 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 24' ' ' PHE . 7.4 p90 -139.01 172.49 12.76 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.544 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 15.2 p90 -110.19 121.75 46.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.9 . . . . 0.0 109.282 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.0 t80 . . . . . 0 N--CA 1.495 1.809 0 O-C-N 121.069 -1.019 . . . . 0.0 109.666 179.987 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.562 0.696 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.44 -37.54 14.29 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.35 -50.68 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.491 -1.005 . . . . 0.0 109.956 -179.288 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.499 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 4.3 t -69.37 -64.93 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 120.592 -1.317 . . . . 0.0 111.692 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 46' ' ' ARG . 31.3 mm-40 -57.03 -51.87 67.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.804 -1.185 . . . . 0.0 110.262 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.555 ' NE2' HE21 ' A' ' 53' ' ' GLN . 17.5 tt0 -45.6 -48.69 14.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.082 -1.012 . . . . 0.0 110.138 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 47' ' ' SER . 86.2 m -84.08 -53.9 5.21 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.199 -0.938 . . . . 0.0 109.992 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 54.0 t -60.82 -51.59 68.68 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.054 -1.029 . . . . 0.0 110.064 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 42' ' ' GLU . 2.9 tmt_? -68.06 -35.67 78.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.135 -0.978 . . . . 0.0 110.003 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 44' ' ' CYS . 23.2 m -136.52 147.73 47.24 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.15 -0.969 . . . . 0.0 109.331 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 63.4 mt -68.49 99.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.022 -1.049 . . . . 0.0 109.312 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.5 p -82.42 138.1 34.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.431 -0.793 . . . . 0.0 108.993 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 m -68.75 158.87 33.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.777 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.8 mt -53.59 -31.72 48.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.351 -0.843 . . . . 0.0 108.964 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -49.01 -51.91 28.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.408 -0.808 . . . . 0.0 109.23 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.555 HE21 ' NE2' ' A' ' 43' ' ' GLN . 24.4 mt-30 -63.32 -49.41 74.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.234 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.6 mt -56.85 -32.77 66.13 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.015 -1.053 . . . . 0.0 108.249 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -74.55 -9.26 58.41 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -79.76 -22.14 43.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 111.103 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.487 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.5 m-85 -99.5 -4.93 30.2 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.048 -1.033 . . . . 0.0 110.712 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 75.5 m -62.19 102.48 0.3 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.06 -1.025 . . . . 0.0 109.827 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.318 0 CA-C-O 118.026 -1.43 . . . . 0.0 109.557 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.498 1.963 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 58.1 m -129.21 124.94 35.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.374 -0.829 . . . . 0.0 110.056 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.61 -137.36 44.6 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 m -41.5 -35.61 0.74 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.751 -0.852 . . . . 0.0 110.71 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.45 -35.95 75.01 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.899 -1.125 . . . . 0.0 108.817 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' A' ' 8' ' ' GLY . 10.8 tp -71.05 -50.03 38.43 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -59.6 -61.43 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.497 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 81.7 mt-10 -44.38 -29.9 0.76 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.847 -0.533 . . . . 0.0 110.004 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.34 -60.76 1.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.155 -0.966 . . . . 0.0 109.79 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.3 mt -47.01 -36.49 7.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.08 -1.012 . . . . 0.0 109.57 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.7 -40.79 60.77 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.497 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.49 -50.75 11.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 0.0 108.992 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -49.89 -53.48 10.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.538 0.685 . . . . 0.0 109.295 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 m -78.79 -22.32 46.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.596 -0.69 . . . . 0.0 110.585 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.24 -114.07 3.45 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 2.2 mp0 -85.28 -24.03 27.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.174 -1.192 . . . . 0.0 109.974 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -54.66 -38.43 66.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.056 -1.028 . . . . 0.0 109.35 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.33 163.39 9.73 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 24' ' ' PHE . 8.2 p90 -138.37 173.05 12.02 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.529 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 17.6 p90 -111.85 122.61 48.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.29 -0.881 . . . . 0.0 109.54 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.3 t80 . . . . . 0 N--CA 1.497 1.919 0 O-C-N 121.088 -1.007 . . . . 0.0 108.396 179.38 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.482 0.658 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.49 -33.7 24.61 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.33 -51.55 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.463 -1.022 . . . . 0.0 110.044 -179.274 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 3.0 t -69.18 -65.1 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 120.485 -1.384 . . . . 0.0 111.525 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' ARG . 78.1 mm-40 -57.55 -49.19 77.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.834 -1.166 . . . . 0.0 110.556 -178.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -47.53 -51.9 19.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.845 -1.159 . . . . 0.0 109.838 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 47' ' ' SER . 89.2 m -80.69 -52.02 8.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.26 -0.9 . . . . 0.0 110.09 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.8 t -60.42 -52.06 66.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.805 -1.184 . . . . 0.0 109.827 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.516 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -64.56 -38.09 89.81 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.247 -0.908 . . . . 0.0 110.074 -179.383 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 44' ' ' CYS . 39.4 m -137.3 149.16 46.88 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.144 -0.973 . . . . 0.0 109.552 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.2 mt -68.2 99.31 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.062 -1.024 . . . . 0.0 109.448 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.9 p -81.8 140.92 33.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.396 -0.815 . . . . 0.0 108.956 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.5 m -70.18 159.03 34.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 109.717 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 40.7 mt -52.91 -31.65 41.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.37 -0.832 . . . . 0.0 108.999 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -48.24 -53.78 15.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 109.356 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.517 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 47.0 mt-30 -61.52 -50.62 71.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 109.445 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.0 mt -56.06 -35.05 66.49 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.126 -0.984 . . . . 0.0 108.605 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -72.61 -9.58 58.77 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -78.5 -22.57 47.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.31 -0.869 . . . . 0.0 111.039 -178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.517 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.4 m-85 -100.97 -7.03 23.72 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.158 -0.964 . . . . 0.0 110.147 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 96.8 m -62.04 96.34 0.07 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.201 -0.937 . . . . 0.0 109.607 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.33 0 CA-C-O 118.011 -1.438 . . . . 0.0 109.606 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 62.5 m -129.64 124.97 34.98 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.255 -0.903 . . . . 0.0 109.946 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.5 -138.01 42.71 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.7 m -42.69 -34.89 0.98 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.61 -0.935 . . . . 0.0 110.664 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -58.56 -34.27 70.84 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.896 -1.128 . . . . 0.0 109.006 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 tp -72.33 -53.53 12.12 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.2 t -57.05 -58.95 3.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.499 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.9 mt-10 -45.4 -28.81 0.94 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.695 -0.628 . . . . 0.0 109.918 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.62 -61.26 1.77 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.965 . . . . 0.0 109.579 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.7 mt -46.36 -35.03 5.05 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.21 -0.932 . . . . 0.0 109.409 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -53.19 -40.29 64.3 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.499 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -79.44 -51.01 9.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 108.782 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.8 t -49.89 -53.14 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.61 0.719 . . . . 0.0 109.187 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.5 m -79.37 -22.15 44.79 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.619 -0.676 . . . . 0.0 110.592 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 51.69 -115.19 3.65 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -84.89 -21.92 29.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.098 -1.237 . . . . 0.0 109.482 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -54.75 -39.07 67.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 109.191 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.6 160.75 7.73 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 24' ' ' PHE . 9.9 p90 -138.62 173.52 11.5 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.533 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.1 p90 -112.51 121.64 45.4 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.075 -1.016 . . . . 0.0 110.044 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.7 t80 . . . . . 0 N--CA 1.501 2.086 0 O-C-N 121.235 -0.916 . . . . 0.0 109.262 179.769 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.597 ' CG ' HH21 ' A' ' 38' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.56 0.695 . . . . 0.0 109.659 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.23 -33.61 25.6 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.51 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.55 -51.77 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.208 -1.172 . . . . 0.0 110.332 -178.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.51 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 4.4 t -67.54 -64.06 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.662 -1.274 . . . . 0.0 111.709 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 46' ' ' ARG . 53.8 mt-10 -56.93 -54.81 42.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.832 -1.167 . . . . 0.0 110.861 -178.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.667 HE21 ' NE2' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -44.68 -49.74 10.27 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.704 -1.248 . . . . 0.0 110.327 -178.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 47' ' ' SER . 99.5 m -79.63 -50.51 10.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.906 -1.121 . . . . 0.0 110.003 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 47.9 t -61.06 -53.02 62.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.073 -1.017 . . . . 0.0 110.512 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 42' ' ' GLU . 13.0 tpt180 -69.56 -38.44 77.43 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.876 -1.14 . . . . 0.0 109.902 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 44' ' ' CYS . 1.6 m -127.09 144.09 51.12 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.249 -0.907 . . . . 0.0 109.469 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.6 mt -69.14 99.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.059 -1.026 . . . . 0.0 108.901 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.7 p -82.9 141.51 32.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.347 -0.846 . . . . 0.0 109.28 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 m -72.13 163.45 27.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.187 -0.946 . . . . 0.0 109.492 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.7 mt -56.02 -32.34 63.9 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.312 -0.867 . . . . 0.0 109.074 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -47.31 -56.06 7.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.935 . . . . 0.0 109.476 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.667 ' NE2' HE21 ' A' ' 43' ' ' GLN . 24.1 mt-30 -58.91 -51.27 70.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 109.324 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.0 mt -55.49 -35.02 65.11 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.099 -1.001 . . . . 0.0 108.779 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -72.63 -9.11 58.22 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.584 0.707 . . . . 0.0 109.106 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -79.98 -22.16 42.86 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.369 -0.832 . . . . 0.0 111.081 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.499 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.0 m-85 -99.91 -9.3 22.97 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.105 -0.997 . . . . 0.0 109.98 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 88.9 m -60.02 93.13 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.385 -0.822 . . . . 0.0 109.54 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.253 0 CA-C-O 117.974 -1.459 . . . . 0.0 109.727 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.409 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 61.9 m -128.96 124.68 35.7 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.321 -0.862 . . . . 0.0 109.985 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.45 -137.0 44.89 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.2 m -42.13 -36.11 1.09 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.723 -0.869 . . . . 0.0 110.6 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.409 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 0.8 OUTLIER -58.22 -35.51 71.79 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.897 -1.127 . . . . 0.0 108.789 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 8' ' ' GLY . 11.7 tp -71.56 -50.92 26.54 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.1 t -58.94 -59.75 3.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.503 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 24.9 mt-10 -45.17 -30.04 1.08 Allowed 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.862 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.73 -61.05 1.85 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.928 . . . . 0.0 109.74 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.3 mt -46.67 -36.6 7.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.064 -1.023 . . . . 0.0 109.704 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -52.1 -40.49 61.33 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 108.946 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.503 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.52 -50.75 11.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.146 -0.972 . . . . 0.0 108.89 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -49.87 -53.15 11.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 121.556 0.693 . . . . 0.0 109.203 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.0 m -79.95 -22.28 42.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.598 -0.689 . . . . 0.0 110.453 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.73 -115.48 4.96 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -85.02 -23.44 28.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.143 -1.21 . . . . 0.0 109.818 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -54.58 -38.29 66.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.115 -0.99 . . . . 0.0 109.222 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.77 163.02 9.95 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 24' ' ' PHE . 7.8 p90 -138.53 172.17 13.28 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.54 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 14.8 p90 -111.41 120.59 42.67 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.4 t80 . . . . . 0 N--CA 1.492 1.643 0 O-C-N 120.894 -1.129 . . . . 0.0 108.847 -179.649 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.276 0.56 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.28 -40.82 8.87 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.235 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -99.54 -51.39 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.046 -1.267 . . . . 0.0 110.788 -178.123 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.504 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 8.3 t -66.47 -63.61 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.523 -1.36 . . . . 0.0 111.57 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.528 ' N ' ' OE2' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -55.48 -57.07 13.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.935 -1.103 . . . . 0.0 111.106 -178.238 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.7 HE21 HE22 ' A' ' 53' ' ' GLN . 0.1 OUTLIER -43.87 -48.16 8.35 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.934 -1.104 . . . . 0.0 110.515 -178.383 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.446 ' O ' ' O ' ' A' ' 47' ' ' SER . 95.7 m -81.53 -50.88 8.86 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.974 -1.078 . . . . 0.0 110.034 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.0 t -61.38 -52.91 62.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.202 -0.936 . . . . 0.0 110.584 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 42' ' ' GLU . 4.7 tpt180 -69.07 -38.48 79.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.915 -1.115 . . . . 0.0 109.781 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 44' ' ' CYS . 13.0 m -128.93 145.98 51.08 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.188 -0.945 . . . . 0.0 109.714 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.0 mt -69.02 99.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.231 -0.918 . . . . 0.0 109.315 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.1 p -84.09 140.56 31.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.281 -0.887 . . . . 0.0 109.208 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.3 m -71.54 161.31 31.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.728 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.2 mt -54.15 -31.55 52.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.177 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -48.98 -55.65 11.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 0.0 109.298 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.7 HE22 HE21 ' A' ' 43' ' ' GLN . 28.0 mt-30 -58.79 -51.04 71.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 109.242 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.0 mt -55.89 -35.08 66.12 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.134 -0.979 . . . . 0.0 108.559 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -72.63 -9.15 58.26 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.558 0.694 . . . . 0.0 109.181 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -79.7 -22.61 43.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.496 -0.752 . . . . 0.0 110.79 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.473 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.5 m-85 -99.86 -6.83 26.16 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.11 -0.994 . . . . 0.0 110.268 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 82.0 m -62.05 96.13 0.07 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.075 -1.016 . . . . 0.0 109.595 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.495 2.573 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.558 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.497 1.91 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.413 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 60.7 m -129.41 124.98 35.51 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.242 -0.911 . . . . 0.0 110.168 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 61.86 -136.93 46.32 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.1 m -41.64 -34.58 0.62 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.719 -0.871 . . . . 0.0 110.739 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.413 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 0.8 OUTLIER -61.12 -35.36 76.83 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.912 -1.117 . . . . 0.0 108.905 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 8' ' ' GLY . 11.1 tp -71.7 -48.68 45.68 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.7 t -59.82 -61.61 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.493 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 42.6 mt-10 -44.02 -30.28 0.71 Allowed 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.371 -0.531 . . . . 0.0 109.968 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.78 -60.76 1.96 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.181 -0.95 . . . . 0.0 109.989 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.0 mt -47.48 -36.77 10.66 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.975 -1.078 . . . . 0.0 109.465 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -51.15 -40.08 57.76 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.493 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -78.26 -50.92 10.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 108.785 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.1 t -50.23 -54.36 8.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.585 0.707 . . . . 0.0 109.294 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.2 m -79.38 -22.13 44.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.599 -0.688 . . . . 0.0 110.659 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.45 -116.42 7.0 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -85.29 -25.7 27.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.136 -1.214 . . . . 0.0 110.335 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.412 ' O ' ' O ' ' A' ' 59' ' ' GLY . 61.8 mtt180 -54.44 -36.61 64.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.944 -1.097 . . . . 0.0 109.267 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.11 165.91 16.41 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.58 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 24' ' ' PHE . 9.3 p90 -139.0 172.89 12.18 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.513 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 10.8 p90 -110.23 126.68 54.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.181 -0.949 . . . . 0.0 109.073 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.3 t80 . . . . . 0 N--CA 1.498 1.96 0 O-C-N 121.033 -1.042 . . . . 0.0 108.96 179.78 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.402 ' HG3' HH21 ' A' ' 38' ' ' ARG . 2.3 ptm180 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.68 -30.42 32.69 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -101.11 -50.96 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.506 -0.997 . . . . 0.0 110.065 -179.382 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.504 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 3.2 t -69.36 -65.13 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.536 -1.353 . . . . 0.0 111.388 -178.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' ARG . 77.7 mt-10 -57.93 -48.86 78.66 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.808 -1.183 . . . . 0.0 110.377 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -46.64 -50.27 17.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.847 -1.158 . . . . 0.0 109.969 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.474 ' O ' ' O ' ' A' ' 47' ' ' SER . 88.5 m -84.04 -52.71 6.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.268 -0.895 . . . . 0.0 110.208 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.6 t -60.98 -45.36 95.08 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.88 -1.137 . . . . 0.0 110.064 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.549 ' CG ' HH21 ' A' ' 46' ' ' ARG . 0.0 OUTLIER -71.13 -37.46 72.31 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.976 -1.078 . . . . 0.0 109.722 -179.522 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 44' ' ' CYS . 14.4 m -137.77 153.62 49.68 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.172 -0.955 . . . . 0.0 110.011 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.7 mt -68.96 99.41 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.122 -0.986 . . . . 0.0 109.441 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.5 p -84.23 140.27 31.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -0.926 . . . . 0.0 108.925 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.8 m -71.41 161.15 31.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.184 -0.948 . . . . 0.0 109.837 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.7 mt -54.59 -32.56 58.91 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.328 -0.857 . . . . 0.0 109.183 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -48.15 -52.89 18.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.296 -0.877 . . . . 0.0 109.327 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.529 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 39.7 mt-30 -62.43 -51.27 68.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 109.291 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.2 mt -56.15 -32.99 64.79 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.064 -1.023 . . . . 0.0 108.667 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -75.12 -8.83 57.66 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.513 0.673 . . . . 0.0 109.191 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -79.96 -21.93 43.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.453 -0.779 . . . . 0.0 110.874 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.529 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.9 m-85 -99.99 -6.35 26.68 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.17 -0.957 . . . . 0.0 110.458 -178.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.3 m -61.18 99.66 0.1 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.081 -1.012 . . . . 0.0 109.542 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.498 1.954 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 67.7 m -129.58 124.98 35.14 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.29 -0.881 . . . . 0.0 110.378 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.85 -137.27 44.0 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.1 m -42.74 -34.91 1.0 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.612 -0.934 . . . . 0.0 110.55 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -58.94 -34.12 71.38 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.898 -1.126 . . . . 0.0 108.735 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 8' ' ' GLY . 9.2 tp -71.95 -53.54 12.75 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.4 t -57.67 -59.93 2.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.485 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 87.5 mt-10 -43.97 -29.77 0.63 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.808 -0.558 . . . . 0.0 109.985 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.22 -60.95 1.86 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.952 . . . . 0.0 109.468 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.3 mt -46.43 -36.0 6.11 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.203 -0.936 . . . . 0.0 109.647 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -52.7 -40.03 62.56 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.38 -0.825 . . . . 0.0 108.994 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.485 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.85 -51.55 9.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 108.822 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.2 t -49.76 -53.78 9.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.584 0.707 . . . . 0.0 109.231 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.3 m -78.63 -22.23 47.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.564 -0.71 . . . . 0.0 110.272 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.37 -115.54 4.82 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.513 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 4.0 mp0 -84.88 -23.58 28.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -1.162 . . . . 0.0 109.668 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.562 ' CG ' HH21 ' A' ' 22' ' ' ARG . 4.8 mtt-85 -54.31 -38.71 66.27 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.142 -0.974 . . . . 0.0 109.041 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.58 162.87 9.52 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.514 ' CD1' ' N ' ' A' ' 24' ' ' PHE . 8.1 p90 -138.46 173.3 11.74 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.554 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.3 p90 -110.86 120.13 41.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.179 -0.951 . . . . 0.0 109.882 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.6 t80 . . . . . 0 N--CA 1.499 1.983 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.984 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.4 ' HG3' HH21 ' A' ' 38' ' ' ARG . 1.8 ptm180 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.58 -33.32 31.38 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.512 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -101.2 -51.71 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.432 -1.04 . . . . 0.0 109.439 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.512 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 3.0 t -68.65 -65.0 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 120.622 -1.299 . . . . 0.0 111.466 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 46' ' ' ARG . 57.5 mm-40 -58.85 -45.8 89.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.864 -1.148 . . . . 0.0 110.354 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.614 ' NE2' HE21 ' A' ' 53' ' ' GLN . 24.6 tt0 -48.91 -52.59 23.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.57 -1.331 . . . . 0.0 109.652 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.45 ' O ' ' O ' ' A' ' 47' ' ' SER . 91.8 m -79.33 -52.42 8.12 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.259 -0.901 . . . . 0.0 109.82 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.6 t -60.16 -52.23 66.23 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.032 -1.042 . . . . 0.0 109.988 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 42' ' ' GLU . 4.2 tmm_? -68.02 -36.04 79.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.283 -0.886 . . . . 0.0 110.066 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 44' ' ' CYS . 9.2 m -135.23 147.65 49.37 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.052 -1.03 . . . . 0.0 109.576 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.5 mt -68.77 99.56 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.155 -0.966 . . . . 0.0 109.494 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 25.3 p -86.21 138.53 31.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.37 -0.831 . . . . 0.0 109.042 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.4 m -69.53 157.32 37.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 110.0 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.9 mt -51.32 -32.67 26.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.397 -0.815 . . . . 0.0 109.211 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -50.13 -53.62 26.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.374 -0.829 . . . . 0.0 109.125 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.614 HE21 ' NE2' ' A' ' 43' ' ' GLN . 19.8 mt-30 -58.75 -49.17 78.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.89 . . . . 0.0 109.002 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.2 mt -57.07 -34.16 68.0 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -71.91 -9.41 58.31 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -79.05 -22.78 44.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.408 -0.807 . . . . 0.0 111.086 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.439 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.9 m-85 -101.1 -6.9 23.72 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.093 -1.004 . . . . 0.0 110.183 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 86.6 m -61.64 96.06 0.06 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.56 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.42 ' O ' ' O ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.632 ' CG2' ' H ' ' A' ' 3' ' ' ASN . 2.1 p -61.98 -113.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.174 -0.954 . . . . 0.0 108.863 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.632 ' H ' ' CG2' ' A' ' 2' ' ' VAL . 43.3 m-80 -166.13 96.04 0.59 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.891 -1.13 . . . . 0.0 109.072 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.51 ' OE1' ' NE2' ' A' ' 10' ' ' HIS . 3.2 pt20 -161.65 173.3 14.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 109.238 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.59 ' CD2' ' N ' ' A' ' 5' ' ' HIS . 0.0 OUTLIER -77.57 129.97 36.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.343 -0.848 . . . . 0.0 109.422 -179.366 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp -91.27 116.18 28.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.427 -0.795 . . . . 0.0 109.024 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.4 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 63.5 m -129.29 125.03 35.87 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.267 -0.896 . . . . 0.0 110.309 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.77 -136.72 44.09 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.6 m -42.18 -35.46 0.95 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.691 -0.888 . . . . 0.0 110.624 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.51 ' NE2' ' OE1' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -59.74 -35.34 74.37 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.821 -1.174 . . . . 0.0 108.851 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 8' ' ' GLY . 10.5 tp -71.89 -50.1 32.25 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.3 t -59.88 -61.2 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.5 mt-10 -45.06 -29.48 0.88 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.851 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.1 -60.82 1.93 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.157 -0.964 . . . . 0.0 109.715 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.5 mt -47.3 -36.97 10.0 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.028 -1.045 . . . . 0.0 109.562 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -50.72 -40.22 53.76 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.496 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -78.54 -50.67 11.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 108.754 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.1 t -50.19 -54.18 9.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-O 121.555 0.693 . . . . 0.0 109.282 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.4 m -78.71 -22.42 46.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.561 -0.712 . . . . 0.0 110.646 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.69 -113.35 3.44 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -85.68 -29.22 24.15 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.191 -1.182 . . . . 0.0 110.842 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -54.35 -36.72 64.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.884 -1.135 . . . . 0.0 109.412 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.53 167.16 17.5 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.249 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.538 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 8.5 p90 -138.1 173.63 11.42 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.536 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 18.8 p90 -109.0 121.09 44.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 110.36 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.444 ' O ' ' C ' ' A' ' 27' ' ' THR . 8.2 t80 -107.78 145.81 33.06 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.444 ' C ' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -37.43 101.48 0.22 Allowed Pre-proline 0 N--CA 1.504 2.241 0 O-C-N 121.653 -0.655 . . . . 0.0 110.157 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -67.47 -26.27 40.75 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 120.883 1.055 . . . . 0.0 110.372 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.545 ' N ' ' CD ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -154.48 -16.8 0.13 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.123 -0.986 . . . . 0.0 108.922 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.496 ' C ' ' H ' ' A' ' 32' ' ' GLU . 18.0 p -70.45 36.41 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.128 -0.983 . . . . 0.0 109.476 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.536 ' H ' ' C ' ' A' ' 29' ' ' ARG . 35.6 mt-10 -51.24 -10.64 0.09 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.146 -0.972 . . . . 0.0 109.277 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.496 ' H ' ' C ' ' A' ' 30' ' ' THR . 42.5 mm-40 -86.52 -25.36 25.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 109.328 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.89 144.5 7.69 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.7 t -158.82 -137.89 0.05 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.504 -0.998 . . . . 0.0 109.046 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.467 ' HG3' ' H ' ' A' ' 36' ' ' ARG . 17.4 ptt180 -48.44 -56.56 7.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.098 -1.001 . . . . 0.0 109.079 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.574 ' O ' ' N ' ' A' ' 38' ' ' ARG . 37.1 mtt180 -84.63 -142.85 0.08 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.231 -0.918 . . . . 0.0 109.102 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.7 t 56.77 -69.21 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.849 -0.532 . . . . 0.0 110.939 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.574 ' N ' ' O ' ' A' ' 36' ' ' ARG . 17.3 ptt180 -58.21 -12.38 3.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.719 -1.238 . . . . 0.0 108.648 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.52 -35.12 20.84 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.88 -50.32 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.546 -0.973 . . . . 0.0 109.908 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.501 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.4 t -69.47 -65.04 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.53 -1.356 . . . . 0.0 111.329 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 46' ' ' ARG . 69.5 mm-40 -58.64 -47.04 85.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.795 -1.191 . . . . 0.0 110.475 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.504 ' NE2' HE21 ' A' ' 53' ' ' GLN . 19.2 tt0 -48.75 -50.07 35.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.687 -1.258 . . . . 0.0 109.577 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 47' ' ' SER . 84.8 m -81.99 -53.35 6.2 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.165 -0.959 . . . . 0.0 109.851 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.401 ' N ' ' O ' ' A' ' 41' ' ' VAL . 53.2 t -60.04 -50.99 71.55 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.958 -1.089 . . . . 0.0 109.952 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -68.5 -35.74 77.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.082 -1.011 . . . . 0.0 110.049 -179.323 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 44' ' ' CYS . 58.4 m -136.78 148.4 47.19 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.029 -1.045 . . . . 0.0 109.562 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.3 mt -68.6 99.53 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.989 -1.069 . . . . 0.0 109.573 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.7 p -84.2 139.65 32.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 109.026 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 m -71.78 160.67 32.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 109.815 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.3 mt -54.11 -32.55 55.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.344 -0.847 . . . . 0.0 109.191 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -48.75 -46.28 40.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.891 . . . . 0.0 109.306 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.525 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 21.9 mt-30 -69.57 -49.76 51.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.319 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.8 mt -56.25 -33.78 65.75 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.152 -0.967 . . . . 0.0 108.598 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.03 -8.88 57.76 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -79.64 -22.11 43.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.512 -0.743 . . . . 0.0 110.933 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.525 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.1 m-85 -99.99 -7.32 25.24 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.089 -1.007 . . . . 0.0 110.321 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 82.4 m -60.9 98.55 0.07 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.293 -0.88 . . . . 0.0 109.64 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.267 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.503 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 1' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.458 ' C ' ' O ' ' A' ' 1' ' ' PHE . 6.7 m 31.41 -117.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 CA-C-O 121.275 0.559 . . . . 0.0 111.169 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.407 ' N ' ' OD1' ' A' ' 3' ' ' ASN . 11.9 p-10 -153.13 114.22 4.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.286 -0.884 . . . . 0.0 109.169 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -157.92 171.71 19.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.219 -0.925 . . . . 0.0 109.599 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.715 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 2.0 p80 -72.61 129.19 37.7 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.344 -0.847 . . . . 0.0 109.636 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 mp -104.75 116.43 32.02 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.552 -0.718 . . . . 0.0 109.358 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.6 m -128.67 125.09 37.32 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.243 -0.91 . . . . 0.0 110.335 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.29 -137.52 45.36 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -42.26 -34.19 0.74 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.587 -0.949 . . . . 0.0 110.575 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -59.33 -35.74 74.39 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.954 -1.091 . . . . 0.0 108.764 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 8' ' ' GLY . 9.4 tp -71.18 -53.09 15.66 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 13' ' ' GLU . 66.3 t -57.53 -59.95 2.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.494 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 26.7 mt-10 -44.01 -29.92 0.66 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.715 -0.616 . . . . 0.0 110.039 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.7 -60.92 1.88 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 109.523 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.2 mt -46.6 -36.2 6.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.14 -0.975 . . . . 0.0 109.641 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -52.22 -42.06 63.25 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.429 -0.794 . . . . 0.0 108.858 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.494 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -76.94 -51.18 11.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 108.873 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -50.17 -54.24 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.646 -0.659 . . . . 0.0 109.249 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.3 m -78.44 -22.32 47.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.54 -0.725 . . . . 0.0 110.371 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 56.71 -118.44 11.84 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -84.95 -23.63 28.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.148 -1.207 . . . . 0.0 110.034 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.4 mtp180 -54.63 -37.4 65.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.985 -1.072 . . . . 0.0 109.124 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.25 163.97 12.7 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 120.071 -1.062 . . . . 0.0 110.869 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 8.7 p90 -138.54 173.1 11.95 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.52 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.4 p90 -110.19 124.38 51.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.092 -1.005 . . . . 0.0 109.39 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.719 ' O ' ' O ' ' A' ' 27' ' ' THR . 10.8 t80 -102.16 105.15 15.8 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.073 -1.017 . . . . 0.0 109.497 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.719 ' O ' ' O ' ' A' ' 26' ' ' TYR . 5.5 t 37.07 143.15 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.607 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.638 ' O ' ' N ' ' A' ' 30' ' ' THR . 9.8 Cg_endo -66.01 116.73 4.15 Favored 'Trans proline' 0 C--O 1.211 -0.855 0 N-CA-C 108.563 -1.36 . . . . 0.0 108.563 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.567 HH21 ' CG ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER 49.65 -79.1 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.761 -0.587 . . . . 0.0 110.641 178.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.638 ' N ' ' O ' ' A' ' 28' ' ' PRO . 15.3 p -141.62 -150.54 0.32 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.107 -0.996 . . . . 0.0 109.374 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.489 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 2.5 mp0 -57.35 -2.39 0.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.155 -0.966 . . . . 0.0 109.325 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.568 ' H ' ' C ' ' A' ' 30' ' ' THR . 1.4 mm-40 -42.6 -32.65 0.59 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.546 -0.721 . . . . 0.0 109.98 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.76 -173.58 14.49 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.0 t -154.93 -91.48 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -1.143 . . . . 0.0 109.55 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.468 ' HG2' HH21 ' A' ' 35' ' ' ARG . 0.3 OUTLIER -44.04 -56.82 3.73 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.419 -0.801 . . . . 0.0 109.916 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.601 ' O ' ' N ' ' A' ' 38' ' ' ARG . 15.8 mmm180 -63.42 -148.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.092 -1.005 . . . . 0.0 108.902 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.0 t 55.64 -70.7 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.99 -0.444 . . . . 0.0 110.748 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.601 ' N ' ' O ' ' A' ' 36' ' ' ARG . 0.6 OUTLIER -58.24 -14.46 7.24 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.882 -1.136 . . . . 0.0 108.872 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.1 -30.15 35.5 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.517 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -101.38 -52.73 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.52 -0.988 . . . . 0.0 110.185 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.517 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 5.7 t -69.49 -64.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.528 -1.358 . . . . 0.0 111.595 -178.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 46' ' ' ARG . 54.2 mt-10 -57.25 -54.24 48.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.847 -1.158 . . . . 0.0 110.569 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.617 ' NE2' ' NE2' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -44.65 -50.59 9.75 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.874 -1.141 . . . . 0.0 110.096 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.441 ' O ' ' O ' ' A' ' 47' ' ' SER . 99.4 m -79.43 -51.28 9.58 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.903 -1.123 . . . . 0.0 110.126 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.2 t -60.36 -53.25 59.81 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.099 -1.0 . . . . 0.0 110.62 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 42' ' ' GLU . 17.8 tpt180 -71.52 -38.53 71.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.87 -1.144 . . . . 0.0 109.9 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 44' ' ' CYS . 2.1 m -124.51 145.09 49.75 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.115 -0.99 . . . . 0.0 109.893 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.2 mt -69.46 99.35 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.004 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.411 ' CB ' HE22 ' A' ' 43' ' ' GLN . 24.8 p -86.37 142.25 28.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.304 -0.872 . . . . 0.0 109.467 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.7 m -72.22 159.82 33.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.722 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.9 mt -54.86 -31.69 59.94 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.35 -0.844 . . . . 0.0 108.849 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -47.49 -54.67 10.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.363 -0.835 . . . . 0.0 109.352 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.617 ' NE2' ' NE2' ' A' ' 43' ' ' GLN . 48.7 mt-30 -60.09 -49.85 76.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.233 -0.917 . . . . 0.0 109.197 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 98.1 mt -55.57 -34.58 64.9 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.161 -0.962 . . . . 0.0 108.688 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.403 ' CD ' ' O ' ' A' ' 55' ' ' GLU . 5.0 tm-20 -73.45 -9.25 58.5 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.677 0.751 . . . . 0.0 109.059 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -79.67 -21.74 44.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.373 -0.829 . . . . 0.0 111.239 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.508 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.3 m-85 -100.17 -6.31 26.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.087 -1.008 . . . . 0.0 110.534 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 71.4 m -60.9 98.72 0.07 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.17 -0.956 . . . . 0.0 109.695 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.314 0 CA-C-O 117.94 -1.478 . . . . 0.0 109.583 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.609 ' CD1' ' N ' ' A' ' 1' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.0 m -58.93 -169.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.414 -0.804 . . . . 0.0 110.092 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -92.2 117.31 29.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.701 -0.624 . . . . 0.0 109.322 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -162.24 166.74 25.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.203 -0.935 . . . . 0.0 109.414 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.673 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 0.0 OUTLIER -84.37 118.67 24.38 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.224 -0.922 . . . . 0.0 108.946 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp -86.51 116.7 24.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.498 -0.751 . . . . 0.0 109.171 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.408 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 58.9 m -129.75 124.85 34.47 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.289 -0.882 . . . . 0.0 110.2 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 61.43 -136.54 47.45 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -41.93 -34.04 0.63 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.693 -0.886 . . . . 0.0 110.767 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.408 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 1.7 t-80 -62.06 -34.69 76.74 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.757 -1.214 . . . . 0.0 108.808 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 8' ' ' GLY . 11.3 tp -71.7 -49.08 42.78 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.7 t -59.28 -61.46 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.497 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 25.1 mt-10 -44.31 -29.64 0.7 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.346 -0.541 . . . . 0.0 109.949 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.35 -61.23 1.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.164 -0.96 . . . . 0.0 109.74 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.0 mt -46.68 -36.91 7.61 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.123 -0.986 . . . . 0.0 109.613 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -51.11 -41.34 59.95 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.404 -0.81 . . . . 0.0 108.871 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.497 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -77.51 -50.91 11.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.93 . . . . 0.0 108.847 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.2 t -50.18 -54.41 8.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.57 0.7 . . . . 0.0 109.142 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.3 m -79.39 -20.83 46.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.595 -0.69 . . . . 0.0 110.328 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.42 -117.11 6.56 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -84.73 -22.22 29.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.152 -1.205 . . . . 0.0 109.622 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.585 HH21 ' CG ' ' A' ' 22' ' ' ARG . 3.2 mtt-85 -54.59 -38.14 66.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.19 -0.944 . . . . 0.0 109.157 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.95 162.05 9.31 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.078 -1.058 . . . . 0.0 110.501 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 8.0 p90 -137.97 172.57 12.74 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.527 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.1 p90 -111.02 121.76 46.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.33 -0.856 . . . . 0.0 108.977 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -86.93 156.63 19.74 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.972 -1.08 . . . . 0.0 108.962 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.0 t -50.49 143.36 13.93 Favored Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.278 -0.889 . . . . 0.0 108.929 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.651 ' O ' ' N ' ' A' ' 30' ' ' THR . 10.3 Cg_endo -65.54 104.56 0.66 Allowed 'Trans proline' 0 C--N 1.321 -0.896 0 N-CA-C 108.915 -1.225 . . . . 0.0 108.915 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 48.07 -80.13 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.545 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.651 ' N ' ' O ' ' A' ' 28' ' ' PRO . 18.7 p -144.07 -71.73 0.29 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.038 -1.038 . . . . 0.0 109.145 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.532 ' N ' ' OG1' ' A' ' 30' ' ' THR . 11.8 mm-40 44.59 36.07 1.61 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.34 -0.85 . . . . 0.0 110.059 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -53.02 -26.07 14.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.134 -0.979 . . . . 0.0 109.441 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.56 -44.05 37.07 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.437 ' OG ' ' N ' ' A' ' 35' ' ' ARG . 45.5 t -86.51 -162.04 0.72 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.369 -1.077 . . . . 0.0 109.605 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 37' ' ' SER . 5.7 ptp180 -99.1 -111.83 0.17 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.414 -0.804 . . . . 0.0 109.309 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.438 ' O ' ' N ' ' A' ' 39' ' ' GLY . 27.3 mmt180 51.16 -84.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.55 -0.719 . . . . 0.0 110.903 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -41.63 -58.14 2.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.668 -0.645 . . . . 0.0 111.321 -178.475 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -58.9 -13.4 6.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.813 -1.179 . . . . 0.0 109.806 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 36' ' ' ARG . . . -82.48 -40.39 9.99 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.509 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.43 -51.15 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.316 -1.108 . . . . 0.0 110.291 -178.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.509 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.9 t -66.41 -64.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 120.627 -1.296 . . . . 0.0 111.775 -178.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 46' ' ' ARG . 81.9 mt-10 -56.06 -54.14 48.51 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.904 -1.122 . . . . 0.0 111.209 -178.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.682 HE21 HE22 ' A' ' 53' ' ' GLN . 0.0 OUTLIER -45.7 -48.68 15.09 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.849 -1.157 . . . . 0.0 110.141 -178.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.47 ' O ' ' O ' ' A' ' 47' ' ' SER . 85.2 m -82.3 -53.58 5.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.062 -1.024 . . . . 0.0 110.042 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.2 t -60.61 -51.91 67.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.999 -1.063 . . . . 0.0 109.987 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 42' ' ' GLU . 3.7 tmt_? -67.04 -36.62 82.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.186 -0.946 . . . . 0.0 110.025 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 44' ' ' CYS . 68.4 m -136.46 148.17 47.57 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.168 -0.958 . . . . 0.0 109.398 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.6 mt -68.46 99.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.12 -0.988 . . . . 0.0 109.512 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.4 p -83.14 140.48 32.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.407 -0.808 . . . . 0.0 109.217 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 m -70.61 160.96 31.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.208 -0.932 . . . . 0.0 109.527 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.407 ' CD2' ' CZ ' ' A' ' 1' ' ' PHE . 36.9 mt -55.48 -31.32 61.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.233 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -49.51 -51.97 32.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 109.216 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.682 HE22 HE21 ' A' ' 43' ' ' GLN . 18.3 mt-30 -62.32 -50.28 72.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.209 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.3 mt -56.68 -33.18 66.16 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.101 -0.999 . . . . 0.0 108.462 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -74.25 -8.96 58.03 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -79.99 -21.97 43.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.44 -0.787 . . . . 0.0 110.932 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.466 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 8.0 m-85 -99.46 -7.18 26.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.069 -1.019 . . . . 0.0 110.514 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.4 m -60.73 99.14 0.08 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.188 -0.945 . . . . 0.0 109.6 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.271 0 CA-C-O 118.022 -1.432 . . . . 0.0 109.562 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t -82.53 -132.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.054 -1.029 . . . . 0.0 108.459 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -132.01 55.55 1.87 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -118.5 172.44 7.47 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -87.03 139.62 30.39 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.355 -0.84 . . . . 0.0 109.772 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.5 mp -95.0 116.33 28.56 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.507 -0.746 . . . . 0.0 109.222 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.4 m -130.29 125.29 34.38 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.22 -0.925 . . . . 0.0 110.633 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 61.56 -136.5 47.15 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.424 ' O ' ' OE2' ' A' ' 13' ' ' GLU . 57.4 m -43.66 -28.74 0.43 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.518 -0.989 . . . . 0.0 110.548 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -66.61 -32.13 73.27 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.815 -1.178 . . . . 0.0 108.814 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 8' ' ' GLY . 9.7 tp -72.48 -51.58 19.5 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.4 t -58.0 -60.42 2.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.485 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.6 mt-10 -43.77 -29.24 0.5 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.748 -0.595 . . . . 0.0 110.106 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.2 -59.94 2.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.648 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.6 mt -46.94 -37.22 8.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.125 -0.984 . . . . 0.0 109.488 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -50.86 -42.02 58.51 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.485 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -76.88 -50.04 14.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 108.786 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.2 t -50.36 -55.08 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.648 0.737 . . . . 0.0 109.039 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.0 m -78.87 -22.32 46.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.559 -0.713 . . . . 0.0 110.426 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.84 -116.05 6.74 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 2.6 mp0 -85.21 -23.91 28.08 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.191 -1.182 . . . . 0.0 110.062 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.557 HH21 ' CG ' ' A' ' 22' ' ' ARG . 4.7 mtt-85 -54.78 -37.55 66.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.098 -1.001 . . . . 0.0 109.356 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.13 164.14 12.46 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.962 -1.114 . . . . 0.0 110.329 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.529 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 7.3 p90 -138.42 172.75 12.43 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.53 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.7 p90 -111.1 122.56 48.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 109.253 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -90.67 169.01 11.35 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.908 -1.12 . . . . 0.0 108.662 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.9 t -69.44 144.45 94.48 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.092 -1.005 . . . . 0.0 109.055 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.79 -83.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.324 -0.724 0 C-N-CA 121.081 1.187 . . . . 0.0 109.579 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.501 ' O ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -164.93 10.08 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.338 -0.851 . . . . 0.0 109.112 -179.321 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 47.1 p -60.49 80.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 109.608 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 29' ' ' ARG . 36.0 mt-10 -58.78 -10.63 2.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -0.878 . . . . 0.0 109.301 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -77.9 -26.23 49.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -0.862 . . . . 0.0 109.404 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.04 160.89 35.69 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.8 t -155.16 -97.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.284 -1.127 . . . . 0.0 109.079 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.42 ' HG3' ' H ' ' A' ' 36' ' ' ARG . 11.4 ptt180 -133.54 -55.03 0.89 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.39 -0.819 . . . . 0.0 109.094 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -60.36 -62.87 1.54 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 109.621 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 t -42.41 -66.52 0.35 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.888 -0.508 . . . . 0.0 110.183 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.42 HH21 ' HG3' ' A' ' 38' ' ' ARG . 4.2 ptm180 -59.5 -14.4 12.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.984 -1.072 . . . . 0.0 108.675 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 36' ' ' ARG . . . -82.64 -34.0 23.41 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.951 -1.659 . . . . 0.0 108.951 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -101.64 -52.49 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.441 -1.035 . . . . 0.0 110.096 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 3.2 t -67.85 -64.03 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 120.663 -1.273 . . . . 0.0 111.813 -178.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' ARG . 67.2 mm-40 -57.34 -54.85 42.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.824 -1.172 . . . . 0.0 111.339 -177.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.548 ' CD ' HE22 ' A' ' 53' ' ' GLN . 0.0 OUTLIER -45.76 -45.86 14.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.553 -1.342 . . . . 0.0 110.012 -178.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' A' ' 47' ' ' SER . 95.1 m -84.44 -53.2 5.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.964 -1.085 . . . . 0.0 110.103 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.406 ' N ' ' O ' ' A' ' 41' ' ' VAL . 53.7 t -63.05 -44.51 95.65 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.984 -1.072 . . . . 0.0 110.332 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 42' ' ' GLU . 3.5 tmt_? -72.21 -36.37 69.15 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.793 -1.192 . . . . 0.0 109.605 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 44' ' ' CYS . 69.5 m -138.03 153.1 49.4 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.203 -0.935 . . . . 0.0 109.946 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.0 mt -68.97 99.15 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 108.857 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.6 p -83.39 148.46 27.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 109.313 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.8 m -78.76 162.61 26.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.261 -0.9 . . . . 0.0 110.063 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.8 mt -57.13 -33.18 67.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.557 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -48.95 -45.42 41.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.184 -0.948 . . . . 0.0 109.163 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.548 HE22 ' CD ' ' A' ' 43' ' ' GLN . 21.5 mt-30 -69.34 -52.76 24.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.369 -0.832 . . . . 0.0 109.191 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 99.2 mt -55.86 -32.47 63.67 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.029 -1.044 . . . . 0.0 108.654 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -76.08 -9.04 58.3 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.595 0.712 . . . . 0.0 109.225 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -79.85 -21.82 43.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.419 -0.801 . . . . 0.0 110.836 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.531 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.6 m-85 -99.27 -6.91 27.18 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.172 -0.955 . . . . 0.0 110.487 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 71.2 m -60.63 100.96 0.12 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.136 -0.978 . . . . 0.0 109.624 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.299 0 CA-C-O 118.048 -1.418 . . . . 0.0 109.581 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 1' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 1' ' ' PHE . 2.6 m -54.83 -168.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.393 -0.817 . . . . 0.0 109.723 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.427 ' O ' ' OD1' ' A' ' 3' ' ' ASN . 6.4 p30 -117.51 95.82 5.12 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.749 -0.594 . . . . 0.0 109.445 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.529 ' OE1' ' NE2' ' A' ' 10' ' ' HIS . 5.1 pt20 -147.81 177.21 9.51 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.087 -1.008 . . . . 0.0 109.422 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -79.49 125.35 29.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.283 -0.886 . . . . 0.0 110.099 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 mp -91.58 116.82 29.18 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.499 -0.75 . . . . 0.0 109.062 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 82.3 m -129.3 125.2 36.23 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.21 -0.931 . . . . 0.0 110.648 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.74 -137.26 44.25 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 m -42.83 -32.24 0.59 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.599 -0.942 . . . . 0.0 110.576 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.529 ' NE2' ' OE1' ' A' ' 4' ' ' GLN . 4.2 t-80 -61.83 -34.23 75.58 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.852 -1.155 . . . . 0.0 108.877 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 8' ' ' GLY . 10.0 tp -71.76 -52.24 18.65 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.0 t -58.52 -60.06 2.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.5 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 51.5 mt-10 -44.5 -28.98 0.64 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.726 -0.609 . . . . 0.0 109.97 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.15 -61.14 1.82 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.599 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.8 mt -46.47 -36.93 7.12 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.167 -0.958 . . . . 0.0 109.581 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -51.13 -40.82 59.39 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.5 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.1 -50.9 11.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -0.869 . . . . 0.0 108.808 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.1 t -50.26 -54.8 7.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.543 0.687 . . . . 0.0 109.317 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.8 m -77.47 -22.22 51.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.57 -0.707 . . . . 0.0 110.634 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.88 -115.65 5.79 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -85.23 -24.16 27.93 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.194 -1.18 . . . . 0.0 110.077 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.585 HH21 ' CG ' ' A' ' 22' ' ' ARG . 3.4 mtt-85 -54.43 -37.99 65.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.046 -1.034 . . . . 0.0 109.367 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.53 164.02 10.88 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.523 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 7.9 p90 -138.2 172.71 12.51 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.543 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 17.0 p90 -109.11 122.01 46.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -0.925 . . . . 0.0 109.554 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -101.62 169.34 8.9 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.208 -0.933 . . . . 0.0 108.863 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 t -75.57 146.54 80.63 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.067 -1.02 . . . . 0.0 108.752 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -67.0 -61.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.323 -0.769 0 N-CA-C 109.106 -1.151 . . . . 0.0 109.106 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.448 ' O ' ' OG1' ' A' ' 30' ' ' THR . 0.0 OUTLIER -155.57 12.71 0.34 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.919 -1.113 . . . . 0.0 109.14 178.578 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.52 ' C ' ' H ' ' A' ' 32' ' ' GLU . 10.7 p 57.58 -150.61 0.44 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.693 -0.629 . . . . 0.0 109.763 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 52.6 10.2 0.13 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.52 ' H ' ' C ' ' A' ' 30' ' ' THR . 39.6 mt-10 -64.71 -24.24 67.51 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.481 -0.762 . . . . 0.0 109.283 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.95 -36.95 3.59 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.8 t -64.13 -138.61 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.427 -1.043 . . . . 0.0 109.235 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 36' ' ' ARG . 19.8 ptt180 -125.49 -111.12 0.3 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.539 -0.726 . . . . 0.0 109.169 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 38' ' ' ARG . 19.5 mmt180 46.38 -170.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.4 -0.813 . . . . 0.0 109.732 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.406 ' C ' ' H ' ' A' ' 39' ' ' GLY . 7.1 t 59.77 -60.84 0.06 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 122.111 -0.368 . . . . 0.0 111.255 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 36' ' ' ARG . 26.0 ptt180 -58.33 -9.52 1.58 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.484 -1.385 . . . . 0.0 109.037 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 37' ' ' SER . . . -82.78 -36.87 14.59 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.494 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.58 -50.21 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.547 -0.972 . . . . 0.0 109.928 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.494 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.5 t -67.58 -65.09 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.61 -1.306 . . . . 0.0 111.455 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 46' ' ' ARG . 13.9 mm-40 -57.58 -48.84 78.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.847 -1.158 . . . . 0.0 110.426 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.47 ' CD ' ' NE2' ' A' ' 53' ' ' GLN . 23.0 tt0 -46.83 -49.41 20.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.776 -1.202 . . . . 0.0 109.86 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.483 ' O ' ' O ' ' A' ' 47' ' ' SER . 94.9 m -84.58 -53.5 5.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 110.172 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.416 ' N ' ' O ' ' A' ' 41' ' ' VAL . 54.1 t -60.93 -46.17 91.76 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.929 -1.107 . . . . 0.0 110.008 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.505 HH21 ' CG ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -69.87 -38.38 76.37 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.876 -1.14 . . . . 0.0 109.576 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.483 ' O ' ' O ' ' A' ' 44' ' ' CYS . 13.9 m -138.08 153.19 49.31 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.151 -0.968 . . . . 0.0 109.72 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.2 mt -68.6 99.68 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.109 -0.995 . . . . 0.0 109.837 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.7 p -83.34 140.56 32.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 108.918 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.2 m -70.36 157.51 37.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.182 -0.949 . . . . 0.0 109.885 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 48.2 mt -53.54 -33.28 54.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.41 -0.806 . . . . 0.0 109.247 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -50.07 -49.03 52.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 108.968 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.519 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 37.3 mt-30 -63.52 -50.33 70.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.853 . . . . 0.0 108.932 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.3 mt -56.78 -32.8 66.01 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.178 -0.951 . . . . 0.0 108.455 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -74.71 -8.85 57.67 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -80.35 -22.21 41.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.523 -0.735 . . . . 0.0 110.961 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.519 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.4 m-85 -98.87 -7.46 27.25 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.066 -1.021 . . . . 0.0 110.332 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 73.4 m -60.51 99.19 0.08 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.249 -0.907 . . . . 0.0 109.813 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.327 0 CA-C-O 118.002 -1.443 . . . . 0.0 109.517 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.48 ' CG ' ' O ' ' A' ' 1' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.3 m -144.69 -109.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -70.04 67.83 0.3 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.325 -0.859 . . . . 0.0 109.458 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.48 ' OE1' ' NE2' ' A' ' 10' ' ' HIS . 11.6 pt20 -152.64 140.76 20.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.16 -0.962 . . . . 0.0 109.566 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.723 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 1.6 p80 -66.29 153.98 41.18 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.393 -0.817 . . . . 0.0 109.395 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.07 117.24 26.71 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.41 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 58.6 m -128.64 125.03 37.26 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.346 -0.846 . . . . 0.0 110.331 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 60.59 -135.21 49.65 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.2 m -42.77 -35.14 1.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.619 -0.93 . . . . 0.0 110.645 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.48 ' NE2' ' OE1' ' A' ' 4' ' ' GLN . 2.6 t-80 -60.54 -34.04 73.55 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.906 -1.121 . . . . 0.0 108.646 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 8' ' ' GLY . 13.4 tp -73.67 -49.1 27.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 t -59.64 -61.85 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.503 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.5 mt-10 -44.8 -29.1 0.73 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.022 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.31 -60.18 2.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.066 -1.021 . . . . 0.0 109.723 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.9 mt -48.1 -37.09 14.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.935 -1.103 . . . . 0.0 109.441 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -50.62 -40.48 53.09 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.503 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -78.42 -51.51 9.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.933 . . . . 0.0 108.815 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 t -50.03 -53.99 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-O 121.531 0.681 . . . . 0.0 109.202 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.4 m -78.92 -21.98 46.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.594 -0.691 . . . . 0.0 110.205 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.23 -115.44 5.19 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.649 -1.781 . . . . 0.0 108.649 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -85.32 -23.64 28.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.161 -1.199 . . . . 0.0 109.964 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 59' ' ' GLY . 89.2 mtt180 -54.62 -37.89 66.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.976 -1.077 . . . . 0.0 109.175 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.83 164.35 11.91 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 9.7 p90 -139.75 173.07 11.9 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.511 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 17.4 p90 -111.04 125.41 53.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.243 -0.911 . . . . 0.0 109.343 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -91.78 159.47 15.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.038 -1.038 . . . . 0.0 109.094 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.533 ' C ' ' H ' ' A' ' 29' ' ' ARG . 6.2 t -44.16 146.58 1.1 Allowed Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.367 -0.833 . . . . 0.0 109.698 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.624 ' C ' ' H ' ' A' ' 30' ' ' THR . 8.8 Cg_endo -68.88 21.29 0.15 Allowed 'Trans proline' 0 N--CA 1.481 0.785 0 C-N-CA 121.598 1.532 . . . . 0.0 110.225 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.533 ' H ' ' C ' ' A' ' 27' ' ' THR . 14.7 mmm180 64.09 -17.96 0.07 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.395 -0.816 . . . . 0.0 110.359 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.624 ' H ' ' C ' ' A' ' 28' ' ' PRO . 17.3 p -49.48 99.68 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.176 -0.952 . . . . 0.0 109.345 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -65.1 -8.68 17.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.881 . . . . 0.0 109.681 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -64.83 -26.74 68.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 109.568 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.33 156.96 16.68 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.1 t -155.3 -130.42 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -1.158 . . . . 0.0 109.281 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.477 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 7.8 ptm180 -98.71 -56.82 2.34 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.287 -0.883 . . . . 0.0 109.216 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.577 ' O ' ' N ' ' A' ' 38' ' ' ARG . 18.0 mtm-85 -70.65 -144.22 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.225 -0.922 . . . . 0.0 109.49 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.5 t 57.16 -69.7 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.895 -0.503 . . . . 0.0 110.639 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.584 ' CG ' HH21 ' A' ' 38' ' ' ARG . 0.0 OUTLIER -58.29 -16.18 13.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.825 -1.172 . . . . 0.0 108.677 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.32 -26.66 46.9 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.52 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -102.01 -53.9 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.435 -1.038 . . . . 0.0 110.337 -179.577 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.52 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 8.6 t -71.32 -65.17 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.554 -1.341 . . . . 0.0 111.271 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 46' ' ' ARG . 67.9 mt-10 -57.09 -50.65 72.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.921 -1.112 . . . . 0.0 110.369 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.703 HE21 HE22 ' A' ' 53' ' ' GLN . 0.4 OUTLIER -48.46 -53.55 17.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.735 -1.228 . . . . 0.0 109.8 -179.504 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.48 ' O ' ' O ' ' A' ' 47' ' ' SER . 97.6 m -75.7 -52.14 11.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.009 -1.057 . . . . 0.0 110.077 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.4 t -60.61 -52.77 63.72 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.913 -1.117 . . . . 0.0 110.229 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 42' ' ' GLU . 1.9 tmm_? -66.27 -36.49 83.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 0.0 110.027 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 44' ' ' CYS . 15.6 m -135.17 145.17 47.49 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.244 -0.91 . . . . 0.0 109.15 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.7 mt -68.24 99.6 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.134 -0.979 . . . . 0.0 109.472 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.4 p -82.98 141.91 31.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.44 -0.788 . . . . 0.0 109.333 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.7 m -70.19 157.04 38.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.701 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 43.8 mt -52.13 -32.36 35.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.374 -0.829 . . . . 0.0 108.978 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -48.43 -55.48 10.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.835 . . . . 0.0 109.314 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.703 HE22 HE21 ' A' ' 43' ' ' GLN . 22.4 mt-30 -57.79 -50.14 74.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.892 . . . . 0.0 109.188 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.0 mt -55.63 -35.48 65.94 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.115 -0.991 . . . . 0.0 108.675 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -72.41 -8.92 57.54 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.462 0.648 . . . . 0.0 109.322 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -80.04 -21.45 43.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.502 -0.749 . . . . 0.0 111.035 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.527 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.6 m-85 -100.76 -7.15 24.0 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.157 -0.965 . . . . 0.0 110.458 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 77.0 m -60.46 97.59 0.05 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.719 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.42 ' O ' ' O ' ' A' ' 2' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 1' ' ' PHE . 3.6 m -53.62 -169.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.443 -0.786 . . . . 0.0 110.406 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -70.99 89.21 0.78 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.641 -0.662 . . . . 0.0 109.416 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.537 ' CD ' ' HE2' ' A' ' 10' ' ' HIS . 19.5 pt20 -149.12 165.58 31.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.297 -0.877 . . . . 0.0 109.143 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.657 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 0.0 OUTLIER -84.79 125.47 32.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.287 -0.883 . . . . 0.0 109.227 -179.52 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 mp -84.15 116.33 22.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.422 -0.799 . . . . 0.0 108.903 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.417 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 64.1 m -128.54 125.09 37.61 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.272 -0.893 . . . . 0.0 110.675 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 60.34 -136.16 49.6 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.8 m -42.17 -33.97 0.68 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.752 -0.852 . . . . 0.0 110.624 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.537 ' HE2' ' CD ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -61.68 -34.99 76.71 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.841 -1.162 . . . . 0.0 108.83 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 8' ' ' GLY . 12.1 tp -71.26 -49.74 40.02 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.5 t -58.6 -59.8 3.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.5 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 74.2 mt-10 -45.38 -30.15 1.26 Allowed 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.304 -0.559 . . . . 0.0 109.909 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.13 -60.87 1.91 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.152 -0.968 . . . . 0.0 109.694 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 mt -47.27 -36.33 8.99 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.004 -1.06 . . . . 0.0 109.64 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.86 -40.94 61.42 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.429 -0.795 . . . . 0.0 108.857 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.5 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -77.98 -51.71 9.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.164 -0.96 . . . . 0.0 108.871 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.3 t -49.91 -53.76 9.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.7 m -80.39 -22.32 41.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.617 -0.677 . . . . 0.0 110.297 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.84 -116.31 5.32 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.487 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 24.7 mp0 -84.48 -22.02 30.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -1.192 . . . . 0.0 109.699 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -54.96 -37.82 66.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.163 -0.961 . . . . 0.0 109.126 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.1 161.22 8.79 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.511 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 9.1 p90 -138.31 173.31 11.74 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.531 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 6.9 p90 -108.94 123.57 49.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.134 -0.979 . . . . 0.0 109.889 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -100.98 161.82 13.33 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.6 t -50.08 144.69 10.59 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.854 -1.154 . . . . 0.0 108.385 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -55.13 -86.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 120.815 1.01 . . . . 0.0 109.97 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.46 23.95 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.241 -0.912 . . . . 0.0 109.211 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.9 p -81.15 107.28 13.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.404 -0.81 . . . . 0.0 110.096 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -89.26 -15.47 33.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.354 -0.842 . . . . 0.0 108.913 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -69.15 -33.25 73.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.374 -0.829 . . . . 0.0 109.095 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.61 147.61 9.96 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.492 ' HG ' ' H ' ' A' ' 35' ' ' ARG . 38.7 t -101.28 -167.51 1.43 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.382 -1.069 . . . . 0.0 109.901 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.492 ' H ' ' HG ' ' A' ' 34' ' ' SER . 21.7 ptt180 -148.3 -117.53 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 38' ' ' ARG . 5.4 mtt-85 -52.14 -44.55 64.6 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.493 -0.755 . . . . 0.0 110.143 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 36' ' ' ARG . 0.7 OUTLIER -26.49 -35.19 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.518 -178.325 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.583 ' CG ' HH21 ' A' ' 38' ' ' ARG . 0.1 OUTLIER -58.27 -15.86 11.83 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.673 -1.267 . . . . 0.0 109.081 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.01 -31.77 22.45 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.521 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.4 -53.84 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.418 -1.048 . . . . 0.0 110.712 -178.425 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.521 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 4.3 t -69.65 -64.09 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 120.392 -1.443 . . . . 0.0 111.012 -178.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -56.16 -51.15 69.01 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.176 -0.952 . . . . 0.0 110.287 -178.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.534 ' NE2' ' OE1' ' A' ' 53' ' ' GLN . 40.9 tt0 -48.77 -53.96 16.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.633 -1.292 . . . . 0.0 110.063 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 47' ' ' SER . 87.3 m -74.83 -52.81 10.41 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.133 -0.98 . . . . 0.0 109.89 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 54.1 t -60.36 -52.47 65.13 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.062 -1.024 . . . . 0.0 110.341 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 42' ' ' GLU . 2.6 tmm_? -69.15 -34.59 75.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.926 -1.109 . . . . 0.0 110.185 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 44' ' ' CYS . 51.3 m -135.24 146.13 48.31 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.09 -1.006 . . . . 0.0 109.323 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.1 mt -68.66 99.64 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.0 -1.063 . . . . 0.0 109.706 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.5 p -83.77 138.41 33.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.319 -0.863 . . . . 0.0 109.09 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.4 m -69.61 160.2 32.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.264 -0.897 . . . . 0.0 110.162 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.0 mt -53.72 -32.86 53.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.504 -0.748 . . . . 0.0 109.133 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -49.71 -49.58 47.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 108.97 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.534 ' OE1' ' NE2' ' A' ' 43' ' ' GLN . 61.7 mt-30 -63.12 -52.53 62.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.358 -0.839 . . . . 0.0 109.095 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.5 mt -54.92 -35.32 64.06 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.292 -0.88 . . . . 0.0 108.718 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -73.13 -8.87 57.69 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.524 0.678 . . . . 0.0 109.303 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -80.16 -21.68 42.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.437 -0.789 . . . . 0.0 110.926 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.511 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.0 m-85 -100.38 -6.33 25.91 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.172 -0.955 . . . . 0.0 110.474 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.4 m -61.19 97.32 0.06 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.114 -0.991 . . . . 0.0 109.507 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.268 0 CA-C-O 117.993 -1.449 . . . . 0.0 109.517 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 1' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 1' ' ' PHE . 2.7 m -54.89 -169.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.313 -0.867 . . . . 0.0 109.686 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 3' ' ' ASN . 0.8 OUTLIER -86.9 131.29 34.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.577 -0.702 . . . . 0.0 109.236 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -171.06 164.75 7.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.506 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.712 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 0.4 OUTLIER -79.02 126.44 30.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.326 -0.859 . . . . 0.0 109.152 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.6 mp -100.26 117.11 33.8 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.521 -0.737 . . . . 0.0 109.421 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 68.9 m -129.39 125.06 35.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.255 -0.903 . . . . 0.0 110.377 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.99 -137.78 43.89 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.0 m -42.68 -34.87 0.97 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.648 -0.913 . . . . 0.0 110.412 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -58.1 -35.66 71.75 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.94 -1.1 . . . . 0.0 108.56 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 8' ' ' GLY . 11.0 tp -71.5 -52.49 18.04 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 75.2 t -58.87 -58.95 4.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.493 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 30.2 mt-10 -44.85 -28.75 0.69 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.74 -0.6 . . . . 0.0 109.909 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.8 -61.31 1.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -0.962 . . . . 0.0 109.52 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.5 mt -46.23 -36.58 6.24 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.171 -0.956 . . . . 0.0 109.713 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -51.97 -41.12 61.87 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.387 -0.821 . . . . 0.0 108.807 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.493 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -77.77 -50.95 11.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 0.0 108.863 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.5 t -50.16 -54.66 7.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.2 m -78.61 -22.01 47.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.601 -0.687 . . . . 0.0 110.258 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.92 -116.74 6.44 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 5.1 mp0 -84.77 -21.65 29.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.072 -1.252 . . . . 0.0 109.676 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -54.94 -38.1 67.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.163 -0.961 . . . . 0.0 109.286 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.14 162.11 9.8 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.497 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 8.0 p90 -139.26 172.42 12.85 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.519 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 19.3 p90 -109.1 123.45 49.2 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -90.44 162.12 15.23 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.939 -1.101 . . . . 0.0 109.839 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.2 t -41.82 147.2 0.54 Allowed Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.865 -0.522 . . . . 0.0 109.663 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.602 ' C ' ' H ' ' A' ' 30' ' ' THR . 10.0 Cg_exo -46.71 130.47 15.31 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 N-CA-C 109.284 -1.083 . . . . 0.0 109.284 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.518 ' H ' ' HD2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -68.43 18.79 0.03 OUTLIER 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.307 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.602 ' H ' ' C ' ' A' ' 28' ' ' PRO . 26.2 p -104.67 -16.8 14.87 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 50.51 17.19 0.35 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.39 -0.819 . . . . 0.0 109.696 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -75.36 -42.34 54.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.222 -0.924 . . . . 0.0 109.391 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.69 149.55 5.02 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.45 ' OG ' ' N ' ' A' ' 35' ' ' ARG . 44.0 t -160.62 -136.26 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.372 -1.075 . . . . 0.0 109.708 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.53 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 2.1 ptp180 -141.81 -51.69 0.42 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.32 -0.863 . . . . 0.0 109.094 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.554 ' CB ' HH21 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -59.31 -49.09 79.16 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.242 -0.911 . . . . 0.0 109.674 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.9 t -37.67 -65.41 0.32 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.491 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.603 ' CG ' HH21 ' A' ' 38' ' ' ARG . 0.0 OUTLIER -58.56 -15.58 11.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.76 -1.213 . . . . 0.0 109.183 -179.141 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 36' ' ' ARG . . . -82.6 -28.72 38.12 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.9 -51.25 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.442 -1.034 . . . . 0.0 110.18 -179.275 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.5 t -69.73 -65.0 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.521 -1.362 . . . . 0.0 111.237 -178.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 46' ' ' ARG . 61.5 mm-40 -57.5 -47.53 81.66 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.897 -1.127 . . . . 0.0 110.38 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -48.66 -53.65 17.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.682 -1.262 . . . . 0.0 109.565 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.468 ' O ' ' O ' ' A' ' 47' ' ' SER . 96.6 m -78.16 -53.65 7.13 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.211 -0.93 . . . . 0.0 109.965 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.7 t -59.96 -52.49 65.19 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.9 -1.125 . . . . 0.0 110.056 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -68.69 -33.13 73.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -0.952 . . . . 0.0 110.362 -179.172 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 44' ' ' CYS . 7.7 m -136.28 144.93 45.02 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.105 -0.997 . . . . 0.0 109.387 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.412 HD12 HG22 ' A' ' 48' ' ' ILE . 55.0 mt -68.43 99.48 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.013 -1.055 . . . . 0.0 109.272 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.6 p -85.5 141.81 29.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.417 -0.802 . . . . 0.0 109.343 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.3 m -73.04 160.56 31.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.634 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 43.8 mt -53.06 -33.01 50.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 109.342 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -48.43 -56.96 6.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -0.9 . . . . 0.0 109.31 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.517 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 17.0 mt-30 -56.47 -50.53 71.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.209 -0.932 . . . . 0.0 109.018 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.8 mt -56.07 -33.97 65.52 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.136 -0.977 . . . . 0.0 108.543 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -73.85 -9.02 58.23 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -79.98 -21.73 43.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.498 -0.751 . . . . 0.0 111.092 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.517 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.6 m-85 -100.64 -6.14 25.62 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.11 -0.994 . . . . 0.0 110.352 -178.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 73.6 m -62.08 97.05 0.08 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.193 -0.942 . . . . 0.0 109.805 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.304 0 CA-C-O 117.98 -1.456 . . . . 0.0 109.515 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.457 ' CG2' HE21 ' A' ' 4' ' ' GLN . 19.9 m -155.34 -153.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -83.6 90.53 7.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.027 -1.045 . . . . 0.0 109.052 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.526 ' OE1' ' NE2' ' A' ' 10' ' ' HIS . 4.9 pt20 -156.87 149.67 23.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 109.683 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.624 ' CD2' ' N ' ' A' ' 5' ' ' HIS . 0.0 OUTLIER -85.27 127.07 34.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.277 -0.89 . . . . 0.0 109.017 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 mp -88.7 116.47 26.98 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.386 -0.821 . . . . 0.0 109.329 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.411 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 57.9 m -130.77 125.23 33.25 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.293 -0.879 . . . . 0.0 110.425 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 61.05 -137.03 48.25 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.3 m -42.36 -31.67 0.43 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.613 -0.934 . . . . 0.0 110.695 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.526 ' NE2' ' OE1' ' A' ' 4' ' ' GLN . 6.7 t-160 -64.39 -34.5 78.32 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.777 -1.202 . . . . 0.0 108.665 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 8' ' ' GLY . 9.6 tp -71.09 -49.72 41.42 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 t -57.71 -60.46 2.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 25.7 mt-10 -44.5 -29.93 0.79 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.068 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.6 -60.55 1.99 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.086 -1.009 . . . . 0.0 109.578 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.7 mt -47.05 -37.34 9.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.055 -1.028 . . . . 0.0 109.745 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -50.89 -40.76 57.4 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.496 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -77.82 -50.6 11.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 108.746 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.7 t -50.26 -55.29 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.4 m -79.17 -22.19 45.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.6 -0.687 . . . . 0.0 110.304 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.72 -116.57 6.13 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -85.01 -22.67 28.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.128 -1.219 . . . . 0.0 109.76 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -54.77 -38.35 67.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.15 -0.969 . . . . 0.0 108.843 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.2 162.69 10.61 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 120.094 -1.051 . . . . 0.0 110.747 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 7.0 p90 -137.43 172.58 12.76 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.533 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 15.7 p90 -110.89 122.21 47.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 0.0 108.995 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.538 ' O ' ' C ' ' A' ' 27' ' ' THR . 9.1 t80 -91.97 108.69 20.11 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.863 -1.148 . . . . 0.0 108.787 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.538 ' C ' ' O ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -8.12 80.52 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.47 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.422 ' N ' ' O ' ' A' ' 26' ' ' TYR . 6.1 Cg_exo -61.81 -8.39 11.4 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 N-CA-C 108.012 -1.572 . . . . 0.0 108.012 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.579 ' N ' ' CD ' ' A' ' 29' ' ' ARG . 6.6 mpt_? -81.37 -25.88 35.96 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.64 ' C ' ' H ' ' A' ' 32' ' ' GLU . 1.4 p 51.05 -164.23 0.05 Allowed 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.465 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -67.54 25.64 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.05 -1.031 . . . . 0.0 109.528 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.64 ' H ' ' C ' ' A' ' 30' ' ' THR . 1.5 mm-40 -94.57 -33.17 13.13 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.94 -136.21 8.94 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.2 t -166.98 -69.96 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.066 -1.255 . . . . 0.0 110.373 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.428 ' HG3' ' H ' ' A' ' 36' ' ' ARG . 9.8 ptm180 -40.12 -55.53 2.09 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.912 -0.493 . . . . 0.0 110.894 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 38' ' ' ARG . 23.6 mmt180 -72.55 -165.58 0.21 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.075 -1.015 . . . . 0.0 109.919 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.6 t 59.41 -63.29 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 122.182 -0.324 . . . . 0.0 111.303 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.516 ' N ' ' O ' ' A' ' 36' ' ' ARG . 15.5 ptm180 -58.08 -13.55 5.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.512 -1.368 . . . . 0.0 108.916 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.32 -36.09 15.63 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.87 -50.79 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.407 -1.054 . . . . 0.0 110.039 -179.255 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.49 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.3 t -67.73 -64.9 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.57 -1.331 . . . . 0.0 111.802 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 46' ' ' ARG . 31.5 mm-40 -55.72 -53.0 61.99 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.934 -1.104 . . . . 0.0 111.377 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.518 ' O ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -47.44 -50.13 23.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.651 -1.28 . . . . 0.0 109.973 -178.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 47' ' ' SER . 94.6 m -81.17 -54.4 5.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.995 -1.066 . . . . 0.0 110.186 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 54.0 t -61.51 -47.87 83.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.872 -1.142 . . . . 0.0 110.074 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 42' ' ' GLU . 1.0 OUTLIER -69.79 -36.32 75.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.999 -1.063 . . . . 0.0 109.722 -179.469 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 44' ' ' CYS . 6.9 m -137.27 150.33 47.74 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.062 -1.024 . . . . 0.0 109.733 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.5 mt -68.64 99.74 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.145 -0.972 . . . . 0.0 109.272 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.1 p -83.27 146.21 28.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.388 -0.82 . . . . 0.0 109.817 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.1 m -79.54 166.28 22.09 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.305 -0.872 . . . . 0.0 109.516 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.0 mt -56.49 -31.99 64.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.484 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -48.31 -48.62 35.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.14 -0.975 . . . . 0.0 109.47 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.522 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 19.9 mt-30 -69.16 -53.38 20.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.343 -0.848 . . . . 0.0 109.633 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 98.0 mt -55.12 -35.44 64.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.142 -0.974 . . . . 0.0 109.021 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -73.91 -9.36 58.56 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -78.83 -22.03 46.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.387 -0.82 . . . . 0.0 110.839 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.522 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.2 m-85 -100.28 -6.45 25.92 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.185 -0.947 . . . . 0.0 110.443 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 74.6 m -62.71 96.51 0.09 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.1 -1.0 . . . . 0.0 109.536 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.283 0 CA-C-O 117.984 -1.453 . . . . 0.0 109.523 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.468 ' CA ' HE21 ' A' ' 4' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.462 ' H ' ' H1 ' ' A' ' 1' ' ' PHE . 27.0 m -59.25 -149.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.367 -0.833 . . . . 0.0 110.328 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.483 ' OD1' ' CD1' ' A' ' 48' ' ' ILE . 18.1 t-20 -74.7 94.93 2.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.576 -0.702 . . . . 0.0 109.421 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.468 HE21 ' CA ' ' A' ' 1' ' ' PHE . 11.4 pt20 -152.3 153.68 34.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.208 -0.933 . . . . 0.0 109.277 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.679 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 0.0 OUTLIER -86.52 124.2 32.57 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.21 -0.932 . . . . 0.0 109.022 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 mp -86.96 116.74 25.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.398 -0.814 . . . . 0.0 109.36 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 68.0 m -129.74 125.17 35.26 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.189 -0.945 . . . . 0.0 110.65 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 60.66 -139.22 48.1 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 8' ' ' GLY . 70.6 m -39.64 -33.34 0.18 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.856 -0.791 . . . . 0.0 110.71 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -60.91 -39.77 90.62 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.878 -1.139 . . . . 0.0 108.699 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.455 ' N ' ' O ' ' A' ' 8' ' ' GLY . 9.2 tp -65.34 -53.96 35.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.408 -0.807 . . . . 0.0 109.109 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.2 t -55.4 -59.75 2.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.493 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 32.5 mt-10 -44.59 -28.77 0.63 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.698 -0.626 . . . . 0.0 110.126 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.77 -60.51 1.97 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.118 -0.989 . . . . 0.0 109.485 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.3 mt -46.96 -35.76 6.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.102 -0.999 . . . . 0.0 109.552 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -52.36 -40.85 62.52 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.493 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.02 -51.13 10.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 108.867 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.6 t -50.15 -54.1 9.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.3 m -78.44 -22.13 48.11 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.634 -0.666 . . . . 0.0 110.32 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.06 -115.04 4.14 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.519 -1.832 . . . . 0.0 108.519 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -85.41 -23.4 27.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.11 -1.229 . . . . 0.0 109.931 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 59' ' ' GLY . 37.2 mtp180 -54.76 -37.79 66.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -0.982 . . . . 0.0 109.286 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.82 162.73 9.76 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.562 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.502 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 9.5 p90 -138.85 173.8 11.19 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.548 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 18.5 p90 -110.7 122.15 47.1 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.173 -0.954 . . . . 0.0 110.273 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -107.38 169.52 8.52 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 t -71.5 146.7 91.86 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 120.944 -1.097 . . . . 0.0 108.484 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -55.72 -79.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.32 -0.952 0 C-N-CA 120.99 1.127 . . . . 0.0 109.724 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.31 0.97 0.06 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.406 -0.809 . . . . 0.0 108.966 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.72 125.15 35.17 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.353 -0.842 . . . . 0.0 109.435 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -80.61 -2.12 45.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.304 -0.872 . . . . 0.0 109.291 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 33' ' ' GLY . 66.9 mm-40 -54.08 -49.01 70.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.912 . . . . 0.0 109.009 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 32' ' ' GLU . . . 59.9 143.3 0.01 OUTLIER Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 35' ' ' ARG . 86.6 p -109.59 -106.61 0.35 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.588 -0.948 . . . . 0.0 109.033 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.516 HH11 ' NH1' ' A' ' 36' ' ' ARG . 0.4 OUTLIER -92.69 -56.15 3.11 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.355 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.582 ' O ' ' N ' ' A' ' 38' ' ' ARG . 15.2 mtt-85 -63.34 -137.01 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.295 -0.878 . . . . 0.0 109.184 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.7 t 54.57 -77.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.576 -0.702 . . . . 0.0 110.165 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.582 ' N ' ' O ' ' A' ' 36' ' ' ARG . 1.6 ptm180 -58.39 -15.21 9.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.011 -1.055 . . . . 0.0 108.513 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.59 -32.45 27.52 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.513 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.77 -51.42 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.479 -1.012 . . . . 0.0 110.121 -179.418 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.513 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 4.1 t -68.79 -64.34 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.649 -1.282 . . . . 0.0 111.409 -178.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 46' ' ' ARG . 68.2 mm-40 -58.26 -53.04 62.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.791 -1.193 . . . . 0.0 110.257 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.473 ' CD ' ' NE2' ' A' ' 53' ' ' GLN . 12.2 tt0 -43.85 -47.48 8.22 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.972 -1.08 . . . . 0.0 110.187 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.451 ' O ' ' O ' ' A' ' 47' ' ' SER . 95.3 m -84.05 -50.47 7.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.036 -1.04 . . . . 0.0 109.933 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.9 t -61.79 -53.12 60.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.243 -0.911 . . . . 0.0 110.472 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 42' ' ' GLU . 7.9 tpp180 -69.68 -39.45 76.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.918 -1.114 . . . . 0.0 109.708 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 44' ' ' CYS . 15.6 m -126.41 144.78 50.72 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.11 -0.993 . . . . 0.0 109.584 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.483 ' CD1' ' OD1' ' A' ' 3' ' ' ASN . 17.5 mt -69.38 99.38 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.173 -0.954 . . . . 0.0 109.24 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.5 p -83.85 143.34 29.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.327 -0.858 . . . . 0.0 109.533 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.0 m -73.35 161.25 30.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.86 . . . . 0.0 109.805 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 42.3 mt -55.52 -34.18 64.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.852 . . . . 0.0 109.342 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -48.63 -53.73 17.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.129 -0.982 . . . . 0.0 109.031 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.52 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 38.1 mt-30 -58.69 -51.75 68.6 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.331 -0.856 . . . . 0.0 108.939 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.4 mt -56.69 -30.77 63.78 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -76.29 -8.86 58.0 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -80.51 -22.85 40.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.533 -0.729 . . . . 0.0 110.869 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.52 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 5.7 m-85 -99.35 -7.43 26.27 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.111 -0.993 . . . . 0.0 110.048 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 91.5 m -61.35 93.98 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.386 -0.821 . . . . 0.0 109.722 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.344 0 CA-C-O 118.029 -1.428 . . . . 0.0 109.568 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.517 ' CG2' HE21 ' A' ' 4' ' ' GLN . 1.2 m -151.87 -105.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.456 ' N ' ' ND2' ' A' ' 3' ' ' ASN . 0.6 OUTLIER -141.39 80.11 1.72 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.465 -0.772 . . . . 0.0 108.955 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.522 ' OE1' ' CE1' ' A' ' 10' ' ' HIS . 16.1 pt20 -150.45 167.47 27.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.35 -0.844 . . . . 0.0 109.659 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.644 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 0.0 OUTLIER -92.43 126.42 37.5 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.391 -0.818 . . . . 0.0 108.968 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 mp -85.22 117.05 23.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.345 -0.847 . . . . 0.0 109.121 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 76.2 m -128.22 125.07 38.24 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.99 0.9 . . . . 0.0 110.839 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.73 -136.85 48.78 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.4 m -42.65 -31.49 0.47 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.605 -0.938 . . . . 0.0 110.484 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.522 ' CE1' ' OE1' ' A' ' 4' ' ' GLN . 1.7 t-160 -62.26 -34.0 75.7 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.944 -1.097 . . . . 0.0 108.758 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.0 tp -72.97 -52.57 13.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.438 -0.789 . . . . 0.0 109.015 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.9 t -56.44 -59.64 2.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.484 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.6 mt-10 -44.25 -28.96 0.58 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.804 -0.56 . . . . 0.0 110.222 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.96 -59.8 2.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.132 -0.98 . . . . 0.0 109.602 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 mt -47.21 -36.77 9.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.164 -0.96 . . . . 0.0 109.513 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.32 -41.13 60.34 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.484 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -77.74 -50.09 13.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 108.856 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.5 t -50.44 -54.55 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-O 121.65 0.738 . . . . 0.0 109.029 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.1 m -79.51 -22.77 43.53 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.696 -0.628 . . . . 0.0 110.506 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 50.09 -109.65 0.7 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.48 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 8.9 mp0 -85.48 -25.58 26.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.213 -1.169 . . . . 0.0 110.269 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.429 ' HG2' HH21 ' A' ' 22' ' ' ARG . 31.7 mtt-85 -54.66 -38.68 67.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.955 -1.091 . . . . 0.0 109.309 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.34 161.54 8.02 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 9.5 p90 -138.4 173.59 11.44 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.469 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 4.9 p90 -106.25 128.53 54.03 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.209 -0.932 . . . . 0.0 110.012 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.47 ' O ' ' C ' ' A' ' 27' ' ' THR . 3.5 t80 -116.17 124.45 50.33 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.343 -0.848 . . . . 0.0 109.069 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.47 ' C ' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER 29.91 84.42 0.16 Allowed Pre-proline 0 N--CA 1.509 2.524 0 O-C-N 121.924 -0.485 . . . . 0.0 111.027 179.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -76.43 -9.17 18.74 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 121.706 1.604 . . . . 0.0 109.688 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.483 ' O ' ' OG1' ' A' ' 30' ' ' THR . 0.1 OUTLIER -172.12 24.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.459 179.694 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.631 ' HG1' ' H ' ' A' ' 32' ' ' GLU . 9.8 p 58.75 157.32 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.595 -0.691 . . . . 0.0 109.596 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.545 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 3.0 mp0 -69.65 13.34 0.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.175 -0.953 . . . . 0.0 108.667 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.631 ' H ' ' HG1' ' A' ' 30' ' ' THR . 10.8 mm-40 -77.95 -25.41 48.24 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.673 -0.642 . . . . 0.0 109.5 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -94.7 -117.09 2.93 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 33' ' ' GLY . 44.4 t -60.15 -117.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.402 -1.058 . . . . 0.0 109.644 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.57 ' CG ' ' H ' ' A' ' 36' ' ' ARG . 0.6 OUTLIER -141.83 -104.62 0.14 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.178 -0.951 . . . . 0.0 109.691 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.57 ' H ' ' CG ' ' A' ' 35' ' ' ARG . 75.6 mtt180 42.33 -150.42 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.703 -0.623 . . . . 0.0 109.776 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 t 58.4 -65.17 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.948 -0.47 . . . . 0.0 110.806 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.57 ' N ' ' O ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -57.73 -12.12 2.73 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.821 -1.174 . . . . 0.0 108.61 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.06 -28.63 40.62 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.514 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -101.1 -54.13 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.475 -1.015 . . . . 0.0 110.283 -179.288 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.514 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.2 t -66.73 -64.83 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.358 -1.464 . . . . 0.0 111.21 -178.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 46' ' ' ARG . 52.5 mm-40 -56.24 -48.55 76.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.919 -1.113 . . . . 0.0 110.08 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -46.98 -55.87 7.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.739 -1.226 . . . . 0.0 109.991 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 47' ' ' SER . 93.6 m -76.94 -52.66 9.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.246 -0.909 . . . . 0.0 110.062 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.8 t -59.47 -52.93 63.48 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.867 -1.145 . . . . 0.0 109.97 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 42' ' ' GLU . 2.7 tmt_? -66.82 -36.3 82.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.289 -0.882 . . . . 0.0 110.235 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 44' ' ' CYS . 16.2 m -134.43 145.25 48.7 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.124 -0.985 . . . . 0.0 109.362 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 57.5 mt -68.21 99.62 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.036 -1.04 . . . . 0.0 109.331 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.8 p -84.93 150.01 25.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.417 -0.802 . . . . 0.0 109.421 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.7 m -88.41 166.17 14.42 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.262 -0.899 . . . . 0.0 110.026 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.1 mt -52.17 -34.25 44.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.421 -0.8 . . . . 0.0 109.519 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -47.52 -43.1 24.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.246 -0.909 . . . . 0.0 109.57 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.512 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 41.8 mt-30 -77.47 -52.33 9.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.374 -0.829 . . . . 0.0 109.792 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 98.7 mt -54.45 -38.08 65.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.031 -1.043 . . . . 0.0 109.007 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -71.0 -9.27 57.72 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 121.544 0.688 . . . . 0.0 109.286 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -78.91 -22.36 45.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 0.0 111.033 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.512 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.7 m-85 -99.98 -8.04 24.39 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.078 -1.013 . . . . 0.0 110.272 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 87.5 m -60.53 94.86 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.511 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 1' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.459 ' CG2' HE21 ' A' ' 4' ' ' GLN . 35.9 m -61.37 -140.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.858 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -138.03 110.93 7.7 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.39 -0.819 . . . . 0.0 109.348 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.53 ' CD ' ' HE2' ' A' ' 10' ' ' HIS . 14.7 pt20 -157.24 178.19 10.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.284 -0.885 . . . . 0.0 109.224 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.654 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 0.0 OUTLIER -78.26 117.01 19.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.206 -0.934 . . . . 0.0 109.354 -179.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 mp -86.76 116.72 25.04 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 86.0 m -128.5 124.98 37.44 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.31 -0.869 . . . . 0.0 110.388 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.56 -137.01 44.63 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 m -42.31 -35.63 1.04 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.707 -0.878 . . . . 0.0 110.568 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.53 ' HE2' ' CD ' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -58.49 -35.12 71.71 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.919 -1.113 . . . . 0.0 108.892 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 8' ' ' GLY . 12.7 tp -72.03 -52.52 16.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.332 -0.855 . . . . 0.0 108.826 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 75.1 t -58.44 -59.25 3.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.499 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 85.7 mt-10 -45.12 -29.0 0.82 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.727 -0.608 . . . . 0.0 109.895 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.53 -60.9 1.86 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -0.939 . . . . 0.0 109.559 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.6 mt -46.87 -36.55 7.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.166 -0.958 . . . . 0.0 109.555 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.7 -41.96 61.86 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.408 -0.808 . . . . 0.0 108.842 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.499 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -76.38 -51.84 11.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 108.735 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 t -49.97 -53.78 9.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.547 0.689 . . . . 0.0 109.203 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 m -79.84 -22.38 43.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.471 -0.768 . . . . 0.0 110.471 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.86 -114.22 3.41 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.744 -1.743 . . . . 0.0 108.744 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -85.29 -23.98 27.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.2 -1.176 . . . . 0.0 110.125 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -54.6 -37.69 65.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.966 -1.084 . . . . 0.0 109.359 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.83 162.24 9.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.516 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 9.3 p90 -138.41 173.51 11.52 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 3.8 p90 -107.72 125.41 51.36 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.086 -1.008 . . . . 0.0 110.231 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.442 ' O ' ' C ' ' A' ' 27' ' ' THR . 2.5 t80 -107.15 171.14 7.54 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.442 ' C ' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -39.42 113.11 0.81 Allowed Pre-proline 0 N--CA 1.505 2.281 0 O-C-N 121.322 -0.862 . . . . 0.0 109.566 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.44 5.91 1.4 Allowed 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 120.879 1.052 . . . . 0.0 110.534 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.42 -50.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.082 -1.011 . . . . 0.0 110.315 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.23 122.87 0.1 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.975 -1.078 . . . . 0.0 110.038 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -5.56 12.73 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 33' ' ' GLY . 9.0 mt-10 -83.1 -29.1 29.01 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.642 -0.661 . . . . 0.0 109.402 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 32' ' ' GLU . . . -55.73 -108.39 0.01 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.6 t -78.97 -138.93 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -1.157 . . . . 0.0 110.037 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.635 HH12 ' NH2' ' A' ' 38' ' ' ARG . 1.4 ptm180 -97.11 -119.43 0.12 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.395 -0.816 . . . . 0.0 109.457 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.589 ' C ' ' H ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER 47.15 -173.25 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.259 -0.901 . . . . 0.0 110.06 179.746 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.9 t 59.13 -25.33 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.622 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.635 ' NH2' HH12 ' A' ' 35' ' ' ARG . 0.0 OUTLIER -75.21 -11.9 60.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.318 -1.489 . . . . 0.0 109.079 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.23 -33.05 24.15 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.502 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -101.29 -53.88 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.159 -1.201 . . . . 0.0 110.837 -178.749 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.502 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.7 t -65.93 -63.65 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.454 -1.404 . . . . 0.0 111.402 -177.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' ARG . 71.4 mt-10 -55.46 -51.59 66.43 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.868 -1.145 . . . . 0.0 111.056 -178.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.474 ' NE2' HE22 ' A' ' 53' ' ' GLN . 0.4 OUTLIER -48.21 -52.05 22.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.622 -1.299 . . . . 0.0 110.044 -179.128 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 47' ' ' SER . 85.4 m -78.01 -53.77 7.04 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.962 -1.086 . . . . 0.0 110.013 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 54.0 t -59.86 -52.18 66.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.89 -1.131 . . . . 0.0 109.939 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -67.03 -35.58 80.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 0.0 110.303 -179.396 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 44' ' ' CYS . 26.4 m -136.67 147.2 46.7 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.059 -1.026 . . . . 0.0 109.307 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.9 mt -68.32 99.71 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.045 -1.034 . . . . 0.0 109.554 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.4 p -85.29 138.77 32.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.364 -0.835 . . . . 0.0 109.175 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.0 m -70.1 163.06 27.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.27 -0.894 . . . . 0.0 109.68 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.1 mt -56.61 -31.0 63.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.337 -0.852 . . . . 0.0 108.892 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -48.91 -51.95 27.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 109.177 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.49 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 56.8 mt-30 -62.99 -50.35 71.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.223 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.8 mt -55.09 -36.01 65.2 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.2 -0.938 . . . . 0.0 108.768 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -71.81 -8.98 57.57 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.485 0.659 . . . . 0.0 109.254 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -79.81 -22.5 42.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.422 -0.798 . . . . 0.0 110.958 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.49 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.8 m-85 -100.04 -8.15 24.16 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.069 -1.019 . . . . 0.0 110.209 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 81.6 m -60.39 93.03 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.357 -0.839 . . . . 0.0 109.44 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.284 0 CA-C-O 117.985 -1.453 . . . . 0.0 109.555 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.443 ' O ' ' C ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.489 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 0.7 OUTLIER 33.1 -94.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 122.125 -0.359 . . . . 0.0 110.659 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.489 ' N ' ' CG2' ' A' ' 2' ' ' VAL . 0.3 OUTLIER 171.32 88.34 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.014 -1.054 . . . . 0.0 108.853 179.396 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -146.66 165.26 30.11 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.223 -0.923 . . . . 0.0 109.536 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -83.91 129.99 34.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.394 -0.816 . . . . 0.0 109.078 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 mp -91.86 116.08 28.61 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.26 -0.9 . . . . 0.0 109.793 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.406 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 63.0 m -130.73 124.57 31.77 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.321 -0.862 . . . . 0.0 109.872 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 63.95 -138.1 41.66 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.6 m -41.69 -35.17 0.72 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.715 -0.873 . . . . 0.0 110.764 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.406 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 7.3 t-160 -59.29 -35.68 74.2 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.878 -1.139 . . . . 0.0 108.89 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 8' ' ' GLY . 8.4 tp -70.18 -52.73 21.12 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.6 t -58.12 -60.38 2.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.489 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 70.9 mt-10 -44.01 -30.17 0.69 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.818 -0.551 . . . . 0.0 110.022 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.9 -61.15 1.85 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.254 -0.904 . . . . 0.0 109.71 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.2 mt -46.1 -36.9 6.22 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.245 -0.909 . . . . 0.0 109.629 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -51.85 -40.43 60.53 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.489 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -78.37 -50.65 11.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 108.761 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.2 t -50.12 -55.02 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.523 0.678 . . . . 0.0 109.362 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.6 m -77.29 -22.34 52.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.556 -0.715 . . . . 0.0 110.615 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.32 -112.59 2.11 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 2.6 mp0 -85.32 -25.11 27.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.226 -1.161 . . . . 0.0 109.972 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -54.44 -38.3 66.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.065 -1.022 . . . . 0.0 109.486 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.15 162.71 8.73 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 9.2 p90 -138.48 173.33 11.71 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.544 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 18.8 p90 -111.96 121.68 45.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 109.643 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.521 ' O ' ' C ' ' A' ' 27' ' ' THR . 13.7 t80 -101.58 108.04 19.48 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.026 -1.046 . . . . 0.0 108.798 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.521 ' C ' ' O ' ' A' ' 26' ' ' TYR . 9.7 t -18.87 85.6 0.04 OUTLIER Pre-proline 0 N--CA 1.507 2.408 0 C-N-CA 122.474 0.31 . . . . 0.0 111.547 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.587 ' C ' ' H ' ' A' ' 30' ' ' THR . 2.2 Cg_endo -62.9 98.48 0.2 Allowed 'Trans proline' 0 C--N 1.316 -1.18 0 N-CA-C 109.619 -0.954 . . . . 0.0 109.619 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.493 ' O ' ' N ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER 61.42 -36.07 0.1 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.402 0.62 . . . . 0.0 111.715 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.587 ' H ' ' C ' ' A' ' 28' ' ' PRO . 21.5 p -53.89 86.05 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.908 0 O-C-N 121.46 -0.775 . . . . 0.0 110.435 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 29' ' ' ARG . 51.3 mm-40 -94.41 4.91 53.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.253 -0.904 . . . . 0.0 109.038 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -87.56 -23.21 24.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.434 -0.791 . . . . 0.0 109.875 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.14 150.95 0.16 Allowed Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -100.56 -74.23 0.62 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.404 -1.057 . . . . 0.0 109.984 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.439 ' HG3' ' H ' ' A' ' 36' ' ' ARG . 3.2 ptp180 -62.06 -56.98 13.45 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.343 -0.848 . . . . 0.0 109.961 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 38' ' ' ARG . 7.9 mtt-85 -57.01 -163.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.134 -0.979 . . . . 0.0 110.598 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 t 47.71 -87.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.737 -0.602 . . . . 0.0 110.447 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 36' ' ' ARG . 9.9 ptm180 -58.56 -17.18 19.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.036 -1.04 . . . . 0.0 108.814 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.55 -31.01 31.42 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.516 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -101.13 -52.49 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.706 -0.879 . . . . 0.0 110.137 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.516 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.9 t -68.97 -64.76 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.514 -1.366 . . . . 0.0 111.473 -178.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 46' ' ' ARG . 97.4 mt-10 -58.23 -49.32 77.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.913 -1.117 . . . . 0.0 110.534 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -46.75 -49.47 19.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.82 -1.175 . . . . 0.0 109.899 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.486 ' O ' ' O ' ' A' ' 47' ' ' SER . 86.4 m -84.16 -51.84 6.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 110.248 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.3 t -61.57 -48.29 81.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.813 -1.179 . . . . 0.0 109.79 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.542 HH21 ' CG ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -66.25 -39.11 89.26 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.99 -1.069 . . . . 0.0 109.703 -179.718 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 44' ' ' CYS . 68.8 m -138.61 152.84 48.48 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.143 -0.973 . . . . 0.0 109.719 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.4 mt -68.53 99.46 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.012 -1.055 . . . . 0.0 109.381 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.3 p -80.87 141.28 34.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 0.0 108.891 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 m -70.39 158.87 35.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -0.951 . . . . 0.0 109.912 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 43.3 mt -53.02 -32.25 45.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.442 -0.786 . . . . 0.0 109.187 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -49.5 -52.09 31.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.257 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.492 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 45.7 mt-30 -62.41 -51.32 68.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 109.326 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.8 mt -56.5 -33.23 65.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.093 -1.004 . . . . 0.0 108.437 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -74.37 -8.95 58.01 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -79.65 -22.22 43.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.452 -0.78 . . . . 0.0 110.897 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.492 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.4 m-85 -100.27 -8.17 23.78 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.187 -0.946 . . . . 0.0 110.056 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 93.4 m -60.63 96.2 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.59 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 1' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 1' ' ' PHE . 3.6 m -54.49 -171.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.339 -0.85 . . . . 0.0 109.899 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.641 ' N ' HD21 ' A' ' 3' ' ' ASN . 0.3 OUTLIER -95.1 112.53 24.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.57 -0.706 . . . . 0.0 109.097 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.515 ' OE1' ' NE2' ' A' ' 10' ' ' HIS . 2.8 pt20 -151.51 164.99 35.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 109.528 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.728 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 1.4 p80 -72.78 136.32 45.43 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.238 -0.914 . . . . 0.0 109.219 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 mp -113.27 115.94 28.96 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.684 -0.635 . . . . 0.0 109.295 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.414 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 62.7 m -128.95 124.86 36.19 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.212 -0.93 . . . . 0.0 110.163 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.14 -136.45 45.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -42.01 -35.44 0.89 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.719 -0.871 . . . . 0.0 110.584 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.515 ' NE2' ' OE1' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -59.4 -36.28 75.53 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.9 -1.125 . . . . 0.0 108.751 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 8' ' ' GLY . 10.7 tp -70.97 -50.16 37.48 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.9 t -59.36 -60.83 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.498 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.7 mt-10 -44.71 -29.73 0.82 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.919 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.2 -61.11 1.85 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.726 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.2 mt -46.72 -36.95 7.73 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.142 -0.974 . . . . 0.0 109.706 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -51.37 -40.43 59.18 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.498 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.34 -50.74 11.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 108.759 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.487 ' O ' ' NH1' ' A' ' 22' ' ' ARG . 21.1 t -49.98 -54.94 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.7 m -79.81 -22.39 43.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.62 -0.675 . . . . 0.0 110.113 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.74 -115.69 5.19 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.769 -1.733 . . . . 0.0 108.769 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 8.9 mp0 -84.6 -22.14 30.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.187 -1.184 . . . . 0.0 109.67 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.487 ' NH1' ' O ' ' A' ' 18' ' ' VAL . 78.5 mtm180 -55.02 -37.84 67.15 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.152 -0.968 . . . . 0.0 109.253 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.85 160.14 7.59 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.48 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 8.6 p90 -137.77 172.63 12.66 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.523 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 9.2 p90 -109.86 124.81 51.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 109.335 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -97.55 160.25 14.43 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.045 -1.034 . . . . 0.0 108.703 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.1 t -65.67 134.77 95.42 Favored Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 121.147 -0.971 . . . . 0.0 108.714 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.625 ' O ' ' N ' ' A' ' 30' ' ' THR . 9.2 Cg_endo -66.68 122.67 10.11 Favored 'Trans proline' 0 C--O 1.211 -0.843 0 N-CA-C 109.193 -1.118 . . . . 0.0 109.193 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.456 HH21 ' CB ' ' A' ' 28' ' ' PRO . 4.7 mpt_? 51.68 -79.41 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.437 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.625 ' N ' ' O ' ' A' ' 28' ' ' PRO . 0.3 OUTLIER -168.61 88.15 0.21 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.958 -1.089 . . . . 0.0 109.956 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 33' ' ' GLY . 46.4 mm-40 -78.89 28.55 0.21 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.089 -1.007 . . . . 0.0 108.315 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.511 ' H ' ' C ' ' A' ' 30' ' ' THR . 75.8 mt-10 -42.77 -25.66 0.1 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.617 -0.677 . . . . 0.0 109.895 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -61.83 -84.6 0.06 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -55.4 -166.48 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.521 -0.988 . . . . 0.0 109.764 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' A' ' 37' ' ' SER . 1.9 ptp180 -90.25 -109.51 0.09 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.449 -0.782 . . . . 0.0 109.628 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.538 ' CG ' HH21 ' A' ' 36' ' ' ARG . 3.5 mtt-85 46.2 -85.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.468 0.651 . . . . 0.0 110.849 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 35' ' ' ARG . 2.7 t -39.03 -49.53 1.74 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.995 -0.441 . . . . 0.0 111.01 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -59.52 -24.8 63.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.839 -1.163 . . . . 0.0 109.678 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 36' ' ' ARG . . . -74.36 -35.74 51.7 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.487 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -101.12 -51.5 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.244 -1.151 . . . . 0.0 110.467 -179.149 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.487 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.5 t -69.56 -64.63 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 120.463 -1.398 . . . . 0.0 111.994 -177.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -55.45 -53.82 51.56 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.849 -1.157 . . . . 0.0 111.028 -177.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.551 HE21 ' C ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -47.19 -49.42 22.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.824 -1.172 . . . . 0.0 109.876 -178.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 47' ' ' SER . 95.1 m -81.14 -54.44 5.53 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.931 -1.105 . . . . 0.0 109.897 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.6 t -60.95 -52.06 66.63 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.922 -1.111 . . . . 0.0 110.102 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -68.89 -33.78 74.34 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.218 -0.926 . . . . 0.0 110.402 -179.031 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 44' ' ' CYS . 25.4 m -136.48 147.63 47.27 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.071 -1.018 . . . . 0.0 109.404 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.5 mt -69.14 99.36 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.088 -1.008 . . . . 0.0 109.125 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.1 p -85.41 146.68 26.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.376 -0.827 . . . . 0.0 109.297 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.3 m -77.62 162.94 26.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.891 . . . . 0.0 109.69 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.5 mt -56.09 -31.76 63.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 0.0 108.969 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -46.9 -54.4 10.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 0.0 109.533 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.534 HE22 ' CD ' ' A' ' 43' ' ' GLN . 16.1 mt-30 -62.36 -50.46 71.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.388 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.3 mt -55.71 -34.14 64.85 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.078 -1.014 . . . . 0.0 108.686 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.487 ' OE2' ' NH2' ' A' ' 22' ' ' ARG . 4.2 tm-20 -74.42 -9.38 58.53 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -79.52 -21.79 44.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.386 -0.822 . . . . 0.0 110.99 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.525 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.9 m-85 -99.17 -7.4 26.63 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.078 -1.014 . . . . 0.0 110.626 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.436 ' O ' ' OXT' ' A' ' 59' ' ' GLY . 78.4 m -59.01 102.17 0.11 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.004 -1.06 . . . . 0.0 109.066 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.492 2.426 0 CA-C-O 117.911 -1.494 . . . . 0.0 109.945 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 1' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 1' ' ' PHE . 2.3 m -55.35 -168.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.354 -0.841 . . . . 0.0 109.768 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -102.69 121.06 41.68 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.637 -0.664 . . . . 0.0 109.613 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.545 ' OE1' ' NE2' ' A' ' 10' ' ' HIS . 6.2 pt20 -168.08 170.5 10.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.486 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.661 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 0.0 OUTLIER -82.67 122.83 28.65 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.204 -0.935 . . . . 0.0 109.443 -179.326 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 mp -90.38 117.49 29.14 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.559 -0.713 . . . . 0.0 109.135 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 58.6 m -130.11 124.99 34.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.177 -0.952 . . . . 0.0 110.516 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.82 -137.27 44.08 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.3 m -43.31 -30.95 0.56 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.54 -0.977 . . . . 0.0 110.419 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.545 ' NE2' ' OE1' ' A' ' 4' ' ' GLN . 2.1 t-80 -63.18 -33.6 75.83 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.97 -1.081 . . . . 0.0 108.811 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 8' ' ' GLY . 9.2 tp -72.12 -51.65 20.42 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 13' ' ' GLU . 76.5 t -58.12 -60.98 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.49 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 29.2 mt-10 -43.55 -29.35 0.46 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.821 -0.549 . . . . 0.0 109.975 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.77 -61.11 1.83 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.435 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.8 mt -46.15 -37.13 6.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.201 -0.937 . . . . 0.0 109.707 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.52 -42.42 61.72 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.407 -0.808 . . . . 0.0 108.842 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.49 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -75.66 -51.23 13.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.281 -0.887 . . . . 0.0 108.763 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.0 t -50.37 -55.1 6.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-O 121.516 0.674 . . . . 0.0 109.337 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.6 m -78.01 -22.31 49.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.481 -0.762 . . . . 0.0 110.613 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.22 -118.38 13.21 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -85.37 -24.9 27.38 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.135 -1.215 . . . . 0.0 110.329 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.586 HH21 ' CG ' ' A' ' 22' ' ' ARG . 2.8 mtt-85 -54.3 -36.66 63.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.946 -1.096 . . . . 0.0 109.303 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.33 166.84 19.98 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.549 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 7.4 p90 -139.01 172.49 12.76 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.544 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 15.2 p90 -110.19 121.75 46.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.9 . . . . 0.0 109.282 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.465 ' CD2' ' N ' ' A' ' 27' ' ' THR . 15.0 t80 -94.81 172.83 7.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.069 -1.019 . . . . 0.0 109.666 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.465 ' N ' ' CD2' ' A' ' 26' ' ' TYR . 5.5 t -113.14 81.68 4.99 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.796 -0.565 . . . . 0.0 110.021 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 30' ' ' THR . 2.1 Cg_endo -59.26 91.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.319 -0.977 0 C-N-CA 120.698 0.932 . . . . 0.0 109.797 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 28' ' ' PRO . 0.0 OUTLIER 22.36 37.31 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.451 178.436 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.624 ' N ' ' O ' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -82.95 96.69 8.38 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.412 -0.805 . . . . 0.0 109.234 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.522 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 1.2 pm0 -74.7 9.98 1.59 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.259 -0.9 . . . . 0.0 109.044 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 30' ' ' THR . 36.1 mt-10 -70.95 -27.59 63.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.279 -0.888 . . . . 0.0 109.444 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.05 162.41 27.35 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.5 t -82.46 -85.07 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -1.136 . . . . 0.0 109.579 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 37' ' ' SER . 3.1 ptt-85 -88.31 -99.86 0.09 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.449 -0.782 . . . . 0.0 109.266 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.602 ' CG ' HH21 ' A' ' 36' ' ' ARG . 0.0 OUTLIER 52.44 -81.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.706 -0.622 . . . . 0.0 111.133 179.232 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 35' ' ' ARG . 1.1 t -44.53 -56.54 4.24 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.353 -0.842 . . . . 0.0 110.795 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -59.12 -9.58 2.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.853 -1.154 . . . . 0.0 109.423 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 36' ' ' ARG . . . -82.44 -37.54 14.29 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.35 -50.68 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.491 -1.005 . . . . 0.0 109.956 -179.288 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.499 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 4.3 t -69.37 -64.93 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 120.592 -1.317 . . . . 0.0 111.692 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 46' ' ' ARG . 31.3 mm-40 -57.03 -51.87 67.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.804 -1.185 . . . . 0.0 110.262 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.555 ' NE2' HE21 ' A' ' 53' ' ' GLN . 17.5 tt0 -45.6 -48.69 14.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.082 -1.012 . . . . 0.0 110.138 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 47' ' ' SER . 86.2 m -84.08 -53.9 5.21 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.199 -0.938 . . . . 0.0 109.992 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 54.0 t -60.82 -51.59 68.68 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.054 -1.029 . . . . 0.0 110.064 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 42' ' ' GLU . 2.9 tmt_? -68.06 -35.67 78.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.135 -0.978 . . . . 0.0 110.003 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 44' ' ' CYS . 23.2 m -136.52 147.73 47.24 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.15 -0.969 . . . . 0.0 109.331 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 63.4 mt -68.49 99.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.022 -1.049 . . . . 0.0 109.312 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.5 p -82.42 138.1 34.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.431 -0.793 . . . . 0.0 108.993 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 m -68.75 158.87 33.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.777 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.8 mt -53.59 -31.72 48.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.351 -0.843 . . . . 0.0 108.964 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -49.01 -51.91 28.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.408 -0.808 . . . . 0.0 109.23 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.555 HE21 ' NE2' ' A' ' 43' ' ' GLN . 24.4 mt-30 -63.32 -49.41 74.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.234 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.6 mt -56.85 -32.77 66.13 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.015 -1.053 . . . . 0.0 108.249 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -74.55 -9.26 58.41 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -79.76 -22.14 43.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 111.103 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.487 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.5 m-85 -99.5 -4.93 30.2 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.048 -1.033 . . . . 0.0 110.712 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 75.5 m -62.19 102.48 0.3 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.06 -1.025 . . . . 0.0 109.827 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.318 0 CA-C-O 118.026 -1.43 . . . . 0.0 109.557 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 1' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 1' ' ' PHE . 3.6 m -54.45 -168.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.344 -0.848 . . . . 0.0 110.019 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -90.94 120.46 31.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.503 -0.748 . . . . 0.0 109.533 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.525 ' OE1' ' NE2' ' A' ' 10' ' ' HIS . 3.0 pt20 -172.55 148.09 1.93 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.433 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.423 ' CD2' ' N ' ' A' ' 5' ' ' HIS . 9.9 m-70 -70.45 148.87 47.82 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.239 -0.913 . . . . 0.0 109.337 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 mp -113.14 116.38 29.75 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.674 -0.641 . . . . 0.0 109.546 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 58.1 m -129.21 124.94 35.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.374 -0.829 . . . . 0.0 110.056 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.61 -137.36 44.6 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 m -41.5 -35.61 0.74 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.751 -0.852 . . . . 0.0 110.71 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.525 ' NE2' ' OE1' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -59.45 -35.95 75.01 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.899 -1.125 . . . . 0.0 108.817 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' A' ' 8' ' ' GLY . 10.8 tp -71.05 -50.03 38.43 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -59.6 -61.43 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.497 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 81.7 mt-10 -44.38 -29.9 0.76 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.847 -0.533 . . . . 0.0 110.004 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.34 -60.76 1.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.155 -0.966 . . . . 0.0 109.79 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.3 mt -47.01 -36.49 7.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.08 -1.012 . . . . 0.0 109.57 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.7 -40.79 60.77 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.497 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.49 -50.75 11.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 0.0 108.992 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -49.89 -53.48 10.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.538 0.685 . . . . 0.0 109.295 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 m -78.79 -22.32 46.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.596 -0.69 . . . . 0.0 110.585 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.24 -114.07 3.45 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 2.2 mp0 -85.28 -24.03 27.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.174 -1.192 . . . . 0.0 109.974 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -54.66 -38.43 66.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.056 -1.028 . . . . 0.0 109.35 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.33 163.39 9.73 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 8.2 p90 -138.37 173.05 12.02 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.529 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 17.6 p90 -111.85 122.61 48.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.29 -0.881 . . . . 0.0 109.54 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -95.0 169.03 10.41 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.088 -1.007 . . . . 0.0 108.396 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.5 t -66.17 141.83 97.58 Favored Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.006 -1.059 . . . . 0.0 109.057 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -74.3 -30.48 8.42 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 N-CA-C 107.905 -1.613 . . . . 0.0 107.905 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.545 ' CG ' ' H ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -140.64 -85.89 0.2 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.575 ' C ' ' H ' ' A' ' 32' ' ' GLU . 82.5 p -149.19 -126.33 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.048 -1.033 . . . . 0.0 111.477 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.661 ' O ' ' N ' ' A' ' 33' ' ' GLY . 32.0 mt-10 -49.74 -9.2 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 109.549 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.575 ' H ' ' C ' ' A' ' 30' ' ' THR . 17.7 mt-10 54.03 -72.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.512 0.673 . . . . 0.0 110.014 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 31' ' ' GLU . . . -164.95 -73.32 0.03 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.7 t -85.57 -127.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.449 -1.03 . . . . 0.0 109.366 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 37' ' ' SER . 2.4 ptp180 -94.56 -100.1 0.15 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.218 -0.926 . . . . 0.0 109.49 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.477 ' O ' ' N ' ' A' ' 39' ' ' GLY . 4.2 mmt-85 53.15 -83.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.713 -0.617 . . . . 0.0 110.611 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -43.98 -62.01 1.27 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.508 -0.745 . . . . 0.0 110.21 -179.232 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -59.39 -9.83 2.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.031 -1.043 . . . . 0.0 109.239 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 36' ' ' ARG . . . -82.49 -33.7 24.61 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.33 -51.55 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.463 -1.022 . . . . 0.0 110.044 -179.274 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 3.0 t -69.18 -65.1 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 120.485 -1.384 . . . . 0.0 111.525 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' ARG . 78.1 mm-40 -57.55 -49.19 77.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.834 -1.166 . . . . 0.0 110.556 -178.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -47.53 -51.9 19.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.845 -1.159 . . . . 0.0 109.838 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 47' ' ' SER . 89.2 m -80.69 -52.02 8.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.26 -0.9 . . . . 0.0 110.09 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.8 t -60.42 -52.06 66.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.805 -1.184 . . . . 0.0 109.827 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.516 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -64.56 -38.09 89.81 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.247 -0.908 . . . . 0.0 110.074 -179.383 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 44' ' ' CYS . 39.4 m -137.3 149.16 46.88 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.144 -0.973 . . . . 0.0 109.552 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.2 mt -68.2 99.31 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.062 -1.024 . . . . 0.0 109.448 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.9 p -81.8 140.92 33.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.396 -0.815 . . . . 0.0 108.956 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.5 m -70.18 159.03 34.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 109.717 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 40.7 mt -52.91 -31.65 41.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.37 -0.832 . . . . 0.0 108.999 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -48.24 -53.78 15.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 109.356 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.517 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 47.0 mt-30 -61.52 -50.62 71.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 109.445 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.0 mt -56.06 -35.05 66.49 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.126 -0.984 . . . . 0.0 108.605 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -72.61 -9.58 58.77 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -78.5 -22.57 47.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.31 -0.869 . . . . 0.0 111.039 -178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.517 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.4 m-85 -100.97 -7.03 23.72 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.158 -0.964 . . . . 0.0 110.147 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 96.8 m -62.04 96.34 0.07 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.201 -0.937 . . . . 0.0 109.607 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.33 0 CA-C-O 118.011 -1.438 . . . . 0.0 109.606 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 1' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.412 ' O ' ' O ' ' A' ' 1' ' ' PHE . 3.0 m -55.35 -169.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.344 -0.848 . . . . 0.0 109.699 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.651 ' H ' ' ND2' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -95.0 116.7 29.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.556 -0.715 . . . . 0.0 109.309 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.51 ' CD ' ' HE2' ' A' ' 10' ' ' HIS . 18.2 pt20 -158.79 162.44 37.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -0.91 . . . . 0.0 109.407 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.698 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 0.1 OUTLIER -79.07 122.71 26.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.286 -0.884 . . . . 0.0 109.18 -179.613 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mp -91.03 115.98 28.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.452 -0.78 . . . . 0.0 109.384 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 62.5 m -129.64 124.97 34.98 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.255 -0.903 . . . . 0.0 109.946 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.5 -138.01 42.71 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.7 m -42.69 -34.89 0.98 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.61 -0.935 . . . . 0.0 110.664 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.51 ' HE2' ' CD ' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -58.56 -34.27 70.84 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.896 -1.128 . . . . 0.0 109.006 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 tp -72.33 -53.53 12.12 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.2 t -57.05 -58.95 3.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.499 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.9 mt-10 -45.4 -28.81 0.94 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.695 -0.628 . . . . 0.0 109.918 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.62 -61.26 1.77 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.965 . . . . 0.0 109.579 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.7 mt -46.36 -35.03 5.05 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.21 -0.932 . . . . 0.0 109.409 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -53.19 -40.29 64.3 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.499 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -79.44 -51.01 9.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 108.782 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.8 t -49.89 -53.14 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.61 0.719 . . . . 0.0 109.187 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.5 m -79.37 -22.15 44.79 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.619 -0.676 . . . . 0.0 110.592 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 51.69 -115.19 3.65 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -84.89 -21.92 29.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.098 -1.237 . . . . 0.0 109.482 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -54.75 -39.07 67.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 109.191 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.6 160.75 7.73 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.496 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 9.9 p90 -138.62 173.52 11.5 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.533 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.1 p90 -112.51 121.64 45.4 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.075 -1.016 . . . . 0.0 110.044 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -103.99 169.43 8.51 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.235 -0.916 . . . . 0.0 109.262 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.8 t -81.28 145.09 55.09 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.37 -75.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 120.817 1.011 . . . . 0.0 109.769 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.4 ' O ' ' C ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -164.82 -3.16 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 108.779 -179.508 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 29' ' ' ARG . 7.9 p -41.62 161.63 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.394 0.616 . . . . 0.0 110.349 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -164.92 -21.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.388 -0.82 . . . . 0.0 109.469 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -54.9 -38.0 67.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -0.976 . . . . 0.0 108.991 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -157.32 159.74 29.97 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.6 t -127.93 -177.04 3.97 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.259 -1.142 . . . . 0.0 110.542 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.552 ' CG ' HH21 ' A' ' 35' ' ' ARG . 0.0 OUTLIER -165.18 -51.92 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.236 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.474 ' O ' ' N ' ' A' ' 39' ' ' GLY . 9.1 mtp180 -105.37 -47.61 3.9 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.994 0.902 . . . . 0.0 109.076 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 t -41.47 -46.59 3.5 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.461 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.597 ' CG ' HH21 ' A' ' 38' ' ' ARG . 0.0 OUTLIER -63.46 -20.59 65.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.051 -1.031 . . . . 0.0 109.659 -179.621 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 36' ' ' ARG . . . -82.23 -33.61 25.6 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.51 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.55 -51.77 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.208 -1.172 . . . . 0.0 110.332 -178.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.51 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 4.4 t -67.54 -64.06 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.662 -1.274 . . . . 0.0 111.709 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 46' ' ' ARG . 53.8 mt-10 -56.93 -54.81 42.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.832 -1.167 . . . . 0.0 110.861 -178.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.667 HE21 ' NE2' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -44.68 -49.74 10.27 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.704 -1.248 . . . . 0.0 110.327 -178.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 47' ' ' SER . 99.5 m -79.63 -50.51 10.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.906 -1.121 . . . . 0.0 110.003 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 47.9 t -61.06 -53.02 62.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.073 -1.017 . . . . 0.0 110.512 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 42' ' ' GLU . 13.0 tpt180 -69.56 -38.44 77.43 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.876 -1.14 . . . . 0.0 109.902 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 44' ' ' CYS . 1.6 m -127.09 144.09 51.12 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.249 -0.907 . . . . 0.0 109.469 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.6 mt -69.14 99.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.059 -1.026 . . . . 0.0 108.901 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.7 p -82.9 141.51 32.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.347 -0.846 . . . . 0.0 109.28 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 m -72.13 163.45 27.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.187 -0.946 . . . . 0.0 109.492 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.4 ' CD2' ' CZ ' ' A' ' 1' ' ' PHE . 35.7 mt -56.02 -32.34 63.9 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.312 -0.867 . . . . 0.0 109.074 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -47.31 -56.06 7.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.935 . . . . 0.0 109.476 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.667 ' NE2' HE21 ' A' ' 43' ' ' GLN . 24.1 mt-30 -58.91 -51.27 70.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 109.324 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.0 mt -55.49 -35.02 65.11 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.099 -1.001 . . . . 0.0 108.779 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -72.63 -9.11 58.22 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.584 0.707 . . . . 0.0 109.106 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -79.98 -22.16 42.86 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.369 -0.832 . . . . 0.0 111.081 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.499 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.0 m-85 -99.91 -9.3 22.97 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.105 -0.997 . . . . 0.0 109.98 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 88.9 m -60.02 93.13 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.385 -0.822 . . . . 0.0 109.54 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.253 0 CA-C-O 117.974 -1.459 . . . . 0.0 109.727 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' A' ' 1' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 1' ' ' PHE . 3.8 m -58.24 -114.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 0.0 110.089 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -160.01 100.19 1.39 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.161 -0.962 . . . . 0.0 109.853 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.41 HE21 ' CG2' ' A' ' 2' ' ' VAL . 28.6 mt-30 -147.15 178.2 8.57 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.224 -0.922 . . . . 0.0 109.303 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.69 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 0.0 OUTLIER -83.99 126.1 32.7 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.485 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.9 mp -93.24 116.19 28.77 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.363 -0.836 . . . . 0.0 110.188 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.409 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 61.9 m -128.96 124.68 35.7 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.321 -0.862 . . . . 0.0 109.985 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.45 -137.0 44.89 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.2 m -42.13 -36.11 1.09 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.723 -0.869 . . . . 0.0 110.6 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.409 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 0.8 OUTLIER -58.22 -35.51 71.79 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.897 -1.127 . . . . 0.0 108.789 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 8' ' ' GLY . 11.7 tp -71.56 -50.92 26.54 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.1 t -58.94 -59.75 3.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.503 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 24.9 mt-10 -45.17 -30.04 1.08 Allowed 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.862 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.73 -61.05 1.85 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.928 . . . . 0.0 109.74 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.3 mt -46.67 -36.6 7.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.064 -1.023 . . . . 0.0 109.704 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -52.1 -40.49 61.33 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 108.946 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.503 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.52 -50.75 11.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.146 -0.972 . . . . 0.0 108.89 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -49.87 -53.15 11.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 121.556 0.693 . . . . 0.0 109.203 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.0 m -79.95 -22.28 42.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.598 -0.689 . . . . 0.0 110.453 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.73 -115.48 4.96 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -85.02 -23.44 28.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.143 -1.21 . . . . 0.0 109.818 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -54.58 -38.29 66.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.115 -0.99 . . . . 0.0 109.222 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.77 163.02 9.95 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.51 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 7.8 p90 -138.53 172.17 13.28 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.54 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 14.8 p90 -111.41 120.59 42.67 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -82.14 160.26 23.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.894 -1.129 . . . . 0.0 108.847 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.408 ' OG1' ' CB ' ' A' ' 37' ' ' SER . 15.2 t -42.59 145.91 0.78 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.646 -0.659 . . . . 0.0 109.72 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.583 ' C ' ' H ' ' A' ' 30' ' ' THR . 9.1 Cg_exo -47.51 110.11 0.28 Allowed 'Trans proline' 0 C--N 1.321 -0.88 0 N-CA-C 108.867 -1.244 . . . . 0.0 108.867 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.501 ' CD ' ' H ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -72.01 38.77 0.07 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 122.042 0.925 . . . . 0.0 108.692 -179.382 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.583 ' H ' ' C ' ' A' ' 28' ' ' PRO . 11.7 p -131.72 125.5 32.17 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -72.79 45.98 0.15 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.296 -0.877 . . . . 0.0 109.211 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.452 ' H ' ' C ' ' A' ' 30' ' ' THR . 5.7 mm-40 -67.63 -53.95 23.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.445 -0.784 . . . . 0.0 109.842 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 34' ' ' SER . . . 144.28 -18.2 2.1 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -51.73 -173.28 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.49 -1.006 . . . . 0.0 110.168 -179.422 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.565 ' CG ' HH21 ' A' ' 35' ' ' ARG . 0.0 OUTLIER -115.7 -102.15 0.42 Allowed 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.44 ' H ' ' HG3' ' A' ' 35' ' ' ARG . 28.6 mmt180 60.19 -61.63 0.06 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.048 0.451 . . . . 0.0 111.179 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -43.89 -43.33 6.33 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.589 -179.352 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -59.68 -20.7 57.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.079 -1.013 . . . . 0.0 110.296 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.28 -40.82 8.87 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.235 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -99.54 -51.39 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.046 -1.267 . . . . 0.0 110.788 -178.123 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.504 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 8.3 t -66.47 -63.61 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.523 -1.36 . . . . 0.0 111.57 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.528 ' N ' ' OE2' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -55.48 -57.07 13.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.935 -1.103 . . . . 0.0 111.106 -178.238 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.7 HE21 HE22 ' A' ' 53' ' ' GLN . 0.1 OUTLIER -43.87 -48.16 8.35 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.934 -1.104 . . . . 0.0 110.515 -178.383 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.446 ' O ' ' O ' ' A' ' 47' ' ' SER . 95.7 m -81.53 -50.88 8.86 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.974 -1.078 . . . . 0.0 110.034 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.0 t -61.38 -52.91 62.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.202 -0.936 . . . . 0.0 110.584 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 42' ' ' GLU . 4.7 tpt180 -69.07 -38.48 79.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.915 -1.115 . . . . 0.0 109.781 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 44' ' ' CYS . 13.0 m -128.93 145.98 51.08 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.188 -0.945 . . . . 0.0 109.714 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.0 mt -69.02 99.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.231 -0.918 . . . . 0.0 109.315 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.1 p -84.09 140.56 31.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.281 -0.887 . . . . 0.0 109.208 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.3 m -71.54 161.31 31.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.728 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.2 mt -54.15 -31.55 52.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.177 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -48.98 -55.65 11.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 0.0 109.298 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.7 HE22 HE21 ' A' ' 43' ' ' GLN . 28.0 mt-30 -58.79 -51.04 71.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 109.242 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.0 mt -55.89 -35.08 66.12 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.134 -0.979 . . . . 0.0 108.559 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -72.63 -9.15 58.26 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.558 0.694 . . . . 0.0 109.181 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -79.7 -22.61 43.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.496 -0.752 . . . . 0.0 110.79 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.473 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.5 m-85 -99.86 -6.83 26.16 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.11 -0.994 . . . . 0.0 110.268 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 82.0 m -62.05 96.13 0.07 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.075 -1.016 . . . . 0.0 109.595 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.495 2.573 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.558 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.401 ' CZ ' ' CD2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.1 m -150.75 -166.88 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.378 -0.827 . . . . 0.0 108.793 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -98.06 92.8 5.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.342 -0.848 . . . . 0.0 109.397 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.513 ' OE1' ' NE2' ' A' ' 10' ' ' HIS . 2.6 pt20 -162.95 156.73 20.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.266 -0.896 . . . . 0.0 109.255 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -83.67 147.65 27.56 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.216 -0.927 . . . . 0.0 109.76 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp -106.65 116.34 31.76 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.413 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 60.7 m -129.41 124.98 35.51 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.242 -0.911 . . . . 0.0 110.168 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 61.86 -136.93 46.32 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.1 m -41.64 -34.58 0.62 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.719 -0.871 . . . . 0.0 110.739 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.513 ' NE2' ' OE1' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -61.12 -35.36 76.83 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.912 -1.117 . . . . 0.0 108.905 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 8' ' ' GLY . 11.1 tp -71.7 -48.68 45.68 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.7 t -59.82 -61.61 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.493 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 42.6 mt-10 -44.02 -30.28 0.71 Allowed 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.371 -0.531 . . . . 0.0 109.968 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.78 -60.76 1.96 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.181 -0.95 . . . . 0.0 109.989 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.0 mt -47.48 -36.77 10.66 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.975 -1.078 . . . . 0.0 109.465 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -51.15 -40.08 57.76 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.493 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -78.26 -50.92 10.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 108.785 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.1 t -50.23 -54.36 8.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.585 0.707 . . . . 0.0 109.294 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.2 m -79.38 -22.13 44.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.599 -0.688 . . . . 0.0 110.659 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.45 -116.42 7.0 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -85.29 -25.7 27.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.136 -1.214 . . . . 0.0 110.335 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.412 ' O ' ' O ' ' A' ' 59' ' ' GLY . 61.8 mtt180 -54.44 -36.61 64.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.944 -1.097 . . . . 0.0 109.267 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.11 165.91 16.41 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.58 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 9.3 p90 -139.0 172.89 12.18 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.513 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 10.8 p90 -110.23 126.68 54.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.181 -0.949 . . . . 0.0 109.073 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -96.11 167.81 10.99 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.033 -1.042 . . . . 0.0 108.96 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.4 t -68.06 145.6 97.77 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.109 -0.994 . . . . 0.0 108.645 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -69.57 -71.29 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.764 0 N-CA-C 108.882 -1.238 . . . . 0.0 108.882 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.92 -76.54 0.42 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.089 -1.007 . . . . 0.0 108.882 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.571 ' C ' ' H ' ' A' ' 32' ' ' GLU . 7.9 t -164.62 -141.69 0.05 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.329 -0.857 . . . . 0.0 110.313 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 16.9 mp0 -54.65 -5.0 0.07 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.571 ' H ' ' C ' ' A' ' 30' ' ' THR . 10.2 mt-10 -46.66 -32.41 3.51 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.205 -0.934 . . . . 0.0 109.762 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.63 154.8 7.07 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 t -85.22 -62.15 1.6 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.313 -1.11 . . . . 0.0 109.361 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 36' ' ' ARG . 8.5 ptm180 -101.29 -55.08 2.63 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.678 -0.639 . . . . 0.0 109.446 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.56 ' O ' ' N ' ' A' ' 38' ' ' ARG . 9.4 ptp180 -57.69 -159.86 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.27 -0.894 . . . . 0.0 109.976 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.8 t 53.61 -81.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.598 -0.689 . . . . 0.0 110.06 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' A' ' 36' ' ' ARG . 2.3 ptm180 -58.67 -18.27 29.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.954 -1.091 . . . . 0.0 108.63 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.68 -30.42 32.69 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -101.11 -50.96 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.506 -0.997 . . . . 0.0 110.065 -179.382 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.504 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 3.2 t -69.36 -65.13 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.536 -1.353 . . . . 0.0 111.388 -178.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' ARG . 77.7 mt-10 -57.93 -48.86 78.66 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.808 -1.183 . . . . 0.0 110.377 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -46.64 -50.27 17.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.847 -1.158 . . . . 0.0 109.969 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.474 ' O ' ' O ' ' A' ' 47' ' ' SER . 88.5 m -84.04 -52.71 6.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.268 -0.895 . . . . 0.0 110.208 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.6 t -60.98 -45.36 95.08 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.88 -1.137 . . . . 0.0 110.064 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.549 HH21 ' CG ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -71.13 -37.46 72.31 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.976 -1.078 . . . . 0.0 109.722 -179.522 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 44' ' ' CYS . 14.4 m -137.77 153.62 49.68 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.172 -0.955 . . . . 0.0 110.011 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.7 mt -68.96 99.41 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.122 -0.986 . . . . 0.0 109.441 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.5 p -84.23 140.27 31.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -0.926 . . . . 0.0 108.925 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.8 m -71.41 161.15 31.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.184 -0.948 . . . . 0.0 109.837 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.401 ' CD2' ' CZ ' ' A' ' 1' ' ' PHE . 38.7 mt -54.59 -32.56 58.91 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.328 -0.857 . . . . 0.0 109.183 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -48.15 -52.89 18.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.296 -0.877 . . . . 0.0 109.327 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.529 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 39.7 mt-30 -62.43 -51.27 68.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 109.291 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.2 mt -56.15 -32.99 64.79 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.064 -1.023 . . . . 0.0 108.667 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -75.12 -8.83 57.66 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.513 0.673 . . . . 0.0 109.191 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -79.96 -21.93 43.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.453 -0.779 . . . . 0.0 110.874 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.529 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.9 m-85 -99.99 -6.35 26.68 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.17 -0.957 . . . . 0.0 110.458 -178.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.3 m -61.18 99.66 0.1 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.081 -1.012 . . . . 0.0 109.542 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.559 ' O ' ' CD2' ' A' ' 1' ' ' PHE . 1.3 t80 . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.0 m -100.75 -112.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.37 -0.831 . . . . 0.0 109.076 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -84.35 79.31 9.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 109.149 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -141.32 167.72 21.5 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.346 -0.846 . . . . 0.0 109.407 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.675 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 0.1 OUTLIER -93.17 136.64 33.25 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.211 -0.931 . . . . 0.0 109.127 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mp -106.35 117.24 33.51 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.564 -0.71 . . . . 0.0 109.784 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 67.7 m -129.58 124.98 35.14 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.29 -0.881 . . . . 0.0 110.378 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.85 -137.27 44.0 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.1 m -42.74 -34.91 1.0 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.612 -0.934 . . . . 0.0 110.55 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -58.94 -34.12 71.38 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.898 -1.126 . . . . 0.0 108.735 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 8' ' ' GLY . 9.2 tp -71.95 -53.54 12.75 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.4 t -57.67 -59.93 2.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.485 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 87.5 mt-10 -43.97 -29.77 0.63 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.808 -0.558 . . . . 0.0 109.985 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.22 -60.95 1.86 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.952 . . . . 0.0 109.468 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.3 mt -46.43 -36.0 6.11 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.203 -0.936 . . . . 0.0 109.647 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -52.7 -40.03 62.56 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.38 -0.825 . . . . 0.0 108.994 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.485 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.85 -51.55 9.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 108.822 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.2 t -49.76 -53.78 9.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.584 0.707 . . . . 0.0 109.231 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.3 m -78.63 -22.23 47.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.564 -0.71 . . . . 0.0 110.272 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.37 -115.54 4.82 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.513 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 4.0 mp0 -84.88 -23.58 28.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -1.162 . . . . 0.0 109.668 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.562 HH21 ' CG ' ' A' ' 22' ' ' ARG . 4.8 mtt-85 -54.31 -38.71 66.27 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.142 -0.974 . . . . 0.0 109.041 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.58 162.87 9.52 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.514 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 8.1 p90 -138.46 173.3 11.74 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.554 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.3 p90 -110.86 120.13 41.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.179 -0.951 . . . . 0.0 109.882 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.557 ' O ' ' C ' ' A' ' 27' ' ' THR . 9.6 t80 -103.66 106.65 17.23 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.557 ' C ' ' O ' ' A' ' 26' ' ' TYR . 6.5 t -2.9 76.94 0.03 OUTLIER Pre-proline 0 N--CA 1.513 2.68 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.43 ' N ' ' O ' ' A' ' 26' ' ' TYR . 10.6 Cg_endo -77.14 -19.13 13.86 Favored 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 121.766 1.644 . . . . 0.0 109.755 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.49 ' O ' ' N ' ' A' ' 31' ' ' GLU . 13.7 mmm180 -99.45 -8.73 24.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.541 -0.724 . . . . 0.0 109.266 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.501 ' C ' ' H ' ' A' ' 32' ' ' GLU . 5.5 p 49.95 11.48 0.06 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.629 -0.67 . . . . 0.0 109.293 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 29' ' ' ARG . 52.7 mt-10 -73.56 44.19 0.16 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 34' ' ' SER . 32.6 mt-10 -40.52 -64.79 0.48 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.767 -0.583 . . . . 0.0 110.016 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 32' ' ' GLU . . . 37.18 -92.28 0.01 OUTLIER Glycine 0 N--CA 1.499 2.852 0 N-CA-C 110.654 -0.979 . . . . 0.0 110.654 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 32' ' ' GLU . 36.8 t -56.02 -104.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.547 -0.972 . . . . 0.0 109.595 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.604 ' CG ' HH21 ' A' ' 35' ' ' ARG . 0.0 OUTLIER -138.56 -103.53 0.18 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.213 -0.929 . . . . 0.0 109.655 -179.628 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 39' ' ' GLY . 30.6 mtt180 55.2 -80.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.524 0.678 . . . . 0.0 110.303 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 35' ' ' ARG . 2.4 t -44.75 -60.72 1.88 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.67 -0.643 . . . . 0.0 109.881 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.4 ' HG3' HH21 ' A' ' 38' ' ' ARG . 1.8 ptm180 -59.43 -11.6 4.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.991 -1.068 . . . . 0.0 108.42 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 36' ' ' ARG . . . -80.58 -33.32 31.38 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.512 ' CG2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -101.2 -51.71 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.432 -1.04 . . . . 0.0 109.439 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.512 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 3.0 t -68.65 -65.0 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 120.622 -1.299 . . . . 0.0 111.466 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 46' ' ' ARG . 57.5 mm-40 -58.85 -45.8 89.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.864 -1.148 . . . . 0.0 110.354 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.614 ' NE2' HE21 ' A' ' 53' ' ' GLN . 24.6 tt0 -48.91 -52.59 23.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.57 -1.331 . . . . 0.0 109.652 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.45 ' O ' ' O ' ' A' ' 47' ' ' SER . 91.8 m -79.33 -52.42 8.12 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.259 -0.901 . . . . 0.0 109.82 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.6 t -60.16 -52.23 66.23 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.032 -1.042 . . . . 0.0 109.988 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 42' ' ' GLU . 4.2 tmm_? -68.02 -36.04 79.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.283 -0.886 . . . . 0.0 110.066 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 44' ' ' CYS . 9.2 m -135.23 147.65 49.37 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.052 -1.03 . . . . 0.0 109.576 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.5 mt -68.77 99.56 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.155 -0.966 . . . . 0.0 109.494 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 25.3 p -86.21 138.53 31.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.37 -0.831 . . . . 0.0 109.042 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.4 m -69.53 157.32 37.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 110.0 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.9 mt -51.32 -32.67 26.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.397 -0.815 . . . . 0.0 109.211 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -50.13 -53.62 26.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.374 -0.829 . . . . 0.0 109.125 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.614 HE21 ' NE2' ' A' ' 43' ' ' GLN . 19.8 mt-30 -58.75 -49.17 78.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.89 . . . . 0.0 109.002 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.2 mt -57.07 -34.16 68.0 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -71.91 -9.41 58.31 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -79.05 -22.78 44.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.408 -0.807 . . . . 0.0 111.086 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.439 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.9 m-85 -101.1 -6.9 23.72 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.093 -1.004 . . . . 0.0 110.183 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 86.6 m -61.64 96.06 0.06 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.56 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.495 1.796 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.428 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 63.5 m -129.29 125.03 35.87 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.267 -0.896 . . . . 0.0 110.309 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.77 -136.72 44.09 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.6 m -42.18 -35.46 0.95 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.691 -0.888 . . . . 0.0 110.624 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.428 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 0.8 OUTLIER -59.74 -35.34 74.37 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.821 -1.174 . . . . 0.0 108.851 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.727 HD21 HD12 ' A' ' 40' ' ' ILE . 10.5 tp -71.89 -50.1 32.25 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.3 t -59.88 -61.2 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.5 mt-10 -45.06 -29.48 0.88 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.851 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.1 -60.82 1.93 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.157 -0.964 . . . . 0.0 109.715 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.522 HD13 ' CD2' ' A' ' 24' ' ' PHE . 13.5 mt -47.3 -36.97 10.0 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.028 -1.045 . . . . 0.0 109.562 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -50.72 -40.22 53.76 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.496 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -78.54 -50.67 11.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 108.754 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.1 t -50.19 -54.18 9.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-O 121.555 0.693 . . . . 0.0 109.282 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.4 m -78.71 -22.42 46.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.561 -0.712 . . . . 0.0 110.646 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.69 -113.35 3.44 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -85.68 -29.22 24.15 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.191 -1.182 . . . . 0.0 110.842 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -54.35 -36.72 64.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.884 -1.135 . . . . 0.0 109.412 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.53 167.16 17.5 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.249 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' A' ' 24' ' ' PHE . 8.5 p90 -138.1 173.63 11.42 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.536 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 18.8 p90 -109.0 121.09 44.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 110.36 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.2 t80 . . . . . 0 N--CA 1.5 2.06 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.209 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.52 -35.12 20.84 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.727 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.88 -50.32 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.546 -0.973 . . . . 0.0 109.908 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.501 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.4 t -69.47 -65.04 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.53 -1.356 . . . . 0.0 111.329 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 46' ' ' ARG . 69.5 mm-40 -58.64 -47.04 85.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.795 -1.191 . . . . 0.0 110.475 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -48.75 -50.07 35.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.687 -1.258 . . . . 0.0 109.577 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.587 ' SG ' HD21 ' A' ' 54' ' ' LEU . 84.8 m -81.99 -53.35 6.2 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.165 -0.959 . . . . 0.0 109.851 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.401 ' N ' ' O ' ' A' ' 41' ' ' VAL . 53.2 t -60.04 -50.99 71.55 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.958 -1.089 . . . . 0.0 109.952 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -68.5 -35.74 77.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.082 -1.011 . . . . 0.0 110.049 -179.323 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 44' ' ' CYS . 58.4 m -136.78 148.4 47.19 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.029 -1.045 . . . . 0.0 109.562 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.3 mt -68.6 99.53 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.989 -1.069 . . . . 0.0 109.573 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.7 p -84.2 139.65 32.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 109.026 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 m -71.78 160.67 32.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 109.815 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.3 mt -54.11 -32.55 55.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.344 -0.847 . . . . 0.0 109.191 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -48.75 -46.28 40.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.891 . . . . 0.0 109.306 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.525 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 59.2 mt-30 -69.57 -49.76 51.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.319 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.587 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.8 mt -56.25 -33.78 65.75 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.152 -0.967 . . . . 0.0 108.598 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.03 -8.88 57.76 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -79.64 -22.11 43.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.512 -0.743 . . . . 0.0 110.933 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.525 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.1 m-85 -99.99 -7.32 25.24 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.089 -1.007 . . . . 0.0 110.321 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 82.4 m -60.9 98.55 0.07 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.293 -0.88 . . . . 0.0 109.64 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.267 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.503 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.427 HD21 ' CB ' ' A' ' 14' ' ' ALA . 4.3 mp . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 64.6 m -128.67 125.09 37.32 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.243 -0.91 . . . . 0.0 110.335 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.29 -137.52 45.36 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -42.26 -34.19 0.74 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.587 -0.949 . . . . 0.0 110.575 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.403 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 2.1 t-160 -59.33 -35.74 74.39 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.954 -1.091 . . . . 0.0 108.764 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.735 HD21 HD12 ' A' ' 40' ' ' ILE . 9.4 tp -71.18 -53.09 15.66 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.511 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 66.3 t -57.53 -59.95 2.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.494 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 26.7 mt-10 -44.01 -29.92 0.66 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.715 -0.616 . . . . 0.0 110.039 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.427 ' CB ' HD21 ' A' ' 6' ' ' LEU . . . -85.7 -60.92 1.88 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 109.523 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.522 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.2 mt -46.6 -36.2 6.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.14 -0.975 . . . . 0.0 109.641 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -52.22 -42.06 63.25 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.429 -0.794 . . . . 0.0 108.858 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.494 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -76.94 -51.18 11.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 108.873 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -50.17 -54.24 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.646 -0.659 . . . . 0.0 109.249 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.3 m -78.44 -22.32 47.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.54 -0.725 . . . . 0.0 110.371 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 56.71 -118.44 11.84 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -84.95 -23.63 28.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.148 -1.207 . . . . 0.0 110.034 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.4 mtp180 -54.63 -37.4 65.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.985 -1.072 . . . . 0.0 109.124 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.25 163.97 12.7 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 120.071 -1.062 . . . . 0.0 110.869 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 8.7 p90 -138.54 173.1 11.95 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.52 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.4 p90 -110.19 124.38 51.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.092 -1.005 . . . . 0.0 109.39 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.8 t80 . . . . . 0 N--CA 1.499 2.015 0 O-C-N 121.073 -1.017 . . . . 0.0 109.497 179.875 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.1 -30.15 35.5 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.735 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.38 -52.73 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.52 -0.988 . . . . 0.0 110.185 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.517 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 5.7 t -69.49 -64.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.528 -1.358 . . . . 0.0 111.595 -178.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 46' ' ' ARG . 54.2 mt-10 -57.25 -54.24 48.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.847 -1.158 . . . . 0.0 110.569 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.587 ' O ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -44.65 -50.59 9.75 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.874 -1.141 . . . . 0.0 110.096 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.566 ' SG ' HD21 ' A' ' 54' ' ' LEU . 99.4 m -79.43 -51.28 9.58 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.903 -1.123 . . . . 0.0 110.126 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.2 t -60.36 -53.25 59.81 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.099 -1.0 . . . . 0.0 110.62 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 42' ' ' GLU . 17.8 tpt180 -71.52 -38.53 71.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.87 -1.144 . . . . 0.0 109.9 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 44' ' ' CYS . 2.1 m -124.51 145.09 49.75 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.115 -0.99 . . . . 0.0 109.893 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.2 mt -69.46 99.35 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.004 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 24.8 p -86.37 142.25 28.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.304 -0.872 . . . . 0.0 109.467 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.7 m -72.22 159.82 33.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.722 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.9 mt -54.86 -31.69 59.94 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.35 -0.844 . . . . 0.0 108.849 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -47.49 -54.67 10.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.363 -0.835 . . . . 0.0 109.352 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.508 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 20.2 mt-30 -60.09 -49.85 76.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.233 -0.917 . . . . 0.0 109.197 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.566 HD21 ' SG ' ' A' ' 44' ' ' CYS . 98.1 mt -55.57 -34.58 64.9 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.161 -0.962 . . . . 0.0 108.688 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.403 ' CD ' ' O ' ' A' ' 55' ' ' GLU . 5.0 tm-20 -73.45 -9.25 58.5 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.677 0.751 . . . . 0.0 109.059 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -79.67 -21.74 44.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.373 -0.829 . . . . 0.0 111.239 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.508 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.3 m-85 -100.17 -6.31 26.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.087 -1.008 . . . . 0.0 110.534 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 71.4 m -60.9 98.72 0.07 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.17 -0.956 . . . . 0.0 109.695 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.314 0 CA-C-O 117.94 -1.478 . . . . 0.0 109.583 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.43 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 58.9 m -129.75 124.85 34.47 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.289 -0.882 . . . . 0.0 110.2 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 61.43 -136.54 47.45 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -41.93 -34.04 0.63 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.693 -0.886 . . . . 0.0 110.767 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.43 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 1.7 t-80 -62.06 -34.69 76.74 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.757 -1.214 . . . . 0.0 108.808 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.74 HD21 HD12 ' A' ' 40' ' ' ILE . 11.3 tp -71.7 -49.08 42.78 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.7 t -59.28 -61.46 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.497 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 25.1 mt-10 -44.31 -29.64 0.7 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.346 -0.541 . . . . 0.0 109.949 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.35 -61.23 1.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.164 -0.96 . . . . 0.0 109.74 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.545 HD13 ' CD2' ' A' ' 24' ' ' PHE . 15.0 mt -46.68 -36.91 7.61 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.123 -0.986 . . . . 0.0 109.613 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -51.11 -41.34 59.95 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.404 -0.81 . . . . 0.0 108.871 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.497 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -77.51 -50.91 11.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.93 . . . . 0.0 108.847 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.404 ' H ' HG23 ' A' ' 18' ' ' VAL . 19.2 t -50.18 -54.41 8.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.57 0.7 . . . . 0.0 109.142 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.3 m -79.39 -20.83 46.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.595 -0.69 . . . . 0.0 110.328 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.42 -117.11 6.56 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -84.73 -22.22 29.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.152 -1.205 . . . . 0.0 109.622 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.596 HH21 ' CG ' ' A' ' 22' ' ' ARG . 3.2 mtt-85 -54.59 -38.14 66.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.19 -0.944 . . . . 0.0 109.157 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.95 162.05 9.31 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.078 -1.058 . . . . 0.0 110.501 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.545 ' CD2' HD13 ' A' ' 15' ' ' LEU . 8.0 p90 -137.97 172.57 12.74 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.527 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.1 p90 -111.02 121.76 46.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.33 -0.856 . . . . 0.0 108.977 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.1 t80 . . . . . 0 N--CA 1.495 1.785 0 O-C-N 120.972 -1.08 . . . . 0.0 108.962 -179.953 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.336 0.588 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.48 -40.39 9.99 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.74 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.43 -51.15 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.316 -1.108 . . . . 0.0 110.291 -178.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.509 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.9 t -66.41 -64.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 120.627 -1.296 . . . . 0.0 111.775 -178.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 46' ' ' ARG . 81.9 mt-10 -56.06 -54.14 48.51 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.904 -1.122 . . . . 0.0 111.209 -178.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.7 -48.68 15.09 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.849 -1.157 . . . . 0.0 110.141 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.609 ' SG ' HD21 ' A' ' 54' ' ' LEU . 85.2 m -82.3 -53.58 5.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.062 -1.024 . . . . 0.0 110.042 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.2 t -60.61 -51.91 67.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.999 -1.063 . . . . 0.0 109.987 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 42' ' ' GLU . 3.7 tmt_? -67.04 -36.62 82.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.186 -0.946 . . . . 0.0 110.025 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 44' ' ' CYS . 68.4 m -136.46 148.17 47.57 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.168 -0.958 . . . . 0.0 109.398 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.6 mt -68.46 99.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.12 -0.988 . . . . 0.0 109.512 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.4 p -83.14 140.48 32.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.407 -0.808 . . . . 0.0 109.217 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 m -70.61 160.96 31.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.208 -0.932 . . . . 0.0 109.527 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.9 mt -55.48 -31.32 61.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.233 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -49.51 -51.97 32.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 109.216 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.466 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 62.9 mt-30 -62.32 -50.28 72.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.209 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.609 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.3 mt -56.68 -33.18 66.16 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.101 -0.999 . . . . 0.0 108.462 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -74.25 -8.96 58.03 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -79.99 -21.97 43.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.44 -0.787 . . . . 0.0 110.932 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.466 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 8.0 m-85 -99.46 -7.18 26.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.069 -1.019 . . . . 0.0 110.514 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.4 m -60.73 99.14 0.08 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.188 -0.945 . . . . 0.0 109.6 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.271 0 CA-C-O 118.022 -1.432 . . . . 0.0 109.562 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.412 HD21 ' CB ' ' A' ' 14' ' ' ALA . 5.5 mp . . . . . 0 N--CA 1.496 1.851 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.417 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 81.4 m -130.29 125.29 34.38 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.22 -0.925 . . . . 0.0 110.633 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 61.56 -136.5 47.15 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.424 ' O ' ' OE2' ' A' ' 13' ' ' GLU . 57.4 m -43.66 -28.74 0.43 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.518 -0.989 . . . . 0.0 110.548 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.417 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 1.7 t-160 -66.61 -32.13 73.27 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.815 -1.178 . . . . 0.0 108.814 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.698 HD21 HD12 ' A' ' 40' ' ' ILE . 9.7 tp -72.48 -51.58 19.5 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.507 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 70.4 t -58.0 -60.42 2.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.485 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.6 mt-10 -43.77 -29.24 0.5 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.748 -0.595 . . . . 0.0 110.106 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.412 ' CB ' HD21 ' A' ' 6' ' ' LEU . . . -86.2 -59.94 2.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.648 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.53 HD13 ' CD2' ' A' ' 24' ' ' PHE . 13.6 mt -46.94 -37.22 8.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.125 -0.984 . . . . 0.0 109.488 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -50.86 -42.02 58.51 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.485 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -76.88 -50.04 14.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 108.786 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.2 t -50.36 -55.08 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.648 0.737 . . . . 0.0 109.039 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.0 m -78.87 -22.32 46.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.559 -0.713 . . . . 0.0 110.426 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.84 -116.05 6.74 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.56 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 2.6 mp0 -85.21 -23.91 28.08 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.191 -1.182 . . . . 0.0 110.062 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.57 HH21 ' CG ' ' A' ' 22' ' ' ARG . 4.7 mtt-85 -54.78 -37.55 66.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.098 -1.001 . . . . 0.0 109.356 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.13 164.14 12.46 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.962 -1.114 . . . . 0.0 110.329 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.53 ' CD2' HD13 ' A' ' 15' ' ' LEU . 7.3 p90 -138.42 172.75 12.43 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.53 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.7 p90 -111.1 122.56 48.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 109.253 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.8 t80 . . . . . 0 N--CA 1.496 1.827 0 O-C-N 120.908 -1.12 . . . . 0.0 108.662 179.739 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.438 HH21 ' HG3' ' A' ' 38' ' ' ARG . 4.2 ptm180 . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.64 -34.0 23.41 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.951 -1.659 . . . . 0.0 108.951 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.698 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.64 -52.49 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.441 -1.035 . . . . 0.0 110.096 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 3.2 t -67.85 -64.03 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 120.663 -1.273 . . . . 0.0 111.813 -178.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' ARG . 67.2 mm-40 -57.34 -54.85 42.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.824 -1.172 . . . . 0.0 111.339 -177.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.565 HE21 ' C ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -45.76 -45.86 14.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.553 -1.342 . . . . 0.0 110.012 -178.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.646 ' SG ' HD21 ' A' ' 54' ' ' LEU . 95.1 m -84.44 -53.2 5.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.964 -1.085 . . . . 0.0 110.103 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.7 t -63.05 -44.51 95.65 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.984 -1.072 . . . . 0.0 110.332 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 42' ' ' GLU . 3.5 tmt_? -72.21 -36.37 69.15 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.793 -1.192 . . . . 0.0 109.605 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 44' ' ' CYS . 69.5 m -138.03 153.1 49.4 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.203 -0.935 . . . . 0.0 109.946 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.0 mt -68.97 99.15 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 108.857 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.6 p -83.39 148.46 27.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 109.313 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.8 m -78.76 162.61 26.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.261 -0.9 . . . . 0.0 110.063 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.8 mt -57.13 -33.18 67.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.557 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -48.95 -45.42 41.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.184 -0.948 . . . . 0.0 109.163 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.531 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 71.8 mt-30 -69.34 -52.76 24.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.369 -0.832 . . . . 0.0 109.191 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.646 HD21 ' SG ' ' A' ' 44' ' ' CYS . 99.2 mt -55.86 -32.47 63.67 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.029 -1.044 . . . . 0.0 108.654 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -76.08 -9.04 58.3 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.595 0.712 . . . . 0.0 109.225 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -79.85 -21.82 43.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.419 -0.801 . . . . 0.0 110.836 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.531 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.6 m-85 -99.27 -6.91 27.18 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.172 -0.955 . . . . 0.0 110.487 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 71.2 m -60.63 100.96 0.12 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.136 -0.978 . . . . 0.0 109.624 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.299 0 CA-C-O 118.048 -1.418 . . . . 0.0 109.581 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.401 HD21 ' CB ' ' A' ' 14' ' ' ALA . 4.3 mp . . . . . 0 N--CA 1.496 1.852 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.4 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 82.3 m -129.3 125.2 36.23 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.21 -0.931 . . . . 0.0 110.648 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.74 -137.26 44.25 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 m -42.83 -32.24 0.59 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.599 -0.942 . . . . 0.0 110.576 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.4 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 4.2 t-80 -61.83 -34.23 75.58 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.852 -1.155 . . . . 0.0 108.877 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.747 HD21 HD12 ' A' ' 40' ' ' ILE . 10.0 tp -71.76 -52.24 18.65 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.517 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 73.0 t -58.52 -60.06 2.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.5 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 51.5 mt-10 -44.5 -28.98 0.64 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.726 -0.609 . . . . 0.0 109.97 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.401 ' CB ' HD21 ' A' ' 6' ' ' LEU . . . -86.15 -61.14 1.82 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.599 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.514 HD13 ' CD2' ' A' ' 24' ' ' PHE . 13.8 mt -46.47 -36.93 7.12 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.167 -0.958 . . . . 0.0 109.581 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -51.13 -40.82 59.39 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.5 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.1 -50.9 11.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -0.869 . . . . 0.0 108.808 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 18' ' ' VAL . 18.1 t -50.26 -54.8 7.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.543 0.687 . . . . 0.0 109.317 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.8 m -77.47 -22.22 51.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.57 -0.707 . . . . 0.0 110.634 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.88 -115.65 5.79 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -85.23 -24.16 27.93 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.194 -1.18 . . . . 0.0 110.077 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.598 HH21 ' CG ' ' A' ' 22' ' ' ARG . 3.4 mtt-85 -54.43 -37.99 65.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.046 -1.034 . . . . 0.0 109.367 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.53 164.02 10.88 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.523 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 7.9 p90 -138.2 172.71 12.51 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.543 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 17.0 p90 -109.11 122.01 46.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -0.925 . . . . 0.0 109.554 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.9 t80 . . . . . 0 N--CA 1.498 1.968 0 O-C-N 121.208 -0.933 . . . . 0.0 108.863 179.67 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.632 0.729 . . . . 0.0 109.037 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.78 -36.87 14.59 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.747 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.58 -50.21 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.547 -0.972 . . . . 0.0 109.928 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.494 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.5 t -67.58 -65.09 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.61 -1.306 . . . . 0.0 111.455 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 46' ' ' ARG . 13.9 mm-40 -57.58 -48.84 78.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.847 -1.158 . . . . 0.0 110.426 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -46.83 -49.41 20.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.776 -1.202 . . . . 0.0 109.86 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.616 ' SG ' HD21 ' A' ' 54' ' ' LEU . 94.9 m -84.58 -53.5 5.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 110.172 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.416 ' N ' ' O ' ' A' ' 41' ' ' VAL . 54.1 t -60.93 -46.17 91.76 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.929 -1.107 . . . . 0.0 110.008 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.52 HH21 ' CG ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -69.87 -38.38 76.37 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.876 -1.14 . . . . 0.0 109.576 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.483 ' O ' ' O ' ' A' ' 44' ' ' CYS . 13.9 m -138.08 153.19 49.31 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.151 -0.968 . . . . 0.0 109.72 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.2 mt -68.6 99.68 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.109 -0.995 . . . . 0.0 109.837 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.7 p -83.34 140.56 32.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 108.918 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.558 ' H ' HE21 ' A' ' 53' ' ' GLN . 3.2 m -70.36 157.51 37.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.182 -0.949 . . . . 0.0 109.885 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 48.2 mt -53.54 -33.28 54.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.41 -0.806 . . . . 0.0 109.247 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -50.07 -49.03 52.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 108.968 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.558 HE21 ' H ' ' A' ' 50' ' ' SER . 53.3 mt-30 -63.52 -50.33 70.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.853 . . . . 0.0 108.932 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.616 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.3 mt -56.78 -32.8 66.01 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.178 -0.951 . . . . 0.0 108.455 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -74.71 -8.85 57.67 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -80.35 -22.21 41.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.523 -0.735 . . . . 0.0 110.961 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.519 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.4 m-85 -98.87 -7.46 27.25 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.066 -1.021 . . . . 0.0 110.332 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 73.4 m -60.51 99.19 0.08 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.249 -0.907 . . . . 0.0 109.813 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.327 0 CA-C-O 118.002 -1.443 . . . . 0.0 109.517 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.414 HD21 ' CB ' ' A' ' 14' ' ' ALA . 5.5 mp . . . . . 0 N--CA 1.499 1.98 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.437 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 58.6 m -128.64 125.03 37.26 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.346 -0.846 . . . . 0.0 110.331 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 60.59 -135.21 49.65 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.2 m -42.77 -35.14 1.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.619 -0.93 . . . . 0.0 110.645 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.437 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 2.6 t-80 -60.54 -34.04 73.55 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.906 -1.121 . . . . 0.0 108.646 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.711 HD21 HD12 ' A' ' 40' ' ' ILE . 13.4 tp -73.67 -49.1 27.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 t -59.64 -61.85 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.503 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.5 mt-10 -44.8 -29.1 0.73 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.022 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.414 ' CB ' HD21 ' A' ' 6' ' ' LEU . . . -85.31 -60.18 2.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.066 -1.021 . . . . 0.0 109.723 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.558 HD13 ' CD2' ' A' ' 24' ' ' PHE . 13.9 mt -48.1 -37.09 14.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.935 -1.103 . . . . 0.0 109.441 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -50.62 -40.48 53.09 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.503 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -78.42 -51.51 9.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.933 . . . . 0.0 108.815 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 t -50.03 -53.99 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-O 121.531 0.681 . . . . 0.0 109.202 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.4 m -78.92 -21.98 46.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.594 -0.691 . . . . 0.0 110.205 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.23 -115.44 5.19 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.649 -1.781 . . . . 0.0 108.649 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -85.32 -23.64 28.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.161 -1.199 . . . . 0.0 109.964 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 59' ' ' GLY . 89.2 mtt180 -54.62 -37.89 66.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.976 -1.077 . . . . 0.0 109.175 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.83 164.35 11.91 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.558 ' CD2' HD13 ' A' ' 15' ' ' LEU . 9.7 p90 -139.75 173.07 11.9 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.511 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 17.4 p90 -111.04 125.41 53.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.243 -0.911 . . . . 0.0 109.343 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.6 t80 . . . . . 0 N--CA 1.499 1.99 0 O-C-N 121.038 -1.038 . . . . 0.0 109.094 179.918 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.594 ' CG ' HH21 ' A' ' 38' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.32 -26.66 46.9 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.711 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -102.01 -53.9 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.435 -1.038 . . . . 0.0 110.337 -179.577 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.52 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 8.6 t -71.32 -65.17 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.554 -1.341 . . . . 0.0 111.271 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 46' ' ' ARG . 67.9 mt-10 -57.09 -50.65 72.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.921 -1.112 . . . . 0.0 110.369 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.411 ' O ' ' OE1' ' A' ' 43' ' ' GLN . 0.4 OUTLIER -48.46 -53.55 17.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.735 -1.228 . . . . 0.0 109.8 -179.504 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.515 ' SG ' HD21 ' A' ' 54' ' ' LEU . 97.6 m -75.7 -52.14 11.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.009 -1.057 . . . . 0.0 110.077 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.4 t -60.61 -52.77 63.72 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.913 -1.117 . . . . 0.0 110.229 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 42' ' ' GLU . 1.9 tmm_? -66.27 -36.49 83.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 0.0 110.027 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 44' ' ' CYS . 15.6 m -135.17 145.17 47.49 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.244 -0.91 . . . . 0.0 109.15 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.7 mt -68.24 99.6 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.134 -0.979 . . . . 0.0 109.472 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.4 p -82.98 141.91 31.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.44 -0.788 . . . . 0.0 109.333 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.7 m -70.19 157.04 38.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.701 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 43.8 mt -52.13 -32.36 35.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.374 -0.829 . . . . 0.0 108.978 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -48.43 -55.48 10.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.835 . . . . 0.0 109.314 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.527 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 60.9 mt-30 -57.79 -50.14 74.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.892 . . . . 0.0 109.188 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.515 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.0 mt -55.63 -35.48 65.94 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.115 -0.991 . . . . 0.0 108.675 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -72.41 -8.92 57.54 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.462 0.648 . . . . 0.0 109.322 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -80.04 -21.45 43.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.502 -0.749 . . . . 0.0 111.035 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.527 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.6 m-85 -100.76 -7.15 24.0 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.157 -0.965 . . . . 0.0 110.458 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 77.0 m -60.46 97.59 0.05 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.719 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.42 HD21 ' CB ' ' A' ' 14' ' ' ALA . 5.6 mp . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.444 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 64.1 m -128.54 125.09 37.61 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.272 -0.893 . . . . 0.0 110.675 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 60.34 -136.16 49.6 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.8 m -42.17 -33.97 0.68 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.752 -0.852 . . . . 0.0 110.624 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.444 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 1.0 OUTLIER -61.68 -34.99 76.71 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.841 -1.162 . . . . 0.0 108.83 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.697 HD21 HD12 ' A' ' 40' ' ' ILE . 12.1 tp -71.26 -49.74 40.02 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.5 t -58.6 -59.8 3.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.5 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 74.2 mt-10 -45.38 -30.15 1.26 Allowed 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.304 -0.559 . . . . 0.0 109.909 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.42 ' CB ' HD21 ' A' ' 6' ' ' LEU . . . -85.13 -60.87 1.91 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.152 -0.968 . . . . 0.0 109.694 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.568 HD13 ' CD2' ' A' ' 24' ' ' PHE . 15.6 mt -47.27 -36.33 8.99 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.004 -1.06 . . . . 0.0 109.64 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.86 -40.94 61.42 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.429 -0.795 . . . . 0.0 108.857 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.5 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -77.98 -51.71 9.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.164 -0.96 . . . . 0.0 108.871 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.3 t -49.91 -53.76 9.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.7 m -80.39 -22.32 41.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.617 -0.677 . . . . 0.0 110.297 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.84 -116.31 5.32 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.532 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 24.7 mp0 -84.48 -22.02 30.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -1.192 . . . . 0.0 109.699 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -54.96 -37.82 66.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.163 -0.961 . . . . 0.0 109.126 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.1 161.22 8.79 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.568 ' CD2' HD13 ' A' ' 15' ' ' LEU . 9.1 p90 -138.31 173.31 11.74 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.531 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 6.9 p90 -108.94 123.57 49.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.134 -0.979 . . . . 0.0 109.889 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.3 t80 . . . . . 0 N--CA 1.5 2.037 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.133 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.599 ' CG ' HH21 ' A' ' 38' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 121.681 0.753 . . . . 0.0 109.081 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.01 -31.77 22.45 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.697 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.4 -53.84 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.418 -1.048 . . . . 0.0 110.712 -178.425 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.521 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 4.3 t -69.65 -64.09 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 120.392 -1.443 . . . . 0.0 111.012 -178.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -56.16 -51.15 69.01 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.176 -0.952 . . . . 0.0 110.287 -178.517 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 47' ' ' SER . 7.0 tt0 -48.77 -53.96 16.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.633 -1.292 . . . . 0.0 110.063 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.538 ' SG ' HD21 ' A' ' 54' ' ' LEU . 87.3 m -74.83 -52.81 10.41 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.133 -0.98 . . . . 0.0 109.89 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 54.1 t -60.36 -52.47 65.13 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.062 -1.024 . . . . 0.0 110.341 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 42' ' ' GLU . 2.6 tmm_? -69.15 -34.59 75.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.926 -1.109 . . . . 0.0 110.185 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 44' ' ' CYS . 51.3 m -135.24 146.13 48.31 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.09 -1.006 . . . . 0.0 109.323 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.1 mt -68.66 99.64 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.0 -1.063 . . . . 0.0 109.706 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.5 p -83.77 138.41 33.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.319 -0.863 . . . . 0.0 109.09 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.4 m -69.61 160.2 32.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.264 -0.897 . . . . 0.0 110.162 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.0 mt -53.72 -32.86 53.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.504 -0.748 . . . . 0.0 109.133 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -49.71 -49.58 47.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 108.97 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.511 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 61.7 mt-30 -63.12 -52.53 62.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.358 -0.839 . . . . 0.0 109.095 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.538 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.5 mt -54.92 -35.32 64.06 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.292 -0.88 . . . . 0.0 108.718 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -73.13 -8.87 57.69 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.524 0.678 . . . . 0.0 109.303 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -80.16 -21.68 42.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.437 -0.789 . . . . 0.0 110.926 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.511 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.0 m-85 -100.38 -6.33 25.91 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.172 -0.955 . . . . 0.0 110.474 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.4 m -61.19 97.32 0.06 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.114 -0.991 . . . . 0.0 109.507 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.268 0 CA-C-O 117.993 -1.449 . . . . 0.0 109.517 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.407 HD21 ' CB ' ' A' ' 14' ' ' ALA . 4.6 mp . . . . . 0 N--CA 1.497 1.911 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.419 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 68.9 m -129.39 125.06 35.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.255 -0.903 . . . . 0.0 110.377 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.99 -137.78 43.89 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.0 m -42.68 -34.87 0.97 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.648 -0.913 . . . . 0.0 110.412 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.419 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 2.1 t-160 -58.1 -35.66 71.75 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.94 -1.1 . . . . 0.0 108.56 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.726 HD21 HD12 ' A' ' 40' ' ' ILE . 11.0 tp -71.5 -52.49 18.04 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.523 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 75.2 t -58.87 -58.95 4.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.493 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 30.2 mt-10 -44.85 -28.75 0.69 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.74 -0.6 . . . . 0.0 109.909 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.407 ' CB ' HD21 ' A' ' 6' ' ' LEU . . . -86.8 -61.31 1.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -0.962 . . . . 0.0 109.52 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.553 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.5 mt -46.23 -36.58 6.24 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.171 -0.956 . . . . 0.0 109.713 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -51.97 -41.12 61.87 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.387 -0.821 . . . . 0.0 108.807 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.493 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -77.77 -50.95 11.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 0.0 108.863 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.5 t -50.16 -54.66 7.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.2 m -78.61 -22.01 47.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.601 -0.687 . . . . 0.0 110.258 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.92 -116.74 6.44 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.544 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 5.1 mp0 -84.77 -21.65 29.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.072 -1.252 . . . . 0.0 109.676 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -54.94 -38.1 67.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.163 -0.961 . . . . 0.0 109.286 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.14 162.11 9.8 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.553 ' CD2' HD13 ' A' ' 15' ' ' LEU . 8.0 p90 -139.26 172.42 12.85 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.519 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 19.3 p90 -109.1 123.45 49.2 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.4 t80 . . . . . 0 N--CA 1.496 1.86 0 O-C-N 120.939 -1.101 . . . . 0.0 109.839 -179.355 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.616 ' CG ' HH21 ' A' ' 38' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.569 0.699 . . . . 0.0 109.183 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.6 -28.72 38.12 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.726 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.9 -51.25 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.442 -1.034 . . . . 0.0 110.18 -179.275 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.5 t -69.73 -65.0 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.521 -1.362 . . . . 0.0 111.237 -178.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' ARG . 61.5 mm-40 -57.5 -47.53 81.66 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.897 -1.127 . . . . 0.0 110.38 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -48.66 -53.65 17.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.682 -1.262 . . . . 0.0 109.565 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.586 ' SG ' HD21 ' A' ' 54' ' ' LEU . 96.6 m -78.16 -53.65 7.13 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.211 -0.93 . . . . 0.0 109.965 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.7 t -59.96 -52.49 65.19 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.9 -1.125 . . . . 0.0 110.056 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.545 HH21 ' CG ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -68.69 -33.13 73.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -0.952 . . . . 0.0 110.362 -179.172 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 44' ' ' CYS . 7.7 m -136.28 144.93 45.02 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.105 -0.997 . . . . 0.0 109.387 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 55.0 mt -68.43 99.48 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.013 -1.055 . . . . 0.0 109.272 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.6 p -85.5 141.81 29.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.417 -0.802 . . . . 0.0 109.343 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.3 m -73.04 160.56 31.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.634 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.414 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 43.8 mt -53.06 -33.01 50.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 109.342 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -48.43 -56.96 6.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -0.9 . . . . 0.0 109.31 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.517 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 64.1 mt-30 -56.47 -50.53 71.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.209 -0.932 . . . . 0.0 109.018 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.586 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.8 mt -56.07 -33.97 65.52 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.136 -0.977 . . . . 0.0 108.543 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -73.85 -9.02 58.23 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -79.98 -21.73 43.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.498 -0.751 . . . . 0.0 111.092 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.517 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.6 m-85 -100.64 -6.14 25.62 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.11 -0.994 . . . . 0.0 110.352 -178.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 73.6 m -62.08 97.05 0.08 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.193 -0.942 . . . . 0.0 109.805 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.304 0 CA-C-O 117.98 -1.456 . . . . 0.0 109.515 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.456 HD21 ' CB ' ' A' ' 14' ' ' ALA . 5.9 mp . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.437 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 57.9 m -130.77 125.23 33.25 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.293 -0.879 . . . . 0.0 110.425 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 61.05 -137.03 48.25 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.3 m -42.36 -31.67 0.43 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.613 -0.934 . . . . 0.0 110.695 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.437 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 6.7 t-160 -64.39 -34.5 78.32 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.777 -1.202 . . . . 0.0 108.665 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.708 HD21 HD12 ' A' ' 40' ' ' ILE . 9.6 tp -71.09 -49.72 41.42 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 t -57.71 -60.46 2.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 25.7 mt-10 -44.5 -29.93 0.79 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.068 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.456 ' CB ' HD21 ' A' ' 6' ' ' LEU . . . -85.6 -60.55 1.99 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.086 -1.009 . . . . 0.0 109.578 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.525 HD13 ' CD2' ' A' ' 24' ' ' PHE . 15.7 mt -47.05 -37.34 9.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.055 -1.028 . . . . 0.0 109.745 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -50.89 -40.76 57.4 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.496 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -77.82 -50.6 11.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 108.746 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.7 t -50.26 -55.29 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.4 m -79.17 -22.19 45.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.6 -0.687 . . . . 0.0 110.304 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.72 -116.57 6.13 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -85.01 -22.67 28.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.128 -1.219 . . . . 0.0 109.76 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -54.77 -38.35 67.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.15 -0.969 . . . . 0.0 108.843 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.2 162.69 10.61 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 120.094 -1.051 . . . . 0.0 110.747 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 24' ' ' PHE . 7.0 p90 -137.43 172.58 12.76 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.533 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 15.7 p90 -110.89 122.21 47.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 0.0 108.995 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.1 t80 . . . . . 0 N--CA 1.497 1.924 0 O-C-N 120.863 -1.148 . . . . 0.0 108.787 179.9 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.32 -36.09 15.63 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.708 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.87 -50.79 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.407 -1.054 . . . . 0.0 110.039 -179.255 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.49 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.3 t -67.73 -64.9 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.57 -1.331 . . . . 0.0 111.802 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 46' ' ' ARG . 31.5 mm-40 -55.72 -53.0 61.99 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.934 -1.104 . . . . 0.0 111.377 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -47.44 -50.13 23.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.651 -1.28 . . . . 0.0 109.973 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.625 ' SG ' HD21 ' A' ' 54' ' ' LEU . 94.6 m -81.17 -54.4 5.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.995 -1.066 . . . . 0.0 110.186 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 54.0 t -61.51 -47.87 83.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.872 -1.142 . . . . 0.0 110.074 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 42' ' ' GLU . 1.0 OUTLIER -69.79 -36.32 75.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.999 -1.063 . . . . 0.0 109.722 -179.469 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 44' ' ' CYS . 6.9 m -137.27 150.33 47.74 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.062 -1.024 . . . . 0.0 109.733 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.5 mt -68.64 99.74 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.145 -0.972 . . . . 0.0 109.272 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.1 p -83.27 146.21 28.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.388 -0.82 . . . . 0.0 109.817 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.1 m -79.54 166.28 22.09 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.305 -0.872 . . . . 0.0 109.516 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.0 mt -56.49 -31.99 64.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.484 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -48.31 -48.62 35.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.14 -0.975 . . . . 0.0 109.47 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.522 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 61.0 mt-30 -69.16 -53.38 20.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.343 -0.848 . . . . 0.0 109.633 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.625 HD21 ' SG ' ' A' ' 44' ' ' CYS . 98.0 mt -55.12 -35.44 64.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.142 -0.974 . . . . 0.0 109.021 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -73.91 -9.36 58.56 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -78.83 -22.03 46.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.387 -0.82 . . . . 0.0 110.839 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.522 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.2 m-85 -100.28 -6.45 25.92 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.185 -0.947 . . . . 0.0 110.443 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 74.6 m -62.71 96.51 0.09 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.1 -1.0 . . . . 0.0 109.536 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.283 0 CA-C-O 117.984 -1.453 . . . . 0.0 109.523 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.471 HD21 ' CB ' ' A' ' 14' ' ' ALA . 6.6 mp . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.4 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 68.0 m -129.74 125.17 35.26 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.189 -0.945 . . . . 0.0 110.65 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 60.66 -139.22 48.1 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 8' ' ' GLY . 70.6 m -39.64 -33.34 0.18 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.856 -0.791 . . . . 0.0 110.71 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.4 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 2.2 t-160 -60.91 -39.77 90.62 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.878 -1.139 . . . . 0.0 108.699 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.753 HD21 HD12 ' A' ' 40' ' ' ILE . 9.2 tp -65.34 -53.96 35.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.408 -0.807 . . . . 0.0 109.109 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.52 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 73.2 t -55.4 -59.75 2.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.493 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 32.5 mt-10 -44.59 -28.77 0.63 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.698 -0.626 . . . . 0.0 110.126 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.471 ' CB ' HD21 ' A' ' 6' ' ' LEU . . . -86.77 -60.51 1.97 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.118 -0.989 . . . . 0.0 109.485 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.533 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.3 mt -46.96 -35.76 6.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.102 -0.999 . . . . 0.0 109.552 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -52.36 -40.85 62.52 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.493 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.02 -51.13 10.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 108.867 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.6 t -50.15 -54.1 9.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.3 m -78.44 -22.13 48.11 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.634 -0.666 . . . . 0.0 110.32 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.06 -115.04 4.14 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.519 -1.832 . . . . 0.0 108.519 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -85.41 -23.4 27.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.11 -1.229 . . . . 0.0 109.931 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 59' ' ' GLY . 37.2 mtp180 -54.76 -37.79 66.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -0.982 . . . . 0.0 109.286 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.82 162.73 9.76 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.562 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.533 ' CD2' HD13 ' A' ' 15' ' ' LEU . 9.5 p90 -138.85 173.8 11.19 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.548 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 18.5 p90 -110.7 122.15 47.1 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.173 -0.954 . . . . 0.0 110.273 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.1 t80 . . . . . 0 N--CA 1.5 2.052 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.906 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.419 HH21 ' HG3' ' A' ' 38' ' ' ARG . 1.6 ptm180 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.59 -32.45 27.52 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.753 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.77 -51.42 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.479 -1.012 . . . . 0.0 110.121 -179.418 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.513 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 4.1 t -68.79 -64.34 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.649 -1.282 . . . . 0.0 111.409 -178.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 46' ' ' ARG . 68.2 mm-40 -58.26 -53.04 62.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.791 -1.193 . . . . 0.0 110.257 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -43.85 -47.48 8.22 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.972 -1.08 . . . . 0.0 110.187 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.647 ' SG ' HD21 ' A' ' 54' ' ' LEU . 95.3 m -84.05 -50.47 7.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.036 -1.04 . . . . 0.0 109.933 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.9 t -61.79 -53.12 60.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.243 -0.911 . . . . 0.0 110.472 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 42' ' ' GLU . 7.9 tpp180 -69.68 -39.45 76.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.918 -1.114 . . . . 0.0 109.708 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 44' ' ' CYS . 15.6 m -126.41 144.78 50.72 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.11 -0.993 . . . . 0.0 109.584 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.5 mt -69.38 99.38 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.173 -0.954 . . . . 0.0 109.24 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.5 p -83.85 143.34 29.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.327 -0.858 . . . . 0.0 109.533 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.483 ' H ' HE21 ' A' ' 53' ' ' GLN . 5.0 m -73.35 161.25 30.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.86 . . . . 0.0 109.805 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 42.3 mt -55.52 -34.18 64.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.852 . . . . 0.0 109.342 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -48.63 -53.73 17.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.129 -0.982 . . . . 0.0 109.031 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.52 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 56.4 mt-30 -58.69 -51.75 68.6 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.331 -0.856 . . . . 0.0 108.939 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.647 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.4 mt -56.69 -30.77 63.78 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -76.29 -8.86 58.0 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -80.51 -22.85 40.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.533 -0.729 . . . . 0.0 110.869 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.52 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 5.7 m-85 -99.35 -7.43 26.27 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.111 -0.993 . . . . 0.0 110.048 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 91.5 m -61.35 93.98 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.386 -0.821 . . . . 0.0 109.722 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.344 0 CA-C-O 118.029 -1.428 . . . . 0.0 109.568 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.428 HD21 ' CB ' ' A' ' 14' ' ' ALA . 4.1 mp . . . . . 0 N--CA 1.493 1.677 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.415 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 76.2 m -128.22 125.07 38.24 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.99 0.9 . . . . 0.0 110.839 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.73 -136.85 48.78 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.4 m -42.65 -31.49 0.47 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.605 -0.938 . . . . 0.0 110.484 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.415 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 1.7 t-160 -62.26 -34.0 75.7 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.944 -1.097 . . . . 0.0 108.758 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.708 HD21 HD12 ' A' ' 40' ' ' ILE . 12.0 tp -72.97 -52.57 13.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.438 -0.789 . . . . 0.0 109.015 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.512 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 66.9 t -56.44 -59.64 2.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.484 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.6 mt-10 -44.25 -28.96 0.58 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.804 -0.56 . . . . 0.0 110.222 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.428 ' CB ' HD21 ' A' ' 6' ' ' LEU . . . -86.96 -59.8 2.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.132 -0.98 . . . . 0.0 109.602 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.547 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.9 mt -47.21 -36.77 9.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.164 -0.96 . . . . 0.0 109.513 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.32 -41.13 60.34 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.484 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -77.74 -50.09 13.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 108.856 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.5 t -50.44 -54.55 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-O 121.65 0.738 . . . . 0.0 109.029 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.1 m -79.51 -22.77 43.53 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.696 -0.628 . . . . 0.0 110.506 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 50.09 -109.65 0.7 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 8.9 mp0 -85.48 -25.58 26.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.213 -1.169 . . . . 0.0 110.269 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HG2' HH21 ' A' ' 22' ' ' ARG . 31.7 mtt-85 -54.66 -38.68 67.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.955 -1.091 . . . . 0.0 109.309 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.34 161.54 8.02 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.547 ' CD2' HD13 ' A' ' 15' ' ' LEU . 9.5 p90 -138.4 173.59 11.44 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.469 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 4.9 p90 -106.25 128.53 54.03 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.209 -0.932 . . . . 0.0 110.012 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.5 t80 . . . . . 0 N--CA 1.506 2.33 0 O-C-N 121.343 -0.848 . . . . 0.0 109.069 179.691 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.526 ' HG2' HH21 ' A' ' 38' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.06 -28.63 40.62 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.708 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.1 -54.13 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.475 -1.015 . . . . 0.0 110.283 -179.288 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.514 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.2 t -66.73 -64.83 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.358 -1.464 . . . . 0.0 111.21 -178.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 46' ' ' ARG . 52.5 mm-40 -56.24 -48.55 76.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.919 -1.113 . . . . 0.0 110.08 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -46.98 -55.87 7.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.739 -1.226 . . . . 0.0 109.991 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.563 ' SG ' HD21 ' A' ' 54' ' ' LEU . 93.6 m -76.94 -52.66 9.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.246 -0.909 . . . . 0.0 110.062 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.8 t -59.47 -52.93 63.48 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.867 -1.145 . . . . 0.0 109.97 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 42' ' ' GLU . 2.7 tmt_? -66.82 -36.3 82.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.289 -0.882 . . . . 0.0 110.235 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 44' ' ' CYS . 16.2 m -134.43 145.25 48.7 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.124 -0.985 . . . . 0.0 109.362 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 57.5 mt -68.21 99.62 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.036 -1.04 . . . . 0.0 109.331 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.8 p -84.93 150.01 25.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.417 -0.802 . . . . 0.0 109.421 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.7 m -88.41 166.17 14.42 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.262 -0.899 . . . . 0.0 110.026 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.1 mt -52.17 -34.25 44.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.421 -0.8 . . . . 0.0 109.519 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -47.52 -43.1 24.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.246 -0.909 . . . . 0.0 109.57 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.512 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 41.8 mt-30 -77.47 -52.33 9.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.374 -0.829 . . . . 0.0 109.792 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.563 HD21 ' SG ' ' A' ' 44' ' ' CYS . 98.7 mt -54.45 -38.08 65.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.031 -1.043 . . . . 0.0 109.007 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -71.0 -9.27 57.72 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 121.544 0.688 . . . . 0.0 109.286 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -78.91 -22.36 45.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 0.0 111.033 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.512 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.7 m-85 -99.98 -8.04 24.39 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.078 -1.013 . . . . 0.0 110.272 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 87.5 m -60.53 94.86 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.511 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 mp . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 86.0 m -128.5 124.98 37.44 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.31 -0.869 . . . . 0.0 110.388 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.56 -137.01 44.63 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 m -42.31 -35.63 1.04 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.707 -0.878 . . . . 0.0 110.568 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.403 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 0.8 OUTLIER -58.49 -35.12 71.71 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.919 -1.113 . . . . 0.0 108.892 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.722 HD21 HD12 ' A' ' 40' ' ' ILE . 12.7 tp -72.03 -52.52 16.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.332 -0.855 . . . . 0.0 108.826 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.507 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 75.1 t -58.44 -59.25 3.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.499 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 85.7 mt-10 -45.12 -29.0 0.82 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.727 -0.608 . . . . 0.0 109.895 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.53 -60.9 1.86 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -0.939 . . . . 0.0 109.559 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.567 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.6 mt -46.87 -36.55 7.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.166 -0.958 . . . . 0.0 109.555 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.7 -41.96 61.86 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.408 -0.808 . . . . 0.0 108.842 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.499 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -76.38 -51.84 11.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 108.735 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 t -49.97 -53.78 9.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.547 0.689 . . . . 0.0 109.203 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 m -79.84 -22.38 43.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.471 -0.768 . . . . 0.0 110.471 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.86 -114.22 3.41 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.744 -1.743 . . . . 0.0 108.744 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -85.29 -23.98 27.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.2 -1.176 . . . . 0.0 110.125 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -54.6 -37.69 65.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.966 -1.084 . . . . 0.0 109.359 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.83 162.24 9.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.567 ' CD2' HD13 ' A' ' 15' ' ' LEU . 9.3 p90 -138.41 173.51 11.52 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 3.8 p90 -107.72 125.41 51.36 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.086 -1.008 . . . . 0.0 110.231 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.5 t80 . . . . . 0 N--CA 1.502 2.165 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.045 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.587 ' CG ' HH21 ' A' ' 38' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.23 -33.05 24.15 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.722 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.29 -53.88 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.159 -1.201 . . . . 0.0 110.837 -178.749 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.502 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.7 t -65.93 -63.65 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.454 -1.404 . . . . 0.0 111.402 -177.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' ARG . 71.4 mt-10 -55.46 -51.59 66.43 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.868 -1.145 . . . . 0.0 111.056 -178.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.591 ' O ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -48.21 -52.05 22.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.622 -1.299 . . . . 0.0 110.044 -179.128 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.572 ' SG ' HD21 ' A' ' 54' ' ' LEU . 85.4 m -78.01 -53.77 7.04 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.962 -1.086 . . . . 0.0 110.013 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 54.0 t -59.86 -52.18 66.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.89 -1.131 . . . . 0.0 109.939 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -67.03 -35.58 80.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 0.0 110.303 -179.396 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 44' ' ' CYS . 26.4 m -136.67 147.2 46.7 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.059 -1.026 . . . . 0.0 109.307 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.9 mt -68.32 99.71 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.045 -1.034 . . . . 0.0 109.554 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.4 p -85.29 138.77 32.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.364 -0.835 . . . . 0.0 109.175 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.0 m -70.1 163.06 27.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.27 -0.894 . . . . 0.0 109.68 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.1 mt -56.61 -31.0 63.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.337 -0.852 . . . . 0.0 108.892 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -48.91 -51.95 27.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 109.177 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.49 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 56.8 mt-30 -62.99 -50.35 71.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.223 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.572 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.8 mt -55.09 -36.01 65.2 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.2 -0.938 . . . . 0.0 108.768 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -71.81 -8.98 57.57 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.485 0.659 . . . . 0.0 109.254 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -79.81 -22.5 42.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.422 -0.798 . . . . 0.0 110.958 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.49 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.8 m-85 -100.04 -8.15 24.16 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.069 -1.019 . . . . 0.0 110.209 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 81.6 m -60.39 93.03 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.357 -0.839 . . . . 0.0 109.44 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.284 0 CA-C-O 117.985 -1.453 . . . . 0.0 109.555 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.402 HD21 ' CB ' ' A' ' 14' ' ' ALA . 5.0 mp . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.424 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 63.0 m -130.73 124.57 31.77 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.321 -0.862 . . . . 0.0 109.872 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 63.95 -138.1 41.66 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.6 m -41.69 -35.17 0.72 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.715 -0.873 . . . . 0.0 110.764 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.424 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 7.3 t-160 -59.29 -35.68 74.2 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.878 -1.139 . . . . 0.0 108.89 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.721 HD21 HD12 ' A' ' 40' ' ' ILE . 8.4 tp -70.18 -52.73 21.12 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.511 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 64.6 t -58.12 -60.38 2.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.489 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 70.9 mt-10 -44.01 -30.17 0.69 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.818 -0.551 . . . . 0.0 110.022 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.402 ' CB ' HD21 ' A' ' 6' ' ' LEU . . . -84.9 -61.15 1.85 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.254 -0.904 . . . . 0.0 109.71 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.498 HD13 ' CD2' ' A' ' 24' ' ' PHE . 13.2 mt -46.1 -36.9 6.22 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.245 -0.909 . . . . 0.0 109.629 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -51.85 -40.43 60.53 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.489 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -78.37 -50.65 11.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 108.761 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.418 ' H ' HG23 ' A' ' 18' ' ' VAL . 19.2 t -50.12 -55.02 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.523 0.678 . . . . 0.0 109.362 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.6 m -77.29 -22.34 52.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.556 -0.715 . . . . 0.0 110.615 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.32 -112.59 2.11 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.571 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 2.6 mp0 -85.32 -25.11 27.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.226 -1.161 . . . . 0.0 109.972 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -54.44 -38.3 66.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.065 -1.022 . . . . 0.0 109.486 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.15 162.71 8.73 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.511 ' HZ ' HG13 ' A' ' 12' ' ' VAL . 9.2 p90 -138.48 173.33 11.71 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.544 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 18.8 p90 -111.96 121.68 45.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 109.643 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 13.7 t80 . . . . . 0 N--CA 1.498 1.953 0 O-C-N 121.026 -1.046 . . . . 0.0 108.798 179.27 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.55 -31.01 31.42 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.721 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.13 -52.49 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.706 -0.879 . . . . 0.0 110.137 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.516 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.9 t -68.97 -64.76 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.514 -1.366 . . . . 0.0 111.473 -178.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 46' ' ' ARG . 97.4 mt-10 -58.23 -49.32 77.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.913 -1.117 . . . . 0.0 110.534 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -46.75 -49.47 19.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.82 -1.175 . . . . 0.0 109.899 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.606 ' SG ' HD21 ' A' ' 54' ' ' LEU . 86.4 m -84.16 -51.84 6.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 110.248 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.3 t -61.57 -48.29 81.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.813 -1.179 . . . . 0.0 109.79 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.553 HH21 ' CG ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -66.25 -39.11 89.26 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.99 -1.069 . . . . 0.0 109.703 -179.718 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 44' ' ' CYS . 68.8 m -138.61 152.84 48.48 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.143 -0.973 . . . . 0.0 109.719 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.4 mt -68.53 99.46 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.012 -1.055 . . . . 0.0 109.381 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.3 p -80.87 141.28 34.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 0.0 108.891 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 m -70.39 158.87 35.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -0.951 . . . . 0.0 109.912 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 43.3 mt -53.02 -32.25 45.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.442 -0.786 . . . . 0.0 109.187 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -49.5 -52.09 31.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.257 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.492 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 45.7 mt-30 -62.41 -51.32 68.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 109.326 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.606 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.8 mt -56.5 -33.23 65.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.093 -1.004 . . . . 0.0 108.437 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -74.37 -8.95 58.01 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -79.65 -22.22 43.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.452 -0.78 . . . . 0.0 110.897 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.492 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.4 m-85 -100.27 -8.17 23.78 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.187 -0.946 . . . . 0.0 110.056 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 93.4 m -60.63 96.2 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.59 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.407 HD21 ' CB ' ' A' ' 14' ' ' ALA . 4.7 mp . . . . . 0 N--CA 1.499 1.994 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.446 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 62.7 m -128.95 124.86 36.19 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.212 -0.93 . . . . 0.0 110.163 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.14 -136.45 45.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -42.01 -35.44 0.89 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.719 -0.871 . . . . 0.0 110.584 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.446 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 0.8 OUTLIER -59.4 -36.28 75.53 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.9 -1.125 . . . . 0.0 108.751 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.716 HD21 HD12 ' A' ' 40' ' ' ILE . 10.7 tp -70.97 -50.16 37.48 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.9 t -59.36 -60.83 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.498 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.7 mt-10 -44.71 -29.73 0.82 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.919 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.407 ' CB ' HD21 ' A' ' 6' ' ' LEU . . . -85.2 -61.11 1.85 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.726 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.529 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.2 mt -46.72 -36.95 7.73 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.142 -0.974 . . . . 0.0 109.706 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -51.37 -40.43 59.18 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.498 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.34 -50.74 11.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 108.759 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.487 ' O ' ' NH1' ' A' ' 22' ' ' ARG . 21.1 t -49.98 -54.94 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.7 m -79.81 -22.39 43.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.62 -0.675 . . . . 0.0 110.113 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.74 -115.69 5.19 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.769 -1.733 . . . . 0.0 108.769 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 8.9 mp0 -84.6 -22.14 30.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.187 -1.184 . . . . 0.0 109.67 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.487 ' NH1' ' O ' ' A' ' 18' ' ' VAL . 78.5 mtm180 -55.02 -37.84 67.15 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.152 -0.968 . . . . 0.0 109.253 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.85 160.14 7.59 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.48 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.529 ' CD2' HD13 ' A' ' 15' ' ' LEU . 8.6 p90 -137.77 172.63 12.66 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.523 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 9.2 p90 -109.86 124.81 51.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 109.335 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.7 t80 . . . . . 0 N--CA 1.497 1.918 0 O-C-N 121.045 -1.034 . . . . 0.0 108.703 179.378 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.616 0.722 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.36 -35.74 51.7 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.716 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.12 -51.5 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.244 -1.151 . . . . 0.0 110.467 -179.149 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.487 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.5 t -69.56 -64.63 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 120.463 -1.398 . . . . 0.0 111.994 -177.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -55.45 -53.82 51.56 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.849 -1.157 . . . . 0.0 111.028 -177.881 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.587 HE21 ' C ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -47.19 -49.42 22.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.824 -1.172 . . . . 0.0 109.876 -178.91 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.61 ' SG ' HD21 ' A' ' 54' ' ' LEU . 95.1 m -81.14 -54.44 5.53 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.931 -1.105 . . . . 0.0 109.897 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.6 t -60.95 -52.06 66.63 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.922 -1.111 . . . . 0.0 110.102 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -68.89 -33.78 74.34 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.218 -0.926 . . . . 0.0 110.402 -179.031 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 44' ' ' CYS . 25.4 m -136.48 147.63 47.27 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.071 -1.018 . . . . 0.0 109.404 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.5 mt -69.14 99.36 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.088 -1.008 . . . . 0.0 109.125 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.1 p -85.41 146.68 26.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.376 -0.827 . . . . 0.0 109.297 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.3 m -77.62 162.94 26.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.891 . . . . 0.0 109.69 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.5 mt -56.09 -31.76 63.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 0.0 108.969 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -46.9 -54.4 10.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 0.0 109.533 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.525 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 63.4 mt-30 -62.36 -50.46 71.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.388 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.61 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.3 mt -55.71 -34.14 64.85 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.078 -1.014 . . . . 0.0 108.686 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.487 ' OE2' ' NH2' ' A' ' 22' ' ' ARG . 4.2 tm-20 -74.42 -9.38 58.53 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -79.52 -21.79 44.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.386 -0.822 . . . . 0.0 110.99 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.525 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.9 m-85 -99.17 -7.4 26.63 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.078 -1.014 . . . . 0.0 110.626 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.436 ' O ' ' OXT' ' A' ' 59' ' ' GLY . 78.4 m -59.01 102.17 0.11 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.004 -1.06 . . . . 0.0 109.066 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.492 2.426 0 CA-C-O 117.911 -1.494 . . . . 0.0 109.945 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.411 HD21 ' CB ' ' A' ' 14' ' ' ALA . 4.3 mp . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.41 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 58.6 m -130.11 124.99 34.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.177 -0.952 . . . . 0.0 110.516 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.82 -137.27 44.08 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.3 m -43.31 -30.95 0.56 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.54 -0.977 . . . . 0.0 110.419 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.41 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 2.1 t-80 -63.18 -33.6 75.83 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.97 -1.081 . . . . 0.0 108.811 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.714 HD21 HD12 ' A' ' 40' ' ' ILE . 9.2 tp -72.12 -51.65 20.42 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.517 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 76.5 t -58.12 -60.98 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.49 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 29.2 mt-10 -43.55 -29.35 0.46 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.821 -0.549 . . . . 0.0 109.975 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.411 ' CB ' HD21 ' A' ' 6' ' ' LEU . . . -85.77 -61.11 1.83 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.435 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.513 HD13 ' CD2' ' A' ' 24' ' ' PHE . 13.8 mt -46.15 -37.13 6.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.201 -0.937 . . . . 0.0 109.707 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.52 -42.42 61.72 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.407 -0.808 . . . . 0.0 108.842 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.49 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -75.66 -51.23 13.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.281 -0.887 . . . . 0.0 108.763 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.418 ' H ' HG23 ' A' ' 18' ' ' VAL . 19.0 t -50.37 -55.1 6.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-O 121.516 0.674 . . . . 0.0 109.337 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.6 m -78.01 -22.31 49.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.481 -0.762 . . . . 0.0 110.613 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.22 -118.38 13.21 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -85.37 -24.9 27.38 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.135 -1.215 . . . . 0.0 110.329 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.603 HH21 ' CG ' ' A' ' 22' ' ' ARG . 2.8 mtt-85 -54.3 -36.66 63.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.946 -1.096 . . . . 0.0 109.303 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.33 166.84 19.98 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.549 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 7.4 p90 -139.01 172.49 12.76 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.544 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 15.2 p90 -110.19 121.75 46.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.9 . . . . 0.0 109.282 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.0 t80 . . . . . 0 N--CA 1.495 1.809 0 O-C-N 121.069 -1.019 . . . . 0.0 109.666 179.987 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.562 0.696 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.44 -37.54 14.29 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.714 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.35 -50.68 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.491 -1.005 . . . . 0.0 109.956 -179.288 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.499 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 4.3 t -69.37 -64.93 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 120.592 -1.317 . . . . 0.0 111.692 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 46' ' ' ARG . 31.3 mm-40 -57.03 -51.87 67.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.804 -1.185 . . . . 0.0 110.262 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -45.6 -48.69 14.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.082 -1.012 . . . . 0.0 110.138 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.629 ' SG ' HD21 ' A' ' 54' ' ' LEU . 86.2 m -84.08 -53.9 5.21 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.199 -0.938 . . . . 0.0 109.992 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 54.0 t -60.82 -51.59 68.68 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.054 -1.029 . . . . 0.0 110.064 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 42' ' ' GLU . 2.9 tmt_? -68.06 -35.67 78.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.135 -0.978 . . . . 0.0 110.003 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 44' ' ' CYS . 23.2 m -136.52 147.73 47.24 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.15 -0.969 . . . . 0.0 109.331 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 63.4 mt -68.49 99.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.022 -1.049 . . . . 0.0 109.312 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.5 p -82.42 138.1 34.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.431 -0.793 . . . . 0.0 108.993 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 m -68.75 158.87 33.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.777 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.8 mt -53.59 -31.72 48.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.351 -0.843 . . . . 0.0 108.964 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -49.01 -51.91 28.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.408 -0.808 . . . . 0.0 109.23 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.487 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 64.7 mt-30 -63.32 -49.41 74.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.234 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.629 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.6 mt -56.85 -32.77 66.13 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.015 -1.053 . . . . 0.0 108.249 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -74.55 -9.26 58.41 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -79.76 -22.14 43.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 111.103 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.487 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.5 m-85 -99.5 -4.93 30.2 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.048 -1.033 . . . . 0.0 110.712 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 75.5 m -62.19 102.48 0.3 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.06 -1.025 . . . . 0.0 109.827 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.318 0 CA-C-O 118.026 -1.43 . . . . 0.0 109.557 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.498 1.963 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.421 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 58.1 m -129.21 124.94 35.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.374 -0.829 . . . . 0.0 110.056 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.61 -137.36 44.6 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 m -41.5 -35.61 0.74 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.751 -0.852 . . . . 0.0 110.71 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.421 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 0.8 OUTLIER -59.45 -35.95 75.01 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.899 -1.125 . . . . 0.0 108.817 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.696 HD21 HD12 ' A' ' 40' ' ' ILE . 10.8 tp -71.05 -50.03 38.43 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -59.6 -61.43 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.497 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 81.7 mt-10 -44.38 -29.9 0.76 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.847 -0.533 . . . . 0.0 110.004 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.34 -60.76 1.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.155 -0.966 . . . . 0.0 109.79 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.538 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.3 mt -47.01 -36.49 7.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.08 -1.012 . . . . 0.0 109.57 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.7 -40.79 60.77 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.497 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.49 -50.75 11.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 0.0 108.992 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -49.89 -53.48 10.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.538 0.685 . . . . 0.0 109.295 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 m -78.79 -22.32 46.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.596 -0.69 . . . . 0.0 110.585 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.24 -114.07 3.45 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 2.2 mp0 -85.28 -24.03 27.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.174 -1.192 . . . . 0.0 109.974 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -54.66 -38.43 66.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.056 -1.028 . . . . 0.0 109.35 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.33 163.39 9.73 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.538 ' CD2' HD13 ' A' ' 15' ' ' LEU . 8.2 p90 -138.37 173.05 12.02 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.529 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 17.6 p90 -111.85 122.61 48.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.29 -0.881 . . . . 0.0 109.54 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.3 t80 . . . . . 0 N--CA 1.497 1.919 0 O-C-N 121.088 -1.007 . . . . 0.0 108.396 179.38 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.482 0.658 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.49 -33.7 24.61 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.696 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.33 -51.55 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.463 -1.022 . . . . 0.0 110.044 -179.274 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 3.0 t -69.18 -65.1 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 120.485 -1.384 . . . . 0.0 111.525 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' ARG . 78.1 mm-40 -57.55 -49.19 77.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.834 -1.166 . . . . 0.0 110.556 -178.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -47.53 -51.9 19.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.845 -1.159 . . . . 0.0 109.838 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.566 ' SG ' HD21 ' A' ' 54' ' ' LEU . 89.2 m -80.69 -52.02 8.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.26 -0.9 . . . . 0.0 110.09 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.8 t -60.42 -52.06 66.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.805 -1.184 . . . . 0.0 109.827 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.516 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -64.56 -38.09 89.81 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.247 -0.908 . . . . 0.0 110.074 -179.383 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 44' ' ' CYS . 39.4 m -137.3 149.16 46.88 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.144 -0.973 . . . . 0.0 109.552 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.2 mt -68.2 99.31 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.062 -1.024 . . . . 0.0 109.448 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.9 p -81.8 140.92 33.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.396 -0.815 . . . . 0.0 108.956 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.5 m -70.18 159.03 34.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 109.717 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 40.7 mt -52.91 -31.65 41.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.37 -0.832 . . . . 0.0 108.999 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -48.24 -53.78 15.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 109.356 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.517 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 47.0 mt-30 -61.52 -50.62 71.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 109.445 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.566 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.0 mt -56.06 -35.05 66.49 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.126 -0.984 . . . . 0.0 108.605 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -72.61 -9.58 58.77 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -78.5 -22.57 47.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.31 -0.869 . . . . 0.0 111.039 -178.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.517 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.4 m-85 -100.97 -7.03 23.72 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.158 -0.964 . . . . 0.0 110.147 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 96.8 m -62.04 96.34 0.07 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.201 -0.937 . . . . 0.0 109.607 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.33 0 CA-C-O 118.011 -1.438 . . . . 0.0 109.606 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.422 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 62.5 m -129.64 124.97 34.98 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.255 -0.903 . . . . 0.0 109.946 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.5 -138.01 42.71 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.7 m -42.69 -34.89 0.98 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.61 -0.935 . . . . 0.0 110.664 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.422 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 0.8 OUTLIER -58.56 -34.27 70.84 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.896 -1.128 . . . . 0.0 109.006 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.739 HD21 HD12 ' A' ' 40' ' ' ILE . 9.1 tp -72.33 -53.53 12.12 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.524 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 71.2 t -57.05 -58.95 3.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.499 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.9 mt-10 -45.4 -28.81 0.94 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.695 -0.628 . . . . 0.0 109.918 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.62 -61.26 1.77 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.965 . . . . 0.0 109.579 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.512 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.7 mt -46.36 -35.03 5.05 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.21 -0.932 . . . . 0.0 109.409 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -53.19 -40.29 64.3 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.499 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -79.44 -51.01 9.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 108.782 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.403 ' H ' HG23 ' A' ' 18' ' ' VAL . 20.8 t -49.89 -53.14 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.61 0.719 . . . . 0.0 109.187 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.5 m -79.37 -22.15 44.79 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.619 -0.676 . . . . 0.0 110.592 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 51.69 -115.19 3.65 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -84.89 -21.92 29.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.098 -1.237 . . . . 0.0 109.482 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -54.75 -39.07 67.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 109.191 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.6 160.75 7.73 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.524 ' HZ ' HG13 ' A' ' 12' ' ' VAL . 9.9 p90 -138.62 173.52 11.5 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.533 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.1 p90 -112.51 121.64 45.4 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.075 -1.016 . . . . 0.0 110.044 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.7 t80 . . . . . 0 N--CA 1.501 2.086 0 O-C-N 121.235 -0.916 . . . . 0.0 109.262 179.769 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.611 ' CG ' HH21 ' A' ' 38' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.56 0.695 . . . . 0.0 109.659 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.23 -33.61 25.6 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.739 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.55 -51.77 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.208 -1.172 . . . . 0.0 110.332 -178.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.51 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 4.4 t -67.54 -64.06 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.662 -1.274 . . . . 0.0 111.709 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 46' ' ' ARG . 53.8 mt-10 -56.93 -54.81 42.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.832 -1.167 . . . . 0.0 110.861 -178.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -44.68 -49.74 10.27 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.704 -1.248 . . . . 0.0 110.327 -178.954 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.582 ' SG ' HD21 ' A' ' 54' ' ' LEU . 99.5 m -79.63 -50.51 10.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.906 -1.121 . . . . 0.0 110.003 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 47.9 t -61.06 -53.02 62.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.073 -1.017 . . . . 0.0 110.512 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 42' ' ' GLU . 13.0 tpt180 -69.56 -38.44 77.43 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.876 -1.14 . . . . 0.0 109.902 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 44' ' ' CYS . 1.6 m -127.09 144.09 51.12 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.249 -0.907 . . . . 0.0 109.469 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.6 mt -69.14 99.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.059 -1.026 . . . . 0.0 108.901 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.7 p -82.9 141.51 32.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.347 -0.846 . . . . 0.0 109.28 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 m -72.13 163.45 27.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.187 -0.946 . . . . 0.0 109.492 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.7 mt -56.02 -32.34 63.9 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.312 -0.867 . . . . 0.0 109.074 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -47.31 -56.06 7.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.935 . . . . 0.0 109.476 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.499 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 58.2 mt-30 -58.91 -51.27 70.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 109.324 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.582 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.0 mt -55.49 -35.02 65.11 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.099 -1.001 . . . . 0.0 108.779 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -72.63 -9.11 58.22 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.584 0.707 . . . . 0.0 109.106 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -79.98 -22.16 42.86 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.369 -0.832 . . . . 0.0 111.081 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.499 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.0 m-85 -99.91 -9.3 22.97 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.105 -0.997 . . . . 0.0 109.98 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 88.9 m -60.02 93.13 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.385 -0.822 . . . . 0.0 109.54 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.253 0 CA-C-O 117.974 -1.459 . . . . 0.0 109.727 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.416 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 61.9 m -128.96 124.68 35.7 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.321 -0.862 . . . . 0.0 109.985 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.45 -137.0 44.89 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.2 m -42.13 -36.11 1.09 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.723 -0.869 . . . . 0.0 110.6 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.416 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 0.8 OUTLIER -58.22 -35.51 71.79 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.897 -1.127 . . . . 0.0 108.789 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.739 HD21 HD12 ' A' ' 40' ' ' ILE . 11.7 tp -71.56 -50.92 26.54 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.1 t -58.94 -59.75 3.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.503 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 24.9 mt-10 -45.17 -30.04 1.08 Allowed 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.862 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.73 -61.05 1.85 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.928 . . . . 0.0 109.74 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.549 HD13 ' CD2' ' A' ' 24' ' ' PHE . 15.3 mt -46.67 -36.6 7.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.064 -1.023 . . . . 0.0 109.704 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -52.1 -40.49 61.33 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 108.946 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.503 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.52 -50.75 11.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.146 -0.972 . . . . 0.0 108.89 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -49.87 -53.15 11.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 121.556 0.693 . . . . 0.0 109.203 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.0 m -79.95 -22.28 42.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.598 -0.689 . . . . 0.0 110.453 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.73 -115.48 4.96 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -85.02 -23.44 28.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.143 -1.21 . . . . 0.0 109.818 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -54.58 -38.29 66.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.115 -0.99 . . . . 0.0 109.222 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.77 163.02 9.95 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.549 ' CD2' HD13 ' A' ' 15' ' ' LEU . 7.8 p90 -138.53 172.17 13.28 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.54 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 14.8 p90 -111.41 120.59 42.67 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.4 t80 . . . . . 0 N--CA 1.492 1.643 0 O-C-N 120.894 -1.129 . . . . 0.0 108.847 -179.649 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.276 0.56 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.28 -40.82 8.87 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.235 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.739 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -99.54 -51.39 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.046 -1.267 . . . . 0.0 110.788 -178.123 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.504 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 8.3 t -66.47 -63.61 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.523 -1.36 . . . . 0.0 111.57 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.528 ' N ' ' OE2' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -55.48 -57.07 13.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.935 -1.103 . . . . 0.0 111.106 -178.238 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -43.87 -48.16 8.35 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.934 -1.104 . . . . 0.0 110.515 -178.383 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.589 ' SG ' HD21 ' A' ' 54' ' ' LEU . 95.7 m -81.53 -50.88 8.86 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.974 -1.078 . . . . 0.0 110.034 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.0 t -61.38 -52.91 62.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.202 -0.936 . . . . 0.0 110.584 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 42' ' ' GLU . 4.7 tpt180 -69.07 -38.48 79.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.915 -1.115 . . . . 0.0 109.781 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 44' ' ' CYS . 13.0 m -128.93 145.98 51.08 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.188 -0.945 . . . . 0.0 109.714 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.0 mt -69.02 99.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.231 -0.918 . . . . 0.0 109.315 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.1 p -84.09 140.56 31.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.281 -0.887 . . . . 0.0 109.208 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.3 m -71.54 161.31 31.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.728 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.2 mt -54.15 -31.55 52.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.177 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -48.98 -55.65 11.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 0.0 109.298 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.473 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 56.2 mt-30 -58.79 -51.04 71.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 109.242 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.589 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.0 mt -55.89 -35.08 66.12 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.134 -0.979 . . . . 0.0 108.559 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -72.63 -9.15 58.26 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.558 0.694 . . . . 0.0 109.181 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -79.7 -22.61 43.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.496 -0.752 . . . . 0.0 110.79 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.473 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.5 m-85 -99.86 -6.83 26.16 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.11 -0.994 . . . . 0.0 110.268 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 82.0 m -62.05 96.13 0.07 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.075 -1.016 . . . . 0.0 109.595 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.495 2.573 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.558 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.497 1.91 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.447 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 60.7 m -129.41 124.98 35.51 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.242 -0.911 . . . . 0.0 110.168 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 61.86 -136.93 46.32 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.1 m -41.64 -34.58 0.62 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.719 -0.871 . . . . 0.0 110.739 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.447 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 0.8 OUTLIER -61.12 -35.36 76.83 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.912 -1.117 . . . . 0.0 108.905 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.702 HD21 HD12 ' A' ' 40' ' ' ILE . 11.1 tp -71.7 -48.68 45.68 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.7 t -59.82 -61.61 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.493 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 42.6 mt-10 -44.02 -30.28 0.71 Allowed 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.371 -0.531 . . . . 0.0 109.968 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.78 -60.76 1.96 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.181 -0.95 . . . . 0.0 109.989 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.539 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.0 mt -47.48 -36.77 10.66 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.975 -1.078 . . . . 0.0 109.465 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -51.15 -40.08 57.76 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.493 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -78.26 -50.92 10.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 108.785 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.406 ' H ' HG23 ' A' ' 18' ' ' VAL . 19.1 t -50.23 -54.36 8.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.585 0.707 . . . . 0.0 109.294 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.2 m -79.38 -22.13 44.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.599 -0.688 . . . . 0.0 110.659 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.45 -116.42 7.0 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -85.29 -25.7 27.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.136 -1.214 . . . . 0.0 110.335 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.412 ' O ' ' O ' ' A' ' 59' ' ' GLY . 61.8 mtt180 -54.44 -36.61 64.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.944 -1.097 . . . . 0.0 109.267 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.11 165.91 16.41 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.58 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.539 ' CD2' HD13 ' A' ' 15' ' ' LEU . 9.3 p90 -139.0 172.89 12.18 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.513 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 10.8 p90 -110.23 126.68 54.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.181 -0.949 . . . . 0.0 109.073 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.3 t80 . . . . . 0 N--CA 1.498 1.96 0 O-C-N 121.033 -1.042 . . . . 0.0 108.96 179.78 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.421 HH21 ' HG3' ' A' ' 38' ' ' ARG . 2.3 ptm180 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.68 -30.42 32.69 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.702 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.11 -50.96 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.506 -0.997 . . . . 0.0 110.065 -179.382 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.504 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 3.2 t -69.36 -65.13 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.536 -1.353 . . . . 0.0 111.388 -178.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' ARG . 77.7 mt-10 -57.93 -48.86 78.66 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.808 -1.183 . . . . 0.0 110.377 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -46.64 -50.27 17.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.847 -1.158 . . . . 0.0 109.969 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.601 ' SG ' HD21 ' A' ' 54' ' ' LEU . 88.5 m -84.04 -52.71 6.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.268 -0.895 . . . . 0.0 110.208 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.6 t -60.98 -45.36 95.08 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.88 -1.137 . . . . 0.0 110.064 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.564 HH21 ' CG ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -71.13 -37.46 72.31 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.976 -1.078 . . . . 0.0 109.722 -179.522 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 44' ' ' CYS . 14.4 m -137.77 153.62 49.68 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.172 -0.955 . . . . 0.0 110.011 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.7 mt -68.96 99.41 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.122 -0.986 . . . . 0.0 109.441 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.5 p -84.23 140.27 31.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -0.926 . . . . 0.0 108.925 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.8 m -71.41 161.15 31.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.184 -0.948 . . . . 0.0 109.837 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.7 mt -54.59 -32.56 58.91 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.328 -0.857 . . . . 0.0 109.183 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -48.15 -52.89 18.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.296 -0.877 . . . . 0.0 109.327 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.529 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 39.7 mt-30 -62.43 -51.27 68.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 109.291 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.601 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.2 mt -56.15 -32.99 64.79 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.064 -1.023 . . . . 0.0 108.667 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -75.12 -8.83 57.66 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.513 0.673 . . . . 0.0 109.191 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -79.96 -21.93 43.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.453 -0.779 . . . . 0.0 110.874 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.529 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.9 m-85 -99.99 -6.35 26.68 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.17 -0.957 . . . . 0.0 110.458 -178.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.3 m -61.18 99.66 0.1 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.081 -1.012 . . . . 0.0 109.542 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.498 1.954 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.412 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 67.7 m -129.58 124.98 35.14 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.29 -0.881 . . . . 0.0 110.378 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.85 -137.27 44.0 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.1 m -42.74 -34.91 1.0 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.612 -0.934 . . . . 0.0 110.55 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.412 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 4.0 t-80 -58.94 -34.12 71.38 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.898 -1.126 . . . . 0.0 108.735 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.726 HD21 HD12 ' A' ' 40' ' ' ILE . 9.2 tp -71.95 -53.54 12.75 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.511 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 69.4 t -57.67 -59.93 2.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.485 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 87.5 mt-10 -43.97 -29.77 0.63 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.808 -0.558 . . . . 0.0 109.985 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.22 -60.95 1.86 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.952 . . . . 0.0 109.468 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.505 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.3 mt -46.43 -36.0 6.11 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.203 -0.936 . . . . 0.0 109.647 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -52.7 -40.03 62.56 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.38 -0.825 . . . . 0.0 108.994 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.485 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.85 -51.55 9.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 108.822 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.2 t -49.76 -53.78 9.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.584 0.707 . . . . 0.0 109.231 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.3 m -78.63 -22.23 47.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.564 -0.71 . . . . 0.0 110.272 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.37 -115.54 4.82 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.571 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 4.0 mp0 -84.88 -23.58 28.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -1.162 . . . . 0.0 109.668 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.576 HH21 ' CG ' ' A' ' 22' ' ' ARG . 4.8 mtt-85 -54.31 -38.71 66.27 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.142 -0.974 . . . . 0.0 109.041 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.58 162.87 9.52 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.514 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 8.1 p90 -138.46 173.3 11.74 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.554 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.3 p90 -110.86 120.13 41.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.179 -0.951 . . . . 0.0 109.882 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.6 t80 . . . . . 0 N--CA 1.499 1.983 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.984 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.417 HH21 ' HG3' ' A' ' 38' ' ' ARG . 1.8 ptm180 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.58 -33.32 31.38 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.726 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.2 -51.71 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.432 -1.04 . . . . 0.0 109.439 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.512 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 3.0 t -68.65 -65.0 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 120.622 -1.299 . . . . 0.0 111.466 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 46' ' ' ARG . 57.5 mm-40 -58.85 -45.8 89.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.864 -1.148 . . . . 0.0 110.354 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -48.91 -52.59 23.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.57 -1.331 . . . . 0.0 109.652 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.576 ' SG ' HD21 ' A' ' 54' ' ' LEU . 91.8 m -79.33 -52.42 8.12 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.259 -0.901 . . . . 0.0 109.82 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.6 t -60.16 -52.23 66.23 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.032 -1.042 . . . . 0.0 109.988 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 42' ' ' GLU . 4.2 tmm_? -68.02 -36.04 79.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.283 -0.886 . . . . 0.0 110.066 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 44' ' ' CYS . 9.2 m -135.23 147.65 49.37 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.052 -1.03 . . . . 0.0 109.576 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.5 mt -68.77 99.56 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.155 -0.966 . . . . 0.0 109.494 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 25.3 p -86.21 138.53 31.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.37 -0.831 . . . . 0.0 109.042 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.4 m -69.53 157.32 37.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 110.0 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.9 mt -51.32 -32.67 26.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.397 -0.815 . . . . 0.0 109.211 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -50.13 -53.62 26.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.374 -0.829 . . . . 0.0 109.125 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.439 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 69.1 mt-30 -58.75 -49.17 78.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.89 . . . . 0.0 109.002 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.576 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.2 mt -57.07 -34.16 68.0 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -71.91 -9.41 58.31 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -79.05 -22.78 44.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.408 -0.807 . . . . 0.0 111.086 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.439 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.9 m-85 -101.1 -6.9 23.72 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.093 -1.004 . . . . 0.0 110.183 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 86.6 m -61.64 96.06 0.06 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.56 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.582 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.885 HG22 ' H ' ' A' ' 3' ' ' ASN . 2.1 p -61.98 -113.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.174 -0.954 . . . . 0.0 108.863 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.885 ' H ' HG22 ' A' ' 2' ' ' VAL . 43.3 m-80 -166.13 96.04 0.59 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.891 -1.13 . . . . 0.0 109.072 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.51 ' OE1' ' NE2' ' A' ' 10' ' ' HIS . 3.2 pt20 -161.65 173.3 14.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 109.238 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.57 129.97 36.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.343 -0.848 . . . . 0.0 109.422 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp -91.27 116.18 28.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.427 -0.795 . . . . 0.0 109.024 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.428 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 63.5 m -129.29 125.03 35.87 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.267 -0.896 . . . . 0.0 110.309 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.77 -136.72 44.09 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.6 m -42.18 -35.46 0.95 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.691 -0.888 . . . . 0.0 110.624 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.51 ' NE2' ' OE1' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -59.74 -35.34 74.37 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.821 -1.174 . . . . 0.0 108.851 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.727 HD21 HD12 ' A' ' 40' ' ' ILE . 10.5 tp -71.89 -50.1 32.25 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.3 t -59.88 -61.2 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.5 mt-10 -45.06 -29.48 0.88 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.851 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.582 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -85.1 -60.82 1.93 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.157 -0.964 . . . . 0.0 109.715 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.522 HD13 ' CD2' ' A' ' 24' ' ' PHE . 13.5 mt -47.3 -36.97 10.0 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.028 -1.045 . . . . 0.0 109.562 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -50.72 -40.22 53.76 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.496 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -78.54 -50.67 11.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 108.754 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.1 t -50.19 -54.18 9.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-O 121.555 0.693 . . . . 0.0 109.282 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.4 m -78.71 -22.42 46.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.561 -0.712 . . . . 0.0 110.646 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.69 -113.35 3.44 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -85.68 -29.22 24.15 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.191 -1.182 . . . . 0.0 110.842 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -54.35 -36.72 64.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.884 -1.135 . . . . 0.0 109.412 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.53 167.16 17.5 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.249 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.538 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 8.5 p90 -138.1 173.63 11.42 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.536 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 18.8 p90 -109.0 121.09 44.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 110.36 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.444 ' O ' ' C ' ' A' ' 27' ' ' THR . 8.2 t80 -107.78 145.81 33.06 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.444 ' C ' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -37.43 101.48 0.22 Allowed Pre-proline 0 N--CA 1.504 2.241 0 O-C-N 121.653 -0.655 . . . . 0.0 110.157 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -67.47 -26.27 40.75 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 120.883 1.055 . . . . 0.0 110.372 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.545 ' N ' ' CD ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -154.48 -16.8 0.13 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.123 -0.986 . . . . 0.0 108.922 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.477 ' C ' ' N ' ' A' ' 32' ' ' GLU . 18.0 p -70.45 36.41 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.128 -0.983 . . . . 0.0 109.476 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.508 ' H ' ' C ' ' A' ' 29' ' ' ARG . 35.6 mt-10 -51.24 -10.64 0.09 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.146 -0.972 . . . . 0.0 109.277 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.477 ' N ' ' C ' ' A' ' 30' ' ' THR . 42.5 mm-40 -86.52 -25.36 25.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 109.328 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.89 144.5 7.69 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 35' ' ' ARG . 47.7 t -158.82 -137.89 0.05 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.504 -0.998 . . . . 0.0 109.046 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.484 ' HG3' ' H ' ' A' ' 36' ' ' ARG . 17.4 ptt180 -48.44 -56.56 7.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.098 -1.001 . . . . 0.0 109.079 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.574 ' O ' ' N ' ' A' ' 38' ' ' ARG . 37.1 mtt180 -84.63 -142.85 0.08 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.231 -0.918 . . . . 0.0 109.102 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.7 t 56.77 -69.21 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.849 -0.532 . . . . 0.0 110.939 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.574 ' N ' ' O ' ' A' ' 36' ' ' ARG . 17.3 ptt180 -58.21 -12.38 3.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.719 -1.238 . . . . 0.0 108.648 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.52 -35.12 20.84 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.727 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.88 -50.32 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.546 -0.973 . . . . 0.0 109.908 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.501 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.4 t -69.47 -65.04 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.53 -1.356 . . . . 0.0 111.329 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 46' ' ' ARG . 69.5 mm-40 -58.64 -47.04 85.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.795 -1.191 . . . . 0.0 110.475 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -48.75 -50.07 35.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.687 -1.258 . . . . 0.0 109.577 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.587 ' SG ' HD21 ' A' ' 54' ' ' LEU . 84.8 m -81.99 -53.35 6.2 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.165 -0.959 . . . . 0.0 109.851 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.401 ' N ' ' O ' ' A' ' 41' ' ' VAL . 53.2 t -60.04 -50.99 71.55 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.958 -1.089 . . . . 0.0 109.952 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -68.5 -35.74 77.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.082 -1.011 . . . . 0.0 110.049 -179.323 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 44' ' ' CYS . 58.4 m -136.78 148.4 47.19 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.029 -1.045 . . . . 0.0 109.562 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.3 mt -68.6 99.53 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.989 -1.069 . . . . 0.0 109.573 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.7 p -84.2 139.65 32.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 109.026 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 m -71.78 160.67 32.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 109.815 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.3 mt -54.11 -32.55 55.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.344 -0.847 . . . . 0.0 109.191 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -48.75 -46.28 40.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.891 . . . . 0.0 109.306 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.525 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 59.2 mt-30 -69.57 -49.76 51.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.319 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.587 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.8 mt -56.25 -33.78 65.75 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.152 -0.967 . . . . 0.0 108.598 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.03 -8.88 57.76 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -79.64 -22.11 43.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.512 -0.743 . . . . 0.0 110.933 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.525 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.1 m-85 -99.99 -7.32 25.24 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.089 -1.007 . . . . 0.0 110.321 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 82.4 m -60.9 98.55 0.07 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.293 -0.88 . . . . 0.0 109.64 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.267 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.503 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.712 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.458 ' C ' ' O ' ' A' ' 1' ' ' PHE . 6.7 m 31.41 -117.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 CA-C-O 121.275 0.559 . . . . 0.0 111.169 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.407 ' N ' ' OD1' ' A' ' 3' ' ' ASN . 11.9 p-10 -153.13 114.22 4.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.286 -0.884 . . . . 0.0 109.169 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -157.92 171.71 19.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.219 -0.925 . . . . 0.0 109.599 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -72.61 129.19 37.7 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.344 -0.847 . . . . 0.0 109.636 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.427 HD21 ' CB ' ' A' ' 14' ' ' ALA . 4.3 mp -104.75 116.43 32.02 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.552 -0.718 . . . . 0.0 109.358 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 64.6 m -128.67 125.09 37.32 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.243 -0.91 . . . . 0.0 110.335 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.29 -137.52 45.36 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -42.26 -34.19 0.74 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.587 -0.949 . . . . 0.0 110.575 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.403 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 2.1 t-160 -59.33 -35.74 74.39 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.954 -1.091 . . . . 0.0 108.764 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.735 HD21 HD12 ' A' ' 40' ' ' ILE . 9.4 tp -71.18 -53.09 15.66 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.511 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 66.3 t -57.53 -59.95 2.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.494 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 26.7 mt-10 -44.01 -29.92 0.66 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.715 -0.616 . . . . 0.0 110.039 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.712 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -85.7 -60.92 1.88 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 109.523 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.522 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.2 mt -46.6 -36.2 6.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.14 -0.975 . . . . 0.0 109.641 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -52.22 -42.06 63.25 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.429 -0.794 . . . . 0.0 108.858 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.494 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -76.94 -51.18 11.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 108.873 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -50.17 -54.24 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.646 -0.659 . . . . 0.0 109.249 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.3 m -78.44 -22.32 47.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.54 -0.725 . . . . 0.0 110.371 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 56.71 -118.44 11.84 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -84.95 -23.63 28.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.148 -1.207 . . . . 0.0 110.034 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.4 mtp180 -54.63 -37.4 65.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.985 -1.072 . . . . 0.0 109.124 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.25 163.97 12.7 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 120.071 -1.062 . . . . 0.0 110.869 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 8.7 p90 -138.54 173.1 11.95 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.52 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.4 p90 -110.19 124.38 51.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.092 -1.005 . . . . 0.0 109.39 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.719 ' O ' ' O ' ' A' ' 27' ' ' THR . 10.8 t80 -102.16 105.15 15.8 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.073 -1.017 . . . . 0.0 109.497 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.719 ' O ' ' O ' ' A' ' 26' ' ' TYR . 5.5 t 37.07 143.15 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.607 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.638 ' O ' ' N ' ' A' ' 30' ' ' THR . 9.8 Cg_endo -66.01 116.73 4.15 Favored 'Trans proline' 0 C--O 1.211 -0.855 0 N-CA-C 108.563 -1.36 . . . . 0.0 108.563 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.584 HH21 ' CG ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER 49.65 -79.1 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.761 -0.587 . . . . 0.0 110.641 178.51 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.638 ' N ' ' O ' ' A' ' 28' ' ' PRO . 15.3 p -141.62 -150.54 0.32 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.107 -0.996 . . . . 0.0 109.374 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.559 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 2.5 mp0 -57.35 -2.39 0.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.155 -0.966 . . . . 0.0 109.325 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' A' ' 30' ' ' THR . 1.4 mm-40 -42.6 -32.65 0.59 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.546 -0.721 . . . . 0.0 109.98 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.76 -173.58 14.49 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.0 t -154.93 -91.48 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -1.143 . . . . 0.0 109.55 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.498 ' HG2' HH21 ' A' ' 35' ' ' ARG . 0.3 OUTLIER -44.04 -56.82 3.73 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.419 -0.801 . . . . 0.0 109.916 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.601 ' O ' ' N ' ' A' ' 38' ' ' ARG . 15.8 mmm180 -63.42 -148.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.092 -1.005 . . . . 0.0 108.902 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.0 t 55.64 -70.7 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.99 -0.444 . . . . 0.0 110.748 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.601 ' N ' ' O ' ' A' ' 36' ' ' ARG . 0.6 OUTLIER -58.24 -14.46 7.24 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.882 -1.136 . . . . 0.0 108.872 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.1 -30.15 35.5 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.735 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.38 -52.73 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.52 -0.988 . . . . 0.0 110.185 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.517 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 5.7 t -69.49 -64.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.528 -1.358 . . . . 0.0 111.595 -178.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 46' ' ' ARG . 54.2 mt-10 -57.25 -54.24 48.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.847 -1.158 . . . . 0.0 110.569 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.587 ' O ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -44.65 -50.59 9.75 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.874 -1.141 . . . . 0.0 110.096 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.566 ' SG ' HD21 ' A' ' 54' ' ' LEU . 99.4 m -79.43 -51.28 9.58 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.903 -1.123 . . . . 0.0 110.126 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.2 t -60.36 -53.25 59.81 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.099 -1.0 . . . . 0.0 110.62 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 42' ' ' GLU . 17.8 tpt180 -71.52 -38.53 71.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.87 -1.144 . . . . 0.0 109.9 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 44' ' ' CYS . 2.1 m -124.51 145.09 49.75 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.115 -0.99 . . . . 0.0 109.893 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.2 mt -69.46 99.35 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.004 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 24.8 p -86.37 142.25 28.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.304 -0.872 . . . . 0.0 109.467 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.7 m -72.22 159.82 33.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.722 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.9 mt -54.86 -31.69 59.94 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.35 -0.844 . . . . 0.0 108.849 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -47.49 -54.67 10.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.363 -0.835 . . . . 0.0 109.352 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.508 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 20.2 mt-30 -60.09 -49.85 76.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.233 -0.917 . . . . 0.0 109.197 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.566 HD21 ' SG ' ' A' ' 44' ' ' CYS . 98.1 mt -55.57 -34.58 64.9 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.161 -0.962 . . . . 0.0 108.688 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.403 ' CD ' ' O ' ' A' ' 55' ' ' GLU . 5.0 tm-20 -73.45 -9.25 58.5 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.677 0.751 . . . . 0.0 109.059 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -79.67 -21.74 44.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.373 -0.829 . . . . 0.0 111.239 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.508 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.3 m-85 -100.17 -6.31 26.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.087 -1.008 . . . . 0.0 110.534 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 71.4 m -60.9 98.72 0.07 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.17 -0.956 . . . . 0.0 109.695 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.314 0 CA-C-O 117.94 -1.478 . . . . 0.0 109.583 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.609 ' CD1' ' N ' ' A' ' 1' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.466 ' H ' HG22 ' A' ' 2' ' ' VAL . 3.0 m -58.93 -169.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.414 -0.804 . . . . 0.0 110.092 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -92.2 117.31 29.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.701 -0.624 . . . . 0.0 109.322 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -162.24 166.74 25.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.203 -0.935 . . . . 0.0 109.414 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.417 ' ND1' ' N ' ' A' ' 5' ' ' HIS . 0.0 OUTLIER -84.37 118.67 24.38 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.224 -0.922 . . . . 0.0 108.946 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp -86.51 116.7 24.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.498 -0.751 . . . . 0.0 109.171 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.43 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 58.9 m -129.75 124.85 34.47 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.289 -0.882 . . . . 0.0 110.2 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 61.43 -136.54 47.45 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -41.93 -34.04 0.63 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.693 -0.886 . . . . 0.0 110.767 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.43 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 1.7 t-80 -62.06 -34.69 76.74 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.757 -1.214 . . . . 0.0 108.808 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.74 HD21 HD12 ' A' ' 40' ' ' ILE . 11.3 tp -71.7 -49.08 42.78 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.7 t -59.28 -61.46 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.497 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 25.1 mt-10 -44.31 -29.64 0.7 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.346 -0.541 . . . . 0.0 109.949 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.547 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -85.35 -61.23 1.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.164 -0.96 . . . . 0.0 109.74 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.545 HD13 ' CD2' ' A' ' 24' ' ' PHE . 15.0 mt -46.68 -36.91 7.61 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.123 -0.986 . . . . 0.0 109.613 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -51.11 -41.34 59.95 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.404 -0.81 . . . . 0.0 108.871 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.497 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -77.51 -50.91 11.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.93 . . . . 0.0 108.847 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.404 ' H ' HG23 ' A' ' 18' ' ' VAL . 19.2 t -50.18 -54.41 8.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.57 0.7 . . . . 0.0 109.142 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.3 m -79.39 -20.83 46.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.595 -0.69 . . . . 0.0 110.328 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.42 -117.11 6.56 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -84.73 -22.22 29.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.152 -1.205 . . . . 0.0 109.622 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.596 HH21 ' CG ' ' A' ' 22' ' ' ARG . 3.2 mtt-85 -54.59 -38.14 66.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.19 -0.944 . . . . 0.0 109.157 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.95 162.05 9.31 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.078 -1.058 . . . . 0.0 110.501 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.545 ' CD2' HD13 ' A' ' 15' ' ' LEU . 8.0 p90 -137.97 172.57 12.74 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.527 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.1 p90 -111.02 121.76 46.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.33 -0.856 . . . . 0.0 108.977 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -86.93 156.63 19.74 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.972 -1.08 . . . . 0.0 108.962 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.0 t -50.49 143.36 13.93 Favored Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.278 -0.889 . . . . 0.0 108.929 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.651 ' O ' ' N ' ' A' ' 30' ' ' THR . 10.3 Cg_endo -65.54 104.56 0.66 Allowed 'Trans proline' 0 C--N 1.321 -0.896 0 N-CA-C 108.915 -1.225 . . . . 0.0 108.915 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.411 ' HG2' HH21 ' A' ' 29' ' ' ARG . 0.5 OUTLIER 48.07 -80.13 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.545 178.277 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.651 ' N ' ' O ' ' A' ' 28' ' ' PRO . 18.7 p -144.07 -71.73 0.29 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.038 -1.038 . . . . 0.0 109.145 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.532 ' N ' ' OG1' ' A' ' 30' ' ' THR . 11.8 mm-40 44.59 36.07 1.61 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.34 -0.85 . . . . 0.0 110.059 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -53.02 -26.07 14.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.134 -0.979 . . . . 0.0 109.441 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.56 -44.05 37.07 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.437 ' OG ' ' N ' ' A' ' 35' ' ' ARG . 45.5 t -86.51 -162.04 0.72 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.369 -1.077 . . . . 0.0 109.605 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 37' ' ' SER . 5.7 ptp180 -99.1 -111.83 0.17 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.414 -0.804 . . . . 0.0 109.309 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 39' ' ' GLY . 27.3 mmt180 51.16 -84.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.55 -0.719 . . . . 0.0 110.903 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -41.63 -58.14 2.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.668 -0.645 . . . . 0.0 111.321 -178.475 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -58.9 -13.4 6.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.813 -1.179 . . . . 0.0 109.806 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 36' ' ' ARG . . . -82.48 -40.39 9.99 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.74 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.43 -51.15 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.316 -1.108 . . . . 0.0 110.291 -178.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.509 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.9 t -66.41 -64.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 120.627 -1.296 . . . . 0.0 111.775 -178.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 46' ' ' ARG . 81.9 mt-10 -56.06 -54.14 48.51 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.904 -1.122 . . . . 0.0 111.209 -178.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.7 -48.68 15.09 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.849 -1.157 . . . . 0.0 110.141 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.609 ' SG ' HD21 ' A' ' 54' ' ' LEU . 85.2 m -82.3 -53.58 5.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.062 -1.024 . . . . 0.0 110.042 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.2 t -60.61 -51.91 67.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.999 -1.063 . . . . 0.0 109.987 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 42' ' ' GLU . 3.7 tmt_? -67.04 -36.62 82.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.186 -0.946 . . . . 0.0 110.025 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 44' ' ' CYS . 68.4 m -136.46 148.17 47.57 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.168 -0.958 . . . . 0.0 109.398 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.6 mt -68.46 99.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.12 -0.988 . . . . 0.0 109.512 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.4 p -83.14 140.48 32.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.407 -0.808 . . . . 0.0 109.217 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 m -70.61 160.96 31.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.208 -0.932 . . . . 0.0 109.527 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.407 ' CD2' ' CZ ' ' A' ' 1' ' ' PHE . 36.9 mt -55.48 -31.32 61.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.233 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -49.51 -51.97 32.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 109.216 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.466 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 62.9 mt-30 -62.32 -50.28 72.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.209 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.609 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.3 mt -56.68 -33.18 66.16 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.101 -0.999 . . . . 0.0 108.462 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -74.25 -8.96 58.03 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -79.99 -21.97 43.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.44 -0.787 . . . . 0.0 110.932 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.466 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 8.0 m-85 -99.46 -7.18 26.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.069 -1.019 . . . . 0.0 110.514 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.4 m -60.73 99.14 0.08 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.188 -0.945 . . . . 0.0 109.6 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.271 0 CA-C-O 118.022 -1.432 . . . . 0.0 109.562 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.459 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t -82.53 -132.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.054 -1.029 . . . . 0.0 108.459 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -132.01 55.55 1.87 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -118.5 172.44 7.47 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -87.03 139.62 30.39 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.355 -0.84 . . . . 0.0 109.772 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.412 HD21 ' CB ' ' A' ' 14' ' ' ALA . 5.5 mp -95.0 116.33 28.56 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.507 -0.746 . . . . 0.0 109.222 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.417 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 81.4 m -130.29 125.29 34.38 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.22 -0.925 . . . . 0.0 110.633 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 61.56 -136.5 47.15 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.424 ' O ' ' OE2' ' A' ' 13' ' ' GLU . 57.4 m -43.66 -28.74 0.43 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.518 -0.989 . . . . 0.0 110.548 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.417 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 2.5 t-80 -66.61 -32.13 73.27 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.815 -1.178 . . . . 0.0 108.814 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.698 HD21 HD12 ' A' ' 40' ' ' ILE . 9.7 tp -72.48 -51.58 19.5 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.507 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 70.4 t -58.0 -60.42 2.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.485 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.6 mt-10 -43.77 -29.24 0.5 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.748 -0.595 . . . . 0.0 110.106 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.459 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -86.2 -59.94 2.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.648 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.53 HD13 ' CD2' ' A' ' 24' ' ' PHE . 13.6 mt -46.94 -37.22 8.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.125 -0.984 . . . . 0.0 109.488 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -50.86 -42.02 58.51 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.485 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -76.88 -50.04 14.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 108.786 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.2 t -50.36 -55.08 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.648 0.737 . . . . 0.0 109.039 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.0 m -78.87 -22.32 46.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.559 -0.713 . . . . 0.0 110.426 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.84 -116.05 6.74 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.56 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 2.6 mp0 -85.21 -23.91 28.08 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.191 -1.182 . . . . 0.0 110.062 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.57 HH21 ' CG ' ' A' ' 22' ' ' ARG . 4.7 mtt-85 -54.78 -37.55 66.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.098 -1.001 . . . . 0.0 109.356 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.13 164.14 12.46 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.962 -1.114 . . . . 0.0 110.329 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.53 ' CD2' HD13 ' A' ' 15' ' ' LEU . 7.3 p90 -138.42 172.75 12.43 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.53 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.7 p90 -111.1 122.56 48.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 109.253 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -90.67 169.01 11.35 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.908 -1.12 . . . . 0.0 108.662 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.9 t -69.44 144.45 94.48 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.092 -1.005 . . . . 0.0 109.055 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.79 -83.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.324 -0.724 0 C-N-CA 121.081 1.187 . . . . 0.0 109.579 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.501 ' O ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -164.93 10.08 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.338 -0.851 . . . . 0.0 109.112 -179.321 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 47.1 p -60.49 80.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 109.608 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 29' ' ' ARG . 36.0 mt-10 -58.78 -10.63 2.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -0.878 . . . . 0.0 109.301 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -77.9 -26.23 49.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -0.862 . . . . 0.0 109.404 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.04 160.89 35.69 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.8 t -155.16 -97.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.284 -1.127 . . . . 0.0 109.079 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.422 ' HG3' ' H ' ' A' ' 36' ' ' ARG . 11.4 ptt180 -133.54 -55.03 0.89 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.39 -0.819 . . . . 0.0 109.094 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -60.36 -62.87 1.54 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 109.621 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 t -42.41 -66.52 0.35 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.888 -0.508 . . . . 0.0 110.183 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.438 HH21 ' HG3' ' A' ' 38' ' ' ARG . 4.2 ptm180 -59.5 -14.4 12.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.984 -1.072 . . . . 0.0 108.675 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 36' ' ' ARG . . . -82.64 -34.0 23.41 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.951 -1.659 . . . . 0.0 108.951 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.698 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.64 -52.49 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.441 -1.035 . . . . 0.0 110.096 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 3.2 t -67.85 -64.03 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 120.663 -1.273 . . . . 0.0 111.813 -178.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' ARG . 67.2 mm-40 -57.34 -54.85 42.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.824 -1.172 . . . . 0.0 111.339 -177.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.565 HE21 ' C ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -45.76 -45.86 14.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.553 -1.342 . . . . 0.0 110.012 -178.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.646 ' SG ' HD21 ' A' ' 54' ' ' LEU . 95.1 m -84.44 -53.2 5.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.964 -1.085 . . . . 0.0 110.103 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.7 t -63.05 -44.51 95.65 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.984 -1.072 . . . . 0.0 110.332 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 42' ' ' GLU . 3.5 tmt_? -72.21 -36.37 69.15 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.793 -1.192 . . . . 0.0 109.605 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 44' ' ' CYS . 69.5 m -138.03 153.1 49.4 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.203 -0.935 . . . . 0.0 109.946 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.0 mt -68.97 99.15 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 108.857 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.6 p -83.39 148.46 27.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 109.313 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.8 m -78.76 162.61 26.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.261 -0.9 . . . . 0.0 110.063 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.8 mt -57.13 -33.18 67.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.557 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -48.95 -45.42 41.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.184 -0.948 . . . . 0.0 109.163 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.531 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 71.8 mt-30 -69.34 -52.76 24.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.369 -0.832 . . . . 0.0 109.191 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.646 HD21 ' SG ' ' A' ' 44' ' ' CYS . 99.2 mt -55.86 -32.47 63.67 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.029 -1.044 . . . . 0.0 108.654 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -76.08 -9.04 58.3 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.595 0.712 . . . . 0.0 109.225 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -79.85 -21.82 43.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.419 -0.801 . . . . 0.0 110.836 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.531 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.6 m-85 -99.27 -6.91 27.18 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.172 -0.955 . . . . 0.0 110.487 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 71.2 m -60.63 100.96 0.12 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.136 -0.978 . . . . 0.0 109.624 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.299 0 CA-C-O 118.048 -1.418 . . . . 0.0 109.581 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.552 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 1' ' ' PHE . 2.6 m -54.83 -168.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.393 -0.817 . . . . 0.0 109.723 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.553 ' O ' ' ND2' ' A' ' 3' ' ' ASN . 0.4 OUTLIER -117.51 95.82 5.12 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.749 -0.594 . . . . 0.0 109.445 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.529 ' OE1' ' NE2' ' A' ' 10' ' ' HIS . 5.1 pt20 -147.81 177.21 9.51 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.087 -1.008 . . . . 0.0 109.422 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -79.49 125.35 29.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.283 -0.886 . . . . 0.0 110.099 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.401 HD21 ' CB ' ' A' ' 14' ' ' ALA . 4.3 mp -91.58 116.82 29.18 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.499 -0.75 . . . . 0.0 109.062 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.4 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 82.3 m -129.3 125.2 36.23 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.21 -0.931 . . . . 0.0 110.648 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.74 -137.26 44.25 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 m -42.83 -32.24 0.59 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.599 -0.942 . . . . 0.0 110.576 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.529 ' NE2' ' OE1' ' A' ' 4' ' ' GLN . 4.2 t-80 -61.83 -34.23 75.58 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.852 -1.155 . . . . 0.0 108.877 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.747 HD21 HD12 ' A' ' 40' ' ' ILE . 10.0 tp -71.76 -52.24 18.65 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.517 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 73.0 t -58.52 -60.06 2.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.5 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 51.5 mt-10 -44.5 -28.98 0.64 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.726 -0.609 . . . . 0.0 109.97 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.552 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -86.15 -61.14 1.82 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.599 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.514 HD13 ' CD2' ' A' ' 24' ' ' PHE . 13.8 mt -46.47 -36.93 7.12 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.167 -0.958 . . . . 0.0 109.581 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -51.13 -40.82 59.39 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.5 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.1 -50.9 11.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -0.869 . . . . 0.0 108.808 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 18' ' ' VAL . 18.1 t -50.26 -54.8 7.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.543 0.687 . . . . 0.0 109.317 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.8 m -77.47 -22.22 51.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.57 -0.707 . . . . 0.0 110.634 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.88 -115.65 5.79 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -85.23 -24.16 27.93 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.194 -1.18 . . . . 0.0 110.077 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.598 HH21 ' CG ' ' A' ' 22' ' ' ARG . 3.4 mtt-85 -54.43 -37.99 65.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.046 -1.034 . . . . 0.0 109.367 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.53 164.02 10.88 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.523 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 7.9 p90 -138.2 172.71 12.51 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.543 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 17.0 p90 -109.11 122.01 46.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -0.925 . . . . 0.0 109.554 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -101.62 169.34 8.9 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.208 -0.933 . . . . 0.0 108.863 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 t -75.57 146.54 80.63 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.067 -1.02 . . . . 0.0 108.752 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -67.0 -61.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.323 -0.769 0 N-CA-C 109.106 -1.151 . . . . 0.0 109.106 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.427 ' O ' ' OG1' ' A' ' 30' ' ' THR . 0.0 OUTLIER -155.57 12.71 0.34 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.919 -1.113 . . . . 0.0 109.14 178.578 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.482 ' C ' ' H ' ' A' ' 32' ' ' GLU . 10.7 p 57.58 -150.61 0.44 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.693 -0.629 . . . . 0.0 109.763 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 52.6 10.2 0.13 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.482 ' H ' ' C ' ' A' ' 30' ' ' THR . 39.6 mt-10 -64.71 -24.24 67.51 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.481 -0.762 . . . . 0.0 109.283 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.95 -36.95 3.59 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.8 t -64.13 -138.61 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.427 -1.043 . . . . 0.0 109.235 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 36' ' ' ARG . 19.8 ptt180 -125.49 -111.12 0.3 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.539 -0.726 . . . . 0.0 109.169 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 38' ' ' ARG . 19.5 mmt180 46.38 -170.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.4 -0.813 . . . . 0.0 109.732 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.1 t 59.77 -60.84 0.06 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 122.111 -0.368 . . . . 0.0 111.255 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 36' ' ' ARG . 26.0 ptt180 -58.33 -9.52 1.58 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.484 -1.385 . . . . 0.0 109.037 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.78 -36.87 14.59 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.747 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.58 -50.21 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.547 -0.972 . . . . 0.0 109.928 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.494 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.5 t -67.58 -65.09 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.61 -1.306 . . . . 0.0 111.455 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 46' ' ' ARG . 13.9 mm-40 -57.58 -48.84 78.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.847 -1.158 . . . . 0.0 110.426 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -46.83 -49.41 20.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.776 -1.202 . . . . 0.0 109.86 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.616 ' SG ' HD21 ' A' ' 54' ' ' LEU . 94.9 m -84.58 -53.5 5.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 110.172 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.416 ' N ' ' O ' ' A' ' 41' ' ' VAL . 54.1 t -60.93 -46.17 91.76 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.929 -1.107 . . . . 0.0 110.008 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.52 HH21 ' CG ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -69.87 -38.38 76.37 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.876 -1.14 . . . . 0.0 109.576 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.483 ' O ' ' O ' ' A' ' 44' ' ' CYS . 13.9 m -138.08 153.19 49.31 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.151 -0.968 . . . . 0.0 109.72 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.2 mt -68.6 99.68 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.109 -0.995 . . . . 0.0 109.837 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.7 p -83.34 140.56 32.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 108.918 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.558 ' H ' HE21 ' A' ' 53' ' ' GLN . 3.2 m -70.36 157.51 37.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.182 -0.949 . . . . 0.0 109.885 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 48.2 mt -53.54 -33.28 54.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.41 -0.806 . . . . 0.0 109.247 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -50.07 -49.03 52.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 108.968 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.558 HE21 ' H ' ' A' ' 50' ' ' SER . 53.3 mt-30 -63.52 -50.33 70.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.853 . . . . 0.0 108.932 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.616 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.3 mt -56.78 -32.8 66.01 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.178 -0.951 . . . . 0.0 108.455 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -74.71 -8.85 57.67 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -80.35 -22.21 41.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.523 -0.735 . . . . 0.0 110.961 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.519 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.4 m-85 -98.87 -7.46 27.25 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.066 -1.021 . . . . 0.0 110.332 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 73.4 m -60.51 99.19 0.08 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.249 -0.907 . . . . 0.0 109.813 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.327 0 CA-C-O 118.002 -1.443 . . . . 0.0 109.517 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.701 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 4' ' ' GLN . 2.3 m -144.69 -109.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -70.04 67.83 0.3 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.325 -0.859 . . . . 0.0 109.458 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.635 ' NE2' ' NE2' ' A' ' 10' ' ' HIS . 9.4 pt20 -152.64 140.76 20.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.16 -0.962 . . . . 0.0 109.566 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.473 ' O ' HD12 ' A' ' 6' ' ' LEU . 1.7 p-80 -66.29 153.98 41.18 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.393 -0.817 . . . . 0.0 109.395 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 5' ' ' HIS . 5.5 mp -121.07 117.24 26.71 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.437 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 58.6 m -128.64 125.03 37.26 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.346 -0.846 . . . . 0.0 110.331 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 60.59 -135.21 49.65 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.2 m -42.77 -35.14 1.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.619 -0.93 . . . . 0.0 110.645 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.635 ' NE2' ' NE2' ' A' ' 4' ' ' GLN . 2.6 t-80 -60.54 -34.04 73.55 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.906 -1.121 . . . . 0.0 108.646 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.711 HD21 HD12 ' A' ' 40' ' ' ILE . 13.4 tp -73.67 -49.1 27.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 t -59.64 -61.85 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.503 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.5 mt-10 -44.8 -29.1 0.73 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.022 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.701 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -85.31 -60.18 2.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.066 -1.021 . . . . 0.0 109.723 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.558 HD13 ' CD2' ' A' ' 24' ' ' PHE . 13.9 mt -48.1 -37.09 14.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.935 -1.103 . . . . 0.0 109.441 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -50.62 -40.48 53.09 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.503 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -78.42 -51.51 9.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.933 . . . . 0.0 108.815 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 t -50.03 -53.99 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-O 121.531 0.681 . . . . 0.0 109.202 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.4 m -78.92 -21.98 46.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.594 -0.691 . . . . 0.0 110.205 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.23 -115.44 5.19 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.649 -1.781 . . . . 0.0 108.649 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -85.32 -23.64 28.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.161 -1.199 . . . . 0.0 109.964 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 59' ' ' GLY . 89.2 mtt180 -54.62 -37.89 66.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.976 -1.077 . . . . 0.0 109.175 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.83 164.35 11.91 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.558 ' CD2' HD13 ' A' ' 15' ' ' LEU . 9.7 p90 -139.75 173.07 11.9 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.511 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 17.4 p90 -111.04 125.41 53.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.243 -0.911 . . . . 0.0 109.343 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -91.78 159.47 15.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.038 -1.038 . . . . 0.0 109.094 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.526 ' C ' ' H ' ' A' ' 29' ' ' ARG . 6.2 t -44.16 146.58 1.1 Allowed Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.367 -0.833 . . . . 0.0 109.698 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.597 ' C ' ' H ' ' A' ' 30' ' ' THR . 8.8 Cg_endo -68.88 21.29 0.15 Allowed 'Trans proline' 0 N--CA 1.481 0.785 0 C-N-CA 121.598 1.532 . . . . 0.0 110.225 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.526 ' H ' ' C ' ' A' ' 27' ' ' THR . 14.7 mmm180 64.09 -17.96 0.07 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.395 -0.816 . . . . 0.0 110.359 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.597 ' H ' ' C ' ' A' ' 28' ' ' PRO . 17.3 p -49.48 99.68 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.176 -0.952 . . . . 0.0 109.345 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -65.1 -8.68 17.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.881 . . . . 0.0 109.681 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -64.83 -26.74 68.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 109.568 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.33 156.96 16.68 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.1 t -155.3 -130.42 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -1.158 . . . . 0.0 109.281 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.477 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 7.8 ptm180 -98.71 -56.82 2.34 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.287 -0.883 . . . . 0.0 109.216 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.579 ' O ' ' N ' ' A' ' 38' ' ' ARG . 18.0 mtm-85 -70.65 -144.22 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.225 -0.922 . . . . 0.0 109.49 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.5 t 57.16 -69.7 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.895 -0.503 . . . . 0.0 110.639 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.594 ' CG ' HH21 ' A' ' 38' ' ' ARG . 0.0 OUTLIER -58.29 -16.18 13.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.825 -1.172 . . . . 0.0 108.677 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.32 -26.66 46.9 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.711 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -102.01 -53.9 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.435 -1.038 . . . . 0.0 110.337 -179.577 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.52 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 8.6 t -71.32 -65.17 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.554 -1.341 . . . . 0.0 111.271 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 46' ' ' ARG . 67.9 mt-10 -57.09 -50.65 72.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.921 -1.112 . . . . 0.0 110.369 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.411 ' O ' ' OE1' ' A' ' 43' ' ' GLN . 0.4 OUTLIER -48.46 -53.55 17.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.735 -1.228 . . . . 0.0 109.8 -179.504 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.515 ' SG ' HD21 ' A' ' 54' ' ' LEU . 97.6 m -75.7 -52.14 11.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.009 -1.057 . . . . 0.0 110.077 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.4 t -60.61 -52.77 63.72 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.913 -1.117 . . . . 0.0 110.229 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 42' ' ' GLU . 1.9 tmm_? -66.27 -36.49 83.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 0.0 110.027 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 44' ' ' CYS . 15.6 m -135.17 145.17 47.49 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.244 -0.91 . . . . 0.0 109.15 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.7 mt -68.24 99.6 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.134 -0.979 . . . . 0.0 109.472 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.4 p -82.98 141.91 31.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.44 -0.788 . . . . 0.0 109.333 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.7 m -70.19 157.04 38.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.701 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 43.8 mt -52.13 -32.36 35.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.374 -0.829 . . . . 0.0 108.978 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -48.43 -55.48 10.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.835 . . . . 0.0 109.314 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.527 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 60.9 mt-30 -57.79 -50.14 74.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.892 . . . . 0.0 109.188 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.515 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.0 mt -55.63 -35.48 65.94 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.115 -0.991 . . . . 0.0 108.675 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -72.41 -8.92 57.54 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.462 0.648 . . . . 0.0 109.322 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -80.04 -21.45 43.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.502 -0.749 . . . . 0.0 111.035 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.527 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.6 m-85 -100.76 -7.15 24.0 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.157 -0.965 . . . . 0.0 110.458 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 77.0 m -60.46 97.59 0.05 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.719 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.837 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 1' ' ' PHE . 3.6 m -53.62 -169.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.443 -0.786 . . . . 0.0 110.406 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -70.99 89.21 0.78 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.641 -0.662 . . . . 0.0 109.416 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -149.12 165.58 31.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.297 -0.877 . . . . 0.0 109.143 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.409 ' ND1' ' N ' ' A' ' 5' ' ' HIS . 0.0 OUTLIER -84.79 125.47 32.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.287 -0.883 . . . . 0.0 109.227 -179.52 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.42 HD21 ' CB ' ' A' ' 14' ' ' ALA . 5.6 mp -84.15 116.33 22.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.422 -0.799 . . . . 0.0 108.903 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.444 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 64.1 m -128.54 125.09 37.61 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.272 -0.893 . . . . 0.0 110.675 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 60.34 -136.16 49.6 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.8 m -42.17 -33.97 0.68 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.752 -0.852 . . . . 0.0 110.624 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.444 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 1.0 OUTLIER -61.68 -34.99 76.71 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.841 -1.162 . . . . 0.0 108.83 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.697 HD21 HD12 ' A' ' 40' ' ' ILE . 12.1 tp -71.26 -49.74 40.02 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.5 t -58.6 -59.8 3.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.5 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 74.2 mt-10 -45.38 -30.15 1.26 Allowed 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.304 -0.559 . . . . 0.0 109.909 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.837 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -85.13 -60.87 1.91 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.152 -0.968 . . . . 0.0 109.694 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.568 HD13 ' CD2' ' A' ' 24' ' ' PHE . 15.6 mt -47.27 -36.33 8.99 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.004 -1.06 . . . . 0.0 109.64 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.86 -40.94 61.42 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.429 -0.795 . . . . 0.0 108.857 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.5 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -77.98 -51.71 9.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.164 -0.96 . . . . 0.0 108.871 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.3 t -49.91 -53.76 9.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.7 m -80.39 -22.32 41.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.617 -0.677 . . . . 0.0 110.297 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.84 -116.31 5.32 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.532 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 24.7 mp0 -84.48 -22.02 30.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -1.192 . . . . 0.0 109.699 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -54.96 -37.82 66.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.163 -0.961 . . . . 0.0 109.126 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.1 161.22 8.79 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.568 ' CD2' HD13 ' A' ' 15' ' ' LEU . 9.1 p90 -138.31 173.31 11.74 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.531 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 6.9 p90 -108.94 123.57 49.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.134 -0.979 . . . . 0.0 109.889 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -100.98 161.82 13.33 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.6 t -50.08 144.69 10.59 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.854 -1.154 . . . . 0.0 108.385 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -55.13 -86.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 120.815 1.01 . . . . 0.0 109.97 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.46 23.95 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.241 -0.912 . . . . 0.0 109.211 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.9 p -81.15 107.28 13.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.404 -0.81 . . . . 0.0 110.096 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -89.26 -15.47 33.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.354 -0.842 . . . . 0.0 108.913 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -69.15 -33.25 73.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.374 -0.829 . . . . 0.0 109.095 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.61 147.61 9.96 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 35' ' ' ARG . 38.7 t -101.28 -167.51 1.43 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.382 -1.069 . . . . 0.0 109.901 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.425 ' HG3' ' H ' ' A' ' 36' ' ' ARG . 21.7 ptt180 -148.3 -117.53 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 38' ' ' ARG . 5.4 mtt-85 -52.14 -44.55 64.6 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.493 -0.755 . . . . 0.0 110.143 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 36' ' ' ARG . 0.7 OUTLIER -26.49 -35.19 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.518 -178.325 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.599 ' CG ' HH21 ' A' ' 38' ' ' ARG . 0.1 OUTLIER -58.27 -15.86 11.83 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.673 -1.267 . . . . 0.0 109.081 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.01 -31.77 22.45 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.697 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.4 -53.84 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.418 -1.048 . . . . 0.0 110.712 -178.425 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.521 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 4.3 t -69.65 -64.09 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 120.392 -1.443 . . . . 0.0 111.012 -178.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -56.16 -51.15 69.01 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.176 -0.952 . . . . 0.0 110.287 -178.517 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 47' ' ' SER . 7.0 tt0 -48.77 -53.96 16.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.633 -1.292 . . . . 0.0 110.063 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.538 ' SG ' HD21 ' A' ' 54' ' ' LEU . 87.3 m -74.83 -52.81 10.41 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.133 -0.98 . . . . 0.0 109.89 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 54.1 t -60.36 -52.47 65.13 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.062 -1.024 . . . . 0.0 110.341 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 42' ' ' GLU . 2.6 tmm_? -69.15 -34.59 75.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.926 -1.109 . . . . 0.0 110.185 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 44' ' ' CYS . 51.3 m -135.24 146.13 48.31 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.09 -1.006 . . . . 0.0 109.323 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.1 mt -68.66 99.64 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.0 -1.063 . . . . 0.0 109.706 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.5 p -83.77 138.41 33.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.319 -0.863 . . . . 0.0 109.09 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.4 m -69.61 160.2 32.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.264 -0.897 . . . . 0.0 110.162 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.0 mt -53.72 -32.86 53.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.504 -0.748 . . . . 0.0 109.133 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -49.71 -49.58 47.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 108.97 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.511 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 61.7 mt-30 -63.12 -52.53 62.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.358 -0.839 . . . . 0.0 109.095 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.538 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.5 mt -54.92 -35.32 64.06 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.292 -0.88 . . . . 0.0 108.718 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -73.13 -8.87 57.69 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.524 0.678 . . . . 0.0 109.303 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -80.16 -21.68 42.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.437 -0.789 . . . . 0.0 110.926 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.511 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.0 m-85 -100.38 -6.33 25.91 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.172 -0.955 . . . . 0.0 110.474 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.4 m -61.19 97.32 0.06 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.114 -0.991 . . . . 0.0 109.507 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.268 0 CA-C-O 117.993 -1.449 . . . . 0.0 109.517 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 1' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.44 ' H ' HG22 ' A' ' 2' ' ' VAL . 2.7 m -54.89 -169.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.313 -0.867 . . . . 0.0 109.686 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 3' ' ' ASN . 0.8 OUTLIER -86.9 131.29 34.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.577 -0.702 . . . . 0.0 109.236 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -171.06 164.75 7.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.506 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.02 126.44 30.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.326 -0.859 . . . . 0.0 109.152 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.407 HD21 ' CB ' ' A' ' 14' ' ' ALA . 4.6 mp -100.26 117.11 33.8 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.521 -0.737 . . . . 0.0 109.421 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.419 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 68.9 m -129.39 125.06 35.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.255 -0.903 . . . . 0.0 110.377 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.99 -137.78 43.89 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.0 m -42.68 -34.87 0.97 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.648 -0.913 . . . . 0.0 110.412 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.419 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 2.1 t-160 -58.1 -35.66 71.75 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.94 -1.1 . . . . 0.0 108.56 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.726 HD21 HD12 ' A' ' 40' ' ' ILE . 11.0 tp -71.5 -52.49 18.04 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.523 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 75.2 t -58.87 -58.95 4.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.493 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 30.2 mt-10 -44.85 -28.75 0.69 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.74 -0.6 . . . . 0.0 109.909 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.603 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -86.8 -61.31 1.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -0.962 . . . . 0.0 109.52 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.553 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.5 mt -46.23 -36.58 6.24 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.171 -0.956 . . . . 0.0 109.713 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -51.97 -41.12 61.87 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.387 -0.821 . . . . 0.0 108.807 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.493 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -77.77 -50.95 11.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 0.0 108.863 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.5 t -50.16 -54.66 7.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.2 m -78.61 -22.01 47.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.601 -0.687 . . . . 0.0 110.258 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.92 -116.74 6.44 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.544 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 5.1 mp0 -84.77 -21.65 29.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.072 -1.252 . . . . 0.0 109.676 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -54.94 -38.1 67.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.163 -0.961 . . . . 0.0 109.286 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.14 162.11 9.8 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.553 ' CD2' HD13 ' A' ' 15' ' ' LEU . 8.0 p90 -139.26 172.42 12.85 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.519 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 19.3 p90 -109.1 123.45 49.2 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.451 ' CD2' HG22 ' A' ' 27' ' ' THR . 9.4 t80 -90.44 162.12 15.23 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.939 -1.101 . . . . 0.0 109.839 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.451 HG22 ' CD2' ' A' ' 26' ' ' TYR . 8.2 t -41.82 147.2 0.54 Allowed Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.865 -0.522 . . . . 0.0 109.663 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.57 ' C ' ' H ' ' A' ' 30' ' ' THR . 10.0 Cg_exo -46.71 130.47 15.31 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 N-CA-C 109.284 -1.083 . . . . 0.0 109.284 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.582 ' H ' ' HD2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -68.43 18.79 0.03 OUTLIER 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.307 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.57 ' H ' ' C ' ' A' ' 28' ' ' PRO . 26.2 p -104.67 -16.8 14.87 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 50.51 17.19 0.35 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.39 -0.819 . . . . 0.0 109.696 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -75.36 -42.34 54.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.222 -0.924 . . . . 0.0 109.391 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.69 149.55 5.02 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.45 ' OG ' ' N ' ' A' ' 35' ' ' ARG . 44.0 t -160.62 -136.26 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.372 -1.075 . . . . 0.0 109.708 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.53 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 2.1 ptp180 -141.81 -51.69 0.42 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.32 -0.863 . . . . 0.0 109.094 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.578 ' CB ' HH21 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -59.31 -49.09 79.16 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.242 -0.911 . . . . 0.0 109.674 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.9 t -37.67 -65.41 0.32 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.491 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.616 ' CG ' HH21 ' A' ' 38' ' ' ARG . 0.0 OUTLIER -58.56 -15.58 11.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.76 -1.213 . . . . 0.0 109.183 -179.141 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 36' ' ' ARG . . . -82.6 -28.72 38.12 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.726 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.9 -51.25 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.442 -1.034 . . . . 0.0 110.18 -179.275 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.5 t -69.73 -65.0 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.521 -1.362 . . . . 0.0 111.237 -178.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' ARG . 61.5 mm-40 -57.5 -47.53 81.66 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.897 -1.127 . . . . 0.0 110.38 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -48.66 -53.65 17.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.682 -1.262 . . . . 0.0 109.565 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.586 ' SG ' HD21 ' A' ' 54' ' ' LEU . 96.6 m -78.16 -53.65 7.13 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.211 -0.93 . . . . 0.0 109.965 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.7 t -59.96 -52.49 65.19 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.9 -1.125 . . . . 0.0 110.056 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.545 HH21 ' CG ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -68.69 -33.13 73.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -0.952 . . . . 0.0 110.362 -179.172 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 44' ' ' CYS . 7.7 m -136.28 144.93 45.02 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.105 -0.997 . . . . 0.0 109.387 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 55.0 mt -68.43 99.48 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.013 -1.055 . . . . 0.0 109.272 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.6 p -85.5 141.81 29.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.417 -0.802 . . . . 0.0 109.343 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.3 m -73.04 160.56 31.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.634 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.414 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 43.8 mt -53.06 -33.01 50.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 109.342 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -48.43 -56.96 6.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -0.9 . . . . 0.0 109.31 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.517 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 64.1 mt-30 -56.47 -50.53 71.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.209 -0.932 . . . . 0.0 109.018 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.586 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.8 mt -56.07 -33.97 65.52 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.136 -0.977 . . . . 0.0 108.543 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -73.85 -9.02 58.23 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -79.98 -21.73 43.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.498 -0.751 . . . . 0.0 111.092 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.517 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.6 m-85 -100.64 -6.14 25.62 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.11 -0.994 . . . . 0.0 110.352 -178.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 73.6 m -62.08 97.05 0.08 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.193 -0.942 . . . . 0.0 109.805 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.304 0 CA-C-O 117.98 -1.456 . . . . 0.0 109.515 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.69 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 2.2 m-85 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.474 ' CG2' HE21 ' A' ' 4' ' ' GLN . 19.9 m -155.34 -153.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -83.6 90.53 7.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.027 -1.045 . . . . 0.0 109.052 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.526 ' OE1' ' NE2' ' A' ' 10' ' ' HIS . 4.9 pt20 -156.87 149.67 23.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 109.683 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.4 ' ND1' ' N ' ' A' ' 5' ' ' HIS . 0.0 OUTLIER -85.27 127.07 34.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.277 -0.89 . . . . 0.0 109.017 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.456 HD21 ' CB ' ' A' ' 14' ' ' ALA . 5.9 mp -88.7 116.47 26.98 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.386 -0.821 . . . . 0.0 109.329 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.437 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 57.9 m -130.77 125.23 33.25 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.293 -0.879 . . . . 0.0 110.425 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 61.05 -137.03 48.25 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.3 m -42.36 -31.67 0.43 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.613 -0.934 . . . . 0.0 110.695 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.526 ' NE2' ' OE1' ' A' ' 4' ' ' GLN . 6.7 t-160 -64.39 -34.5 78.32 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.777 -1.202 . . . . 0.0 108.665 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.708 HD21 HD12 ' A' ' 40' ' ' ILE . 9.6 tp -71.09 -49.72 41.42 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 t -57.71 -60.46 2.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 25.7 mt-10 -44.5 -29.93 0.79 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.068 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.69 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -85.6 -60.55 1.99 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.086 -1.009 . . . . 0.0 109.578 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.525 HD13 ' CD2' ' A' ' 24' ' ' PHE . 15.7 mt -47.05 -37.34 9.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.055 -1.028 . . . . 0.0 109.745 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -50.89 -40.76 57.4 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.496 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -77.82 -50.6 11.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 108.746 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.7 t -50.26 -55.29 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.4 m -79.17 -22.19 45.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.6 -0.687 . . . . 0.0 110.304 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.72 -116.57 6.13 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -85.01 -22.67 28.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.128 -1.219 . . . . 0.0 109.76 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -54.77 -38.35 67.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.15 -0.969 . . . . 0.0 108.843 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.2 162.69 10.61 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 120.094 -1.051 . . . . 0.0 110.747 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 7.0 p90 -137.43 172.58 12.76 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.533 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 15.7 p90 -110.89 122.21 47.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 0.0 108.995 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.538 ' O ' ' C ' ' A' ' 27' ' ' THR . 9.1 t80 -91.97 108.69 20.11 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.863 -1.148 . . . . 0.0 108.787 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.538 ' C ' ' O ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -8.12 80.52 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.47 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.423 ' HB2' HH21 ' A' ' 29' ' ' ARG . 6.1 Cg_exo -61.81 -8.39 11.4 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 N-CA-C 108.012 -1.572 . . . . 0.0 108.012 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.579 ' N ' ' CD ' ' A' ' 29' ' ' ARG . 6.6 mpt_? -81.37 -25.88 35.96 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.604 ' C ' ' H ' ' A' ' 32' ' ' GLU . 1.4 p 51.05 -164.23 0.05 Allowed 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.465 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -67.54 25.64 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.05 -1.031 . . . . 0.0 109.528 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.604 ' H ' ' C ' ' A' ' 30' ' ' THR . 1.5 mm-40 -94.57 -33.17 13.13 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.94 -136.21 8.94 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.2 t -166.98 -69.96 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.066 -1.255 . . . . 0.0 110.373 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.439 ' HG3' ' H ' ' A' ' 36' ' ' ARG . 9.8 ptm180 -40.12 -55.53 2.09 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.912 -0.493 . . . . 0.0 110.894 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 38' ' ' ARG . 23.6 mmt180 -72.55 -165.58 0.21 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.075 -1.015 . . . . 0.0 109.919 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.6 t 59.41 -63.29 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 122.182 -0.324 . . . . 0.0 111.303 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 36' ' ' ARG . 15.5 ptm180 -58.08 -13.55 5.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.512 -1.368 . . . . 0.0 108.916 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.32 -36.09 15.63 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.708 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.87 -50.79 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.407 -1.054 . . . . 0.0 110.039 -179.255 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.49 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.3 t -67.73 -64.9 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.57 -1.331 . . . . 0.0 111.802 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 46' ' ' ARG . 31.5 mm-40 -55.72 -53.0 61.99 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.934 -1.104 . . . . 0.0 111.377 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -47.44 -50.13 23.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.651 -1.28 . . . . 0.0 109.973 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.625 ' SG ' HD21 ' A' ' 54' ' ' LEU . 94.6 m -81.17 -54.4 5.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.995 -1.066 . . . . 0.0 110.186 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 54.0 t -61.51 -47.87 83.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.872 -1.142 . . . . 0.0 110.074 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 42' ' ' GLU . 1.0 OUTLIER -69.79 -36.32 75.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.999 -1.063 . . . . 0.0 109.722 -179.469 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 44' ' ' CYS . 6.9 m -137.27 150.33 47.74 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.062 -1.024 . . . . 0.0 109.733 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.5 mt -68.64 99.74 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.145 -0.972 . . . . 0.0 109.272 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.1 p -83.27 146.21 28.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.388 -0.82 . . . . 0.0 109.817 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.1 m -79.54 166.28 22.09 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.305 -0.872 . . . . 0.0 109.516 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.0 mt -56.49 -31.99 64.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.484 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -48.31 -48.62 35.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.14 -0.975 . . . . 0.0 109.47 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.522 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 61.0 mt-30 -69.16 -53.38 20.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.343 -0.848 . . . . 0.0 109.633 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.625 HD21 ' SG ' ' A' ' 44' ' ' CYS . 98.0 mt -55.12 -35.44 64.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.142 -0.974 . . . . 0.0 109.021 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -73.91 -9.36 58.56 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -78.83 -22.03 46.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.387 -0.82 . . . . 0.0 110.839 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.522 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.2 m-85 -100.28 -6.45 25.92 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.185 -0.947 . . . . 0.0 110.443 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 74.6 m -62.71 96.51 0.09 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.1 -1.0 . . . . 0.0 109.536 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.283 0 CA-C-O 117.984 -1.453 . . . . 0.0 109.523 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.871 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 1' ' ' PHE . 27.0 m -59.25 -149.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.367 -0.833 . . . . 0.0 110.328 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.483 ' OD1' ' CD1' ' A' ' 48' ' ' ILE . 18.1 t-20 -74.7 94.93 2.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.576 -0.702 . . . . 0.0 109.421 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.535 ' NE2' ' CE1' ' A' ' 10' ' ' HIS . 2.1 pt20 -152.3 153.68 34.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.208 -0.933 . . . . 0.0 109.277 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -86.52 124.2 32.57 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.21 -0.932 . . . . 0.0 109.022 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.471 HD21 ' CB ' ' A' ' 14' ' ' ALA . 6.6 mp -86.96 116.74 25.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.398 -0.814 . . . . 0.0 109.36 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.4 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 68.0 m -129.74 125.17 35.26 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.189 -0.945 . . . . 0.0 110.65 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 60.66 -139.22 48.1 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 8' ' ' GLY . 70.6 m -39.64 -33.34 0.18 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.856 -0.791 . . . . 0.0 110.71 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.535 ' CE1' ' NE2' ' A' ' 4' ' ' GLN . 2.2 t-160 -60.91 -39.77 90.62 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.878 -1.139 . . . . 0.0 108.699 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.753 HD21 HD12 ' A' ' 40' ' ' ILE . 9.2 tp -65.34 -53.96 35.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.408 -0.807 . . . . 0.0 109.109 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.52 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 73.2 t -55.4 -59.75 2.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.493 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 32.5 mt-10 -44.59 -28.77 0.63 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.698 -0.626 . . . . 0.0 110.126 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.871 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -86.77 -60.51 1.97 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.118 -0.989 . . . . 0.0 109.485 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.533 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.3 mt -46.96 -35.76 6.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.102 -0.999 . . . . 0.0 109.552 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -52.36 -40.85 62.52 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.493 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.02 -51.13 10.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 108.867 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.6 t -50.15 -54.1 9.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.3 m -78.44 -22.13 48.11 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.634 -0.666 . . . . 0.0 110.32 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.06 -115.04 4.14 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.519 -1.832 . . . . 0.0 108.519 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -85.41 -23.4 27.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.11 -1.229 . . . . 0.0 109.931 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 59' ' ' GLY . 37.2 mtp180 -54.76 -37.79 66.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -0.982 . . . . 0.0 109.286 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.82 162.73 9.76 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.562 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.533 ' CD2' HD13 ' A' ' 15' ' ' LEU . 9.5 p90 -138.85 173.8 11.19 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.548 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 18.5 p90 -110.7 122.15 47.1 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.173 -0.954 . . . . 0.0 110.273 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -107.38 169.52 8.52 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.447 ' H ' HG22 ' A' ' 27' ' ' THR . 1.3 t -71.5 146.7 91.86 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 120.944 -1.097 . . . . 0.0 108.484 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -55.72 -79.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.32 -0.952 0 C-N-CA 120.99 1.127 . . . . 0.0 109.724 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.414 ' H ' ' H ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -161.31 0.97 0.06 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.406 -0.809 . . . . 0.0 108.966 -179.249 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.414 ' H ' ' H ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -89.72 125.15 35.17 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.353 -0.842 . . . . 0.0 109.435 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -80.61 -2.12 45.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.304 -0.872 . . . . 0.0 109.291 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 33' ' ' GLY . 66.9 mm-40 -54.08 -49.01 70.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.912 . . . . 0.0 109.009 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 32' ' ' GLU . . . 59.9 143.3 0.01 OUTLIER Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 35' ' ' ARG . 86.6 p -109.59 -106.61 0.35 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.588 -0.948 . . . . 0.0 109.033 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.535 HH11 ' NH1' ' A' ' 36' ' ' ARG . 0.4 OUTLIER -92.69 -56.15 3.11 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.355 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.582 ' O ' ' N ' ' A' ' 38' ' ' ARG . 15.2 mtt-85 -63.34 -137.01 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.295 -0.878 . . . . 0.0 109.184 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.7 t 54.57 -77.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.576 -0.702 . . . . 0.0 110.165 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.582 ' N ' ' O ' ' A' ' 36' ' ' ARG . 1.6 ptm180 -58.39 -15.21 9.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.011 -1.055 . . . . 0.0 108.513 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.59 -32.45 27.52 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.753 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.77 -51.42 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.479 -1.012 . . . . 0.0 110.121 -179.418 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.513 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 4.1 t -68.79 -64.34 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.649 -1.282 . . . . 0.0 111.409 -178.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 46' ' ' ARG . 68.2 mm-40 -58.26 -53.04 62.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.791 -1.193 . . . . 0.0 110.257 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -43.85 -47.48 8.22 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.972 -1.08 . . . . 0.0 110.187 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.647 ' SG ' HD21 ' A' ' 54' ' ' LEU . 95.3 m -84.05 -50.47 7.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.036 -1.04 . . . . 0.0 109.933 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.9 t -61.79 -53.12 60.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.243 -0.911 . . . . 0.0 110.472 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 42' ' ' GLU . 7.9 tpp180 -69.68 -39.45 76.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.918 -1.114 . . . . 0.0 109.708 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 44' ' ' CYS . 15.6 m -126.41 144.78 50.72 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.11 -0.993 . . . . 0.0 109.584 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.483 ' CD1' ' OD1' ' A' ' 3' ' ' ASN . 17.5 mt -69.38 99.38 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.173 -0.954 . . . . 0.0 109.24 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.5 p -83.85 143.34 29.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.327 -0.858 . . . . 0.0 109.533 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.483 ' H ' HE21 ' A' ' 53' ' ' GLN . 5.0 m -73.35 161.25 30.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.86 . . . . 0.0 109.805 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 42.3 mt -55.52 -34.18 64.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.852 . . . . 0.0 109.342 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -48.63 -53.73 17.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.129 -0.982 . . . . 0.0 109.031 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.52 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 56.4 mt-30 -58.69 -51.75 68.6 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.331 -0.856 . . . . 0.0 108.939 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.647 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.4 mt -56.69 -30.77 63.78 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -76.29 -8.86 58.0 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -80.51 -22.85 40.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.533 -0.729 . . . . 0.0 110.869 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.52 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 5.7 m-85 -99.35 -7.43 26.27 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.111 -0.993 . . . . 0.0 110.048 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 91.5 m -61.35 93.98 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.386 -0.821 . . . . 0.0 109.722 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.344 0 CA-C-O 118.029 -1.428 . . . . 0.0 109.568 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.612 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 9.8 m-85 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.557 ' CG2' HE21 ' A' ' 4' ' ' GLN . 1.2 m -151.87 -105.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.444 ' H ' HG23 ' A' ' 2' ' ' VAL . 3.0 m120 -141.39 80.11 1.72 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.465 -0.772 . . . . 0.0 108.955 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.557 HE21 ' CG2' ' A' ' 2' ' ' VAL . 16.1 pt20 -150.45 167.47 27.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.35 -0.844 . . . . 0.0 109.659 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.43 126.42 37.5 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.391 -0.818 . . . . 0.0 108.968 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.428 HD21 ' CB ' ' A' ' 14' ' ' ALA . 4.1 mp -85.22 117.05 23.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.345 -0.847 . . . . 0.0 109.121 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.415 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 76.2 m -128.22 125.07 38.24 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.99 0.9 . . . . 0.0 110.839 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.73 -136.85 48.78 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.4 m -42.65 -31.49 0.47 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.605 -0.938 . . . . 0.0 110.484 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.522 ' CE1' ' OE1' ' A' ' 4' ' ' GLN . 1.7 t-160 -62.26 -34.0 75.7 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.944 -1.097 . . . . 0.0 108.758 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.708 HD21 HD12 ' A' ' 40' ' ' ILE . 12.0 tp -72.97 -52.57 13.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.438 -0.789 . . . . 0.0 109.015 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.512 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 66.9 t -56.44 -59.64 2.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.484 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.6 mt-10 -44.25 -28.96 0.58 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.804 -0.56 . . . . 0.0 110.222 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.612 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -86.96 -59.8 2.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.132 -0.98 . . . . 0.0 109.602 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.547 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.9 mt -47.21 -36.77 9.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.164 -0.96 . . . . 0.0 109.513 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.32 -41.13 60.34 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.484 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -77.74 -50.09 13.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 108.856 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.5 t -50.44 -54.55 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-O 121.65 0.738 . . . . 0.0 109.029 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.1 m -79.51 -22.77 43.53 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.696 -0.628 . . . . 0.0 110.506 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 50.09 -109.65 0.7 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 8.9 mp0 -85.48 -25.58 26.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.213 -1.169 . . . . 0.0 110.269 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HG2' HH21 ' A' ' 22' ' ' ARG . 31.7 mtt-85 -54.66 -38.68 67.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.955 -1.091 . . . . 0.0 109.309 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.34 161.54 8.02 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.547 ' CD2' HD13 ' A' ' 15' ' ' LEU . 9.5 p90 -138.4 173.59 11.44 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.469 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 4.9 p90 -106.25 128.53 54.03 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.209 -0.932 . . . . 0.0 110.012 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.47 ' O ' ' C ' ' A' ' 27' ' ' THR . 3.5 t80 -116.17 124.45 50.33 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.343 -0.848 . . . . 0.0 109.069 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.47 ' C ' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER 29.91 84.42 0.16 Allowed Pre-proline 0 N--CA 1.509 2.524 0 O-C-N 121.924 -0.485 . . . . 0.0 111.027 179.773 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -76.43 -9.17 18.74 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 121.706 1.604 . . . . 0.0 109.688 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -172.12 24.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.459 179.694 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.543 ' C ' ' H ' ' A' ' 32' ' ' GLU . 9.8 p 58.75 157.32 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.595 -0.691 . . . . 0.0 109.596 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.599 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 3.0 mp0 -69.65 13.34 0.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.175 -0.953 . . . . 0.0 108.667 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.543 ' H ' ' C ' ' A' ' 30' ' ' THR . 10.8 mm-40 -77.95 -25.41 48.24 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.673 -0.642 . . . . 0.0 109.5 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -94.7 -117.09 2.93 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 33' ' ' GLY . 44.4 t -60.15 -117.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.402 -1.058 . . . . 0.0 109.644 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.537 ' CG ' ' H ' ' A' ' 36' ' ' ARG . 0.6 OUTLIER -141.83 -104.62 0.14 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.178 -0.951 . . . . 0.0 109.691 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.57 ' O ' ' N ' ' A' ' 38' ' ' ARG . 75.6 mtt180 42.33 -150.42 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.703 -0.623 . . . . 0.0 109.776 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 t 58.4 -65.17 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.948 -0.47 . . . . 0.0 110.806 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.57 ' N ' ' O ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -57.73 -12.12 2.73 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.821 -1.174 . . . . 0.0 108.61 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.06 -28.63 40.62 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.708 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.1 -54.13 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.475 -1.015 . . . . 0.0 110.283 -179.288 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.514 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.2 t -66.73 -64.83 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.358 -1.464 . . . . 0.0 111.21 -178.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 46' ' ' ARG . 52.5 mm-40 -56.24 -48.55 76.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.919 -1.113 . . . . 0.0 110.08 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -46.98 -55.87 7.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.739 -1.226 . . . . 0.0 109.991 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.563 ' SG ' HD21 ' A' ' 54' ' ' LEU . 93.6 m -76.94 -52.66 9.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.246 -0.909 . . . . 0.0 110.062 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.8 t -59.47 -52.93 63.48 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.867 -1.145 . . . . 0.0 109.97 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 42' ' ' GLU . 2.7 tmt_? -66.82 -36.3 82.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.289 -0.882 . . . . 0.0 110.235 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 44' ' ' CYS . 16.2 m -134.43 145.25 48.7 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.124 -0.985 . . . . 0.0 109.362 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 57.5 mt -68.21 99.62 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.036 -1.04 . . . . 0.0 109.331 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.8 p -84.93 150.01 25.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.417 -0.802 . . . . 0.0 109.421 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.7 m -88.41 166.17 14.42 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.262 -0.899 . . . . 0.0 110.026 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.1 mt -52.17 -34.25 44.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.421 -0.8 . . . . 0.0 109.519 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -47.52 -43.1 24.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.246 -0.909 . . . . 0.0 109.57 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.512 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 41.8 mt-30 -77.47 -52.33 9.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.374 -0.829 . . . . 0.0 109.792 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.563 HD21 ' SG ' ' A' ' 44' ' ' CYS . 98.7 mt -54.45 -38.08 65.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.031 -1.043 . . . . 0.0 109.007 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -71.0 -9.27 57.72 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 121.544 0.688 . . . . 0.0 109.286 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -78.91 -22.36 45.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 0.0 111.033 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.512 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.7 m-85 -99.98 -8.04 24.39 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.078 -1.013 . . . . 0.0 110.272 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 87.5 m -60.53 94.86 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.511 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 1' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 1' ' ' PHE . 35.9 m -61.37 -140.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.858 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -138.03 110.93 7.7 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.39 -0.819 . . . . 0.0 109.348 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -157.24 178.19 10.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.284 -0.885 . . . . 0.0 109.224 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.26 117.01 19.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.206 -0.934 . . . . 0.0 109.354 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 mp -86.76 116.72 25.04 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 86.0 m -128.5 124.98 37.44 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.31 -0.869 . . . . 0.0 110.388 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.56 -137.01 44.63 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 m -42.31 -35.63 1.04 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.707 -0.878 . . . . 0.0 110.568 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.403 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 0.8 OUTLIER -58.49 -35.12 71.71 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.919 -1.113 . . . . 0.0 108.892 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.722 HD21 HD12 ' A' ' 40' ' ' ILE . 12.7 tp -72.03 -52.52 16.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.332 -0.855 . . . . 0.0 108.826 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.507 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 75.1 t -58.44 -59.25 3.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.499 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 85.7 mt-10 -45.12 -29.0 0.82 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.727 -0.608 . . . . 0.0 109.895 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.56 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -86.53 -60.9 1.86 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -0.939 . . . . 0.0 109.559 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.567 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.6 mt -46.87 -36.55 7.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.166 -0.958 . . . . 0.0 109.555 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.7 -41.96 61.86 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.408 -0.808 . . . . 0.0 108.842 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.499 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -76.38 -51.84 11.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 108.735 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 t -49.97 -53.78 9.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.547 0.689 . . . . 0.0 109.203 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 m -79.84 -22.38 43.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.471 -0.768 . . . . 0.0 110.471 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.86 -114.22 3.41 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.744 -1.743 . . . . 0.0 108.744 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -85.29 -23.98 27.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.2 -1.176 . . . . 0.0 110.125 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -54.6 -37.69 65.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.966 -1.084 . . . . 0.0 109.359 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.83 162.24 9.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.567 ' CD2' HD13 ' A' ' 15' ' ' LEU . 9.3 p90 -138.41 173.51 11.52 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 3.8 p90 -107.72 125.41 51.36 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.086 -1.008 . . . . 0.0 110.231 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.485 ' CD2' HG22 ' A' ' 27' ' ' THR . 2.5 t80 -107.15 171.14 7.54 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.485 HG22 ' CD2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -39.42 113.11 0.81 Allowed Pre-proline 0 N--CA 1.505 2.281 0 O-C-N 121.322 -0.862 . . . . 0.0 109.566 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.44 5.91 1.4 Allowed 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 120.879 1.052 . . . . 0.0 110.534 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.439 ' C ' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -175.42 -50.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.082 -1.011 . . . . 0.0 110.315 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.439 HG22 ' C ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -178.23 122.87 0.1 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.975 -1.078 . . . . 0.0 110.038 -179.454 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -5.56 12.73 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 33' ' ' GLY . 9.0 mt-10 -83.1 -29.1 29.01 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.642 -0.661 . . . . 0.0 109.402 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 32' ' ' GLU . . . -55.73 -108.39 0.01 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.401 ' OG ' ' N ' ' A' ' 35' ' ' ARG . 35.6 t -78.97 -138.93 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -1.157 . . . . 0.0 110.037 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.649 HH12 ' NH2' ' A' ' 38' ' ' ARG . 1.4 ptm180 -97.11 -119.43 0.12 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.395 -0.816 . . . . 0.0 109.457 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.602 ' CG ' HH21 ' A' ' 36' ' ' ARG . 0.0 OUTLIER 47.15 -173.25 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.259 -0.901 . . . . 0.0 110.06 179.746 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.9 t 59.13 -25.33 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.622 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.649 ' NH2' HH12 ' A' ' 35' ' ' ARG . 0.0 OUTLIER -75.21 -11.9 60.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.318 -1.489 . . . . 0.0 109.079 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.23 -33.05 24.15 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.722 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.29 -53.88 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.159 -1.201 . . . . 0.0 110.837 -178.749 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.502 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.7 t -65.93 -63.65 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.454 -1.404 . . . . 0.0 111.402 -177.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' ARG . 71.4 mt-10 -55.46 -51.59 66.43 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.868 -1.145 . . . . 0.0 111.056 -178.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.591 ' O ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -48.21 -52.05 22.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.622 -1.299 . . . . 0.0 110.044 -179.128 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.572 ' SG ' HD21 ' A' ' 54' ' ' LEU . 85.4 m -78.01 -53.77 7.04 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.962 -1.086 . . . . 0.0 110.013 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 54.0 t -59.86 -52.18 66.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.89 -1.131 . . . . 0.0 109.939 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -67.03 -35.58 80.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 0.0 110.303 -179.396 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 44' ' ' CYS . 26.4 m -136.67 147.2 46.7 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.059 -1.026 . . . . 0.0 109.307 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.9 mt -68.32 99.71 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.045 -1.034 . . . . 0.0 109.554 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.4 p -85.29 138.77 32.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.364 -0.835 . . . . 0.0 109.175 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.0 m -70.1 163.06 27.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.27 -0.894 . . . . 0.0 109.68 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.1 mt -56.61 -31.0 63.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.337 -0.852 . . . . 0.0 108.892 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -48.91 -51.95 27.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 109.177 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.49 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 56.8 mt-30 -62.99 -50.35 71.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.223 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.572 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.8 mt -55.09 -36.01 65.2 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.2 -0.938 . . . . 0.0 108.768 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -71.81 -8.98 57.57 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.485 0.659 . . . . 0.0 109.254 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -79.81 -22.5 42.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.422 -0.798 . . . . 0.0 110.958 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.49 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.8 m-85 -100.04 -8.15 24.16 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.069 -1.019 . . . . 0.0 110.209 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 81.6 m -60.39 93.03 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.357 -0.839 . . . . 0.0 109.44 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.284 0 CA-C-O 117.985 -1.453 . . . . 0.0 109.555 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.485 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.744 HG22 ' N ' ' A' ' 3' ' ' ASN . 0.7 OUTLIER 33.1 -94.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 122.125 -0.359 . . . . 0.0 110.659 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.744 ' N ' HG22 ' A' ' 2' ' ' VAL . 0.3 OUTLIER 171.32 88.34 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.014 -1.054 . . . . 0.0 108.853 179.396 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -146.66 165.26 30.11 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.223 -0.923 . . . . 0.0 109.536 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -83.91 129.99 34.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.394 -0.816 . . . . 0.0 109.078 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.402 HD21 ' CB ' ' A' ' 14' ' ' ALA . 5.0 mp -91.86 116.08 28.61 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.26 -0.9 . . . . 0.0 109.793 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.424 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 63.0 m -130.73 124.57 31.77 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.321 -0.862 . . . . 0.0 109.872 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 63.95 -138.1 41.66 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.6 m -41.69 -35.17 0.72 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.715 -0.873 . . . . 0.0 110.764 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.424 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 7.3 t-160 -59.29 -35.68 74.2 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.878 -1.139 . . . . 0.0 108.89 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.721 HD21 HD12 ' A' ' 40' ' ' ILE . 8.4 tp -70.18 -52.73 21.12 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.511 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 64.6 t -58.12 -60.38 2.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.489 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 70.9 mt-10 -44.01 -30.17 0.69 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.818 -0.551 . . . . 0.0 110.022 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.485 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -84.9 -61.15 1.85 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.254 -0.904 . . . . 0.0 109.71 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.498 HD13 ' CD2' ' A' ' 24' ' ' PHE . 13.2 mt -46.1 -36.9 6.22 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.245 -0.909 . . . . 0.0 109.629 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -51.85 -40.43 60.53 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.489 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -78.37 -50.65 11.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 108.761 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.418 ' H ' HG23 ' A' ' 18' ' ' VAL . 19.2 t -50.12 -55.02 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.523 0.678 . . . . 0.0 109.362 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.6 m -77.29 -22.34 52.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.556 -0.715 . . . . 0.0 110.615 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.32 -112.59 2.11 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.571 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 2.6 mp0 -85.32 -25.11 27.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.226 -1.161 . . . . 0.0 109.972 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -54.44 -38.3 66.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.065 -1.022 . . . . 0.0 109.486 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.15 162.71 8.73 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.511 ' HZ ' HG13 ' A' ' 12' ' ' VAL . 9.2 p90 -138.48 173.33 11.71 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.544 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 18.8 p90 -111.96 121.68 45.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 109.643 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.521 ' O ' ' C ' ' A' ' 27' ' ' THR . 13.7 t80 -101.58 108.04 19.48 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.026 -1.046 . . . . 0.0 108.798 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.746 ' O ' HG23 ' A' ' 27' ' ' THR . 9.7 t -18.87 85.6 0.04 OUTLIER Pre-proline 0 N--CA 1.507 2.408 0 C-N-CA 122.474 0.31 . . . . 0.0 111.547 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.559 ' O ' ' N ' ' A' ' 30' ' ' THR . 2.2 Cg_endo -62.9 98.48 0.2 Allowed 'Trans proline' 0 C--N 1.316 -1.18 0 N-CA-C 109.619 -0.954 . . . . 0.0 109.619 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.493 ' O ' ' N ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER 61.42 -36.07 0.1 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.402 0.62 . . . . 0.0 111.715 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.559 ' N ' ' O ' ' A' ' 28' ' ' PRO . 21.5 p -53.89 86.05 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.908 0 O-C-N 121.46 -0.775 . . . . 0.0 110.435 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 29' ' ' ARG . 51.3 mm-40 -94.41 4.91 53.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.253 -0.904 . . . . 0.0 109.038 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -87.56 -23.21 24.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.434 -0.791 . . . . 0.0 109.875 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.14 150.95 0.16 Allowed Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -100.56 -74.23 0.62 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.404 -1.057 . . . . 0.0 109.984 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.439 ' H ' ' HG2' ' A' ' 35' ' ' ARG . 3.2 ptp180 -62.06 -56.98 13.45 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.343 -0.848 . . . . 0.0 109.961 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 38' ' ' ARG . 7.9 mtt-85 -57.01 -163.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.134 -0.979 . . . . 0.0 110.598 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 t 47.71 -87.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.737 -0.602 . . . . 0.0 110.447 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 36' ' ' ARG . 9.9 ptm180 -58.56 -17.18 19.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.036 -1.04 . . . . 0.0 108.814 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.55 -31.01 31.42 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.721 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.13 -52.49 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.706 -0.879 . . . . 0.0 110.137 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.516 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.9 t -68.97 -64.76 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.514 -1.366 . . . . 0.0 111.473 -178.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 46' ' ' ARG . 97.4 mt-10 -58.23 -49.32 77.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.913 -1.117 . . . . 0.0 110.534 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -46.75 -49.47 19.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.82 -1.175 . . . . 0.0 109.899 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.606 ' SG ' HD21 ' A' ' 54' ' ' LEU . 86.4 m -84.16 -51.84 6.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 110.248 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.3 t -61.57 -48.29 81.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.813 -1.179 . . . . 0.0 109.79 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.553 HH21 ' CG ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -66.25 -39.11 89.26 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.99 -1.069 . . . . 0.0 109.703 -179.718 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 44' ' ' CYS . 68.8 m -138.61 152.84 48.48 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.143 -0.973 . . . . 0.0 109.719 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.4 mt -68.53 99.46 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.012 -1.055 . . . . 0.0 109.381 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.3 p -80.87 141.28 34.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 0.0 108.891 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 m -70.39 158.87 35.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -0.951 . . . . 0.0 109.912 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 43.3 mt -53.02 -32.25 45.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.442 -0.786 . . . . 0.0 109.187 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -49.5 -52.09 31.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.257 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.492 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 45.7 mt-30 -62.41 -51.32 68.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 109.326 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.606 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.8 mt -56.5 -33.23 65.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.093 -1.004 . . . . 0.0 108.437 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -74.37 -8.95 58.01 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -79.65 -22.22 43.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.452 -0.78 . . . . 0.0 110.897 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.492 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.4 m-85 -100.27 -8.17 23.78 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.187 -0.946 . . . . 0.0 110.056 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 93.4 m -60.63 96.2 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.59 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 1' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 1' ' ' PHE . 3.6 m -54.49 -171.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.339 -0.85 . . . . 0.0 109.899 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.418 ' N ' ' OD1' ' A' ' 3' ' ' ASN . 2.1 m120 -95.1 112.53 24.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.57 -0.706 . . . . 0.0 109.097 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.515 ' OE1' ' NE2' ' A' ' 10' ' ' HIS . 2.8 pt20 -151.51 164.99 35.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 109.528 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -72.78 136.32 45.43 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.238 -0.914 . . . . 0.0 109.219 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.407 HD21 ' CB ' ' A' ' 14' ' ' ALA . 4.7 mp -113.27 115.94 28.96 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.684 -0.635 . . . . 0.0 109.295 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.446 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 62.7 m -128.95 124.86 36.19 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.212 -0.93 . . . . 0.0 110.163 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.14 -136.45 45.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -42.01 -35.44 0.89 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.719 -0.871 . . . . 0.0 110.584 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.515 ' NE2' ' OE1' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -59.4 -36.28 75.53 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.9 -1.125 . . . . 0.0 108.751 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.716 HD21 HD12 ' A' ' 40' ' ' ILE . 10.7 tp -70.97 -50.16 37.48 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.9 t -59.36 -60.83 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.498 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.7 mt-10 -44.71 -29.73 0.82 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.919 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.538 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -85.2 -61.11 1.85 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.726 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.529 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.2 mt -46.72 -36.95 7.73 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.142 -0.974 . . . . 0.0 109.706 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -51.37 -40.43 59.18 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.498 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.34 -50.74 11.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 108.759 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.487 ' O ' ' NH1' ' A' ' 22' ' ' ARG . 21.1 t -49.98 -54.94 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.7 m -79.81 -22.39 43.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.62 -0.675 . . . . 0.0 110.113 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.74 -115.69 5.19 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.769 -1.733 . . . . 0.0 108.769 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 8.9 mp0 -84.6 -22.14 30.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.187 -1.184 . . . . 0.0 109.67 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.487 ' NH1' ' O ' ' A' ' 18' ' ' VAL . 78.5 mtm180 -55.02 -37.84 67.15 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.152 -0.968 . . . . 0.0 109.253 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.85 160.14 7.59 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.48 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.529 ' CD2' HD13 ' A' ' 15' ' ' LEU . 8.6 p90 -137.77 172.63 12.66 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.523 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 9.2 p90 -109.86 124.81 51.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 109.335 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -97.55 160.25 14.43 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.045 -1.034 . . . . 0.0 108.703 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.422 ' O ' HG23 ' A' ' 27' ' ' THR . 7.1 t -65.67 134.77 95.42 Favored Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 121.147 -0.971 . . . . 0.0 108.714 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.625 ' O ' ' N ' ' A' ' 30' ' ' THR . 9.2 Cg_endo -66.68 122.67 10.11 Favored 'Trans proline' 0 C--O 1.211 -0.843 0 N-CA-C 109.193 -1.118 . . . . 0.0 109.193 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.475 HH21 ' CB ' ' A' ' 28' ' ' PRO . 4.7 mpt_? 51.68 -79.41 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.437 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.625 ' N ' ' O ' ' A' ' 28' ' ' PRO . 0.3 OUTLIER -168.61 88.15 0.21 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.958 -1.089 . . . . 0.0 109.956 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 33' ' ' GLY . 46.4 mm-40 -78.89 28.55 0.21 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.089 -1.007 . . . . 0.0 108.315 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' A' ' 30' ' ' THR . 75.8 mt-10 -42.77 -25.66 0.1 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.617 -0.677 . . . . 0.0 109.895 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -61.83 -84.6 0.06 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -55.4 -166.48 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.521 -0.988 . . . . 0.0 109.764 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' A' ' 37' ' ' SER . 1.9 ptp180 -90.25 -109.51 0.09 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.449 -0.782 . . . . 0.0 109.628 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.548 ' CG ' HH21 ' A' ' 36' ' ' ARG . 3.5 mtt-85 46.2 -85.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.468 0.651 . . . . 0.0 110.849 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 35' ' ' ARG . 2.7 t -39.03 -49.53 1.74 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.995 -0.441 . . . . 0.0 111.01 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.409 ' HE ' ' HB2' ' A' ' 35' ' ' ARG . 24.8 ptt180 -59.52 -24.8 63.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.839 -1.163 . . . . 0.0 109.678 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 36' ' ' ARG . . . -74.36 -35.74 51.7 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.716 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.12 -51.5 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.244 -1.151 . . . . 0.0 110.467 -179.149 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.487 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.5 t -69.56 -64.63 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 120.463 -1.398 . . . . 0.0 111.994 -177.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -55.45 -53.82 51.56 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.849 -1.157 . . . . 0.0 111.028 -177.881 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.587 HE21 ' C ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -47.19 -49.42 22.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.824 -1.172 . . . . 0.0 109.876 -178.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.61 ' SG ' HD21 ' A' ' 54' ' ' LEU . 95.1 m -81.14 -54.44 5.53 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.931 -1.105 . . . . 0.0 109.897 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.6 t -60.95 -52.06 66.63 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.922 -1.111 . . . . 0.0 110.102 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -68.89 -33.78 74.34 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.218 -0.926 . . . . 0.0 110.402 -179.031 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 44' ' ' CYS . 25.4 m -136.48 147.63 47.27 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.071 -1.018 . . . . 0.0 109.404 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.5 mt -69.14 99.36 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.088 -1.008 . . . . 0.0 109.125 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.1 p -85.41 146.68 26.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.376 -0.827 . . . . 0.0 109.297 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.3 m -77.62 162.94 26.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.891 . . . . 0.0 109.69 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.5 mt -56.09 -31.76 63.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 0.0 108.969 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -46.9 -54.4 10.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 0.0 109.533 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.525 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 63.4 mt-30 -62.36 -50.46 71.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.388 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.61 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.3 mt -55.71 -34.14 64.85 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.078 -1.014 . . . . 0.0 108.686 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.487 ' OE2' ' NH2' ' A' ' 22' ' ' ARG . 4.2 tm-20 -74.42 -9.38 58.53 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -79.52 -21.79 44.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.386 -0.822 . . . . 0.0 110.99 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.525 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.9 m-85 -99.17 -7.4 26.63 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.078 -1.014 . . . . 0.0 110.626 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.436 ' O ' ' OXT' ' A' ' 59' ' ' GLY . 78.4 m -59.01 102.17 0.11 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.004 -1.06 . . . . 0.0 109.066 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.492 2.426 0 CA-C-O 117.911 -1.494 . . . . 0.0 109.945 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.558 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.567 HG23 HE21 ' A' ' 4' ' ' GLN . 2.3 m -55.35 -168.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.354 -0.841 . . . . 0.0 109.768 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -102.69 121.06 41.68 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.637 -0.664 . . . . 0.0 109.613 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.567 HE21 HG23 ' A' ' 2' ' ' VAL . 6.2 pt20 -168.08 170.5 10.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.486 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.67 122.83 28.65 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.204 -0.935 . . . . 0.0 109.443 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.411 HD21 ' CB ' ' A' ' 14' ' ' ALA . 4.3 mp -90.38 117.49 29.14 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.559 -0.713 . . . . 0.0 109.135 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.41 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 58.6 m -130.11 124.99 34.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.177 -0.952 . . . . 0.0 110.516 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.82 -137.27 44.08 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.3 m -43.31 -30.95 0.56 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.54 -0.977 . . . . 0.0 110.419 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.545 ' NE2' ' OE1' ' A' ' 4' ' ' GLN . 2.1 t-80 -63.18 -33.6 75.83 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.97 -1.081 . . . . 0.0 108.811 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.714 HD21 HD12 ' A' ' 40' ' ' ILE . 9.2 tp -72.12 -51.65 20.42 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.517 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 76.5 t -58.12 -60.98 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.49 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 29.2 mt-10 -43.55 -29.35 0.46 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.821 -0.549 . . . . 0.0 109.975 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.558 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -85.77 -61.11 1.83 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.435 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.513 HD13 ' CD2' ' A' ' 24' ' ' PHE . 13.8 mt -46.15 -37.13 6.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.201 -0.937 . . . . 0.0 109.707 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.52 -42.42 61.72 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.407 -0.808 . . . . 0.0 108.842 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.49 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -75.66 -51.23 13.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.281 -0.887 . . . . 0.0 108.763 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.418 ' H ' HG23 ' A' ' 18' ' ' VAL . 19.0 t -50.37 -55.1 6.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-O 121.516 0.674 . . . . 0.0 109.337 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.6 m -78.01 -22.31 49.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.481 -0.762 . . . . 0.0 110.613 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.22 -118.38 13.21 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -85.37 -24.9 27.38 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.135 -1.215 . . . . 0.0 110.329 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.603 HH21 ' CG ' ' A' ' 22' ' ' ARG . 2.8 mtt-85 -54.3 -36.66 63.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.946 -1.096 . . . . 0.0 109.303 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.33 166.84 19.98 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.549 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 7.4 p90 -139.01 172.49 12.76 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.544 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 15.2 p90 -110.19 121.75 46.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.9 . . . . 0.0 109.282 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.465 ' CD2' ' N ' ' A' ' 27' ' ' THR . 15.0 t80 -94.81 172.83 7.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.069 -1.019 . . . . 0.0 109.666 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.698 ' O ' HG23 ' A' ' 27' ' ' THR . 5.5 t -113.14 81.68 4.99 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.796 -0.565 . . . . 0.0 110.021 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 30' ' ' THR . 2.1 Cg_endo -59.26 91.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.319 -0.977 0 C-N-CA 120.698 0.932 . . . . 0.0 109.797 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.461 ' HG3' HH21 ' A' ' 29' ' ' ARG . 0.0 OUTLIER 22.36 37.31 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.451 178.436 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.624 ' N ' ' O ' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -82.95 96.69 8.38 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.412 -0.805 . . . . 0.0 109.234 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.612 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 1.2 pm0 -74.7 9.98 1.59 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.259 -0.9 . . . . 0.0 109.044 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.4 ' H ' ' C ' ' A' ' 30' ' ' THR . 36.1 mt-10 -70.95 -27.59 63.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.279 -0.888 . . . . 0.0 109.444 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.05 162.41 27.35 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.5 t -82.46 -85.07 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -1.136 . . . . 0.0 109.579 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 37' ' ' SER . 3.1 ptt-85 -88.31 -99.86 0.09 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.449 -0.782 . . . . 0.0 109.266 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.615 ' CG ' HH21 ' A' ' 36' ' ' ARG . 0.0 OUTLIER 52.44 -81.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.706 -0.622 . . . . 0.0 111.133 179.232 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 35' ' ' ARG . 1.1 t -44.53 -56.54 4.24 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.353 -0.842 . . . . 0.0 110.795 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -59.12 -9.58 2.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.853 -1.154 . . . . 0.0 109.423 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.44 -37.54 14.29 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.714 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.35 -50.68 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.491 -1.005 . . . . 0.0 109.956 -179.288 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.499 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 4.3 t -69.37 -64.93 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 120.592 -1.317 . . . . 0.0 111.692 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 46' ' ' ARG . 31.3 mm-40 -57.03 -51.87 67.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.804 -1.185 . . . . 0.0 110.262 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -45.6 -48.69 14.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.082 -1.012 . . . . 0.0 110.138 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.629 ' SG ' HD21 ' A' ' 54' ' ' LEU . 86.2 m -84.08 -53.9 5.21 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.199 -0.938 . . . . 0.0 109.992 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 54.0 t -60.82 -51.59 68.68 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.054 -1.029 . . . . 0.0 110.064 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 42' ' ' GLU . 2.9 tmt_? -68.06 -35.67 78.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.135 -0.978 . . . . 0.0 110.003 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 44' ' ' CYS . 23.2 m -136.52 147.73 47.24 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.15 -0.969 . . . . 0.0 109.331 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 63.4 mt -68.49 99.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.022 -1.049 . . . . 0.0 109.312 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.5 p -82.42 138.1 34.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.431 -0.793 . . . . 0.0 108.993 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 m -68.75 158.87 33.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.777 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.8 mt -53.59 -31.72 48.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.351 -0.843 . . . . 0.0 108.964 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -49.01 -51.91 28.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.408 -0.808 . . . . 0.0 109.23 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.487 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 64.7 mt-30 -63.32 -49.41 74.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.234 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.629 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.6 mt -56.85 -32.77 66.13 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.015 -1.053 . . . . 0.0 108.249 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -74.55 -9.26 58.41 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -79.76 -22.14 43.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 111.103 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.487 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.5 m-85 -99.5 -4.93 30.2 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.048 -1.033 . . . . 0.0 110.712 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 75.5 m -62.19 102.48 0.3 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.06 -1.025 . . . . 0.0 109.827 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.318 0 CA-C-O 118.026 -1.43 . . . . 0.0 109.557 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 1' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 1' ' ' PHE . 3.6 m -54.45 -168.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.344 -0.848 . . . . 0.0 110.019 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -90.94 120.46 31.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.503 -0.748 . . . . 0.0 109.533 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.525 ' OE1' ' NE2' ' A' ' 10' ' ' HIS . 3.0 pt20 -172.55 148.09 1.93 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.433 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.487 ' CE1' HG13 ' A' ' 48' ' ' ILE . 5.0 m80 -70.45 148.87 47.82 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.239 -0.913 . . . . 0.0 109.337 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 mp -113.14 116.38 29.75 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.674 -0.641 . . . . 0.0 109.546 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.421 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 58.1 m -129.21 124.94 35.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.374 -0.829 . . . . 0.0 110.056 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.61 -137.36 44.6 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 m -41.5 -35.61 0.74 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.751 -0.852 . . . . 0.0 110.71 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.525 ' NE2' ' OE1' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -59.45 -35.95 75.01 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.899 -1.125 . . . . 0.0 108.817 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.696 HD21 HD12 ' A' ' 40' ' ' ILE . 10.8 tp -71.05 -50.03 38.43 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -59.6 -61.43 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.497 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 81.7 mt-10 -44.38 -29.9 0.76 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.847 -0.533 . . . . 0.0 110.004 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.529 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -85.34 -60.76 1.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.155 -0.966 . . . . 0.0 109.79 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.538 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.3 mt -47.01 -36.49 7.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.08 -1.012 . . . . 0.0 109.57 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.7 -40.79 60.77 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.497 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.49 -50.75 11.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 0.0 108.992 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -49.89 -53.48 10.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.538 0.685 . . . . 0.0 109.295 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 m -78.79 -22.32 46.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.596 -0.69 . . . . 0.0 110.585 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.24 -114.07 3.45 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 2.2 mp0 -85.28 -24.03 27.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.174 -1.192 . . . . 0.0 109.974 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -54.66 -38.43 66.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.056 -1.028 . . . . 0.0 109.35 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.33 163.39 9.73 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.538 ' CD2' HD13 ' A' ' 15' ' ' LEU . 8.2 p90 -138.37 173.05 12.02 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.529 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 17.6 p90 -111.85 122.61 48.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.29 -0.881 . . . . 0.0 109.54 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -95.0 169.03 10.41 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.088 -1.007 . . . . 0.0 108.396 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.5 t -66.17 141.83 97.58 Favored Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.006 -1.059 . . . . 0.0 109.057 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -74.3 -30.48 8.42 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 N-CA-C 107.905 -1.613 . . . . 0.0 107.905 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.52 ' CG ' ' H ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -140.64 -85.89 0.2 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.521 ' C ' ' H ' ' A' ' 32' ' ' GLU . 82.5 p -149.19 -126.33 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.048 -1.033 . . . . 0.0 111.477 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.661 ' O ' ' N ' ' A' ' 33' ' ' GLY . 32.0 mt-10 -49.74 -9.2 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 109.549 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.521 ' H ' ' C ' ' A' ' 30' ' ' THR . 17.7 mt-10 54.03 -72.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.512 0.673 . . . . 0.0 110.014 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 31' ' ' GLU . . . -164.95 -73.32 0.03 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.7 t -85.57 -127.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.449 -1.03 . . . . 0.0 109.366 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 37' ' ' SER . 2.4 ptp180 -94.56 -100.1 0.15 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.218 -0.926 . . . . 0.0 109.49 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.477 ' O ' ' N ' ' A' ' 39' ' ' GLY . 4.2 mmt-85 53.15 -83.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.713 -0.617 . . . . 0.0 110.611 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -43.98 -62.01 1.27 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.508 -0.745 . . . . 0.0 110.21 -179.232 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -59.39 -9.83 2.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.031 -1.043 . . . . 0.0 109.239 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 36' ' ' ARG . . . -82.49 -33.7 24.61 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.696 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.33 -51.55 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.463 -1.022 . . . . 0.0 110.044 -179.274 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 3.0 t -69.18 -65.1 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 120.485 -1.384 . . . . 0.0 111.525 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' ARG . 78.1 mm-40 -57.55 -49.19 77.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.834 -1.166 . . . . 0.0 110.556 -178.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -47.53 -51.9 19.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.845 -1.159 . . . . 0.0 109.838 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.566 ' SG ' HD21 ' A' ' 54' ' ' LEU . 89.2 m -80.69 -52.02 8.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.26 -0.9 . . . . 0.0 110.09 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.8 t -60.42 -52.06 66.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.805 -1.184 . . . . 0.0 109.827 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.516 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -64.56 -38.09 89.81 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.247 -0.908 . . . . 0.0 110.074 -179.383 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 44' ' ' CYS . 39.4 m -137.3 149.16 46.88 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.144 -0.973 . . . . 0.0 109.552 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.487 HG13 ' CE1' ' A' ' 5' ' ' HIS . 70.2 mt -68.2 99.31 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.062 -1.024 . . . . 0.0 109.448 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.9 p -81.8 140.92 33.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.396 -0.815 . . . . 0.0 108.956 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.5 m -70.18 159.03 34.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 109.717 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 40.7 mt -52.91 -31.65 41.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.37 -0.832 . . . . 0.0 108.999 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -48.24 -53.78 15.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 109.356 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.517 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 47.0 mt-30 -61.52 -50.62 71.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 109.445 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.566 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.0 mt -56.06 -35.05 66.49 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.126 -0.984 . . . . 0.0 108.605 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -72.61 -9.58 58.77 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -78.5 -22.57 47.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.31 -0.869 . . . . 0.0 111.039 -178.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.517 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.4 m-85 -100.97 -7.03 23.72 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.158 -0.964 . . . . 0.0 110.147 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 96.8 m -62.04 96.34 0.07 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.201 -0.937 . . . . 0.0 109.607 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.33 0 CA-C-O 118.011 -1.438 . . . . 0.0 109.606 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 1' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.412 ' O ' ' O ' ' A' ' 1' ' ' PHE . 3.0 m -55.35 -169.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.344 -0.848 . . . . 0.0 109.699 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.433 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 9.2 p30 -95.0 116.7 29.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.556 -0.715 . . . . 0.0 109.309 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.547 ' CD ' ' HE2' ' A' ' 10' ' ' HIS . 18.2 pt20 -158.79 162.44 37.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -0.91 . . . . 0.0 109.407 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.07 122.71 26.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.286 -0.884 . . . . 0.0 109.18 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mp -91.03 115.98 28.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.452 -0.78 . . . . 0.0 109.384 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.422 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 62.5 m -129.64 124.97 34.98 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.255 -0.903 . . . . 0.0 109.946 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.5 -138.01 42.71 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.7 m -42.69 -34.89 0.98 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.61 -0.935 . . . . 0.0 110.664 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.547 ' HE2' ' CD ' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -58.56 -34.27 70.84 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.896 -1.128 . . . . 0.0 109.006 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.739 HD21 HD12 ' A' ' 40' ' ' ILE . 9.1 tp -72.33 -53.53 12.12 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.524 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 71.2 t -57.05 -58.95 3.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.499 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.9 mt-10 -45.4 -28.81 0.94 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.695 -0.628 . . . . 0.0 109.918 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.514 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -86.62 -61.26 1.77 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.965 . . . . 0.0 109.579 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.512 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.7 mt -46.36 -35.03 5.05 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.21 -0.932 . . . . 0.0 109.409 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -53.19 -40.29 64.3 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.499 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -79.44 -51.01 9.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 108.782 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.403 ' H ' HG23 ' A' ' 18' ' ' VAL . 20.8 t -49.89 -53.14 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.61 0.719 . . . . 0.0 109.187 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.5 m -79.37 -22.15 44.79 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.619 -0.676 . . . . 0.0 110.592 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 51.69 -115.19 3.65 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -84.89 -21.92 29.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.098 -1.237 . . . . 0.0 109.482 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -54.75 -39.07 67.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 109.191 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.6 160.75 7.73 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.524 ' HZ ' HG13 ' A' ' 12' ' ' VAL . 9.9 p90 -138.62 173.52 11.5 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.533 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.1 p90 -112.51 121.64 45.4 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.075 -1.016 . . . . 0.0 110.044 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -103.99 169.43 8.51 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.235 -0.916 . . . . 0.0 109.262 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.8 t -81.28 145.09 55.09 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.37 -75.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 120.817 1.011 . . . . 0.0 109.769 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.417 ' HD2' ' N ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -164.82 -3.16 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 108.779 -179.508 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.416 ' H ' ' H ' ' A' ' 29' ' ' ARG . 7.9 p -41.62 161.63 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.394 0.616 . . . . 0.0 110.349 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -164.92 -21.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.388 -0.82 . . . . 0.0 109.469 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.418 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 4.3 mt-10 -54.9 -38.0 67.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -0.976 . . . . 0.0 108.991 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -157.32 159.74 29.97 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.6 t -127.93 -177.04 3.97 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.259 -1.142 . . . . 0.0 110.542 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.564 ' CG ' HH21 ' A' ' 35' ' ' ARG . 0.0 OUTLIER -165.18 -51.92 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.236 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.474 ' O ' ' N ' ' A' ' 39' ' ' GLY . 9.1 mtp180 -105.37 -47.61 3.9 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.994 0.902 . . . . 0.0 109.076 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 t -41.47 -46.59 3.5 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.461 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.611 ' CG ' HH21 ' A' ' 38' ' ' ARG . 0.0 OUTLIER -63.46 -20.59 65.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.051 -1.031 . . . . 0.0 109.659 -179.621 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 36' ' ' ARG . . . -82.23 -33.61 25.6 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.739 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.55 -51.77 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.208 -1.172 . . . . 0.0 110.332 -178.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.51 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 4.4 t -67.54 -64.06 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.662 -1.274 . . . . 0.0 111.709 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 46' ' ' ARG . 53.8 mt-10 -56.93 -54.81 42.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.832 -1.167 . . . . 0.0 110.861 -178.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -44.68 -49.74 10.27 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.704 -1.248 . . . . 0.0 110.327 -178.954 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.582 ' SG ' HD21 ' A' ' 54' ' ' LEU . 99.5 m -79.63 -50.51 10.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.906 -1.121 . . . . 0.0 110.003 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 47.9 t -61.06 -53.02 62.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.073 -1.017 . . . . 0.0 110.512 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 42' ' ' GLU . 13.0 tpt180 -69.56 -38.44 77.43 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.876 -1.14 . . . . 0.0 109.902 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 44' ' ' CYS . 1.6 m -127.09 144.09 51.12 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.249 -0.907 . . . . 0.0 109.469 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.6 mt -69.14 99.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.059 -1.026 . . . . 0.0 108.901 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.7 p -82.9 141.51 32.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.347 -0.846 . . . . 0.0 109.28 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 m -72.13 163.45 27.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.187 -0.946 . . . . 0.0 109.492 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.4 ' CD2' ' CZ ' ' A' ' 1' ' ' PHE . 35.7 mt -56.02 -32.34 63.9 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.312 -0.867 . . . . 0.0 109.074 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -47.31 -56.06 7.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.935 . . . . 0.0 109.476 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.499 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 58.2 mt-30 -58.91 -51.27 70.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 109.324 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.582 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.0 mt -55.49 -35.02 65.11 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.099 -1.001 . . . . 0.0 108.779 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -72.63 -9.11 58.22 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.584 0.707 . . . . 0.0 109.106 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -79.98 -22.16 42.86 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.369 -0.832 . . . . 0.0 111.081 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.499 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.0 m-85 -99.91 -9.3 22.97 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.105 -0.997 . . . . 0.0 109.98 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 88.9 m -60.02 93.13 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.385 -0.822 . . . . 0.0 109.54 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.253 0 CA-C-O 117.974 -1.459 . . . . 0.0 109.727 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' A' ' 1' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 1' ' ' PHE . 3.8 m -58.24 -114.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 0.0 110.089 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -160.01 100.19 1.39 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.161 -0.962 . . . . 0.0 109.853 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -147.15 178.2 8.57 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.224 -0.922 . . . . 0.0 109.303 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.99 126.1 32.7 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.9 mp -93.24 116.19 28.77 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.363 -0.836 . . . . 0.0 110.188 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.416 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 61.9 m -128.96 124.68 35.7 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.321 -0.862 . . . . 0.0 109.985 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.45 -137.0 44.89 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.2 m -42.13 -36.11 1.09 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.723 -0.869 . . . . 0.0 110.6 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.416 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 0.8 OUTLIER -58.22 -35.51 71.79 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.897 -1.127 . . . . 0.0 108.789 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.739 HD21 HD12 ' A' ' 40' ' ' ILE . 11.7 tp -71.56 -50.92 26.54 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.1 t -58.94 -59.75 3.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.503 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 24.9 mt-10 -45.17 -30.04 1.08 Allowed 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.862 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.561 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -85.73 -61.05 1.85 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.928 . . . . 0.0 109.74 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.549 HD13 ' CD2' ' A' ' 24' ' ' PHE . 15.3 mt -46.67 -36.6 7.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.064 -1.023 . . . . 0.0 109.704 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -52.1 -40.49 61.33 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 108.946 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.503 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.52 -50.75 11.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.146 -0.972 . . . . 0.0 108.89 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -49.87 -53.15 11.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 121.556 0.693 . . . . 0.0 109.203 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.0 m -79.95 -22.28 42.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.598 -0.689 . . . . 0.0 110.453 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.73 -115.48 4.96 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -85.02 -23.44 28.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.143 -1.21 . . . . 0.0 109.818 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -54.58 -38.29 66.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.115 -0.99 . . . . 0.0 109.222 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.77 163.02 9.95 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.549 ' CD2' HD13 ' A' ' 15' ' ' LEU . 7.8 p90 -138.53 172.17 13.28 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.54 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 14.8 p90 -111.41 120.59 42.67 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.404 ' CD2' HG22 ' A' ' 27' ' ' THR . 8.4 t80 -82.14 160.26 23.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.894 -1.129 . . . . 0.0 108.847 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.408 ' OG1' ' CB ' ' A' ' 37' ' ' SER . 15.2 t -42.59 145.91 0.78 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.646 -0.659 . . . . 0.0 109.72 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.545 ' C ' ' H ' ' A' ' 30' ' ' THR . 9.1 Cg_exo -47.51 110.11 0.28 Allowed 'Trans proline' 0 C--N 1.321 -0.88 0 N-CA-C 108.867 -1.244 . . . . 0.0 108.867 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.582 ' CD ' ' H ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -72.01 38.77 0.07 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 122.042 0.925 . . . . 0.0 108.692 -179.382 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.545 ' H ' ' C ' ' A' ' 28' ' ' PRO . 11.7 p -131.72 125.5 32.17 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -72.79 45.98 0.15 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.296 -0.877 . . . . 0.0 109.211 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.63 -53.95 23.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.445 -0.784 . . . . 0.0 109.842 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 34' ' ' SER . . . 144.28 -18.2 2.1 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -51.73 -173.28 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.49 -1.006 . . . . 0.0 110.168 -179.422 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.577 ' CG ' HH21 ' A' ' 35' ' ' ARG . 0.0 OUTLIER -115.7 -102.15 0.42 Allowed 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.83 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.405 ' H ' ' HG3' ' A' ' 35' ' ' ARG . 28.6 mmt180 60.19 -61.63 0.06 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.048 0.451 . . . . 0.0 111.179 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -43.89 -43.33 6.33 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.589 -179.352 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -59.68 -20.7 57.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.079 -1.013 . . . . 0.0 110.296 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.28 -40.82 8.87 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.235 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.739 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -99.54 -51.39 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.046 -1.267 . . . . 0.0 110.788 -178.123 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.504 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 8.3 t -66.47 -63.61 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.523 -1.36 . . . . 0.0 111.57 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.528 ' N ' ' OE2' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -55.48 -57.07 13.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.935 -1.103 . . . . 0.0 111.106 -178.238 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -43.87 -48.16 8.35 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.934 -1.104 . . . . 0.0 110.515 -178.383 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.589 ' SG ' HD21 ' A' ' 54' ' ' LEU . 95.7 m -81.53 -50.88 8.86 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.974 -1.078 . . . . 0.0 110.034 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.0 t -61.38 -52.91 62.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.202 -0.936 . . . . 0.0 110.584 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 42' ' ' GLU . 4.7 tpt180 -69.07 -38.48 79.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.915 -1.115 . . . . 0.0 109.781 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 44' ' ' CYS . 13.0 m -128.93 145.98 51.08 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.188 -0.945 . . . . 0.0 109.714 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.0 mt -69.02 99.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.231 -0.918 . . . . 0.0 109.315 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.1 p -84.09 140.56 31.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.281 -0.887 . . . . 0.0 109.208 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.3 m -71.54 161.31 31.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.728 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.2 mt -54.15 -31.55 52.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.177 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -48.98 -55.65 11.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 0.0 109.298 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.473 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 56.2 mt-30 -58.79 -51.04 71.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 109.242 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.589 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.0 mt -55.89 -35.08 66.12 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.134 -0.979 . . . . 0.0 108.559 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -72.63 -9.15 58.26 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.558 0.694 . . . . 0.0 109.181 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -79.7 -22.61 43.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.496 -0.752 . . . . 0.0 110.79 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.473 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.5 m-85 -99.86 -6.83 26.16 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.11 -0.994 . . . . 0.0 110.268 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 82.0 m -62.05 96.13 0.07 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.075 -1.016 . . . . 0.0 109.595 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.495 2.573 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.558 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.478 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.1 m -150.75 -166.88 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.378 -0.827 . . . . 0.0 108.793 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -98.06 92.8 5.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.342 -0.848 . . . . 0.0 109.397 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.513 ' OE1' ' NE2' ' A' ' 10' ' ' HIS . 2.6 pt20 -162.95 156.73 20.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.266 -0.896 . . . . 0.0 109.255 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -83.67 147.65 27.56 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.216 -0.927 . . . . 0.0 109.76 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp -106.65 116.34 31.76 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.447 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 60.7 m -129.41 124.98 35.51 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.242 -0.911 . . . . 0.0 110.168 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 61.86 -136.93 46.32 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.1 m -41.64 -34.58 0.62 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.719 -0.871 . . . . 0.0 110.739 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.513 ' NE2' ' OE1' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -61.12 -35.36 76.83 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.912 -1.117 . . . . 0.0 108.905 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.702 HD21 HD12 ' A' ' 40' ' ' ILE . 11.1 tp -71.7 -48.68 45.68 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.7 t -59.82 -61.61 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.493 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 42.6 mt-10 -44.02 -30.28 0.71 Allowed 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.371 -0.531 . . . . 0.0 109.968 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.478 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -84.78 -60.76 1.96 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.181 -0.95 . . . . 0.0 109.989 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.539 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.0 mt -47.48 -36.77 10.66 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.975 -1.078 . . . . 0.0 109.465 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -51.15 -40.08 57.76 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.493 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -78.26 -50.92 10.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 108.785 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.406 ' H ' HG23 ' A' ' 18' ' ' VAL . 19.1 t -50.23 -54.36 8.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.585 0.707 . . . . 0.0 109.294 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.2 m -79.38 -22.13 44.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.599 -0.688 . . . . 0.0 110.659 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.45 -116.42 7.0 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -85.29 -25.7 27.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.136 -1.214 . . . . 0.0 110.335 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.412 ' O ' ' O ' ' A' ' 59' ' ' GLY . 61.8 mtt180 -54.44 -36.61 64.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.944 -1.097 . . . . 0.0 109.267 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.11 165.91 16.41 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.58 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.539 ' CD2' HD13 ' A' ' 15' ' ' LEU . 9.3 p90 -139.0 172.89 12.18 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.513 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 10.8 p90 -110.23 126.68 54.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.181 -0.949 . . . . 0.0 109.073 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -96.11 167.81 10.99 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.033 -1.042 . . . . 0.0 108.96 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.4 t -68.06 145.6 97.77 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.109 -0.994 . . . . 0.0 108.645 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -69.57 -71.29 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.764 0 N-CA-C 108.882 -1.238 . . . . 0.0 108.882 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.92 -76.54 0.42 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.089 -1.007 . . . . 0.0 108.882 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.515 ' C ' ' H ' ' A' ' 32' ' ' GLU . 7.9 t -164.62 -141.69 0.05 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.329 -0.857 . . . . 0.0 110.313 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.559 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 16.9 mp0 -54.65 -5.0 0.07 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.515 ' H ' ' C ' ' A' ' 30' ' ' THR . 10.2 mt-10 -46.66 -32.41 3.51 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.205 -0.934 . . . . 0.0 109.762 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.63 154.8 7.07 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 t -85.22 -62.15 1.6 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.313 -1.11 . . . . 0.0 109.361 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 36' ' ' ARG . 8.5 ptm180 -101.29 -55.08 2.63 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.678 -0.639 . . . . 0.0 109.446 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.56 ' O ' ' N ' ' A' ' 38' ' ' ARG . 9.4 ptp180 -57.69 -159.86 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.27 -0.894 . . . . 0.0 109.976 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.8 t 53.61 -81.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.598 -0.689 . . . . 0.0 110.06 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' A' ' 36' ' ' ARG . 2.3 ptm180 -58.67 -18.27 29.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.954 -1.091 . . . . 0.0 108.63 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.68 -30.42 32.69 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.702 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.11 -50.96 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.506 -0.997 . . . . 0.0 110.065 -179.382 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.504 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 3.2 t -69.36 -65.13 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.536 -1.353 . . . . 0.0 111.388 -178.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' ARG . 77.7 mt-10 -57.93 -48.86 78.66 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.808 -1.183 . . . . 0.0 110.377 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -46.64 -50.27 17.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.847 -1.158 . . . . 0.0 109.969 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.601 ' SG ' HD21 ' A' ' 54' ' ' LEU . 88.5 m -84.04 -52.71 6.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.268 -0.895 . . . . 0.0 110.208 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.6 t -60.98 -45.36 95.08 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.88 -1.137 . . . . 0.0 110.064 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.564 HH21 ' CG ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -71.13 -37.46 72.31 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.976 -1.078 . . . . 0.0 109.722 -179.522 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 44' ' ' CYS . 14.4 m -137.77 153.62 49.68 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.172 -0.955 . . . . 0.0 110.011 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.7 mt -68.96 99.41 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.122 -0.986 . . . . 0.0 109.441 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.5 p -84.23 140.27 31.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -0.926 . . . . 0.0 108.925 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.8 m -71.41 161.15 31.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.184 -0.948 . . . . 0.0 109.837 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.401 ' CD2' ' CZ ' ' A' ' 1' ' ' PHE . 38.7 mt -54.59 -32.56 58.91 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.328 -0.857 . . . . 0.0 109.183 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -48.15 -52.89 18.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.296 -0.877 . . . . 0.0 109.327 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.529 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 39.7 mt-30 -62.43 -51.27 68.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 109.291 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.601 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.2 mt -56.15 -32.99 64.79 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.064 -1.023 . . . . 0.0 108.667 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -75.12 -8.83 57.66 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.513 0.673 . . . . 0.0 109.191 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -79.96 -21.93 43.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.453 -0.779 . . . . 0.0 110.874 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.529 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.9 m-85 -99.99 -6.35 26.68 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.17 -0.957 . . . . 0.0 110.458 -178.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.3 m -61.18 99.66 0.1 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.081 -1.012 . . . . 0.0 109.542 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.593 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 1.3 t80 . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.402 ' H ' HG22 ' A' ' 2' ' ' VAL . 3.0 m -100.75 -112.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.37 -0.831 . . . . 0.0 109.076 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -84.35 79.31 9.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 109.149 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -141.32 167.72 21.5 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.346 -0.846 . . . . 0.0 109.407 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.17 136.64 33.25 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.211 -0.931 . . . . 0.0 109.127 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mp -106.35 117.24 33.51 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.564 -0.71 . . . . 0.0 109.784 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.412 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 67.7 m -129.58 124.98 35.14 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.29 -0.881 . . . . 0.0 110.378 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.85 -137.27 44.0 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.1 m -42.74 -34.91 1.0 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.612 -0.934 . . . . 0.0 110.55 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.412 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 4.0 t-80 -58.94 -34.12 71.38 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.898 -1.126 . . . . 0.0 108.735 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.726 HD21 HD12 ' A' ' 40' ' ' ILE . 9.2 tp -71.95 -53.54 12.75 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.511 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 69.4 t -57.67 -59.93 2.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.485 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 87.5 mt-10 -43.97 -29.77 0.63 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.808 -0.558 . . . . 0.0 109.985 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.593 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -86.22 -60.95 1.86 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.952 . . . . 0.0 109.468 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.505 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.3 mt -46.43 -36.0 6.11 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.203 -0.936 . . . . 0.0 109.647 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -52.7 -40.03 62.56 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.38 -0.825 . . . . 0.0 108.994 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.485 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.85 -51.55 9.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 108.822 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.2 t -49.76 -53.78 9.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.584 0.707 . . . . 0.0 109.231 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.3 m -78.63 -22.23 47.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.564 -0.71 . . . . 0.0 110.272 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.37 -115.54 4.82 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.571 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 4.0 mp0 -84.88 -23.58 28.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -1.162 . . . . 0.0 109.668 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.576 HH21 ' CG ' ' A' ' 22' ' ' ARG . 4.8 mtt-85 -54.31 -38.71 66.27 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.142 -0.974 . . . . 0.0 109.041 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.58 162.87 9.52 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.514 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 8.1 p90 -138.46 173.3 11.74 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.554 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.3 p90 -110.86 120.13 41.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.179 -0.951 . . . . 0.0 109.882 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.557 ' O ' ' C ' ' A' ' 27' ' ' THR . 9.6 t80 -103.66 106.65 17.23 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.568 ' O ' HG23 ' A' ' 27' ' ' THR . 6.5 t -2.9 76.94 0.03 OUTLIER Pre-proline 0 N--CA 1.513 2.68 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.43 ' N ' ' O ' ' A' ' 26' ' ' TYR . 10.6 Cg_endo -77.14 -19.13 13.86 Favored 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 121.766 1.644 . . . . 0.0 109.755 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.49 ' O ' ' N ' ' A' ' 31' ' ' GLU . 13.7 mmm180 -99.45 -8.73 24.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.541 -0.724 . . . . 0.0 109.266 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 29' ' ' ARG . 5.5 p 49.95 11.48 0.06 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.629 -0.67 . . . . 0.0 109.293 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 29' ' ' ARG . 52.7 mt-10 -73.56 44.19 0.16 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 34' ' ' SER . 32.6 mt-10 -40.52 -64.79 0.48 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.767 -0.583 . . . . 0.0 110.016 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 32' ' ' GLU . . . 37.18 -92.28 0.01 OUTLIER Glycine 0 N--CA 1.499 2.852 0 N-CA-C 110.654 -0.979 . . . . 0.0 110.654 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 32' ' ' GLU . 36.8 t -56.02 -104.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.547 -0.972 . . . . 0.0 109.595 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.617 ' CG ' HH21 ' A' ' 35' ' ' ARG . 0.0 OUTLIER -138.56 -103.53 0.18 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.213 -0.929 . . . . 0.0 109.655 -179.628 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 39' ' ' GLY . 30.6 mtt180 55.2 -80.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.524 0.678 . . . . 0.0 110.303 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 35' ' ' ARG . 2.4 t -44.75 -60.72 1.88 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.67 -0.643 . . . . 0.0 109.881 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.417 HH21 ' HG3' ' A' ' 38' ' ' ARG . 1.8 ptm180 -59.43 -11.6 4.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.991 -1.068 . . . . 0.0 108.42 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 36' ' ' ARG . . . -80.58 -33.32 31.38 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.726 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.2 -51.71 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.432 -1.04 . . . . 0.0 109.439 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.512 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 3.0 t -68.65 -65.0 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 120.622 -1.299 . . . . 0.0 111.466 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 46' ' ' ARG . 57.5 mm-40 -58.85 -45.8 89.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.864 -1.148 . . . . 0.0 110.354 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -48.91 -52.59 23.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.57 -1.331 . . . . 0.0 109.652 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.576 ' SG ' HD21 ' A' ' 54' ' ' LEU . 91.8 m -79.33 -52.42 8.12 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.259 -0.901 . . . . 0.0 109.82 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.6 t -60.16 -52.23 66.23 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.032 -1.042 . . . . 0.0 109.988 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 42' ' ' GLU . 4.2 tmm_? -68.02 -36.04 79.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.283 -0.886 . . . . 0.0 110.066 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 44' ' ' CYS . 9.2 m -135.23 147.65 49.37 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.052 -1.03 . . . . 0.0 109.576 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.5 mt -68.77 99.56 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.155 -0.966 . . . . 0.0 109.494 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 25.3 p -86.21 138.53 31.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.37 -0.831 . . . . 0.0 109.042 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.4 m -69.53 157.32 37.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 110.0 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.9 mt -51.32 -32.67 26.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.397 -0.815 . . . . 0.0 109.211 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -50.13 -53.62 26.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.374 -0.829 . . . . 0.0 109.125 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.439 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 69.1 mt-30 -58.75 -49.17 78.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.89 . . . . 0.0 109.002 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.576 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.2 mt -57.07 -34.16 68.0 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -71.91 -9.41 58.31 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -79.05 -22.78 44.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.408 -0.807 . . . . 0.0 111.086 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.439 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.9 m-85 -101.1 -6.9 23.72 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.093 -1.004 . . . . 0.0 110.183 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 86.6 m -61.64 96.06 0.06 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.56 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.495 1.796 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.428 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 63.5 m -129.29 125.03 35.87 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.267 -0.896 . . . . 0.0 110.309 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.77 -136.72 44.09 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.6 m -42.18 -35.46 0.95 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.691 -0.888 . . . . 0.0 110.624 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.428 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 0.8 OUTLIER -59.74 -35.34 74.37 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.821 -1.174 . . . . 0.0 108.851 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.727 HD21 HD12 ' A' ' 40' ' ' ILE . 10.5 tp -71.89 -50.1 32.25 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.3 t -59.88 -61.2 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.5 mt-10 -45.06 -29.48 0.88 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.851 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.1 -60.82 1.93 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.157 -0.964 . . . . 0.0 109.715 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.522 HD13 ' CD2' ' A' ' 24' ' ' PHE . 13.5 mt -47.3 -36.97 10.0 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.028 -1.045 . . . . 0.0 109.562 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -50.72 -40.22 53.76 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.496 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -78.54 -50.67 11.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 108.754 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.1 t -50.19 -54.18 9.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-O 121.555 0.693 . . . . 0.0 109.282 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.4 m -78.71 -22.42 46.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.561 -0.712 . . . . 0.0 110.646 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.69 -113.35 3.44 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -85.68 -29.22 24.15 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.191 -1.182 . . . . 0.0 110.842 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -54.35 -36.72 64.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.884 -1.135 . . . . 0.0 109.412 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.53 167.16 17.5 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.249 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.538 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 8.5 p90 -138.1 173.63 11.42 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.536 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 18.8 p90 -109.0 121.09 44.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 110.36 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.2 t80 . . . . . 0 N--CA 1.5 2.06 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.209 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.52 -35.12 20.84 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.727 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.88 -50.32 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.546 -0.973 . . . . 0.0 109.908 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.501 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.4 t -69.47 -65.04 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.53 -1.356 . . . . 0.0 111.329 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 46' ' ' ARG . 69.5 mm-40 -58.64 -47.04 85.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.795 -1.191 . . . . 0.0 110.475 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.523 ' NE2' HE21 ' A' ' 53' ' ' GLN . 19.2 tt0 -48.75 -50.07 35.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.687 -1.258 . . . . 0.0 109.577 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.587 ' SG ' HD21 ' A' ' 54' ' ' LEU . 84.8 m -81.99 -53.35 6.2 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.165 -0.959 . . . . 0.0 109.851 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.401 ' N ' ' O ' ' A' ' 41' ' ' VAL . 53.2 t -60.04 -50.99 71.55 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.958 -1.089 . . . . 0.0 109.952 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -68.5 -35.74 77.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.082 -1.011 . . . . 0.0 110.049 -179.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 44' ' ' CYS . 58.4 m -136.78 148.4 47.19 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.029 -1.045 . . . . 0.0 109.562 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.3 mt -68.6 99.53 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.989 -1.069 . . . . 0.0 109.573 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.7 p -84.2 139.65 32.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 109.026 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 m -71.78 160.67 32.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 109.815 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.3 mt -54.11 -32.55 55.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.344 -0.847 . . . . 0.0 109.191 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -48.75 -46.28 40.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.891 . . . . 0.0 109.306 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.525 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 21.9 mt-30 -69.57 -49.76 51.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.319 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.587 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.8 mt -56.25 -33.78 65.75 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.152 -0.967 . . . . 0.0 108.598 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.03 -8.88 57.76 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -79.64 -22.11 43.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.512 -0.743 . . . . 0.0 110.933 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.525 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.1 m-85 -99.99 -7.32 25.24 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.089 -1.007 . . . . 0.0 110.321 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 82.4 m -60.9 98.55 0.07 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.293 -0.88 . . . . 0.0 109.64 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.267 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.503 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.427 HD21 ' CB ' ' A' ' 14' ' ' ALA . 4.3 mp . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 64.6 m -128.67 125.09 37.32 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.243 -0.91 . . . . 0.0 110.335 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.29 -137.52 45.36 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -42.26 -34.19 0.74 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.587 -0.949 . . . . 0.0 110.575 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.403 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 2.1 t-160 -59.33 -35.74 74.39 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.954 -1.091 . . . . 0.0 108.764 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.735 HD21 HD12 ' A' ' 40' ' ' ILE . 9.4 tp -71.18 -53.09 15.66 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.511 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 66.3 t -57.53 -59.95 2.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.494 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 26.7 mt-10 -44.01 -29.92 0.66 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.715 -0.616 . . . . 0.0 110.039 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.427 ' CB ' HD21 ' A' ' 6' ' ' LEU . . . -85.7 -60.92 1.88 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 109.523 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.522 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.2 mt -46.6 -36.2 6.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.14 -0.975 . . . . 0.0 109.641 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -52.22 -42.06 63.25 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.429 -0.794 . . . . 0.0 108.858 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.494 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -76.94 -51.18 11.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 108.873 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -50.17 -54.24 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.646 -0.659 . . . . 0.0 109.249 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.3 m -78.44 -22.32 47.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.54 -0.725 . . . . 0.0 110.371 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 56.71 -118.44 11.84 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -84.95 -23.63 28.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.148 -1.207 . . . . 0.0 110.034 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.4 mtp180 -54.63 -37.4 65.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.985 -1.072 . . . . 0.0 109.124 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.25 163.97 12.7 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 120.071 -1.062 . . . . 0.0 110.869 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 8.7 p90 -138.54 173.1 11.95 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.52 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.4 p90 -110.19 124.38 51.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.092 -1.005 . . . . 0.0 109.39 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.8 t80 . . . . . 0 N--CA 1.499 2.015 0 O-C-N 121.073 -1.017 . . . . 0.0 109.497 179.875 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.1 -30.15 35.5 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.735 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.38 -52.73 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.52 -0.988 . . . . 0.0 110.185 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.517 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 5.7 t -69.49 -64.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.528 -1.358 . . . . 0.0 111.595 -178.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 46' ' ' ARG . 54.2 mt-10 -57.25 -54.24 48.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.847 -1.158 . . . . 0.0 110.569 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.617 ' NE2' ' NE2' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -44.65 -50.59 9.75 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.874 -1.141 . . . . 0.0 110.096 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.566 ' SG ' HD21 ' A' ' 54' ' ' LEU . 99.4 m -79.43 -51.28 9.58 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.903 -1.123 . . . . 0.0 110.126 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.2 t -60.36 -53.25 59.81 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.099 -1.0 . . . . 0.0 110.62 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 42' ' ' GLU . 17.8 tpt180 -71.52 -38.53 71.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.87 -1.144 . . . . 0.0 109.9 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 44' ' ' CYS . 2.1 m -124.51 145.09 49.75 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.115 -0.99 . . . . 0.0 109.893 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.2 mt -69.46 99.35 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.004 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.427 ' CB ' HE22 ' A' ' 43' ' ' GLN . 24.8 p -86.37 142.25 28.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.304 -0.872 . . . . 0.0 109.467 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.7 m -72.22 159.82 33.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.722 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.9 mt -54.86 -31.69 59.94 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.35 -0.844 . . . . 0.0 108.849 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -47.49 -54.67 10.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.363 -0.835 . . . . 0.0 109.352 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.617 ' NE2' ' NE2' ' A' ' 43' ' ' GLN . 48.7 mt-30 -60.09 -49.85 76.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.233 -0.917 . . . . 0.0 109.197 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.566 HD21 ' SG ' ' A' ' 44' ' ' CYS . 98.1 mt -55.57 -34.58 64.9 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.161 -0.962 . . . . 0.0 108.688 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.403 ' CD ' ' O ' ' A' ' 55' ' ' GLU . 5.0 tm-20 -73.45 -9.25 58.5 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.677 0.751 . . . . 0.0 109.059 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -79.67 -21.74 44.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.373 -0.829 . . . . 0.0 111.239 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.508 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.3 m-85 -100.17 -6.31 26.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.087 -1.008 . . . . 0.0 110.534 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 71.4 m -60.9 98.72 0.07 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.17 -0.956 . . . . 0.0 109.695 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.314 0 CA-C-O 117.94 -1.478 . . . . 0.0 109.583 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.43 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 58.9 m -129.75 124.85 34.47 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.289 -0.882 . . . . 0.0 110.2 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 61.43 -136.54 47.45 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -41.93 -34.04 0.63 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.693 -0.886 . . . . 0.0 110.767 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.43 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 1.7 t-80 -62.06 -34.69 76.74 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.757 -1.214 . . . . 0.0 108.808 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.74 HD21 HD12 ' A' ' 40' ' ' ILE . 11.3 tp -71.7 -49.08 42.78 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.7 t -59.28 -61.46 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.497 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 25.1 mt-10 -44.31 -29.64 0.7 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.346 -0.541 . . . . 0.0 109.949 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.35 -61.23 1.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.164 -0.96 . . . . 0.0 109.74 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.545 HD13 ' CD2' ' A' ' 24' ' ' PHE . 15.0 mt -46.68 -36.91 7.61 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.123 -0.986 . . . . 0.0 109.613 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -51.11 -41.34 59.95 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.404 -0.81 . . . . 0.0 108.871 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.497 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -77.51 -50.91 11.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.93 . . . . 0.0 108.847 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.404 ' H ' HG23 ' A' ' 18' ' ' VAL . 19.2 t -50.18 -54.41 8.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.57 0.7 . . . . 0.0 109.142 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.3 m -79.39 -20.83 46.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.595 -0.69 . . . . 0.0 110.328 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.42 -117.11 6.56 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -84.73 -22.22 29.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.152 -1.205 . . . . 0.0 109.622 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.596 HH21 ' CG ' ' A' ' 22' ' ' ARG . 3.2 mtt-85 -54.59 -38.14 66.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.19 -0.944 . . . . 0.0 109.157 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.95 162.05 9.31 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.078 -1.058 . . . . 0.0 110.501 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.545 ' CD2' HD13 ' A' ' 15' ' ' LEU . 8.0 p90 -137.97 172.57 12.74 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.527 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.1 p90 -111.02 121.76 46.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.33 -0.856 . . . . 0.0 108.977 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.1 t80 . . . . . 0 N--CA 1.495 1.785 0 O-C-N 120.972 -1.08 . . . . 0.0 108.962 -179.953 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.336 0.588 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.48 -40.39 9.99 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.74 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.43 -51.15 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.316 -1.108 . . . . 0.0 110.291 -178.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.509 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.9 t -66.41 -64.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 120.627 -1.296 . . . . 0.0 111.775 -178.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 46' ' ' ARG . 81.9 mt-10 -56.06 -54.14 48.51 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.904 -1.122 . . . . 0.0 111.209 -178.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.72 HE21 HE22 ' A' ' 53' ' ' GLN . 0.0 OUTLIER -45.7 -48.68 15.09 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.849 -1.157 . . . . 0.0 110.141 -178.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.609 ' SG ' HD21 ' A' ' 54' ' ' LEU . 85.2 m -82.3 -53.58 5.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.062 -1.024 . . . . 0.0 110.042 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.2 t -60.61 -51.91 67.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.999 -1.063 . . . . 0.0 109.987 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 42' ' ' GLU . 3.7 tmt_? -67.04 -36.62 82.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.186 -0.946 . . . . 0.0 110.025 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 44' ' ' CYS . 68.4 m -136.46 148.17 47.57 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.168 -0.958 . . . . 0.0 109.398 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.6 mt -68.46 99.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.12 -0.988 . . . . 0.0 109.512 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.4 p -83.14 140.48 32.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.407 -0.808 . . . . 0.0 109.217 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 m -70.61 160.96 31.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.208 -0.932 . . . . 0.0 109.527 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.9 mt -55.48 -31.32 61.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.233 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -49.51 -51.97 32.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 109.216 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.72 HE22 HE21 ' A' ' 43' ' ' GLN . 18.3 mt-30 -62.32 -50.28 72.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.209 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.609 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.3 mt -56.68 -33.18 66.16 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.101 -0.999 . . . . 0.0 108.462 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -74.25 -8.96 58.03 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -79.99 -21.97 43.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.44 -0.787 . . . . 0.0 110.932 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.466 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 8.0 m-85 -99.46 -7.18 26.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.069 -1.019 . . . . 0.0 110.514 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.4 m -60.73 99.14 0.08 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.188 -0.945 . . . . 0.0 109.6 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.271 0 CA-C-O 118.022 -1.432 . . . . 0.0 109.562 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.412 HD21 ' CB ' ' A' ' 14' ' ' ALA . 5.5 mp . . . . . 0 N--CA 1.496 1.851 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.417 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 81.4 m -130.29 125.29 34.38 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.22 -0.925 . . . . 0.0 110.633 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 61.56 -136.5 47.15 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.424 ' O ' ' OE2' ' A' ' 13' ' ' GLU . 57.4 m -43.66 -28.74 0.43 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.518 -0.989 . . . . 0.0 110.548 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.417 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 1.7 t-160 -66.61 -32.13 73.27 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.815 -1.178 . . . . 0.0 108.814 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.698 HD21 HD12 ' A' ' 40' ' ' ILE . 9.7 tp -72.48 -51.58 19.5 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.507 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 70.4 t -58.0 -60.42 2.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.485 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.6 mt-10 -43.77 -29.24 0.5 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.748 -0.595 . . . . 0.0 110.106 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.412 ' CB ' HD21 ' A' ' 6' ' ' LEU . . . -86.2 -59.94 2.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.648 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.53 HD13 ' CD2' ' A' ' 24' ' ' PHE . 13.6 mt -46.94 -37.22 8.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.125 -0.984 . . . . 0.0 109.488 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -50.86 -42.02 58.51 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.485 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -76.88 -50.04 14.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 108.786 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.2 t -50.36 -55.08 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.648 0.737 . . . . 0.0 109.039 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.0 m -78.87 -22.32 46.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.559 -0.713 . . . . 0.0 110.426 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.84 -116.05 6.74 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.56 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 2.6 mp0 -85.21 -23.91 28.08 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.191 -1.182 . . . . 0.0 110.062 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.57 HH21 ' CG ' ' A' ' 22' ' ' ARG . 4.7 mtt-85 -54.78 -37.55 66.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.098 -1.001 . . . . 0.0 109.356 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.13 164.14 12.46 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.962 -1.114 . . . . 0.0 110.329 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.53 ' CD2' HD13 ' A' ' 15' ' ' LEU . 7.3 p90 -138.42 172.75 12.43 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.53 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.7 p90 -111.1 122.56 48.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 109.253 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.8 t80 . . . . . 0 N--CA 1.496 1.827 0 O-C-N 120.908 -1.12 . . . . 0.0 108.662 179.739 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.438 HH21 ' HG3' ' A' ' 38' ' ' ARG . 4.2 ptm180 . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.64 -34.0 23.41 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.951 -1.659 . . . . 0.0 108.951 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.698 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.64 -52.49 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.441 -1.035 . . . . 0.0 110.096 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 3.2 t -67.85 -64.03 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 120.663 -1.273 . . . . 0.0 111.813 -178.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' ARG . 67.2 mm-40 -57.34 -54.85 42.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.824 -1.172 . . . . 0.0 111.339 -177.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.591 ' CD ' HE22 ' A' ' 53' ' ' GLN . 0.0 OUTLIER -45.76 -45.86 14.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.553 -1.342 . . . . 0.0 110.012 -178.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.646 ' SG ' HD21 ' A' ' 54' ' ' LEU . 95.1 m -84.44 -53.2 5.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.964 -1.085 . . . . 0.0 110.103 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.7 t -63.05 -44.51 95.65 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.984 -1.072 . . . . 0.0 110.332 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 42' ' ' GLU . 3.5 tmt_? -72.21 -36.37 69.15 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.793 -1.192 . . . . 0.0 109.605 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 44' ' ' CYS . 69.5 m -138.03 153.1 49.4 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.203 -0.935 . . . . 0.0 109.946 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.0 mt -68.97 99.15 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 108.857 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.6 p -83.39 148.46 27.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 109.313 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.8 m -78.76 162.61 26.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.261 -0.9 . . . . 0.0 110.063 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.8 mt -57.13 -33.18 67.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.557 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -48.95 -45.42 41.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.184 -0.948 . . . . 0.0 109.163 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.591 HE22 ' CD ' ' A' ' 43' ' ' GLN . 21.5 mt-30 -69.34 -52.76 24.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.369 -0.832 . . . . 0.0 109.191 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.646 HD21 ' SG ' ' A' ' 44' ' ' CYS . 99.2 mt -55.86 -32.47 63.67 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.029 -1.044 . . . . 0.0 108.654 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -76.08 -9.04 58.3 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.595 0.712 . . . . 0.0 109.225 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -79.85 -21.82 43.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.419 -0.801 . . . . 0.0 110.836 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.531 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.6 m-85 -99.27 -6.91 27.18 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.172 -0.955 . . . . 0.0 110.487 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 71.2 m -60.63 100.96 0.12 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.136 -0.978 . . . . 0.0 109.624 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.299 0 CA-C-O 118.048 -1.418 . . . . 0.0 109.581 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.401 HD21 ' CB ' ' A' ' 14' ' ' ALA . 4.3 mp . . . . . 0 N--CA 1.496 1.852 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.4 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 82.3 m -129.3 125.2 36.23 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.21 -0.931 . . . . 0.0 110.648 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.74 -137.26 44.25 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 m -42.83 -32.24 0.59 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.599 -0.942 . . . . 0.0 110.576 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.4 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 4.2 t-80 -61.83 -34.23 75.58 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.852 -1.155 . . . . 0.0 108.877 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.747 HD21 HD12 ' A' ' 40' ' ' ILE . 10.0 tp -71.76 -52.24 18.65 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.517 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 73.0 t -58.52 -60.06 2.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.5 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 51.5 mt-10 -44.5 -28.98 0.64 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.726 -0.609 . . . . 0.0 109.97 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.401 ' CB ' HD21 ' A' ' 6' ' ' LEU . . . -86.15 -61.14 1.82 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.599 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.514 HD13 ' CD2' ' A' ' 24' ' ' PHE . 13.8 mt -46.47 -36.93 7.12 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.167 -0.958 . . . . 0.0 109.581 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -51.13 -40.82 59.39 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.5 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.1 -50.9 11.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -0.869 . . . . 0.0 108.808 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 18' ' ' VAL . 18.1 t -50.26 -54.8 7.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.543 0.687 . . . . 0.0 109.317 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.8 m -77.47 -22.22 51.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.57 -0.707 . . . . 0.0 110.634 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.88 -115.65 5.79 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -85.23 -24.16 27.93 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.194 -1.18 . . . . 0.0 110.077 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.598 HH21 ' CG ' ' A' ' 22' ' ' ARG . 3.4 mtt-85 -54.43 -37.99 65.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.046 -1.034 . . . . 0.0 109.367 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.53 164.02 10.88 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.523 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 7.9 p90 -138.2 172.71 12.51 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.543 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 17.0 p90 -109.11 122.01 46.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -0.925 . . . . 0.0 109.554 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.9 t80 . . . . . 0 N--CA 1.498 1.968 0 O-C-N 121.208 -0.933 . . . . 0.0 108.863 179.67 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.632 0.729 . . . . 0.0 109.037 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.78 -36.87 14.59 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.747 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.58 -50.21 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.547 -0.972 . . . . 0.0 109.928 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.494 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.5 t -67.58 -65.09 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.61 -1.306 . . . . 0.0 111.455 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 46' ' ' ARG . 13.9 mm-40 -57.58 -48.84 78.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.847 -1.158 . . . . 0.0 110.426 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.47 ' CD ' ' NE2' ' A' ' 53' ' ' GLN . 23.0 tt0 -46.83 -49.41 20.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.776 -1.202 . . . . 0.0 109.86 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.616 ' SG ' HD21 ' A' ' 54' ' ' LEU . 94.9 m -84.58 -53.5 5.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 110.172 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.416 ' N ' ' O ' ' A' ' 41' ' ' VAL . 54.1 t -60.93 -46.17 91.76 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.929 -1.107 . . . . 0.0 110.008 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.52 HH21 ' CG ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -69.87 -38.38 76.37 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.876 -1.14 . . . . 0.0 109.576 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.483 ' O ' ' O ' ' A' ' 44' ' ' CYS . 13.9 m -138.08 153.19 49.31 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.151 -0.968 . . . . 0.0 109.72 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.2 mt -68.6 99.68 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.109 -0.995 . . . . 0.0 109.837 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.7 p -83.34 140.56 32.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 108.918 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.2 m -70.36 157.51 37.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.182 -0.949 . . . . 0.0 109.885 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 48.2 mt -53.54 -33.28 54.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.41 -0.806 . . . . 0.0 109.247 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -50.07 -49.03 52.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 108.968 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.519 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 37.3 mt-30 -63.52 -50.33 70.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.853 . . . . 0.0 108.932 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.616 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.3 mt -56.78 -32.8 66.01 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.178 -0.951 . . . . 0.0 108.455 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -74.71 -8.85 57.67 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -80.35 -22.21 41.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.523 -0.735 . . . . 0.0 110.961 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.519 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.4 m-85 -98.87 -7.46 27.25 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.066 -1.021 . . . . 0.0 110.332 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 73.4 m -60.51 99.19 0.08 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.249 -0.907 . . . . 0.0 109.813 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.327 0 CA-C-O 118.002 -1.443 . . . . 0.0 109.517 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.414 HD21 ' CB ' ' A' ' 14' ' ' ALA . 5.5 mp . . . . . 0 N--CA 1.499 1.98 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.437 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 58.6 m -128.64 125.03 37.26 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.346 -0.846 . . . . 0.0 110.331 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 60.59 -135.21 49.65 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.2 m -42.77 -35.14 1.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.619 -0.93 . . . . 0.0 110.645 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.437 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 2.6 t-80 -60.54 -34.04 73.55 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.906 -1.121 . . . . 0.0 108.646 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.711 HD21 HD12 ' A' ' 40' ' ' ILE . 13.4 tp -73.67 -49.1 27.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 t -59.64 -61.85 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.503 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.5 mt-10 -44.8 -29.1 0.73 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.022 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.414 ' CB ' HD21 ' A' ' 6' ' ' LEU . . . -85.31 -60.18 2.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.066 -1.021 . . . . 0.0 109.723 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.558 HD13 ' CD2' ' A' ' 24' ' ' PHE . 13.9 mt -48.1 -37.09 14.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.935 -1.103 . . . . 0.0 109.441 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -50.62 -40.48 53.09 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.503 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -78.42 -51.51 9.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.933 . . . . 0.0 108.815 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 t -50.03 -53.99 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-O 121.531 0.681 . . . . 0.0 109.202 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.4 m -78.92 -21.98 46.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.594 -0.691 . . . . 0.0 110.205 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.23 -115.44 5.19 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.649 -1.781 . . . . 0.0 108.649 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -85.32 -23.64 28.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.161 -1.199 . . . . 0.0 109.964 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 59' ' ' GLY . 89.2 mtt180 -54.62 -37.89 66.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.976 -1.077 . . . . 0.0 109.175 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.83 164.35 11.91 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.558 ' CD2' HD13 ' A' ' 15' ' ' LEU . 9.7 p90 -139.75 173.07 11.9 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.511 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 17.4 p90 -111.04 125.41 53.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.243 -0.911 . . . . 0.0 109.343 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.6 t80 . . . . . 0 N--CA 1.499 1.99 0 O-C-N 121.038 -1.038 . . . . 0.0 109.094 179.918 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.594 ' CG ' HH21 ' A' ' 38' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.32 -26.66 46.9 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.711 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -102.01 -53.9 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.435 -1.038 . . . . 0.0 110.337 -179.577 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.52 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 8.6 t -71.32 -65.17 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.554 -1.341 . . . . 0.0 111.271 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 46' ' ' ARG . 67.9 mt-10 -57.09 -50.65 72.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.921 -1.112 . . . . 0.0 110.369 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.742 HE21 HE22 ' A' ' 53' ' ' GLN . 0.4 OUTLIER -48.46 -53.55 17.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.735 -1.228 . . . . 0.0 109.8 -179.504 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.515 ' SG ' HD21 ' A' ' 54' ' ' LEU . 97.6 m -75.7 -52.14 11.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.009 -1.057 . . . . 0.0 110.077 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.4 t -60.61 -52.77 63.72 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.913 -1.117 . . . . 0.0 110.229 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 42' ' ' GLU . 1.9 tmm_? -66.27 -36.49 83.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 0.0 110.027 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 44' ' ' CYS . 15.6 m -135.17 145.17 47.49 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.244 -0.91 . . . . 0.0 109.15 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.7 mt -68.24 99.6 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.134 -0.979 . . . . 0.0 109.472 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.4 p -82.98 141.91 31.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.44 -0.788 . . . . 0.0 109.333 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.7 m -70.19 157.04 38.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.701 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 43.8 mt -52.13 -32.36 35.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.374 -0.829 . . . . 0.0 108.978 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -48.43 -55.48 10.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.835 . . . . 0.0 109.314 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.742 HE22 HE21 ' A' ' 43' ' ' GLN . 22.4 mt-30 -57.79 -50.14 74.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.892 . . . . 0.0 109.188 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.515 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.0 mt -55.63 -35.48 65.94 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.115 -0.991 . . . . 0.0 108.675 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -72.41 -8.92 57.54 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.462 0.648 . . . . 0.0 109.322 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -80.04 -21.45 43.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.502 -0.749 . . . . 0.0 111.035 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.527 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.6 m-85 -100.76 -7.15 24.0 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.157 -0.965 . . . . 0.0 110.458 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 77.0 m -60.46 97.59 0.05 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.719 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.42 HD21 ' CB ' ' A' ' 14' ' ' ALA . 5.6 mp . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.444 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 64.1 m -128.54 125.09 37.61 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.272 -0.893 . . . . 0.0 110.675 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 60.34 -136.16 49.6 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.8 m -42.17 -33.97 0.68 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.752 -0.852 . . . . 0.0 110.624 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.444 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 1.0 OUTLIER -61.68 -34.99 76.71 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.841 -1.162 . . . . 0.0 108.83 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.697 HD21 HD12 ' A' ' 40' ' ' ILE . 12.1 tp -71.26 -49.74 40.02 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.5 t -58.6 -59.8 3.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.5 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 74.2 mt-10 -45.38 -30.15 1.26 Allowed 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.304 -0.559 . . . . 0.0 109.909 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.42 ' CB ' HD21 ' A' ' 6' ' ' LEU . . . -85.13 -60.87 1.91 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.152 -0.968 . . . . 0.0 109.694 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.568 HD13 ' CD2' ' A' ' 24' ' ' PHE . 15.6 mt -47.27 -36.33 8.99 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.004 -1.06 . . . . 0.0 109.64 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.86 -40.94 61.42 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.429 -0.795 . . . . 0.0 108.857 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.5 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -77.98 -51.71 9.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.164 -0.96 . . . . 0.0 108.871 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.3 t -49.91 -53.76 9.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.7 m -80.39 -22.32 41.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.617 -0.677 . . . . 0.0 110.297 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.84 -116.31 5.32 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.532 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 24.7 mp0 -84.48 -22.02 30.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -1.192 . . . . 0.0 109.699 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -54.96 -37.82 66.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.163 -0.961 . . . . 0.0 109.126 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.1 161.22 8.79 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.568 ' CD2' HD13 ' A' ' 15' ' ' LEU . 9.1 p90 -138.31 173.31 11.74 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.531 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 6.9 p90 -108.94 123.57 49.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.134 -0.979 . . . . 0.0 109.889 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.3 t80 . . . . . 0 N--CA 1.5 2.037 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.133 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.599 ' CG ' HH21 ' A' ' 38' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 121.681 0.753 . . . . 0.0 109.081 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.01 -31.77 22.45 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.697 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.4 -53.84 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.418 -1.048 . . . . 0.0 110.712 -178.425 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.521 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 4.3 t -69.65 -64.09 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 120.392 -1.443 . . . . 0.0 111.012 -178.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -56.16 -51.15 69.01 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.176 -0.952 . . . . 0.0 110.287 -178.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.534 ' NE2' ' OE1' ' A' ' 53' ' ' GLN . 40.9 tt0 -48.77 -53.96 16.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.633 -1.292 . . . . 0.0 110.063 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.538 ' SG ' HD21 ' A' ' 54' ' ' LEU . 87.3 m -74.83 -52.81 10.41 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.133 -0.98 . . . . 0.0 109.89 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 54.1 t -60.36 -52.47 65.13 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.062 -1.024 . . . . 0.0 110.341 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 42' ' ' GLU . 2.6 tmm_? -69.15 -34.59 75.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.926 -1.109 . . . . 0.0 110.185 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 44' ' ' CYS . 51.3 m -135.24 146.13 48.31 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.09 -1.006 . . . . 0.0 109.323 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.1 mt -68.66 99.64 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.0 -1.063 . . . . 0.0 109.706 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.5 p -83.77 138.41 33.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.319 -0.863 . . . . 0.0 109.09 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.4 m -69.61 160.2 32.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.264 -0.897 . . . . 0.0 110.162 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.0 mt -53.72 -32.86 53.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.504 -0.748 . . . . 0.0 109.133 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -49.71 -49.58 47.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 108.97 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.534 ' OE1' ' NE2' ' A' ' 43' ' ' GLN . 61.7 mt-30 -63.12 -52.53 62.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.358 -0.839 . . . . 0.0 109.095 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.538 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.5 mt -54.92 -35.32 64.06 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.292 -0.88 . . . . 0.0 108.718 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -73.13 -8.87 57.69 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.524 0.678 . . . . 0.0 109.303 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -80.16 -21.68 42.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.437 -0.789 . . . . 0.0 110.926 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.511 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.0 m-85 -100.38 -6.33 25.91 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.172 -0.955 . . . . 0.0 110.474 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.4 m -61.19 97.32 0.06 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.114 -0.991 . . . . 0.0 109.507 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.268 0 CA-C-O 117.993 -1.449 . . . . 0.0 109.517 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.407 HD21 ' CB ' ' A' ' 14' ' ' ALA . 4.6 mp . . . . . 0 N--CA 1.497 1.911 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.419 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 68.9 m -129.39 125.06 35.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.255 -0.903 . . . . 0.0 110.377 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.99 -137.78 43.89 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.0 m -42.68 -34.87 0.97 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.648 -0.913 . . . . 0.0 110.412 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.419 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 2.1 t-160 -58.1 -35.66 71.75 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.94 -1.1 . . . . 0.0 108.56 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.726 HD21 HD12 ' A' ' 40' ' ' ILE . 11.0 tp -71.5 -52.49 18.04 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.523 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 75.2 t -58.87 -58.95 4.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.493 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 30.2 mt-10 -44.85 -28.75 0.69 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.74 -0.6 . . . . 0.0 109.909 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.407 ' CB ' HD21 ' A' ' 6' ' ' LEU . . . -86.8 -61.31 1.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -0.962 . . . . 0.0 109.52 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.553 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.5 mt -46.23 -36.58 6.24 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.171 -0.956 . . . . 0.0 109.713 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -51.97 -41.12 61.87 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.387 -0.821 . . . . 0.0 108.807 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.493 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -77.77 -50.95 11.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 0.0 108.863 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.5 t -50.16 -54.66 7.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.2 m -78.61 -22.01 47.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.601 -0.687 . . . . 0.0 110.258 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.92 -116.74 6.44 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.544 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 5.1 mp0 -84.77 -21.65 29.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.072 -1.252 . . . . 0.0 109.676 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -54.94 -38.1 67.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.163 -0.961 . . . . 0.0 109.286 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.14 162.11 9.8 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.553 ' CD2' HD13 ' A' ' 15' ' ' LEU . 8.0 p90 -139.26 172.42 12.85 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.519 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 19.3 p90 -109.1 123.45 49.2 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.4 t80 . . . . . 0 N--CA 1.496 1.86 0 O-C-N 120.939 -1.101 . . . . 0.0 109.839 -179.355 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.616 ' CG ' HH21 ' A' ' 38' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.569 0.699 . . . . 0.0 109.183 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.6 -28.72 38.12 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.726 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.9 -51.25 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.442 -1.034 . . . . 0.0 110.18 -179.275 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.5 t -69.73 -65.0 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.521 -1.362 . . . . 0.0 111.237 -178.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' ARG . 61.5 mm-40 -57.5 -47.53 81.66 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.897 -1.127 . . . . 0.0 110.38 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -48.66 -53.65 17.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.682 -1.262 . . . . 0.0 109.565 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.586 ' SG ' HD21 ' A' ' 54' ' ' LEU . 96.6 m -78.16 -53.65 7.13 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.211 -0.93 . . . . 0.0 109.965 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.7 t -59.96 -52.49 65.19 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.9 -1.125 . . . . 0.0 110.056 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.545 HH21 ' CG ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -68.69 -33.13 73.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -0.952 . . . . 0.0 110.362 -179.172 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 44' ' ' CYS . 7.7 m -136.28 144.93 45.02 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.105 -0.997 . . . . 0.0 109.387 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 55.0 mt -68.43 99.48 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.013 -1.055 . . . . 0.0 109.272 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.6 p -85.5 141.81 29.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.417 -0.802 . . . . 0.0 109.343 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.3 m -73.04 160.56 31.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.634 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.414 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 43.8 mt -53.06 -33.01 50.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 109.342 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -48.43 -56.96 6.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -0.9 . . . . 0.0 109.31 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.517 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 17.0 mt-30 -56.47 -50.53 71.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.209 -0.932 . . . . 0.0 109.018 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.586 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.8 mt -56.07 -33.97 65.52 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.136 -0.977 . . . . 0.0 108.543 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -73.85 -9.02 58.23 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -79.98 -21.73 43.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.498 -0.751 . . . . 0.0 111.092 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.517 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.6 m-85 -100.64 -6.14 25.62 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.11 -0.994 . . . . 0.0 110.352 -178.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 73.6 m -62.08 97.05 0.08 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.193 -0.942 . . . . 0.0 109.805 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.304 0 CA-C-O 117.98 -1.456 . . . . 0.0 109.515 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.456 HD21 ' CB ' ' A' ' 14' ' ' ALA . 5.9 mp . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.437 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 57.9 m -130.77 125.23 33.25 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.293 -0.879 . . . . 0.0 110.425 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 61.05 -137.03 48.25 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.3 m -42.36 -31.67 0.43 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.613 -0.934 . . . . 0.0 110.695 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.437 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 6.7 t-160 -64.39 -34.5 78.32 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.777 -1.202 . . . . 0.0 108.665 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.708 HD21 HD12 ' A' ' 40' ' ' ILE . 9.6 tp -71.09 -49.72 41.42 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 t -57.71 -60.46 2.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 25.7 mt-10 -44.5 -29.93 0.79 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.068 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.456 ' CB ' HD21 ' A' ' 6' ' ' LEU . . . -85.6 -60.55 1.99 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.086 -1.009 . . . . 0.0 109.578 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.525 HD13 ' CD2' ' A' ' 24' ' ' PHE . 15.7 mt -47.05 -37.34 9.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.055 -1.028 . . . . 0.0 109.745 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -50.89 -40.76 57.4 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.496 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -77.82 -50.6 11.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 108.746 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.7 t -50.26 -55.29 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.4 m -79.17 -22.19 45.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.6 -0.687 . . . . 0.0 110.304 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.72 -116.57 6.13 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -85.01 -22.67 28.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.128 -1.219 . . . . 0.0 109.76 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -54.77 -38.35 67.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.15 -0.969 . . . . 0.0 108.843 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.2 162.69 10.61 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 120.094 -1.051 . . . . 0.0 110.747 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 24' ' ' PHE . 7.0 p90 -137.43 172.58 12.76 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.533 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 15.7 p90 -110.89 122.21 47.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 0.0 108.995 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.1 t80 . . . . . 0 N--CA 1.497 1.924 0 O-C-N 120.863 -1.148 . . . . 0.0 108.787 179.9 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.32 -36.09 15.63 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.708 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.87 -50.79 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.407 -1.054 . . . . 0.0 110.039 -179.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.49 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.3 t -67.73 -64.9 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.57 -1.331 . . . . 0.0 111.802 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 46' ' ' ARG . 31.5 mm-40 -55.72 -53.0 61.99 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.934 -1.104 . . . . 0.0 111.377 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -47.44 -50.13 23.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.651 -1.28 . . . . 0.0 109.973 -178.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.625 ' SG ' HD21 ' A' ' 54' ' ' LEU . 94.6 m -81.17 -54.4 5.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.995 -1.066 . . . . 0.0 110.186 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 54.0 t -61.51 -47.87 83.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.872 -1.142 . . . . 0.0 110.074 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 42' ' ' GLU . 1.0 OUTLIER -69.79 -36.32 75.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.999 -1.063 . . . . 0.0 109.722 -179.469 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 44' ' ' CYS . 6.9 m -137.27 150.33 47.74 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.062 -1.024 . . . . 0.0 109.733 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.5 mt -68.64 99.74 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.145 -0.972 . . . . 0.0 109.272 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.1 p -83.27 146.21 28.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.388 -0.82 . . . . 0.0 109.817 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.1 m -79.54 166.28 22.09 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.305 -0.872 . . . . 0.0 109.516 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.0 mt -56.49 -31.99 64.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.484 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -48.31 -48.62 35.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.14 -0.975 . . . . 0.0 109.47 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.522 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 19.9 mt-30 -69.16 -53.38 20.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.343 -0.848 . . . . 0.0 109.633 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.625 HD21 ' SG ' ' A' ' 44' ' ' CYS . 98.0 mt -55.12 -35.44 64.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.142 -0.974 . . . . 0.0 109.021 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -73.91 -9.36 58.56 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -78.83 -22.03 46.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.387 -0.82 . . . . 0.0 110.839 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.522 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.2 m-85 -100.28 -6.45 25.92 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.185 -0.947 . . . . 0.0 110.443 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 74.6 m -62.71 96.51 0.09 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.1 -1.0 . . . . 0.0 109.536 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.283 0 CA-C-O 117.984 -1.453 . . . . 0.0 109.523 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.471 HD21 ' CB ' ' A' ' 14' ' ' ALA . 6.6 mp . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.4 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 68.0 m -129.74 125.17 35.26 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.189 -0.945 . . . . 0.0 110.65 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 60.66 -139.22 48.1 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 8' ' ' GLY . 70.6 m -39.64 -33.34 0.18 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.856 -0.791 . . . . 0.0 110.71 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.4 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 2.2 t-160 -60.91 -39.77 90.62 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.878 -1.139 . . . . 0.0 108.699 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.753 HD21 HD12 ' A' ' 40' ' ' ILE . 9.2 tp -65.34 -53.96 35.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.408 -0.807 . . . . 0.0 109.109 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.52 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 73.2 t -55.4 -59.75 2.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.493 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 32.5 mt-10 -44.59 -28.77 0.63 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.698 -0.626 . . . . 0.0 110.126 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.471 ' CB ' HD21 ' A' ' 6' ' ' LEU . . . -86.77 -60.51 1.97 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.118 -0.989 . . . . 0.0 109.485 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.533 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.3 mt -46.96 -35.76 6.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.102 -0.999 . . . . 0.0 109.552 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -52.36 -40.85 62.52 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.493 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.02 -51.13 10.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 108.867 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.6 t -50.15 -54.1 9.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.3 m -78.44 -22.13 48.11 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.634 -0.666 . . . . 0.0 110.32 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.06 -115.04 4.14 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.519 -1.832 . . . . 0.0 108.519 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -85.41 -23.4 27.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.11 -1.229 . . . . 0.0 109.931 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 59' ' ' GLY . 37.2 mtp180 -54.76 -37.79 66.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -0.982 . . . . 0.0 109.286 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.82 162.73 9.76 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.562 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.533 ' CD2' HD13 ' A' ' 15' ' ' LEU . 9.5 p90 -138.85 173.8 11.19 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.548 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 18.5 p90 -110.7 122.15 47.1 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.173 -0.954 . . . . 0.0 110.273 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.1 t80 . . . . . 0 N--CA 1.5 2.052 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.906 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.419 HH21 ' HG3' ' A' ' 38' ' ' ARG . 1.6 ptm180 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.59 -32.45 27.52 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.753 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.77 -51.42 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.479 -1.012 . . . . 0.0 110.121 -179.418 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.513 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 4.1 t -68.79 -64.34 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.649 -1.282 . . . . 0.0 111.409 -178.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 46' ' ' ARG . 68.2 mm-40 -58.26 -53.04 62.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.791 -1.193 . . . . 0.0 110.257 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.473 ' CD ' ' NE2' ' A' ' 53' ' ' GLN . 12.2 tt0 -43.85 -47.48 8.22 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.972 -1.08 . . . . 0.0 110.187 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.647 ' SG ' HD21 ' A' ' 54' ' ' LEU . 95.3 m -84.05 -50.47 7.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.036 -1.04 . . . . 0.0 109.933 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.9 t -61.79 -53.12 60.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.243 -0.911 . . . . 0.0 110.472 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 42' ' ' GLU . 7.9 tpp180 -69.68 -39.45 76.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.918 -1.114 . . . . 0.0 109.708 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 44' ' ' CYS . 15.6 m -126.41 144.78 50.72 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.11 -0.993 . . . . 0.0 109.584 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.5 mt -69.38 99.38 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.173 -0.954 . . . . 0.0 109.24 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.5 p -83.85 143.34 29.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.327 -0.858 . . . . 0.0 109.533 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.0 m -73.35 161.25 30.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.86 . . . . 0.0 109.805 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 42.3 mt -55.52 -34.18 64.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.852 . . . . 0.0 109.342 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -48.63 -53.73 17.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.129 -0.982 . . . . 0.0 109.031 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.52 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 38.1 mt-30 -58.69 -51.75 68.6 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.331 -0.856 . . . . 0.0 108.939 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.647 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.4 mt -56.69 -30.77 63.78 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -76.29 -8.86 58.0 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -80.51 -22.85 40.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.533 -0.729 . . . . 0.0 110.869 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.52 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 5.7 m-85 -99.35 -7.43 26.27 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.111 -0.993 . . . . 0.0 110.048 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 91.5 m -61.35 93.98 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.386 -0.821 . . . . 0.0 109.722 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.344 0 CA-C-O 118.029 -1.428 . . . . 0.0 109.568 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.428 HD21 ' CB ' ' A' ' 14' ' ' ALA . 4.1 mp . . . . . 0 N--CA 1.493 1.677 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.415 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 76.2 m -128.22 125.07 38.24 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.99 0.9 . . . . 0.0 110.839 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.73 -136.85 48.78 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.4 m -42.65 -31.49 0.47 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.605 -0.938 . . . . 0.0 110.484 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.415 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 1.7 t-160 -62.26 -34.0 75.7 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.944 -1.097 . . . . 0.0 108.758 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.708 HD21 HD12 ' A' ' 40' ' ' ILE . 12.0 tp -72.97 -52.57 13.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.438 -0.789 . . . . 0.0 109.015 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.512 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 66.9 t -56.44 -59.64 2.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.484 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.6 mt-10 -44.25 -28.96 0.58 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.804 -0.56 . . . . 0.0 110.222 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.428 ' CB ' HD21 ' A' ' 6' ' ' LEU . . . -86.96 -59.8 2.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.132 -0.98 . . . . 0.0 109.602 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.547 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.9 mt -47.21 -36.77 9.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.164 -0.96 . . . . 0.0 109.513 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.32 -41.13 60.34 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.484 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -77.74 -50.09 13.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 108.856 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.5 t -50.44 -54.55 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-O 121.65 0.738 . . . . 0.0 109.029 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.1 m -79.51 -22.77 43.53 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.696 -0.628 . . . . 0.0 110.506 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 50.09 -109.65 0.7 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 8.9 mp0 -85.48 -25.58 26.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.213 -1.169 . . . . 0.0 110.269 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HG2' HH21 ' A' ' 22' ' ' ARG . 31.7 mtt-85 -54.66 -38.68 67.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.955 -1.091 . . . . 0.0 109.309 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.34 161.54 8.02 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.547 ' CD2' HD13 ' A' ' 15' ' ' LEU . 9.5 p90 -138.4 173.59 11.44 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.469 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 4.9 p90 -106.25 128.53 54.03 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.209 -0.932 . . . . 0.0 110.012 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.5 t80 . . . . . 0 N--CA 1.506 2.33 0 O-C-N 121.343 -0.848 . . . . 0.0 109.069 179.691 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.526 ' HG2' HH21 ' A' ' 38' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.06 -28.63 40.62 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.708 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.1 -54.13 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.475 -1.015 . . . . 0.0 110.283 -179.288 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.514 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.2 t -66.73 -64.83 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.358 -1.464 . . . . 0.0 111.21 -178.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 46' ' ' ARG . 52.5 mm-40 -56.24 -48.55 76.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.919 -1.113 . . . . 0.0 110.08 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -46.98 -55.87 7.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.739 -1.226 . . . . 0.0 109.991 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.563 ' SG ' HD21 ' A' ' 54' ' ' LEU . 93.6 m -76.94 -52.66 9.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.246 -0.909 . . . . 0.0 110.062 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.8 t -59.47 -52.93 63.48 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.867 -1.145 . . . . 0.0 109.97 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 42' ' ' GLU . 2.7 tmt_? -66.82 -36.3 82.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.289 -0.882 . . . . 0.0 110.235 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 44' ' ' CYS . 16.2 m -134.43 145.25 48.7 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.124 -0.985 . . . . 0.0 109.362 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 57.5 mt -68.21 99.62 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.036 -1.04 . . . . 0.0 109.331 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.8 p -84.93 150.01 25.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.417 -0.802 . . . . 0.0 109.421 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.7 m -88.41 166.17 14.42 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.262 -0.899 . . . . 0.0 110.026 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.1 mt -52.17 -34.25 44.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.421 -0.8 . . . . 0.0 109.519 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -47.52 -43.1 24.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.246 -0.909 . . . . 0.0 109.57 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.512 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 41.8 mt-30 -77.47 -52.33 9.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.374 -0.829 . . . . 0.0 109.792 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.563 HD21 ' SG ' ' A' ' 44' ' ' CYS . 98.7 mt -54.45 -38.08 65.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.031 -1.043 . . . . 0.0 109.007 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -71.0 -9.27 57.72 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 121.544 0.688 . . . . 0.0 109.286 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -78.91 -22.36 45.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 0.0 111.033 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.512 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.7 m-85 -99.98 -8.04 24.39 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.078 -1.013 . . . . 0.0 110.272 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 87.5 m -60.53 94.86 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.511 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 mp . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 86.0 m -128.5 124.98 37.44 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.31 -0.869 . . . . 0.0 110.388 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.56 -137.01 44.63 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 m -42.31 -35.63 1.04 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.707 -0.878 . . . . 0.0 110.568 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.403 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 0.8 OUTLIER -58.49 -35.12 71.71 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.919 -1.113 . . . . 0.0 108.892 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.722 HD21 HD12 ' A' ' 40' ' ' ILE . 12.7 tp -72.03 -52.52 16.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.332 -0.855 . . . . 0.0 108.826 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.507 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 75.1 t -58.44 -59.25 3.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.499 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 85.7 mt-10 -45.12 -29.0 0.82 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.727 -0.608 . . . . 0.0 109.895 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.53 -60.9 1.86 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -0.939 . . . . 0.0 109.559 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.567 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.6 mt -46.87 -36.55 7.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.166 -0.958 . . . . 0.0 109.555 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.7 -41.96 61.86 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.408 -0.808 . . . . 0.0 108.842 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.499 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -76.38 -51.84 11.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 108.735 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 t -49.97 -53.78 9.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.547 0.689 . . . . 0.0 109.203 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 m -79.84 -22.38 43.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.471 -0.768 . . . . 0.0 110.471 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.86 -114.22 3.41 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.744 -1.743 . . . . 0.0 108.744 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -85.29 -23.98 27.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.2 -1.176 . . . . 0.0 110.125 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -54.6 -37.69 65.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.966 -1.084 . . . . 0.0 109.359 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.83 162.24 9.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.567 ' CD2' HD13 ' A' ' 15' ' ' LEU . 9.3 p90 -138.41 173.51 11.52 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 3.8 p90 -107.72 125.41 51.36 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.086 -1.008 . . . . 0.0 110.231 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.5 t80 . . . . . 0 N--CA 1.502 2.165 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.045 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.587 ' CG ' HH21 ' A' ' 38' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.23 -33.05 24.15 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.722 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.29 -53.88 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.159 -1.201 . . . . 0.0 110.837 -178.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.502 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.7 t -65.93 -63.65 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.454 -1.404 . . . . 0.0 111.402 -177.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' ARG . 71.4 mt-10 -55.46 -51.59 66.43 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.868 -1.145 . . . . 0.0 111.056 -178.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.493 ' NE2' HE22 ' A' ' 53' ' ' GLN . 0.4 OUTLIER -48.21 -52.05 22.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.622 -1.299 . . . . 0.0 110.044 -179.128 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.572 ' SG ' HD21 ' A' ' 54' ' ' LEU . 85.4 m -78.01 -53.77 7.04 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.962 -1.086 . . . . 0.0 110.013 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 54.0 t -59.86 -52.18 66.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.89 -1.131 . . . . 0.0 109.939 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -67.03 -35.58 80.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 0.0 110.303 -179.396 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 44' ' ' CYS . 26.4 m -136.67 147.2 46.7 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.059 -1.026 . . . . 0.0 109.307 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.9 mt -68.32 99.71 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.045 -1.034 . . . . 0.0 109.554 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.4 p -85.29 138.77 32.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.364 -0.835 . . . . 0.0 109.175 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.0 m -70.1 163.06 27.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.27 -0.894 . . . . 0.0 109.68 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.1 mt -56.61 -31.0 63.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.337 -0.852 . . . . 0.0 108.892 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -48.91 -51.95 27.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 109.177 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.493 HE22 ' NE2' ' A' ' 43' ' ' GLN . 56.8 mt-30 -62.99 -50.35 71.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.223 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.572 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.8 mt -55.09 -36.01 65.2 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.2 -0.938 . . . . 0.0 108.768 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -71.81 -8.98 57.57 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.485 0.659 . . . . 0.0 109.254 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -79.81 -22.5 42.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.422 -0.798 . . . . 0.0 110.958 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.49 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.8 m-85 -100.04 -8.15 24.16 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.069 -1.019 . . . . 0.0 110.209 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 81.6 m -60.39 93.03 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.357 -0.839 . . . . 0.0 109.44 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.284 0 CA-C-O 117.985 -1.453 . . . . 0.0 109.555 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.402 HD21 ' CB ' ' A' ' 14' ' ' ALA . 5.0 mp . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.424 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 63.0 m -130.73 124.57 31.77 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.321 -0.862 . . . . 0.0 109.872 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 63.95 -138.1 41.66 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.6 m -41.69 -35.17 0.72 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.715 -0.873 . . . . 0.0 110.764 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.424 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 7.3 t-160 -59.29 -35.68 74.2 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.878 -1.139 . . . . 0.0 108.89 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.721 HD21 HD12 ' A' ' 40' ' ' ILE . 8.4 tp -70.18 -52.73 21.12 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.511 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 64.6 t -58.12 -60.38 2.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.489 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 70.9 mt-10 -44.01 -30.17 0.69 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.818 -0.551 . . . . 0.0 110.022 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.402 ' CB ' HD21 ' A' ' 6' ' ' LEU . . . -84.9 -61.15 1.85 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.254 -0.904 . . . . 0.0 109.71 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.498 HD13 ' CD2' ' A' ' 24' ' ' PHE . 13.2 mt -46.1 -36.9 6.22 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.245 -0.909 . . . . 0.0 109.629 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -51.85 -40.43 60.53 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.489 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -78.37 -50.65 11.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 108.761 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.418 ' H ' HG23 ' A' ' 18' ' ' VAL . 19.2 t -50.12 -55.02 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.523 0.678 . . . . 0.0 109.362 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.6 m -77.29 -22.34 52.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.556 -0.715 . . . . 0.0 110.615 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.32 -112.59 2.11 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.571 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 2.6 mp0 -85.32 -25.11 27.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.226 -1.161 . . . . 0.0 109.972 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -54.44 -38.3 66.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.065 -1.022 . . . . 0.0 109.486 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.15 162.71 8.73 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.511 ' HZ ' HG13 ' A' ' 12' ' ' VAL . 9.2 p90 -138.48 173.33 11.71 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.544 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 18.8 p90 -111.96 121.68 45.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 109.643 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 13.7 t80 . . . . . 0 N--CA 1.498 1.953 0 O-C-N 121.026 -1.046 . . . . 0.0 108.798 179.27 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.55 -31.01 31.42 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.721 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.13 -52.49 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.706 -0.879 . . . . 0.0 110.137 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.516 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.9 t -68.97 -64.76 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.514 -1.366 . . . . 0.0 111.473 -178.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 46' ' ' ARG . 97.4 mt-10 -58.23 -49.32 77.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.913 -1.117 . . . . 0.0 110.534 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -46.75 -49.47 19.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.82 -1.175 . . . . 0.0 109.899 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.606 ' SG ' HD21 ' A' ' 54' ' ' LEU . 86.4 m -84.16 -51.84 6.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 110.248 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.3 t -61.57 -48.29 81.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.813 -1.179 . . . . 0.0 109.79 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.553 HH21 ' CG ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -66.25 -39.11 89.26 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.99 -1.069 . . . . 0.0 109.703 -179.718 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 44' ' ' CYS . 68.8 m -138.61 152.84 48.48 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.143 -0.973 . . . . 0.0 109.719 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.4 mt -68.53 99.46 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.012 -1.055 . . . . 0.0 109.381 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.3 p -80.87 141.28 34.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 0.0 108.891 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 m -70.39 158.87 35.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -0.951 . . . . 0.0 109.912 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 43.3 mt -53.02 -32.25 45.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.442 -0.786 . . . . 0.0 109.187 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -49.5 -52.09 31.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.257 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.492 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 45.7 mt-30 -62.41 -51.32 68.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 109.326 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.606 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.8 mt -56.5 -33.23 65.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.093 -1.004 . . . . 0.0 108.437 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -74.37 -8.95 58.01 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -79.65 -22.22 43.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.452 -0.78 . . . . 0.0 110.897 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.492 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.4 m-85 -100.27 -8.17 23.78 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.187 -0.946 . . . . 0.0 110.056 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 93.4 m -60.63 96.2 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.59 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.407 HD21 ' CB ' ' A' ' 14' ' ' ALA . 4.7 mp . . . . . 0 N--CA 1.499 1.994 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.446 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 62.7 m -128.95 124.86 36.19 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.212 -0.93 . . . . 0.0 110.163 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.14 -136.45 45.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -42.01 -35.44 0.89 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.719 -0.871 . . . . 0.0 110.584 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.446 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 0.8 OUTLIER -59.4 -36.28 75.53 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.9 -1.125 . . . . 0.0 108.751 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.716 HD21 HD12 ' A' ' 40' ' ' ILE . 10.7 tp -70.97 -50.16 37.48 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.9 t -59.36 -60.83 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.498 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.7 mt-10 -44.71 -29.73 0.82 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.919 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.407 ' CB ' HD21 ' A' ' 6' ' ' LEU . . . -85.2 -61.11 1.85 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.726 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.529 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.2 mt -46.72 -36.95 7.73 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.142 -0.974 . . . . 0.0 109.706 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -51.37 -40.43 59.18 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.498 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.34 -50.74 11.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 108.759 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.487 ' O ' ' NH1' ' A' ' 22' ' ' ARG . 21.1 t -49.98 -54.94 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.7 m -79.81 -22.39 43.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.62 -0.675 . . . . 0.0 110.113 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.74 -115.69 5.19 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.769 -1.733 . . . . 0.0 108.769 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 8.9 mp0 -84.6 -22.14 30.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.187 -1.184 . . . . 0.0 109.67 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.487 ' NH1' ' O ' ' A' ' 18' ' ' VAL . 78.5 mtm180 -55.02 -37.84 67.15 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.152 -0.968 . . . . 0.0 109.253 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.85 160.14 7.59 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.48 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.529 ' CD2' HD13 ' A' ' 15' ' ' LEU . 8.6 p90 -137.77 172.63 12.66 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.523 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 9.2 p90 -109.86 124.81 51.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 109.335 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.7 t80 . . . . . 0 N--CA 1.497 1.918 0 O-C-N 121.045 -1.034 . . . . 0.0 108.703 179.378 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.616 0.722 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.36 -35.74 51.7 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.716 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.12 -51.5 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.244 -1.151 . . . . 0.0 110.467 -179.149 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.487 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.5 t -69.56 -64.63 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 120.463 -1.398 . . . . 0.0 111.994 -177.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -55.45 -53.82 51.56 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.849 -1.157 . . . . 0.0 111.028 -177.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.587 HE21 ' C ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -47.19 -49.42 22.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.824 -1.172 . . . . 0.0 109.876 -178.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.61 ' SG ' HD21 ' A' ' 54' ' ' LEU . 95.1 m -81.14 -54.44 5.53 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.931 -1.105 . . . . 0.0 109.897 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.6 t -60.95 -52.06 66.63 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.922 -1.111 . . . . 0.0 110.102 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -68.89 -33.78 74.34 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.218 -0.926 . . . . 0.0 110.402 -179.031 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 44' ' ' CYS . 25.4 m -136.48 147.63 47.27 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.071 -1.018 . . . . 0.0 109.404 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.5 mt -69.14 99.36 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.088 -1.008 . . . . 0.0 109.125 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.1 p -85.41 146.68 26.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.376 -0.827 . . . . 0.0 109.297 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.3 m -77.62 162.94 26.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.891 . . . . 0.0 109.69 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.5 mt -56.09 -31.76 63.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 0.0 108.969 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -46.9 -54.4 10.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 0.0 109.533 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.576 HE22 ' CD ' ' A' ' 43' ' ' GLN . 16.1 mt-30 -62.36 -50.46 71.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.388 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.61 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.3 mt -55.71 -34.14 64.85 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.078 -1.014 . . . . 0.0 108.686 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.487 ' OE2' ' NH2' ' A' ' 22' ' ' ARG . 4.2 tm-20 -74.42 -9.38 58.53 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -79.52 -21.79 44.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.386 -0.822 . . . . 0.0 110.99 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.525 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.9 m-85 -99.17 -7.4 26.63 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.078 -1.014 . . . . 0.0 110.626 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.436 ' O ' ' OXT' ' A' ' 59' ' ' GLY . 78.4 m -59.01 102.17 0.11 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.004 -1.06 . . . . 0.0 109.066 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.492 2.426 0 CA-C-O 117.911 -1.494 . . . . 0.0 109.945 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.411 HD21 ' CB ' ' A' ' 14' ' ' ALA . 4.3 mp . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.41 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 58.6 m -130.11 124.99 34.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.177 -0.952 . . . . 0.0 110.516 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.82 -137.27 44.08 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.3 m -43.31 -30.95 0.56 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.54 -0.977 . . . . 0.0 110.419 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.41 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 2.1 t-80 -63.18 -33.6 75.83 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.97 -1.081 . . . . 0.0 108.811 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.714 HD21 HD12 ' A' ' 40' ' ' ILE . 9.2 tp -72.12 -51.65 20.42 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.517 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 76.5 t -58.12 -60.98 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.49 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 29.2 mt-10 -43.55 -29.35 0.46 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.821 -0.549 . . . . 0.0 109.975 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.411 ' CB ' HD21 ' A' ' 6' ' ' LEU . . . -85.77 -61.11 1.83 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.435 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.513 HD13 ' CD2' ' A' ' 24' ' ' PHE . 13.8 mt -46.15 -37.13 6.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.201 -0.937 . . . . 0.0 109.707 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.52 -42.42 61.72 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.407 -0.808 . . . . 0.0 108.842 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.49 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -75.66 -51.23 13.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.281 -0.887 . . . . 0.0 108.763 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.418 ' H ' HG23 ' A' ' 18' ' ' VAL . 19.0 t -50.37 -55.1 6.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-O 121.516 0.674 . . . . 0.0 109.337 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.6 m -78.01 -22.31 49.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.481 -0.762 . . . . 0.0 110.613 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.22 -118.38 13.21 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -85.37 -24.9 27.38 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.135 -1.215 . . . . 0.0 110.329 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.603 HH21 ' CG ' ' A' ' 22' ' ' ARG . 2.8 mtt-85 -54.3 -36.66 63.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.946 -1.096 . . . . 0.0 109.303 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.33 166.84 19.98 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.549 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 7.4 p90 -139.01 172.49 12.76 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.544 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 15.2 p90 -110.19 121.75 46.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.9 . . . . 0.0 109.282 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.0 t80 . . . . . 0 N--CA 1.495 1.809 0 O-C-N 121.069 -1.019 . . . . 0.0 109.666 179.987 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.562 0.696 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.44 -37.54 14.29 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.714 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.35 -50.68 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.491 -1.005 . . . . 0.0 109.956 -179.288 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.499 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 4.3 t -69.37 -64.93 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 120.592 -1.317 . . . . 0.0 111.692 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 46' ' ' ARG . 31.3 mm-40 -57.03 -51.87 67.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.804 -1.185 . . . . 0.0 110.262 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.584 ' NE2' HE21 ' A' ' 53' ' ' GLN . 17.5 tt0 -45.6 -48.69 14.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.082 -1.012 . . . . 0.0 110.138 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.629 ' SG ' HD21 ' A' ' 54' ' ' LEU . 86.2 m -84.08 -53.9 5.21 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.199 -0.938 . . . . 0.0 109.992 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 54.0 t -60.82 -51.59 68.68 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.054 -1.029 . . . . 0.0 110.064 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 42' ' ' GLU . 2.9 tmt_? -68.06 -35.67 78.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.135 -0.978 . . . . 0.0 110.003 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 44' ' ' CYS . 23.2 m -136.52 147.73 47.24 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.15 -0.969 . . . . 0.0 109.331 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 63.4 mt -68.49 99.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.022 -1.049 . . . . 0.0 109.312 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.5 p -82.42 138.1 34.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.431 -0.793 . . . . 0.0 108.993 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 m -68.75 158.87 33.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.777 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.8 mt -53.59 -31.72 48.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.351 -0.843 . . . . 0.0 108.964 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -49.01 -51.91 28.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.408 -0.808 . . . . 0.0 109.23 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.584 HE21 ' NE2' ' A' ' 43' ' ' GLN . 24.4 mt-30 -63.32 -49.41 74.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.234 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.629 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.6 mt -56.85 -32.77 66.13 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.015 -1.053 . . . . 0.0 108.249 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -74.55 -9.26 58.41 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -79.76 -22.14 43.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 111.103 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.487 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.5 m-85 -99.5 -4.93 30.2 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.048 -1.033 . . . . 0.0 110.712 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 75.5 m -62.19 102.48 0.3 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.06 -1.025 . . . . 0.0 109.827 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.318 0 CA-C-O 118.026 -1.43 . . . . 0.0 109.557 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.498 1.963 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.421 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 58.1 m -129.21 124.94 35.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.374 -0.829 . . . . 0.0 110.056 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.61 -137.36 44.6 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 m -41.5 -35.61 0.74 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.751 -0.852 . . . . 0.0 110.71 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.421 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 0.8 OUTLIER -59.45 -35.95 75.01 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.899 -1.125 . . . . 0.0 108.817 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.696 HD21 HD12 ' A' ' 40' ' ' ILE . 10.8 tp -71.05 -50.03 38.43 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -59.6 -61.43 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.497 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 81.7 mt-10 -44.38 -29.9 0.76 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.847 -0.533 . . . . 0.0 110.004 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.34 -60.76 1.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.155 -0.966 . . . . 0.0 109.79 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.538 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.3 mt -47.01 -36.49 7.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.08 -1.012 . . . . 0.0 109.57 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.7 -40.79 60.77 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.497 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.49 -50.75 11.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 0.0 108.992 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -49.89 -53.48 10.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.538 0.685 . . . . 0.0 109.295 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 m -78.79 -22.32 46.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.596 -0.69 . . . . 0.0 110.585 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.24 -114.07 3.45 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 2.2 mp0 -85.28 -24.03 27.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.174 -1.192 . . . . 0.0 109.974 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -54.66 -38.43 66.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.056 -1.028 . . . . 0.0 109.35 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.33 163.39 9.73 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.538 ' CD2' HD13 ' A' ' 15' ' ' LEU . 8.2 p90 -138.37 173.05 12.02 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.529 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 17.6 p90 -111.85 122.61 48.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.29 -0.881 . . . . 0.0 109.54 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.3 t80 . . . . . 0 N--CA 1.497 1.919 0 O-C-N 121.088 -1.007 . . . . 0.0 108.396 179.38 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.482 0.658 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.49 -33.7 24.61 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.696 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.33 -51.55 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.463 -1.022 . . . . 0.0 110.044 -179.274 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 3.0 t -69.18 -65.1 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 120.485 -1.384 . . . . 0.0 111.525 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' ARG . 78.1 mm-40 -57.55 -49.19 77.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.834 -1.166 . . . . 0.0 110.556 -178.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -47.53 -51.9 19.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.845 -1.159 . . . . 0.0 109.838 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.566 ' SG ' HD21 ' A' ' 54' ' ' LEU . 89.2 m -80.69 -52.02 8.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.26 -0.9 . . . . 0.0 110.09 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.8 t -60.42 -52.06 66.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.805 -1.184 . . . . 0.0 109.827 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.516 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -64.56 -38.09 89.81 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.247 -0.908 . . . . 0.0 110.074 -179.383 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 44' ' ' CYS . 39.4 m -137.3 149.16 46.88 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.144 -0.973 . . . . 0.0 109.552 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.2 mt -68.2 99.31 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.062 -1.024 . . . . 0.0 109.448 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.9 p -81.8 140.92 33.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.396 -0.815 . . . . 0.0 108.956 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.5 m -70.18 159.03 34.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 109.717 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 40.7 mt -52.91 -31.65 41.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.37 -0.832 . . . . 0.0 108.999 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -48.24 -53.78 15.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 109.356 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.517 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 47.0 mt-30 -61.52 -50.62 71.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 109.445 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.566 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.0 mt -56.06 -35.05 66.49 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.126 -0.984 . . . . 0.0 108.605 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -72.61 -9.58 58.77 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -78.5 -22.57 47.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.31 -0.869 . . . . 0.0 111.039 -178.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.517 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.4 m-85 -100.97 -7.03 23.72 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.158 -0.964 . . . . 0.0 110.147 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 96.8 m -62.04 96.34 0.07 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.201 -0.937 . . . . 0.0 109.607 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.33 0 CA-C-O 118.011 -1.438 . . . . 0.0 109.606 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.422 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 62.5 m -129.64 124.97 34.98 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.255 -0.903 . . . . 0.0 109.946 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.5 -138.01 42.71 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.7 m -42.69 -34.89 0.98 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.61 -0.935 . . . . 0.0 110.664 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.422 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 0.8 OUTLIER -58.56 -34.27 70.84 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.896 -1.128 . . . . 0.0 109.006 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.739 HD21 HD12 ' A' ' 40' ' ' ILE . 9.1 tp -72.33 -53.53 12.12 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.524 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 71.2 t -57.05 -58.95 3.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.499 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.9 mt-10 -45.4 -28.81 0.94 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.695 -0.628 . . . . 0.0 109.918 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.62 -61.26 1.77 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.965 . . . . 0.0 109.579 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.512 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.7 mt -46.36 -35.03 5.05 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.21 -0.932 . . . . 0.0 109.409 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -53.19 -40.29 64.3 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.499 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -79.44 -51.01 9.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 108.782 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.403 ' H ' HG23 ' A' ' 18' ' ' VAL . 20.8 t -49.89 -53.14 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.61 0.719 . . . . 0.0 109.187 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.5 m -79.37 -22.15 44.79 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.619 -0.676 . . . . 0.0 110.592 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 51.69 -115.19 3.65 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -84.89 -21.92 29.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.098 -1.237 . . . . 0.0 109.482 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -54.75 -39.07 67.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 109.191 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.6 160.75 7.73 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.524 ' HZ ' HG13 ' A' ' 12' ' ' VAL . 9.9 p90 -138.62 173.52 11.5 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.533 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.1 p90 -112.51 121.64 45.4 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.075 -1.016 . . . . 0.0 110.044 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.7 t80 . . . . . 0 N--CA 1.501 2.086 0 O-C-N 121.235 -0.916 . . . . 0.0 109.262 179.769 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.611 ' CG ' HH21 ' A' ' 38' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.56 0.695 . . . . 0.0 109.659 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.23 -33.61 25.6 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.739 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.55 -51.77 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.208 -1.172 . . . . 0.0 110.332 -178.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.51 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 4.4 t -67.54 -64.06 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.662 -1.274 . . . . 0.0 111.709 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 46' ' ' ARG . 53.8 mt-10 -56.93 -54.81 42.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.832 -1.167 . . . . 0.0 110.861 -178.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.693 HE21 ' NE2' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -44.68 -49.74 10.27 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.704 -1.248 . . . . 0.0 110.327 -178.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.582 ' SG ' HD21 ' A' ' 54' ' ' LEU . 99.5 m -79.63 -50.51 10.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.906 -1.121 . . . . 0.0 110.003 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 47.9 t -61.06 -53.02 62.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.073 -1.017 . . . . 0.0 110.512 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 42' ' ' GLU . 13.0 tpt180 -69.56 -38.44 77.43 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.876 -1.14 . . . . 0.0 109.902 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 44' ' ' CYS . 1.6 m -127.09 144.09 51.12 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.249 -0.907 . . . . 0.0 109.469 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.6 mt -69.14 99.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.059 -1.026 . . . . 0.0 108.901 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.7 p -82.9 141.51 32.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.347 -0.846 . . . . 0.0 109.28 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 m -72.13 163.45 27.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.187 -0.946 . . . . 0.0 109.492 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.7 mt -56.02 -32.34 63.9 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.312 -0.867 . . . . 0.0 109.074 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -47.31 -56.06 7.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.935 . . . . 0.0 109.476 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.693 ' NE2' HE21 ' A' ' 43' ' ' GLN . 24.1 mt-30 -58.91 -51.27 70.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 109.324 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.582 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.0 mt -55.49 -35.02 65.11 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.099 -1.001 . . . . 0.0 108.779 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -72.63 -9.11 58.22 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.584 0.707 . . . . 0.0 109.106 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -79.98 -22.16 42.86 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.369 -0.832 . . . . 0.0 111.081 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.499 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.0 m-85 -99.91 -9.3 22.97 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.105 -0.997 . . . . 0.0 109.98 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 88.9 m -60.02 93.13 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.385 -0.822 . . . . 0.0 109.54 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.253 0 CA-C-O 117.974 -1.459 . . . . 0.0 109.727 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.416 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 61.9 m -128.96 124.68 35.7 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.321 -0.862 . . . . 0.0 109.985 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.45 -137.0 44.89 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.2 m -42.13 -36.11 1.09 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.723 -0.869 . . . . 0.0 110.6 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.416 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 0.8 OUTLIER -58.22 -35.51 71.79 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.897 -1.127 . . . . 0.0 108.789 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.739 HD21 HD12 ' A' ' 40' ' ' ILE . 11.7 tp -71.56 -50.92 26.54 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.1 t -58.94 -59.75 3.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.503 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 24.9 mt-10 -45.17 -30.04 1.08 Allowed 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.862 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.73 -61.05 1.85 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.928 . . . . 0.0 109.74 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.549 HD13 ' CD2' ' A' ' 24' ' ' PHE . 15.3 mt -46.67 -36.6 7.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.064 -1.023 . . . . 0.0 109.704 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -52.1 -40.49 61.33 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 108.946 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.503 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.52 -50.75 11.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.146 -0.972 . . . . 0.0 108.89 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -49.87 -53.15 11.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 121.556 0.693 . . . . 0.0 109.203 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.0 m -79.95 -22.28 42.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.598 -0.689 . . . . 0.0 110.453 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.73 -115.48 4.96 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -85.02 -23.44 28.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.143 -1.21 . . . . 0.0 109.818 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -54.58 -38.29 66.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.115 -0.99 . . . . 0.0 109.222 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.77 163.02 9.95 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.549 ' CD2' HD13 ' A' ' 15' ' ' LEU . 7.8 p90 -138.53 172.17 13.28 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.54 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 14.8 p90 -111.41 120.59 42.67 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.4 t80 . . . . . 0 N--CA 1.492 1.643 0 O-C-N 120.894 -1.129 . . . . 0.0 108.847 -179.649 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.276 0.56 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.28 -40.82 8.87 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.235 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.739 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -99.54 -51.39 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.046 -1.267 . . . . 0.0 110.788 -178.123 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.504 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 8.3 t -66.47 -63.61 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.523 -1.36 . . . . 0.0 111.57 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.528 ' N ' ' OE2' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -55.48 -57.07 13.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.935 -1.103 . . . . 0.0 111.106 -178.238 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.722 HE21 HE22 ' A' ' 53' ' ' GLN . 0.1 OUTLIER -43.87 -48.16 8.35 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.934 -1.104 . . . . 0.0 110.515 -178.383 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.589 ' SG ' HD21 ' A' ' 54' ' ' LEU . 95.7 m -81.53 -50.88 8.86 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.974 -1.078 . . . . 0.0 110.034 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.0 t -61.38 -52.91 62.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.202 -0.936 . . . . 0.0 110.584 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 42' ' ' GLU . 4.7 tpt180 -69.07 -38.48 79.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.915 -1.115 . . . . 0.0 109.781 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 44' ' ' CYS . 13.0 m -128.93 145.98 51.08 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.188 -0.945 . . . . 0.0 109.714 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.0 mt -69.02 99.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.231 -0.918 . . . . 0.0 109.315 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.1 p -84.09 140.56 31.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.281 -0.887 . . . . 0.0 109.208 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.3 m -71.54 161.31 31.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.728 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.2 mt -54.15 -31.55 52.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.177 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -48.98 -55.65 11.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 0.0 109.298 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.722 HE22 HE21 ' A' ' 43' ' ' GLN . 28.0 mt-30 -58.79 -51.04 71.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 109.242 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.589 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.0 mt -55.89 -35.08 66.12 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.134 -0.979 . . . . 0.0 108.559 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -72.63 -9.15 58.26 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.558 0.694 . . . . 0.0 109.181 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -79.7 -22.61 43.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.496 -0.752 . . . . 0.0 110.79 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.473 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.5 m-85 -99.86 -6.83 26.16 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.11 -0.994 . . . . 0.0 110.268 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 82.0 m -62.05 96.13 0.07 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.075 -1.016 . . . . 0.0 109.595 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.495 2.573 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.558 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.497 1.91 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.447 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 60.7 m -129.41 124.98 35.51 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.242 -0.911 . . . . 0.0 110.168 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 61.86 -136.93 46.32 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.1 m -41.64 -34.58 0.62 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.719 -0.871 . . . . 0.0 110.739 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.447 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 0.8 OUTLIER -61.12 -35.36 76.83 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.912 -1.117 . . . . 0.0 108.905 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.702 HD21 HD12 ' A' ' 40' ' ' ILE . 11.1 tp -71.7 -48.68 45.68 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.7 t -59.82 -61.61 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.493 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 42.6 mt-10 -44.02 -30.28 0.71 Allowed 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.371 -0.531 . . . . 0.0 109.968 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.78 -60.76 1.96 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.181 -0.95 . . . . 0.0 109.989 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.539 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.0 mt -47.48 -36.77 10.66 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.975 -1.078 . . . . 0.0 109.465 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -51.15 -40.08 57.76 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.493 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -78.26 -50.92 10.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 108.785 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.406 ' H ' HG23 ' A' ' 18' ' ' VAL . 19.1 t -50.23 -54.36 8.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.585 0.707 . . . . 0.0 109.294 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.2 m -79.38 -22.13 44.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.599 -0.688 . . . . 0.0 110.659 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.45 -116.42 7.0 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -85.29 -25.7 27.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.136 -1.214 . . . . 0.0 110.335 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.412 ' O ' ' O ' ' A' ' 59' ' ' GLY . 61.8 mtt180 -54.44 -36.61 64.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.944 -1.097 . . . . 0.0 109.267 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.11 165.91 16.41 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.58 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.539 ' CD2' HD13 ' A' ' 15' ' ' LEU . 9.3 p90 -139.0 172.89 12.18 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.513 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 10.8 p90 -110.23 126.68 54.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.181 -0.949 . . . . 0.0 109.073 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.3 t80 . . . . . 0 N--CA 1.498 1.96 0 O-C-N 121.033 -1.042 . . . . 0.0 108.96 179.78 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.421 HH21 ' HG3' ' A' ' 38' ' ' ARG . 2.3 ptm180 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.68 -30.42 32.69 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.702 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.11 -50.96 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.506 -0.997 . . . . 0.0 110.065 -179.382 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.504 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 3.2 t -69.36 -65.13 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.536 -1.353 . . . . 0.0 111.388 -178.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' ARG . 77.7 mt-10 -57.93 -48.86 78.66 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.808 -1.183 . . . . 0.0 110.377 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -46.64 -50.27 17.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.847 -1.158 . . . . 0.0 109.969 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.601 ' SG ' HD21 ' A' ' 54' ' ' LEU . 88.5 m -84.04 -52.71 6.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.268 -0.895 . . . . 0.0 110.208 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.6 t -60.98 -45.36 95.08 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.88 -1.137 . . . . 0.0 110.064 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.564 HH21 ' CG ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -71.13 -37.46 72.31 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.976 -1.078 . . . . 0.0 109.722 -179.522 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 44' ' ' CYS . 14.4 m -137.77 153.62 49.68 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.172 -0.955 . . . . 0.0 110.011 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.7 mt -68.96 99.41 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.122 -0.986 . . . . 0.0 109.441 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.5 p -84.23 140.27 31.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -0.926 . . . . 0.0 108.925 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.8 m -71.41 161.15 31.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.184 -0.948 . . . . 0.0 109.837 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.7 mt -54.59 -32.56 58.91 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.328 -0.857 . . . . 0.0 109.183 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -48.15 -52.89 18.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.296 -0.877 . . . . 0.0 109.327 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.529 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 39.7 mt-30 -62.43 -51.27 68.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 109.291 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.601 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.2 mt -56.15 -32.99 64.79 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.064 -1.023 . . . . 0.0 108.667 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -75.12 -8.83 57.66 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.513 0.673 . . . . 0.0 109.191 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -79.96 -21.93 43.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.453 -0.779 . . . . 0.0 110.874 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.529 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.9 m-85 -99.99 -6.35 26.68 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.17 -0.957 . . . . 0.0 110.458 -178.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.3 m -61.18 99.66 0.1 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.081 -1.012 . . . . 0.0 109.542 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.498 1.954 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.412 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 67.7 m -129.58 124.98 35.14 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.29 -0.881 . . . . 0.0 110.378 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.85 -137.27 44.0 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.1 m -42.74 -34.91 1.0 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.612 -0.934 . . . . 0.0 110.55 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.412 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 4.0 t-80 -58.94 -34.12 71.38 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.898 -1.126 . . . . 0.0 108.735 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.726 HD21 HD12 ' A' ' 40' ' ' ILE . 9.2 tp -71.95 -53.54 12.75 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.511 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 69.4 t -57.67 -59.93 2.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.485 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 87.5 mt-10 -43.97 -29.77 0.63 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.808 -0.558 . . . . 0.0 109.985 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.22 -60.95 1.86 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.952 . . . . 0.0 109.468 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.505 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.3 mt -46.43 -36.0 6.11 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.203 -0.936 . . . . 0.0 109.647 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -52.7 -40.03 62.56 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.38 -0.825 . . . . 0.0 108.994 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.485 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.85 -51.55 9.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 108.822 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.2 t -49.76 -53.78 9.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.584 0.707 . . . . 0.0 109.231 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.3 m -78.63 -22.23 47.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.564 -0.71 . . . . 0.0 110.272 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.37 -115.54 4.82 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.571 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 4.0 mp0 -84.88 -23.58 28.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -1.162 . . . . 0.0 109.668 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.576 HH21 ' CG ' ' A' ' 22' ' ' ARG . 4.8 mtt-85 -54.31 -38.71 66.27 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.142 -0.974 . . . . 0.0 109.041 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.58 162.87 9.52 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.514 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 8.1 p90 -138.46 173.3 11.74 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.554 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.3 p90 -110.86 120.13 41.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.179 -0.951 . . . . 0.0 109.882 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.6 t80 . . . . . 0 N--CA 1.499 1.983 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.984 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.417 HH21 ' HG3' ' A' ' 38' ' ' ARG . 1.8 ptm180 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.58 -33.32 31.38 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.726 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.2 -51.71 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.432 -1.04 . . . . 0.0 109.439 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.512 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 3.0 t -68.65 -65.0 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 120.622 -1.299 . . . . 0.0 111.466 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 46' ' ' ARG . 57.5 mm-40 -58.85 -45.8 89.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.864 -1.148 . . . . 0.0 110.354 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.635 ' NE2' HE21 ' A' ' 53' ' ' GLN . 24.6 tt0 -48.91 -52.59 23.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.57 -1.331 . . . . 0.0 109.652 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.576 ' SG ' HD21 ' A' ' 54' ' ' LEU . 91.8 m -79.33 -52.42 8.12 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.259 -0.901 . . . . 0.0 109.82 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.6 t -60.16 -52.23 66.23 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.032 -1.042 . . . . 0.0 109.988 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 42' ' ' GLU . 4.2 tmm_? -68.02 -36.04 79.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.283 -0.886 . . . . 0.0 110.066 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 44' ' ' CYS . 9.2 m -135.23 147.65 49.37 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.052 -1.03 . . . . 0.0 109.576 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.5 mt -68.77 99.56 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.155 -0.966 . . . . 0.0 109.494 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 25.3 p -86.21 138.53 31.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.37 -0.831 . . . . 0.0 109.042 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.4 m -69.53 157.32 37.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 110.0 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.9 mt -51.32 -32.67 26.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.397 -0.815 . . . . 0.0 109.211 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -50.13 -53.62 26.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.374 -0.829 . . . . 0.0 109.125 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.635 HE21 ' NE2' ' A' ' 43' ' ' GLN . 19.8 mt-30 -58.75 -49.17 78.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.89 . . . . 0.0 109.002 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.576 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.2 mt -57.07 -34.16 68.0 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -71.91 -9.41 58.31 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -79.05 -22.78 44.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.408 -0.807 . . . . 0.0 111.086 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.439 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.9 m-85 -101.1 -6.9 23.72 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.093 -1.004 . . . . 0.0 110.183 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 86.6 m -61.64 96.06 0.06 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.56 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.582 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.885 HG22 ' H ' ' A' ' 3' ' ' ASN . 2.1 p -61.98 -113.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.174 -0.954 . . . . 0.0 108.863 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.885 ' H ' HG22 ' A' ' 2' ' ' VAL . 43.3 m-80 -166.13 96.04 0.59 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.891 -1.13 . . . . 0.0 109.072 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.51 ' OE1' ' NE2' ' A' ' 10' ' ' HIS . 3.2 pt20 -161.65 173.3 14.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 109.238 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.614 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 0.0 OUTLIER -77.57 129.97 36.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.343 -0.848 . . . . 0.0 109.422 -179.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp -91.27 116.18 28.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.427 -0.795 . . . . 0.0 109.024 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.428 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 63.5 m -129.29 125.03 35.87 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.267 -0.896 . . . . 0.0 110.309 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.77 -136.72 44.09 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.6 m -42.18 -35.46 0.95 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.691 -0.888 . . . . 0.0 110.624 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.51 ' NE2' ' OE1' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -59.74 -35.34 74.37 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.821 -1.174 . . . . 0.0 108.851 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.727 HD21 HD12 ' A' ' 40' ' ' ILE . 10.5 tp -71.89 -50.1 32.25 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.3 t -59.88 -61.2 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.5 mt-10 -45.06 -29.48 0.88 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.851 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.582 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -85.1 -60.82 1.93 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.157 -0.964 . . . . 0.0 109.715 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.522 HD13 ' CD2' ' A' ' 24' ' ' PHE . 13.5 mt -47.3 -36.97 10.0 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.028 -1.045 . . . . 0.0 109.562 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -50.72 -40.22 53.76 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.496 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -78.54 -50.67 11.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 108.754 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.1 t -50.19 -54.18 9.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-O 121.555 0.693 . . . . 0.0 109.282 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.4 m -78.71 -22.42 46.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.561 -0.712 . . . . 0.0 110.646 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.69 -113.35 3.44 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -85.68 -29.22 24.15 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.191 -1.182 . . . . 0.0 110.842 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -54.35 -36.72 64.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.884 -1.135 . . . . 0.0 109.412 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.53 167.16 17.5 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.249 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.538 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 8.5 p90 -138.1 173.63 11.42 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.536 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 18.8 p90 -109.0 121.09 44.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 110.36 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.444 ' O ' ' C ' ' A' ' 27' ' ' THR . 8.2 t80 -107.78 145.81 33.06 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.444 ' C ' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -37.43 101.48 0.22 Allowed Pre-proline 0 N--CA 1.504 2.241 0 O-C-N 121.653 -0.655 . . . . 0.0 110.157 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -67.47 -26.27 40.75 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 120.883 1.055 . . . . 0.0 110.372 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.545 ' N ' ' CD ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -154.48 -16.8 0.13 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.123 -0.986 . . . . 0.0 108.922 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.477 ' C ' ' N ' ' A' ' 32' ' ' GLU . 18.0 p -70.45 36.41 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.128 -0.983 . . . . 0.0 109.476 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.508 ' H ' ' C ' ' A' ' 29' ' ' ARG . 35.6 mt-10 -51.24 -10.64 0.09 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.146 -0.972 . . . . 0.0 109.277 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.477 ' N ' ' C ' ' A' ' 30' ' ' THR . 42.5 mm-40 -86.52 -25.36 25.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 109.328 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.89 144.5 7.69 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 35' ' ' ARG . 47.7 t -158.82 -137.89 0.05 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.504 -0.998 . . . . 0.0 109.046 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.484 ' HG3' ' H ' ' A' ' 36' ' ' ARG . 17.4 ptt180 -48.44 -56.56 7.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.098 -1.001 . . . . 0.0 109.079 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.574 ' O ' ' N ' ' A' ' 38' ' ' ARG . 37.1 mtt180 -84.63 -142.85 0.08 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.231 -0.918 . . . . 0.0 109.102 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.7 t 56.77 -69.21 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.849 -0.532 . . . . 0.0 110.939 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.574 ' N ' ' O ' ' A' ' 36' ' ' ARG . 17.3 ptt180 -58.21 -12.38 3.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.719 -1.238 . . . . 0.0 108.648 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.52 -35.12 20.84 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.727 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.88 -50.32 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.546 -0.973 . . . . 0.0 109.908 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.501 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.4 t -69.47 -65.04 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.53 -1.356 . . . . 0.0 111.329 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 46' ' ' ARG . 69.5 mm-40 -58.64 -47.04 85.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.795 -1.191 . . . . 0.0 110.475 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.523 ' NE2' HE21 ' A' ' 53' ' ' GLN . 19.2 tt0 -48.75 -50.07 35.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.687 -1.258 . . . . 0.0 109.577 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.587 ' SG ' HD21 ' A' ' 54' ' ' LEU . 84.8 m -81.99 -53.35 6.2 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.165 -0.959 . . . . 0.0 109.851 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.401 ' N ' ' O ' ' A' ' 41' ' ' VAL . 53.2 t -60.04 -50.99 71.55 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.958 -1.089 . . . . 0.0 109.952 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -68.5 -35.74 77.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.082 -1.011 . . . . 0.0 110.049 -179.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 44' ' ' CYS . 58.4 m -136.78 148.4 47.19 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.029 -1.045 . . . . 0.0 109.562 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.3 mt -68.6 99.53 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.989 -1.069 . . . . 0.0 109.573 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.7 p -84.2 139.65 32.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 109.026 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 m -71.78 160.67 32.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 109.815 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.3 mt -54.11 -32.55 55.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.344 -0.847 . . . . 0.0 109.191 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -48.75 -46.28 40.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.891 . . . . 0.0 109.306 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.525 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 21.9 mt-30 -69.57 -49.76 51.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.319 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.587 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.8 mt -56.25 -33.78 65.75 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.152 -0.967 . . . . 0.0 108.598 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.03 -8.88 57.76 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -79.64 -22.11 43.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.512 -0.743 . . . . 0.0 110.933 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.525 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.1 m-85 -99.99 -7.32 25.24 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.089 -1.007 . . . . 0.0 110.321 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 82.4 m -60.9 98.55 0.07 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.293 -0.88 . . . . 0.0 109.64 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.267 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.503 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.712 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.458 ' C ' ' O ' ' A' ' 1' ' ' PHE . 6.7 m 31.41 -117.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 CA-C-O 121.275 0.559 . . . . 0.0 111.169 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.407 ' N ' ' OD1' ' A' ' 3' ' ' ASN . 11.9 p-10 -153.13 114.22 4.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.286 -0.884 . . . . 0.0 109.169 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -157.92 171.71 19.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.219 -0.925 . . . . 0.0 109.599 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.787 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 2.0 p80 -72.61 129.19 37.7 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.344 -0.847 . . . . 0.0 109.636 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.427 HD21 ' CB ' ' A' ' 14' ' ' ALA . 4.3 mp -104.75 116.43 32.02 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.552 -0.718 . . . . 0.0 109.358 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 64.6 m -128.67 125.09 37.32 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.243 -0.91 . . . . 0.0 110.335 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.29 -137.52 45.36 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -42.26 -34.19 0.74 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.587 -0.949 . . . . 0.0 110.575 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.403 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 2.1 t-160 -59.33 -35.74 74.39 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.954 -1.091 . . . . 0.0 108.764 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.735 HD21 HD12 ' A' ' 40' ' ' ILE . 9.4 tp -71.18 -53.09 15.66 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.511 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 66.3 t -57.53 -59.95 2.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.494 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 26.7 mt-10 -44.01 -29.92 0.66 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.715 -0.616 . . . . 0.0 110.039 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.712 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -85.7 -60.92 1.88 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 109.523 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.522 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.2 mt -46.6 -36.2 6.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.14 -0.975 . . . . 0.0 109.641 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -52.22 -42.06 63.25 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.429 -0.794 . . . . 0.0 108.858 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.494 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -76.94 -51.18 11.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 108.873 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -50.17 -54.24 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.646 -0.659 . . . . 0.0 109.249 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.3 m -78.44 -22.32 47.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.54 -0.725 . . . . 0.0 110.371 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 56.71 -118.44 11.84 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -84.95 -23.63 28.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.148 -1.207 . . . . 0.0 110.034 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.4 mtp180 -54.63 -37.4 65.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.985 -1.072 . . . . 0.0 109.124 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.25 163.97 12.7 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 120.071 -1.062 . . . . 0.0 110.869 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 8.7 p90 -138.54 173.1 11.95 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.52 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.4 p90 -110.19 124.38 51.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.092 -1.005 . . . . 0.0 109.39 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.719 ' O ' ' O ' ' A' ' 27' ' ' THR . 10.8 t80 -102.16 105.15 15.8 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.073 -1.017 . . . . 0.0 109.497 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.719 ' O ' ' O ' ' A' ' 26' ' ' TYR . 5.5 t 37.07 143.15 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.607 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.638 ' O ' ' N ' ' A' ' 30' ' ' THR . 9.8 Cg_endo -66.01 116.73 4.15 Favored 'Trans proline' 0 C--O 1.211 -0.855 0 N-CA-C 108.563 -1.36 . . . . 0.0 108.563 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.584 HH21 ' CG ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER 49.65 -79.1 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.761 -0.587 . . . . 0.0 110.641 178.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.638 ' N ' ' O ' ' A' ' 28' ' ' PRO . 15.3 p -141.62 -150.54 0.32 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.107 -0.996 . . . . 0.0 109.374 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.559 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 2.5 mp0 -57.35 -2.39 0.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.155 -0.966 . . . . 0.0 109.325 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' A' ' 30' ' ' THR . 1.4 mm-40 -42.6 -32.65 0.59 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.546 -0.721 . . . . 0.0 109.98 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.76 -173.58 14.49 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.0 t -154.93 -91.48 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -1.143 . . . . 0.0 109.55 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.498 ' HG2' HH21 ' A' ' 35' ' ' ARG . 0.3 OUTLIER -44.04 -56.82 3.73 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.419 -0.801 . . . . 0.0 109.916 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.601 ' O ' ' N ' ' A' ' 38' ' ' ARG . 15.8 mmm180 -63.42 -148.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.092 -1.005 . . . . 0.0 108.902 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.0 t 55.64 -70.7 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.99 -0.444 . . . . 0.0 110.748 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.601 ' N ' ' O ' ' A' ' 36' ' ' ARG . 0.6 OUTLIER -58.24 -14.46 7.24 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.882 -1.136 . . . . 0.0 108.872 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.1 -30.15 35.5 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.735 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.38 -52.73 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.52 -0.988 . . . . 0.0 110.185 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.517 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 5.7 t -69.49 -64.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.528 -1.358 . . . . 0.0 111.595 -178.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 46' ' ' ARG . 54.2 mt-10 -57.25 -54.24 48.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.847 -1.158 . . . . 0.0 110.569 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.617 ' NE2' ' NE2' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -44.65 -50.59 9.75 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.874 -1.141 . . . . 0.0 110.096 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.566 ' SG ' HD21 ' A' ' 54' ' ' LEU . 99.4 m -79.43 -51.28 9.58 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.903 -1.123 . . . . 0.0 110.126 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.2 t -60.36 -53.25 59.81 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.099 -1.0 . . . . 0.0 110.62 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 42' ' ' GLU . 17.8 tpt180 -71.52 -38.53 71.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.87 -1.144 . . . . 0.0 109.9 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 44' ' ' CYS . 2.1 m -124.51 145.09 49.75 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.115 -0.99 . . . . 0.0 109.893 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.2 mt -69.46 99.35 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.004 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.427 ' CB ' HE22 ' A' ' 43' ' ' GLN . 24.8 p -86.37 142.25 28.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.304 -0.872 . . . . 0.0 109.467 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.7 m -72.22 159.82 33.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.722 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.9 mt -54.86 -31.69 59.94 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.35 -0.844 . . . . 0.0 108.849 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -47.49 -54.67 10.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.363 -0.835 . . . . 0.0 109.352 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.617 ' NE2' ' NE2' ' A' ' 43' ' ' GLN . 48.7 mt-30 -60.09 -49.85 76.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.233 -0.917 . . . . 0.0 109.197 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.566 HD21 ' SG ' ' A' ' 44' ' ' CYS . 98.1 mt -55.57 -34.58 64.9 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.161 -0.962 . . . . 0.0 108.688 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.403 ' CD ' ' O ' ' A' ' 55' ' ' GLU . 5.0 tm-20 -73.45 -9.25 58.5 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.677 0.751 . . . . 0.0 109.059 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -79.67 -21.74 44.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.373 -0.829 . . . . 0.0 111.239 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.508 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.3 m-85 -100.17 -6.31 26.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.087 -1.008 . . . . 0.0 110.534 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 71.4 m -60.9 98.72 0.07 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.17 -0.956 . . . . 0.0 109.695 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.314 0 CA-C-O 117.94 -1.478 . . . . 0.0 109.583 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.609 ' CD1' ' N ' ' A' ' 1' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.466 ' H ' HG22 ' A' ' 2' ' ' VAL . 3.0 m -58.93 -169.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.414 -0.804 . . . . 0.0 110.092 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -92.2 117.31 29.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.701 -0.624 . . . . 0.0 109.322 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -162.24 166.74 25.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.203 -0.935 . . . . 0.0 109.414 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.739 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 0.0 OUTLIER -84.37 118.67 24.38 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.224 -0.922 . . . . 0.0 108.946 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp -86.51 116.7 24.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.498 -0.751 . . . . 0.0 109.171 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.43 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 58.9 m -129.75 124.85 34.47 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.289 -0.882 . . . . 0.0 110.2 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 61.43 -136.54 47.45 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -41.93 -34.04 0.63 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.693 -0.886 . . . . 0.0 110.767 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.43 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 1.7 t-80 -62.06 -34.69 76.74 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.757 -1.214 . . . . 0.0 108.808 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.74 HD21 HD12 ' A' ' 40' ' ' ILE . 11.3 tp -71.7 -49.08 42.78 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.7 t -59.28 -61.46 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.497 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 25.1 mt-10 -44.31 -29.64 0.7 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.346 -0.541 . . . . 0.0 109.949 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.547 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -85.35 -61.23 1.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.164 -0.96 . . . . 0.0 109.74 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.545 HD13 ' CD2' ' A' ' 24' ' ' PHE . 15.0 mt -46.68 -36.91 7.61 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.123 -0.986 . . . . 0.0 109.613 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -51.11 -41.34 59.95 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.404 -0.81 . . . . 0.0 108.871 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.497 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -77.51 -50.91 11.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.93 . . . . 0.0 108.847 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.404 ' H ' HG23 ' A' ' 18' ' ' VAL . 19.2 t -50.18 -54.41 8.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.57 0.7 . . . . 0.0 109.142 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.3 m -79.39 -20.83 46.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.595 -0.69 . . . . 0.0 110.328 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.42 -117.11 6.56 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -84.73 -22.22 29.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.152 -1.205 . . . . 0.0 109.622 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.596 HH21 ' CG ' ' A' ' 22' ' ' ARG . 3.2 mtt-85 -54.59 -38.14 66.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.19 -0.944 . . . . 0.0 109.157 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.95 162.05 9.31 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.078 -1.058 . . . . 0.0 110.501 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.545 ' CD2' HD13 ' A' ' 15' ' ' LEU . 8.0 p90 -137.97 172.57 12.74 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.527 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.1 p90 -111.02 121.76 46.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.33 -0.856 . . . . 0.0 108.977 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -86.93 156.63 19.74 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.972 -1.08 . . . . 0.0 108.962 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.0 t -50.49 143.36 13.93 Favored Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.278 -0.889 . . . . 0.0 108.929 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.651 ' O ' ' N ' ' A' ' 30' ' ' THR . 10.3 Cg_endo -65.54 104.56 0.66 Allowed 'Trans proline' 0 C--N 1.321 -0.896 0 N-CA-C 108.915 -1.225 . . . . 0.0 108.915 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.411 ' HG2' HH21 ' A' ' 29' ' ' ARG . 0.5 OUTLIER 48.07 -80.13 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.545 178.277 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.651 ' N ' ' O ' ' A' ' 28' ' ' PRO . 18.7 p -144.07 -71.73 0.29 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.038 -1.038 . . . . 0.0 109.145 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.532 ' N ' ' OG1' ' A' ' 30' ' ' THR . 11.8 mm-40 44.59 36.07 1.61 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.34 -0.85 . . . . 0.0 110.059 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -53.02 -26.07 14.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.134 -0.979 . . . . 0.0 109.441 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.56 -44.05 37.07 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.437 ' OG ' ' N ' ' A' ' 35' ' ' ARG . 45.5 t -86.51 -162.04 0.72 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.369 -1.077 . . . . 0.0 109.605 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 37' ' ' SER . 5.7 ptp180 -99.1 -111.83 0.17 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.414 -0.804 . . . . 0.0 109.309 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 39' ' ' GLY . 27.3 mmt180 51.16 -84.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.55 -0.719 . . . . 0.0 110.903 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -41.63 -58.14 2.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.668 -0.645 . . . . 0.0 111.321 -178.475 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -58.9 -13.4 6.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.813 -1.179 . . . . 0.0 109.806 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 36' ' ' ARG . . . -82.48 -40.39 9.99 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.74 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.43 -51.15 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.316 -1.108 . . . . 0.0 110.291 -178.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.509 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.9 t -66.41 -64.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 120.627 -1.296 . . . . 0.0 111.775 -178.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 46' ' ' ARG . 81.9 mt-10 -56.06 -54.14 48.51 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.904 -1.122 . . . . 0.0 111.209 -178.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.72 HE21 HE22 ' A' ' 53' ' ' GLN . 0.0 OUTLIER -45.7 -48.68 15.09 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.849 -1.157 . . . . 0.0 110.141 -178.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.609 ' SG ' HD21 ' A' ' 54' ' ' LEU . 85.2 m -82.3 -53.58 5.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.062 -1.024 . . . . 0.0 110.042 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.2 t -60.61 -51.91 67.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.999 -1.063 . . . . 0.0 109.987 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 42' ' ' GLU . 3.7 tmt_? -67.04 -36.62 82.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.186 -0.946 . . . . 0.0 110.025 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 44' ' ' CYS . 68.4 m -136.46 148.17 47.57 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.168 -0.958 . . . . 0.0 109.398 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.6 mt -68.46 99.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.12 -0.988 . . . . 0.0 109.512 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.4 p -83.14 140.48 32.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.407 -0.808 . . . . 0.0 109.217 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 m -70.61 160.96 31.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.208 -0.932 . . . . 0.0 109.527 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.407 ' CD2' ' CZ ' ' A' ' 1' ' ' PHE . 36.9 mt -55.48 -31.32 61.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.233 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -49.51 -51.97 32.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 109.216 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.72 HE22 HE21 ' A' ' 43' ' ' GLN . 18.3 mt-30 -62.32 -50.28 72.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.209 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.609 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.3 mt -56.68 -33.18 66.16 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.101 -0.999 . . . . 0.0 108.462 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -74.25 -8.96 58.03 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -79.99 -21.97 43.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.44 -0.787 . . . . 0.0 110.932 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.466 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 8.0 m-85 -99.46 -7.18 26.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.069 -1.019 . . . . 0.0 110.514 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.4 m -60.73 99.14 0.08 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.188 -0.945 . . . . 0.0 109.6 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.271 0 CA-C-O 118.022 -1.432 . . . . 0.0 109.562 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.459 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t -82.53 -132.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.054 -1.029 . . . . 0.0 108.459 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -132.01 55.55 1.87 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -118.5 172.44 7.47 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -87.03 139.62 30.39 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.355 -0.84 . . . . 0.0 109.772 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.412 HD21 ' CB ' ' A' ' 14' ' ' ALA . 5.5 mp -95.0 116.33 28.56 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.507 -0.746 . . . . 0.0 109.222 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.417 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 81.4 m -130.29 125.29 34.38 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.22 -0.925 . . . . 0.0 110.633 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 61.56 -136.5 47.15 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.424 ' O ' ' OE2' ' A' ' 13' ' ' GLU . 57.4 m -43.66 -28.74 0.43 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.518 -0.989 . . . . 0.0 110.548 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.417 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 1.7 t-160 -66.61 -32.13 73.27 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.815 -1.178 . . . . 0.0 108.814 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.698 HD21 HD12 ' A' ' 40' ' ' ILE . 9.7 tp -72.48 -51.58 19.5 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.507 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 70.4 t -58.0 -60.42 2.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.485 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.6 mt-10 -43.77 -29.24 0.5 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.748 -0.595 . . . . 0.0 110.106 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.459 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -86.2 -59.94 2.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.648 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.53 HD13 ' CD2' ' A' ' 24' ' ' PHE . 13.6 mt -46.94 -37.22 8.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.125 -0.984 . . . . 0.0 109.488 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -50.86 -42.02 58.51 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.485 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -76.88 -50.04 14.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 108.786 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.2 t -50.36 -55.08 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.648 0.737 . . . . 0.0 109.039 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.0 m -78.87 -22.32 46.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.559 -0.713 . . . . 0.0 110.426 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.84 -116.05 6.74 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.56 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 2.6 mp0 -85.21 -23.91 28.08 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.191 -1.182 . . . . 0.0 110.062 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.57 HH21 ' CG ' ' A' ' 22' ' ' ARG . 4.7 mtt-85 -54.78 -37.55 66.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.098 -1.001 . . . . 0.0 109.356 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.13 164.14 12.46 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.962 -1.114 . . . . 0.0 110.329 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.53 ' CD2' HD13 ' A' ' 15' ' ' LEU . 7.3 p90 -138.42 172.75 12.43 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.53 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.7 p90 -111.1 122.56 48.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 109.253 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -90.67 169.01 11.35 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.908 -1.12 . . . . 0.0 108.662 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.9 t -69.44 144.45 94.48 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.092 -1.005 . . . . 0.0 109.055 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.79 -83.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.324 -0.724 0 C-N-CA 121.081 1.187 . . . . 0.0 109.579 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.501 ' O ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -164.93 10.08 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.338 -0.851 . . . . 0.0 109.112 -179.321 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 47.1 p -60.49 80.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 109.608 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 29' ' ' ARG . 36.0 mt-10 -58.78 -10.63 2.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -0.878 . . . . 0.0 109.301 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -77.9 -26.23 49.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -0.862 . . . . 0.0 109.404 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.04 160.89 35.69 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.8 t -155.16 -97.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.284 -1.127 . . . . 0.0 109.079 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.422 ' HG3' ' H ' ' A' ' 36' ' ' ARG . 11.4 ptt180 -133.54 -55.03 0.89 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.39 -0.819 . . . . 0.0 109.094 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -60.36 -62.87 1.54 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 109.621 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 t -42.41 -66.52 0.35 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.888 -0.508 . . . . 0.0 110.183 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.438 HH21 ' HG3' ' A' ' 38' ' ' ARG . 4.2 ptm180 -59.5 -14.4 12.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.984 -1.072 . . . . 0.0 108.675 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 36' ' ' ARG . . . -82.64 -34.0 23.41 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.951 -1.659 . . . . 0.0 108.951 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.698 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.64 -52.49 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.441 -1.035 . . . . 0.0 110.096 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 3.2 t -67.85 -64.03 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 120.663 -1.273 . . . . 0.0 111.813 -178.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' ARG . 67.2 mm-40 -57.34 -54.85 42.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.824 -1.172 . . . . 0.0 111.339 -177.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.591 ' CD ' HE22 ' A' ' 53' ' ' GLN . 0.0 OUTLIER -45.76 -45.86 14.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.553 -1.342 . . . . 0.0 110.012 -178.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.646 ' SG ' HD21 ' A' ' 54' ' ' LEU . 95.1 m -84.44 -53.2 5.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.964 -1.085 . . . . 0.0 110.103 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.7 t -63.05 -44.51 95.65 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.984 -1.072 . . . . 0.0 110.332 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 42' ' ' GLU . 3.5 tmt_? -72.21 -36.37 69.15 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.793 -1.192 . . . . 0.0 109.605 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 44' ' ' CYS . 69.5 m -138.03 153.1 49.4 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.203 -0.935 . . . . 0.0 109.946 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.0 mt -68.97 99.15 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 108.857 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.6 p -83.39 148.46 27.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 109.313 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.8 m -78.76 162.61 26.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.261 -0.9 . . . . 0.0 110.063 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.8 mt -57.13 -33.18 67.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.557 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -48.95 -45.42 41.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.184 -0.948 . . . . 0.0 109.163 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.591 HE22 ' CD ' ' A' ' 43' ' ' GLN . 21.5 mt-30 -69.34 -52.76 24.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.369 -0.832 . . . . 0.0 109.191 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.646 HD21 ' SG ' ' A' ' 44' ' ' CYS . 99.2 mt -55.86 -32.47 63.67 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.029 -1.044 . . . . 0.0 108.654 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -76.08 -9.04 58.3 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.595 0.712 . . . . 0.0 109.225 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -79.85 -21.82 43.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.419 -0.801 . . . . 0.0 110.836 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.531 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.6 m-85 -99.27 -6.91 27.18 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.172 -0.955 . . . . 0.0 110.487 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 71.2 m -60.63 100.96 0.12 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.136 -0.978 . . . . 0.0 109.624 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.299 0 CA-C-O 118.048 -1.418 . . . . 0.0 109.581 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.552 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 1' ' ' PHE . 2.6 m -54.83 -168.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.393 -0.817 . . . . 0.0 109.723 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.427 ' O ' ' OD1' ' A' ' 3' ' ' ASN . 6.4 p30 -117.51 95.82 5.12 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.749 -0.594 . . . . 0.0 109.445 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.529 ' OE1' ' NE2' ' A' ' 10' ' ' HIS . 5.1 pt20 -147.81 177.21 9.51 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.087 -1.008 . . . . 0.0 109.422 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -79.49 125.35 29.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.283 -0.886 . . . . 0.0 110.099 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.401 HD21 ' CB ' ' A' ' 14' ' ' ALA . 4.3 mp -91.58 116.82 29.18 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.499 -0.75 . . . . 0.0 109.062 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.4 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 82.3 m -129.3 125.2 36.23 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.21 -0.931 . . . . 0.0 110.648 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.74 -137.26 44.25 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 m -42.83 -32.24 0.59 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.599 -0.942 . . . . 0.0 110.576 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.529 ' NE2' ' OE1' ' A' ' 4' ' ' GLN . 4.2 t-80 -61.83 -34.23 75.58 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.852 -1.155 . . . . 0.0 108.877 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.747 HD21 HD12 ' A' ' 40' ' ' ILE . 10.0 tp -71.76 -52.24 18.65 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.517 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 73.0 t -58.52 -60.06 2.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.5 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 51.5 mt-10 -44.5 -28.98 0.64 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.726 -0.609 . . . . 0.0 109.97 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.552 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -86.15 -61.14 1.82 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.599 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.514 HD13 ' CD2' ' A' ' 24' ' ' PHE . 13.8 mt -46.47 -36.93 7.12 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.167 -0.958 . . . . 0.0 109.581 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -51.13 -40.82 59.39 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.5 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.1 -50.9 11.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -0.869 . . . . 0.0 108.808 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 18' ' ' VAL . 18.1 t -50.26 -54.8 7.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.543 0.687 . . . . 0.0 109.317 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.8 m -77.47 -22.22 51.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.57 -0.707 . . . . 0.0 110.634 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.88 -115.65 5.79 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -85.23 -24.16 27.93 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.194 -1.18 . . . . 0.0 110.077 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.598 HH21 ' CG ' ' A' ' 22' ' ' ARG . 3.4 mtt-85 -54.43 -37.99 65.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.046 -1.034 . . . . 0.0 109.367 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.53 164.02 10.88 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.523 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 7.9 p90 -138.2 172.71 12.51 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.543 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 17.0 p90 -109.11 122.01 46.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -0.925 . . . . 0.0 109.554 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -101.62 169.34 8.9 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.208 -0.933 . . . . 0.0 108.863 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 t -75.57 146.54 80.63 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.067 -1.02 . . . . 0.0 108.752 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -67.0 -61.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.323 -0.769 0 N-CA-C 109.106 -1.151 . . . . 0.0 109.106 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.427 ' O ' ' OG1' ' A' ' 30' ' ' THR . 0.0 OUTLIER -155.57 12.71 0.34 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.919 -1.113 . . . . 0.0 109.14 178.578 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.482 ' C ' ' H ' ' A' ' 32' ' ' GLU . 10.7 p 57.58 -150.61 0.44 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.693 -0.629 . . . . 0.0 109.763 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 52.6 10.2 0.13 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.482 ' H ' ' C ' ' A' ' 30' ' ' THR . 39.6 mt-10 -64.71 -24.24 67.51 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.481 -0.762 . . . . 0.0 109.283 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.95 -36.95 3.59 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.8 t -64.13 -138.61 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.427 -1.043 . . . . 0.0 109.235 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 36' ' ' ARG . 19.8 ptt180 -125.49 -111.12 0.3 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.539 -0.726 . . . . 0.0 109.169 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 38' ' ' ARG . 19.5 mmt180 46.38 -170.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.4 -0.813 . . . . 0.0 109.732 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.1 t 59.77 -60.84 0.06 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 122.111 -0.368 . . . . 0.0 111.255 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 36' ' ' ARG . 26.0 ptt180 -58.33 -9.52 1.58 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.484 -1.385 . . . . 0.0 109.037 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.78 -36.87 14.59 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.747 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.58 -50.21 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.547 -0.972 . . . . 0.0 109.928 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.494 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.5 t -67.58 -65.09 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.61 -1.306 . . . . 0.0 111.455 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 46' ' ' ARG . 13.9 mm-40 -57.58 -48.84 78.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.847 -1.158 . . . . 0.0 110.426 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.47 ' CD ' ' NE2' ' A' ' 53' ' ' GLN . 23.0 tt0 -46.83 -49.41 20.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.776 -1.202 . . . . 0.0 109.86 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.616 ' SG ' HD21 ' A' ' 54' ' ' LEU . 94.9 m -84.58 -53.5 5.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 110.172 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.416 ' N ' ' O ' ' A' ' 41' ' ' VAL . 54.1 t -60.93 -46.17 91.76 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.929 -1.107 . . . . 0.0 110.008 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.52 HH21 ' CG ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -69.87 -38.38 76.37 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.876 -1.14 . . . . 0.0 109.576 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.483 ' O ' ' O ' ' A' ' 44' ' ' CYS . 13.9 m -138.08 153.19 49.31 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.151 -0.968 . . . . 0.0 109.72 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.2 mt -68.6 99.68 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.109 -0.995 . . . . 0.0 109.837 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.7 p -83.34 140.56 32.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 108.918 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.2 m -70.36 157.51 37.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.182 -0.949 . . . . 0.0 109.885 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 48.2 mt -53.54 -33.28 54.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.41 -0.806 . . . . 0.0 109.247 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -50.07 -49.03 52.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 108.968 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.519 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 37.3 mt-30 -63.52 -50.33 70.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.853 . . . . 0.0 108.932 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.616 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.3 mt -56.78 -32.8 66.01 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.178 -0.951 . . . . 0.0 108.455 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -74.71 -8.85 57.67 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -80.35 -22.21 41.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.523 -0.735 . . . . 0.0 110.961 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.519 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.4 m-85 -98.87 -7.46 27.25 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.066 -1.021 . . . . 0.0 110.332 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 73.4 m -60.51 99.19 0.08 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.249 -0.907 . . . . 0.0 109.813 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.327 0 CA-C-O 118.002 -1.443 . . . . 0.0 109.517 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.701 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 4' ' ' GLN . 2.3 m -144.69 -109.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -70.04 67.83 0.3 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.325 -0.859 . . . . 0.0 109.458 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.48 ' OE1' ' NE2' ' A' ' 10' ' ' HIS . 11.6 pt20 -152.64 140.76 20.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.16 -0.962 . . . . 0.0 109.566 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.803 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 1.6 p80 -66.29 153.98 41.18 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.393 -0.817 . . . . 0.0 109.395 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 5' ' ' HIS . 5.5 mp -121.07 117.24 26.71 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.437 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 58.6 m -128.64 125.03 37.26 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.346 -0.846 . . . . 0.0 110.331 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 60.59 -135.21 49.65 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.2 m -42.77 -35.14 1.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.619 -0.93 . . . . 0.0 110.645 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.48 ' NE2' ' OE1' ' A' ' 4' ' ' GLN . 2.6 t-80 -60.54 -34.04 73.55 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.906 -1.121 . . . . 0.0 108.646 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.711 HD21 HD12 ' A' ' 40' ' ' ILE . 13.4 tp -73.67 -49.1 27.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 t -59.64 -61.85 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.503 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.5 mt-10 -44.8 -29.1 0.73 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.022 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.701 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -85.31 -60.18 2.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.066 -1.021 . . . . 0.0 109.723 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.558 HD13 ' CD2' ' A' ' 24' ' ' PHE . 13.9 mt -48.1 -37.09 14.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.935 -1.103 . . . . 0.0 109.441 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -50.62 -40.48 53.09 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.503 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -78.42 -51.51 9.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.933 . . . . 0.0 108.815 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 t -50.03 -53.99 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-O 121.531 0.681 . . . . 0.0 109.202 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.4 m -78.92 -21.98 46.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.594 -0.691 . . . . 0.0 110.205 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.23 -115.44 5.19 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.649 -1.781 . . . . 0.0 108.649 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -85.32 -23.64 28.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.161 -1.199 . . . . 0.0 109.964 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 59' ' ' GLY . 89.2 mtt180 -54.62 -37.89 66.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.976 -1.077 . . . . 0.0 109.175 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.83 164.35 11.91 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.558 ' CD2' HD13 ' A' ' 15' ' ' LEU . 9.7 p90 -139.75 173.07 11.9 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.511 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 17.4 p90 -111.04 125.41 53.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.243 -0.911 . . . . 0.0 109.343 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -91.78 159.47 15.8 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.038 -1.038 . . . . 0.0 109.094 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.526 ' C ' ' H ' ' A' ' 29' ' ' ARG . 6.2 t -44.16 146.58 1.1 Allowed Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.367 -0.833 . . . . 0.0 109.698 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.597 ' C ' ' H ' ' A' ' 30' ' ' THR . 8.8 Cg_endo -68.88 21.29 0.15 Allowed 'Trans proline' 0 N--CA 1.481 0.785 0 C-N-CA 121.598 1.532 . . . . 0.0 110.225 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.526 ' H ' ' C ' ' A' ' 27' ' ' THR . 14.7 mmm180 64.09 -17.96 0.07 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.395 -0.816 . . . . 0.0 110.359 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.597 ' H ' ' C ' ' A' ' 28' ' ' PRO . 17.3 p -49.48 99.68 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.176 -0.952 . . . . 0.0 109.345 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -65.1 -8.68 17.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.881 . . . . 0.0 109.681 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -64.83 -26.74 68.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 109.568 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.33 156.96 16.68 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.1 t -155.3 -130.42 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -1.158 . . . . 0.0 109.281 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.477 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 7.8 ptm180 -98.71 -56.82 2.34 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.287 -0.883 . . . . 0.0 109.216 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.579 ' O ' ' N ' ' A' ' 38' ' ' ARG . 18.0 mtm-85 -70.65 -144.22 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.225 -0.922 . . . . 0.0 109.49 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.5 t 57.16 -69.7 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.895 -0.503 . . . . 0.0 110.639 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.594 ' CG ' HH21 ' A' ' 38' ' ' ARG . 0.0 OUTLIER -58.29 -16.18 13.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.825 -1.172 . . . . 0.0 108.677 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.32 -26.66 46.9 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.711 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -102.01 -53.9 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.435 -1.038 . . . . 0.0 110.337 -179.577 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.52 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 8.6 t -71.32 -65.17 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.554 -1.341 . . . . 0.0 111.271 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 46' ' ' ARG . 67.9 mt-10 -57.09 -50.65 72.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.921 -1.112 . . . . 0.0 110.369 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.742 HE21 HE22 ' A' ' 53' ' ' GLN . 0.4 OUTLIER -48.46 -53.55 17.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.735 -1.228 . . . . 0.0 109.8 -179.504 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.515 ' SG ' HD21 ' A' ' 54' ' ' LEU . 97.6 m -75.7 -52.14 11.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.009 -1.057 . . . . 0.0 110.077 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.4 t -60.61 -52.77 63.72 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.913 -1.117 . . . . 0.0 110.229 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 42' ' ' GLU . 1.9 tmm_? -66.27 -36.49 83.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 0.0 110.027 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 44' ' ' CYS . 15.6 m -135.17 145.17 47.49 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.244 -0.91 . . . . 0.0 109.15 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.7 mt -68.24 99.6 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.134 -0.979 . . . . 0.0 109.472 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.4 p -82.98 141.91 31.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.44 -0.788 . . . . 0.0 109.333 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.7 m -70.19 157.04 38.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.701 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 43.8 mt -52.13 -32.36 35.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.374 -0.829 . . . . 0.0 108.978 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -48.43 -55.48 10.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.835 . . . . 0.0 109.314 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.742 HE22 HE21 ' A' ' 43' ' ' GLN . 22.4 mt-30 -57.79 -50.14 74.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.892 . . . . 0.0 109.188 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.515 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.0 mt -55.63 -35.48 65.94 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.115 -0.991 . . . . 0.0 108.675 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -72.41 -8.92 57.54 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.462 0.648 . . . . 0.0 109.322 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -80.04 -21.45 43.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.502 -0.749 . . . . 0.0 111.035 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.527 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.6 m-85 -100.76 -7.15 24.0 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.157 -0.965 . . . . 0.0 110.458 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 77.0 m -60.46 97.59 0.05 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.719 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.837 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 1' ' ' PHE . 3.6 m -53.62 -169.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.443 -0.786 . . . . 0.0 110.406 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -70.99 89.21 0.78 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.641 -0.662 . . . . 0.0 109.416 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -149.12 165.58 31.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.297 -0.877 . . . . 0.0 109.143 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.705 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 0.0 OUTLIER -84.79 125.47 32.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.287 -0.883 . . . . 0.0 109.227 -179.52 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.42 HD21 ' CB ' ' A' ' 14' ' ' ALA . 5.6 mp -84.15 116.33 22.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.422 -0.799 . . . . 0.0 108.903 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.444 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 64.1 m -128.54 125.09 37.61 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.272 -0.893 . . . . 0.0 110.675 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 60.34 -136.16 49.6 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.8 m -42.17 -33.97 0.68 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.752 -0.852 . . . . 0.0 110.624 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.444 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 1.0 OUTLIER -61.68 -34.99 76.71 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.841 -1.162 . . . . 0.0 108.83 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.697 HD21 HD12 ' A' ' 40' ' ' ILE . 12.1 tp -71.26 -49.74 40.02 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.5 t -58.6 -59.8 3.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.5 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 74.2 mt-10 -45.38 -30.15 1.26 Allowed 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.304 -0.559 . . . . 0.0 109.909 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.837 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -85.13 -60.87 1.91 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.152 -0.968 . . . . 0.0 109.694 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.568 HD13 ' CD2' ' A' ' 24' ' ' PHE . 15.6 mt -47.27 -36.33 8.99 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.004 -1.06 . . . . 0.0 109.64 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.86 -40.94 61.42 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.429 -0.795 . . . . 0.0 108.857 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.5 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -77.98 -51.71 9.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.164 -0.96 . . . . 0.0 108.871 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.3 t -49.91 -53.76 9.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.7 m -80.39 -22.32 41.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.617 -0.677 . . . . 0.0 110.297 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.84 -116.31 5.32 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.532 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 24.7 mp0 -84.48 -22.02 30.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -1.192 . . . . 0.0 109.699 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -54.96 -37.82 66.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.163 -0.961 . . . . 0.0 109.126 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.1 161.22 8.79 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.568 ' CD2' HD13 ' A' ' 15' ' ' LEU . 9.1 p90 -138.31 173.31 11.74 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.531 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 6.9 p90 -108.94 123.57 49.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.134 -0.979 . . . . 0.0 109.889 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -100.98 161.82 13.33 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.6 t -50.08 144.69 10.59 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.854 -1.154 . . . . 0.0 108.385 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -55.13 -86.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 120.815 1.01 . . . . 0.0 109.97 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.46 23.95 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.241 -0.912 . . . . 0.0 109.211 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.9 p -81.15 107.28 13.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.404 -0.81 . . . . 0.0 110.096 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -89.26 -15.47 33.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.354 -0.842 . . . . 0.0 108.913 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -69.15 -33.25 73.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.374 -0.829 . . . . 0.0 109.095 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.61 147.61 9.96 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 35' ' ' ARG . 38.7 t -101.28 -167.51 1.43 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.382 -1.069 . . . . 0.0 109.901 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.425 ' HG3' ' H ' ' A' ' 36' ' ' ARG . 21.7 ptt180 -148.3 -117.53 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 38' ' ' ARG . 5.4 mtt-85 -52.14 -44.55 64.6 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.493 -0.755 . . . . 0.0 110.143 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 36' ' ' ARG . 0.7 OUTLIER -26.49 -35.19 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.518 -178.325 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.599 ' CG ' HH21 ' A' ' 38' ' ' ARG . 0.1 OUTLIER -58.27 -15.86 11.83 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.673 -1.267 . . . . 0.0 109.081 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.01 -31.77 22.45 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.697 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.4 -53.84 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.418 -1.048 . . . . 0.0 110.712 -178.425 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.521 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 4.3 t -69.65 -64.09 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 120.392 -1.443 . . . . 0.0 111.012 -178.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -56.16 -51.15 69.01 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.176 -0.952 . . . . 0.0 110.287 -178.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.534 ' NE2' ' OE1' ' A' ' 53' ' ' GLN . 40.9 tt0 -48.77 -53.96 16.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.633 -1.292 . . . . 0.0 110.063 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.538 ' SG ' HD21 ' A' ' 54' ' ' LEU . 87.3 m -74.83 -52.81 10.41 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.133 -0.98 . . . . 0.0 109.89 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 54.1 t -60.36 -52.47 65.13 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.062 -1.024 . . . . 0.0 110.341 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 42' ' ' GLU . 2.6 tmm_? -69.15 -34.59 75.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.926 -1.109 . . . . 0.0 110.185 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 44' ' ' CYS . 51.3 m -135.24 146.13 48.31 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.09 -1.006 . . . . 0.0 109.323 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.1 mt -68.66 99.64 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.0 -1.063 . . . . 0.0 109.706 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.5 p -83.77 138.41 33.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.319 -0.863 . . . . 0.0 109.09 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.4 m -69.61 160.2 32.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.264 -0.897 . . . . 0.0 110.162 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.0 mt -53.72 -32.86 53.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.504 -0.748 . . . . 0.0 109.133 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -49.71 -49.58 47.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 108.97 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.534 ' OE1' ' NE2' ' A' ' 43' ' ' GLN . 61.7 mt-30 -63.12 -52.53 62.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.358 -0.839 . . . . 0.0 109.095 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.538 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.5 mt -54.92 -35.32 64.06 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.292 -0.88 . . . . 0.0 108.718 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -73.13 -8.87 57.69 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.524 0.678 . . . . 0.0 109.303 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -80.16 -21.68 42.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.437 -0.789 . . . . 0.0 110.926 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.511 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.0 m-85 -100.38 -6.33 25.91 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.172 -0.955 . . . . 0.0 110.474 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.4 m -61.19 97.32 0.06 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.114 -0.991 . . . . 0.0 109.507 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.268 0 CA-C-O 117.993 -1.449 . . . . 0.0 109.517 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 1' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.44 ' H ' HG22 ' A' ' 2' ' ' VAL . 2.7 m -54.89 -169.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.313 -0.867 . . . . 0.0 109.686 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 3' ' ' ASN . 0.8 OUTLIER -86.9 131.29 34.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.577 -0.702 . . . . 0.0 109.236 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -171.06 164.75 7.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.506 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.769 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 0.4 OUTLIER -79.02 126.44 30.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.326 -0.859 . . . . 0.0 109.152 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.407 HD21 ' CB ' ' A' ' 14' ' ' ALA . 4.6 mp -100.26 117.11 33.8 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.521 -0.737 . . . . 0.0 109.421 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.419 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 68.9 m -129.39 125.06 35.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.255 -0.903 . . . . 0.0 110.377 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.99 -137.78 43.89 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.0 m -42.68 -34.87 0.97 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.648 -0.913 . . . . 0.0 110.412 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.419 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 2.1 t-160 -58.1 -35.66 71.75 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.94 -1.1 . . . . 0.0 108.56 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.726 HD21 HD12 ' A' ' 40' ' ' ILE . 11.0 tp -71.5 -52.49 18.04 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.523 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 75.2 t -58.87 -58.95 4.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.493 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 30.2 mt-10 -44.85 -28.75 0.69 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.74 -0.6 . . . . 0.0 109.909 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.603 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -86.8 -61.31 1.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -0.962 . . . . 0.0 109.52 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.553 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.5 mt -46.23 -36.58 6.24 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.171 -0.956 . . . . 0.0 109.713 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -51.97 -41.12 61.87 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.387 -0.821 . . . . 0.0 108.807 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.493 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -77.77 -50.95 11.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 0.0 108.863 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.5 t -50.16 -54.66 7.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.2 m -78.61 -22.01 47.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.601 -0.687 . . . . 0.0 110.258 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.92 -116.74 6.44 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.544 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 5.1 mp0 -84.77 -21.65 29.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.072 -1.252 . . . . 0.0 109.676 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -54.94 -38.1 67.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.163 -0.961 . . . . 0.0 109.286 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.14 162.11 9.8 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.553 ' CD2' HD13 ' A' ' 15' ' ' LEU . 8.0 p90 -139.26 172.42 12.85 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.519 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 19.3 p90 -109.1 123.45 49.2 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.451 ' CD2' HG22 ' A' ' 27' ' ' THR . 9.4 t80 -90.44 162.12 15.23 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.939 -1.101 . . . . 0.0 109.839 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.451 HG22 ' CD2' ' A' ' 26' ' ' TYR . 8.2 t -41.82 147.2 0.54 Allowed Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.865 -0.522 . . . . 0.0 109.663 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.57 ' C ' ' H ' ' A' ' 30' ' ' THR . 10.0 Cg_exo -46.71 130.47 15.31 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 N-CA-C 109.284 -1.083 . . . . 0.0 109.284 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.582 ' H ' ' HD2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -68.43 18.79 0.03 OUTLIER 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.307 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.57 ' H ' ' C ' ' A' ' 28' ' ' PRO . 26.2 p -104.67 -16.8 14.87 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 50.51 17.19 0.35 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.39 -0.819 . . . . 0.0 109.696 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -75.36 -42.34 54.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.222 -0.924 . . . . 0.0 109.391 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.69 149.55 5.02 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.45 ' OG ' ' N ' ' A' ' 35' ' ' ARG . 44.0 t -160.62 -136.26 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.372 -1.075 . . . . 0.0 109.708 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.53 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 2.1 ptp180 -141.81 -51.69 0.42 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.32 -0.863 . . . . 0.0 109.094 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.578 ' CB ' HH21 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -59.31 -49.09 79.16 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.242 -0.911 . . . . 0.0 109.674 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.9 t -37.67 -65.41 0.32 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.491 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.616 ' CG ' HH21 ' A' ' 38' ' ' ARG . 0.0 OUTLIER -58.56 -15.58 11.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.76 -1.213 . . . . 0.0 109.183 -179.141 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 36' ' ' ARG . . . -82.6 -28.72 38.12 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.726 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.9 -51.25 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.442 -1.034 . . . . 0.0 110.18 -179.275 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.5 t -69.73 -65.0 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.521 -1.362 . . . . 0.0 111.237 -178.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' ARG . 61.5 mm-40 -57.5 -47.53 81.66 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.897 -1.127 . . . . 0.0 110.38 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -48.66 -53.65 17.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.682 -1.262 . . . . 0.0 109.565 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.586 ' SG ' HD21 ' A' ' 54' ' ' LEU . 96.6 m -78.16 -53.65 7.13 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.211 -0.93 . . . . 0.0 109.965 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.7 t -59.96 -52.49 65.19 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.9 -1.125 . . . . 0.0 110.056 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.545 HH21 ' CG ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -68.69 -33.13 73.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -0.952 . . . . 0.0 110.362 -179.172 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 44' ' ' CYS . 7.7 m -136.28 144.93 45.02 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.105 -0.997 . . . . 0.0 109.387 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 55.0 mt -68.43 99.48 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.013 -1.055 . . . . 0.0 109.272 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.6 p -85.5 141.81 29.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.417 -0.802 . . . . 0.0 109.343 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.3 m -73.04 160.56 31.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.634 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.414 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 43.8 mt -53.06 -33.01 50.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 109.342 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -48.43 -56.96 6.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -0.9 . . . . 0.0 109.31 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.517 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 17.0 mt-30 -56.47 -50.53 71.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.209 -0.932 . . . . 0.0 109.018 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.586 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.8 mt -56.07 -33.97 65.52 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.136 -0.977 . . . . 0.0 108.543 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -73.85 -9.02 58.23 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -79.98 -21.73 43.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.498 -0.751 . . . . 0.0 111.092 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.517 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.6 m-85 -100.64 -6.14 25.62 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.11 -0.994 . . . . 0.0 110.352 -178.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 73.6 m -62.08 97.05 0.08 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.193 -0.942 . . . . 0.0 109.805 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.304 0 CA-C-O 117.98 -1.456 . . . . 0.0 109.515 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.69 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 2.2 m-85 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.474 ' CG2' HE21 ' A' ' 4' ' ' GLN . 19.9 m -155.34 -153.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -83.6 90.53 7.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.027 -1.045 . . . . 0.0 109.052 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.526 ' OE1' ' NE2' ' A' ' 10' ' ' HIS . 4.9 pt20 -156.87 149.67 23.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 109.683 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.624 ' CD2' ' N ' ' A' ' 5' ' ' HIS . 0.0 OUTLIER -85.27 127.07 34.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.277 -0.89 . . . . 0.0 109.017 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.456 HD21 ' CB ' ' A' ' 14' ' ' ALA . 5.9 mp -88.7 116.47 26.98 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.386 -0.821 . . . . 0.0 109.329 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.437 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 57.9 m -130.77 125.23 33.25 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.293 -0.879 . . . . 0.0 110.425 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 61.05 -137.03 48.25 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.3 m -42.36 -31.67 0.43 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.613 -0.934 . . . . 0.0 110.695 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.526 ' NE2' ' OE1' ' A' ' 4' ' ' GLN . 6.7 t-160 -64.39 -34.5 78.32 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.777 -1.202 . . . . 0.0 108.665 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.708 HD21 HD12 ' A' ' 40' ' ' ILE . 9.6 tp -71.09 -49.72 41.42 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 t -57.71 -60.46 2.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 25.7 mt-10 -44.5 -29.93 0.79 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.068 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.69 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -85.6 -60.55 1.99 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.086 -1.009 . . . . 0.0 109.578 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.525 HD13 ' CD2' ' A' ' 24' ' ' PHE . 15.7 mt -47.05 -37.34 9.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.055 -1.028 . . . . 0.0 109.745 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -50.89 -40.76 57.4 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.496 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -77.82 -50.6 11.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 108.746 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.7 t -50.26 -55.29 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.4 m -79.17 -22.19 45.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.6 -0.687 . . . . 0.0 110.304 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.72 -116.57 6.13 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -85.01 -22.67 28.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.128 -1.219 . . . . 0.0 109.76 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -54.77 -38.35 67.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.15 -0.969 . . . . 0.0 108.843 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.2 162.69 10.61 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 120.094 -1.051 . . . . 0.0 110.747 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 7.0 p90 -137.43 172.58 12.76 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.533 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 15.7 p90 -110.89 122.21 47.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 0.0 108.995 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.538 ' O ' ' C ' ' A' ' 27' ' ' THR . 9.1 t80 -91.97 108.69 20.11 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.863 -1.148 . . . . 0.0 108.787 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.538 ' C ' ' O ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -8.12 80.52 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.47 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.423 ' HB2' HH21 ' A' ' 29' ' ' ARG . 6.1 Cg_exo -61.81 -8.39 11.4 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 N-CA-C 108.012 -1.572 . . . . 0.0 108.012 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.579 ' N ' ' CD ' ' A' ' 29' ' ' ARG . 6.6 mpt_? -81.37 -25.88 35.96 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.604 ' C ' ' H ' ' A' ' 32' ' ' GLU . 1.4 p 51.05 -164.23 0.05 Allowed 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.465 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -67.54 25.64 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.05 -1.031 . . . . 0.0 109.528 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.604 ' H ' ' C ' ' A' ' 30' ' ' THR . 1.5 mm-40 -94.57 -33.17 13.13 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.94 -136.21 8.94 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.2 t -166.98 -69.96 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.066 -1.255 . . . . 0.0 110.373 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.439 ' HG3' ' H ' ' A' ' 36' ' ' ARG . 9.8 ptm180 -40.12 -55.53 2.09 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.912 -0.493 . . . . 0.0 110.894 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 38' ' ' ARG . 23.6 mmt180 -72.55 -165.58 0.21 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.075 -1.015 . . . . 0.0 109.919 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.6 t 59.41 -63.29 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 122.182 -0.324 . . . . 0.0 111.303 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 36' ' ' ARG . 15.5 ptm180 -58.08 -13.55 5.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.512 -1.368 . . . . 0.0 108.916 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.32 -36.09 15.63 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.708 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.87 -50.79 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.407 -1.054 . . . . 0.0 110.039 -179.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.49 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.3 t -67.73 -64.9 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.57 -1.331 . . . . 0.0 111.802 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 46' ' ' ARG . 31.5 mm-40 -55.72 -53.0 61.99 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.934 -1.104 . . . . 0.0 111.377 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.518 ' O ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -47.44 -50.13 23.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.651 -1.28 . . . . 0.0 109.973 -178.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.625 ' SG ' HD21 ' A' ' 54' ' ' LEU . 94.6 m -81.17 -54.4 5.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.995 -1.066 . . . . 0.0 110.186 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 54.0 t -61.51 -47.87 83.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.872 -1.142 . . . . 0.0 110.074 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 42' ' ' GLU . 1.0 OUTLIER -69.79 -36.32 75.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.999 -1.063 . . . . 0.0 109.722 -179.469 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 44' ' ' CYS . 6.9 m -137.27 150.33 47.74 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.062 -1.024 . . . . 0.0 109.733 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.5 mt -68.64 99.74 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.145 -0.972 . . . . 0.0 109.272 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.1 p -83.27 146.21 28.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.388 -0.82 . . . . 0.0 109.817 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.1 m -79.54 166.28 22.09 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.305 -0.872 . . . . 0.0 109.516 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.0 mt -56.49 -31.99 64.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.484 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -48.31 -48.62 35.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.14 -0.975 . . . . 0.0 109.47 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.522 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 19.9 mt-30 -69.16 -53.38 20.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.343 -0.848 . . . . 0.0 109.633 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.625 HD21 ' SG ' ' A' ' 44' ' ' CYS . 98.0 mt -55.12 -35.44 64.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.142 -0.974 . . . . 0.0 109.021 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -73.91 -9.36 58.56 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -78.83 -22.03 46.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.387 -0.82 . . . . 0.0 110.839 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.522 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.2 m-85 -100.28 -6.45 25.92 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.185 -0.947 . . . . 0.0 110.443 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 74.6 m -62.71 96.51 0.09 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.1 -1.0 . . . . 0.0 109.536 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.283 0 CA-C-O 117.984 -1.453 . . . . 0.0 109.523 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.871 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 1' ' ' PHE . 27.0 m -59.25 -149.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.367 -0.833 . . . . 0.0 110.328 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.483 ' OD1' ' CD1' ' A' ' 48' ' ' ILE . 18.1 t-20 -74.7 94.93 2.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.576 -0.702 . . . . 0.0 109.421 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.499 HE21 ' CA ' ' A' ' 1' ' ' PHE . 11.4 pt20 -152.3 153.68 34.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.208 -0.933 . . . . 0.0 109.277 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.751 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 0.0 OUTLIER -86.52 124.2 32.57 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.21 -0.932 . . . . 0.0 109.022 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.471 HD21 ' CB ' ' A' ' 14' ' ' ALA . 6.6 mp -86.96 116.74 25.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.398 -0.814 . . . . 0.0 109.36 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.4 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 68.0 m -129.74 125.17 35.26 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.189 -0.945 . . . . 0.0 110.65 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 60.66 -139.22 48.1 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 8' ' ' GLY . 70.6 m -39.64 -33.34 0.18 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.856 -0.791 . . . . 0.0 110.71 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.4 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 2.2 t-160 -60.91 -39.77 90.62 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.878 -1.139 . . . . 0.0 108.699 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.753 HD21 HD12 ' A' ' 40' ' ' ILE . 9.2 tp -65.34 -53.96 35.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.408 -0.807 . . . . 0.0 109.109 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.52 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 73.2 t -55.4 -59.75 2.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.493 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 32.5 mt-10 -44.59 -28.77 0.63 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.698 -0.626 . . . . 0.0 110.126 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.871 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -86.77 -60.51 1.97 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.118 -0.989 . . . . 0.0 109.485 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.533 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.3 mt -46.96 -35.76 6.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.102 -0.999 . . . . 0.0 109.552 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -52.36 -40.85 62.52 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.493 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.02 -51.13 10.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 108.867 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.6 t -50.15 -54.1 9.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.3 m -78.44 -22.13 48.11 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.634 -0.666 . . . . 0.0 110.32 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.06 -115.04 4.14 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.519 -1.832 . . . . 0.0 108.519 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -85.41 -23.4 27.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.11 -1.229 . . . . 0.0 109.931 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 59' ' ' GLY . 37.2 mtp180 -54.76 -37.79 66.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -0.982 . . . . 0.0 109.286 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.82 162.73 9.76 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.562 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.533 ' CD2' HD13 ' A' ' 15' ' ' LEU . 9.5 p90 -138.85 173.8 11.19 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.548 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 18.5 p90 -110.7 122.15 47.1 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.173 -0.954 . . . . 0.0 110.273 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -107.38 169.52 8.52 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.447 ' H ' HG22 ' A' ' 27' ' ' THR . 1.3 t -71.5 146.7 91.86 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 120.944 -1.097 . . . . 0.0 108.484 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -55.72 -79.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.32 -0.952 0 C-N-CA 120.99 1.127 . . . . 0.0 109.724 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.414 ' H ' ' H ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -161.31 0.97 0.06 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.406 -0.809 . . . . 0.0 108.966 -179.249 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.414 ' H ' ' H ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -89.72 125.15 35.17 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.353 -0.842 . . . . 0.0 109.435 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -80.61 -2.12 45.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.304 -0.872 . . . . 0.0 109.291 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 33' ' ' GLY . 66.9 mm-40 -54.08 -49.01 70.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.912 . . . . 0.0 109.009 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 32' ' ' GLU . . . 59.9 143.3 0.01 OUTLIER Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 35' ' ' ARG . 86.6 p -109.59 -106.61 0.35 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.588 -0.948 . . . . 0.0 109.033 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.535 HH11 ' NH1' ' A' ' 36' ' ' ARG . 0.4 OUTLIER -92.69 -56.15 3.11 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.355 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.582 ' O ' ' N ' ' A' ' 38' ' ' ARG . 15.2 mtt-85 -63.34 -137.01 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.295 -0.878 . . . . 0.0 109.184 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.7 t 54.57 -77.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.576 -0.702 . . . . 0.0 110.165 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.582 ' N ' ' O ' ' A' ' 36' ' ' ARG . 1.6 ptm180 -58.39 -15.21 9.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.011 -1.055 . . . . 0.0 108.513 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.59 -32.45 27.52 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.753 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.77 -51.42 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.479 -1.012 . . . . 0.0 110.121 -179.418 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.513 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 4.1 t -68.79 -64.34 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.649 -1.282 . . . . 0.0 111.409 -178.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 46' ' ' ARG . 68.2 mm-40 -58.26 -53.04 62.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.791 -1.193 . . . . 0.0 110.257 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.473 ' CD ' ' NE2' ' A' ' 53' ' ' GLN . 12.2 tt0 -43.85 -47.48 8.22 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.972 -1.08 . . . . 0.0 110.187 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.647 ' SG ' HD21 ' A' ' 54' ' ' LEU . 95.3 m -84.05 -50.47 7.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.036 -1.04 . . . . 0.0 109.933 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.9 t -61.79 -53.12 60.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.243 -0.911 . . . . 0.0 110.472 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 42' ' ' GLU . 7.9 tpp180 -69.68 -39.45 76.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.918 -1.114 . . . . 0.0 109.708 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 44' ' ' CYS . 15.6 m -126.41 144.78 50.72 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.11 -0.993 . . . . 0.0 109.584 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.483 ' CD1' ' OD1' ' A' ' 3' ' ' ASN . 17.5 mt -69.38 99.38 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.173 -0.954 . . . . 0.0 109.24 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.5 p -83.85 143.34 29.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.327 -0.858 . . . . 0.0 109.533 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.0 m -73.35 161.25 30.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.86 . . . . 0.0 109.805 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 42.3 mt -55.52 -34.18 64.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.852 . . . . 0.0 109.342 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -48.63 -53.73 17.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.129 -0.982 . . . . 0.0 109.031 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.52 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 38.1 mt-30 -58.69 -51.75 68.6 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.331 -0.856 . . . . 0.0 108.939 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.647 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.4 mt -56.69 -30.77 63.78 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -76.29 -8.86 58.0 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -80.51 -22.85 40.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.533 -0.729 . . . . 0.0 110.869 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.52 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 5.7 m-85 -99.35 -7.43 26.27 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.111 -0.993 . . . . 0.0 110.048 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 91.5 m -61.35 93.98 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.386 -0.821 . . . . 0.0 109.722 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.344 0 CA-C-O 118.029 -1.428 . . . . 0.0 109.568 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.612 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 9.8 m-85 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.557 ' CG2' HE21 ' A' ' 4' ' ' GLN . 1.2 m -151.87 -105.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.456 ' N ' ' ND2' ' A' ' 3' ' ' ASN . 0.6 OUTLIER -141.39 80.11 1.72 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.465 -0.772 . . . . 0.0 108.955 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.557 HE21 ' CG2' ' A' ' 2' ' ' VAL . 16.1 pt20 -150.45 167.47 27.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.35 -0.844 . . . . 0.0 109.659 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.695 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 0.0 OUTLIER -92.43 126.42 37.5 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.391 -0.818 . . . . 0.0 108.968 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.428 HD21 ' CB ' ' A' ' 14' ' ' ALA . 4.1 mp -85.22 117.05 23.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.345 -0.847 . . . . 0.0 109.121 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.415 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 76.2 m -128.22 125.07 38.24 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.99 0.9 . . . . 0.0 110.839 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.73 -136.85 48.78 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.4 m -42.65 -31.49 0.47 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.605 -0.938 . . . . 0.0 110.484 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.522 ' CE1' ' OE1' ' A' ' 4' ' ' GLN . 1.7 t-160 -62.26 -34.0 75.7 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.944 -1.097 . . . . 0.0 108.758 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.708 HD21 HD12 ' A' ' 40' ' ' ILE . 12.0 tp -72.97 -52.57 13.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.438 -0.789 . . . . 0.0 109.015 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.512 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 66.9 t -56.44 -59.64 2.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.484 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.6 mt-10 -44.25 -28.96 0.58 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.804 -0.56 . . . . 0.0 110.222 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.612 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -86.96 -59.8 2.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.132 -0.98 . . . . 0.0 109.602 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.547 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.9 mt -47.21 -36.77 9.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.164 -0.96 . . . . 0.0 109.513 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.32 -41.13 60.34 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.484 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -77.74 -50.09 13.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 108.856 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.5 t -50.44 -54.55 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-O 121.65 0.738 . . . . 0.0 109.029 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.1 m -79.51 -22.77 43.53 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.696 -0.628 . . . . 0.0 110.506 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 50.09 -109.65 0.7 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 8.9 mp0 -85.48 -25.58 26.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.213 -1.169 . . . . 0.0 110.269 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HG2' HH21 ' A' ' 22' ' ' ARG . 31.7 mtt-85 -54.66 -38.68 67.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.955 -1.091 . . . . 0.0 109.309 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.34 161.54 8.02 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.547 ' CD2' HD13 ' A' ' 15' ' ' LEU . 9.5 p90 -138.4 173.59 11.44 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.469 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 4.9 p90 -106.25 128.53 54.03 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.209 -0.932 . . . . 0.0 110.012 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.47 ' O ' ' C ' ' A' ' 27' ' ' THR . 3.5 t80 -116.17 124.45 50.33 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.343 -0.848 . . . . 0.0 109.069 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.47 ' C ' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER 29.91 84.42 0.16 Allowed Pre-proline 0 N--CA 1.509 2.524 0 O-C-N 121.924 -0.485 . . . . 0.0 111.027 179.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -76.43 -9.17 18.74 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 121.706 1.604 . . . . 0.0 109.688 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -172.12 24.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.459 179.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.543 ' C ' ' H ' ' A' ' 32' ' ' GLU . 9.8 p 58.75 157.32 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.595 -0.691 . . . . 0.0 109.596 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.599 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 3.0 mp0 -69.65 13.34 0.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.175 -0.953 . . . . 0.0 108.667 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.543 ' H ' ' C ' ' A' ' 30' ' ' THR . 10.8 mm-40 -77.95 -25.41 48.24 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.673 -0.642 . . . . 0.0 109.5 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -94.7 -117.09 2.93 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 33' ' ' GLY . 44.4 t -60.15 -117.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.402 -1.058 . . . . 0.0 109.644 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.537 ' CG ' ' H ' ' A' ' 36' ' ' ARG . 0.6 OUTLIER -141.83 -104.62 0.14 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.178 -0.951 . . . . 0.0 109.691 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.57 ' O ' ' N ' ' A' ' 38' ' ' ARG . 75.6 mtt180 42.33 -150.42 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.703 -0.623 . . . . 0.0 109.776 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 t 58.4 -65.17 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.948 -0.47 . . . . 0.0 110.806 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.57 ' N ' ' O ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -57.73 -12.12 2.73 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.821 -1.174 . . . . 0.0 108.61 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.06 -28.63 40.62 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.708 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.1 -54.13 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.475 -1.015 . . . . 0.0 110.283 -179.288 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.514 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.2 t -66.73 -64.83 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.358 -1.464 . . . . 0.0 111.21 -178.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 46' ' ' ARG . 52.5 mm-40 -56.24 -48.55 76.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.919 -1.113 . . . . 0.0 110.08 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -46.98 -55.87 7.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.739 -1.226 . . . . 0.0 109.991 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.563 ' SG ' HD21 ' A' ' 54' ' ' LEU . 93.6 m -76.94 -52.66 9.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.246 -0.909 . . . . 0.0 110.062 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.8 t -59.47 -52.93 63.48 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.867 -1.145 . . . . 0.0 109.97 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 42' ' ' GLU . 2.7 tmt_? -66.82 -36.3 82.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.289 -0.882 . . . . 0.0 110.235 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 44' ' ' CYS . 16.2 m -134.43 145.25 48.7 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.124 -0.985 . . . . 0.0 109.362 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 57.5 mt -68.21 99.62 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.036 -1.04 . . . . 0.0 109.331 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.8 p -84.93 150.01 25.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.417 -0.802 . . . . 0.0 109.421 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.7 m -88.41 166.17 14.42 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.262 -0.899 . . . . 0.0 110.026 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.1 mt -52.17 -34.25 44.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.421 -0.8 . . . . 0.0 109.519 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -47.52 -43.1 24.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.246 -0.909 . . . . 0.0 109.57 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.512 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 41.8 mt-30 -77.47 -52.33 9.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.374 -0.829 . . . . 0.0 109.792 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.563 HD21 ' SG ' ' A' ' 44' ' ' CYS . 98.7 mt -54.45 -38.08 65.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.031 -1.043 . . . . 0.0 109.007 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -71.0 -9.27 57.72 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 121.544 0.688 . . . . 0.0 109.286 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -78.91 -22.36 45.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 0.0 111.033 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.512 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.7 m-85 -99.98 -8.04 24.39 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.078 -1.013 . . . . 0.0 110.272 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 87.5 m -60.53 94.86 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.511 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 1' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.495 ' CG2' HE21 ' A' ' 4' ' ' GLN . 35.9 m -61.37 -140.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.858 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -138.03 110.93 7.7 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.39 -0.819 . . . . 0.0 109.348 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.495 HE21 ' CG2' ' A' ' 2' ' ' VAL . 14.7 pt20 -157.24 178.19 10.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.284 -0.885 . . . . 0.0 109.224 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.736 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 0.0 OUTLIER -78.26 117.01 19.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.206 -0.934 . . . . 0.0 109.354 -179.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 mp -86.76 116.72 25.04 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 86.0 m -128.5 124.98 37.44 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.31 -0.869 . . . . 0.0 110.388 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.56 -137.01 44.63 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 m -42.31 -35.63 1.04 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.707 -0.878 . . . . 0.0 110.568 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.403 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 0.8 OUTLIER -58.49 -35.12 71.71 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.919 -1.113 . . . . 0.0 108.892 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.722 HD21 HD12 ' A' ' 40' ' ' ILE . 12.7 tp -72.03 -52.52 16.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.332 -0.855 . . . . 0.0 108.826 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.507 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 75.1 t -58.44 -59.25 3.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.499 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 85.7 mt-10 -45.12 -29.0 0.82 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.727 -0.608 . . . . 0.0 109.895 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.56 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -86.53 -60.9 1.86 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -0.939 . . . . 0.0 109.559 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.567 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.6 mt -46.87 -36.55 7.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.166 -0.958 . . . . 0.0 109.555 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.7 -41.96 61.86 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.408 -0.808 . . . . 0.0 108.842 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.499 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -76.38 -51.84 11.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 108.735 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 t -49.97 -53.78 9.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.547 0.689 . . . . 0.0 109.203 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 m -79.84 -22.38 43.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.471 -0.768 . . . . 0.0 110.471 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.86 -114.22 3.41 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.744 -1.743 . . . . 0.0 108.744 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -85.29 -23.98 27.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.2 -1.176 . . . . 0.0 110.125 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -54.6 -37.69 65.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.966 -1.084 . . . . 0.0 109.359 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.83 162.24 9.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.567 ' CD2' HD13 ' A' ' 15' ' ' LEU . 9.3 p90 -138.41 173.51 11.52 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 3.8 p90 -107.72 125.41 51.36 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.086 -1.008 . . . . 0.0 110.231 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.485 ' CD2' HG22 ' A' ' 27' ' ' THR . 2.5 t80 -107.15 171.14 7.54 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.485 HG22 ' CD2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -39.42 113.11 0.81 Allowed Pre-proline 0 N--CA 1.505 2.281 0 O-C-N 121.322 -0.862 . . . . 0.0 109.566 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.44 5.91 1.4 Allowed 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 120.879 1.052 . . . . 0.0 110.534 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.439 ' C ' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -175.42 -50.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.082 -1.011 . . . . 0.0 110.315 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.439 HG22 ' C ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -178.23 122.87 0.1 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.975 -1.078 . . . . 0.0 110.038 -179.454 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -5.56 12.73 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 33' ' ' GLY . 9.0 mt-10 -83.1 -29.1 29.01 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.642 -0.661 . . . . 0.0 109.402 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 32' ' ' GLU . . . -55.73 -108.39 0.01 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.401 ' OG ' ' N ' ' A' ' 35' ' ' ARG . 35.6 t -78.97 -138.93 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -1.157 . . . . 0.0 110.037 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.649 HH12 ' NH2' ' A' ' 38' ' ' ARG . 1.4 ptm180 -97.11 -119.43 0.12 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.395 -0.816 . . . . 0.0 109.457 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.602 ' CG ' HH21 ' A' ' 36' ' ' ARG . 0.0 OUTLIER 47.15 -173.25 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.259 -0.901 . . . . 0.0 110.06 179.746 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.9 t 59.13 -25.33 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.622 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.649 ' NH2' HH12 ' A' ' 35' ' ' ARG . 0.0 OUTLIER -75.21 -11.9 60.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.318 -1.489 . . . . 0.0 109.079 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.23 -33.05 24.15 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.722 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.29 -53.88 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.159 -1.201 . . . . 0.0 110.837 -178.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.502 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.7 t -65.93 -63.65 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.454 -1.404 . . . . 0.0 111.402 -177.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' ARG . 71.4 mt-10 -55.46 -51.59 66.43 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.868 -1.145 . . . . 0.0 111.056 -178.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.493 ' NE2' HE22 ' A' ' 53' ' ' GLN . 0.4 OUTLIER -48.21 -52.05 22.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.622 -1.299 . . . . 0.0 110.044 -179.128 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.572 ' SG ' HD21 ' A' ' 54' ' ' LEU . 85.4 m -78.01 -53.77 7.04 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.962 -1.086 . . . . 0.0 110.013 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 54.0 t -59.86 -52.18 66.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.89 -1.131 . . . . 0.0 109.939 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -67.03 -35.58 80.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 0.0 110.303 -179.396 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 44' ' ' CYS . 26.4 m -136.67 147.2 46.7 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.059 -1.026 . . . . 0.0 109.307 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.9 mt -68.32 99.71 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.045 -1.034 . . . . 0.0 109.554 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.4 p -85.29 138.77 32.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.364 -0.835 . . . . 0.0 109.175 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.0 m -70.1 163.06 27.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.27 -0.894 . . . . 0.0 109.68 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.1 mt -56.61 -31.0 63.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.337 -0.852 . . . . 0.0 108.892 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -48.91 -51.95 27.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 109.177 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.493 HE22 ' NE2' ' A' ' 43' ' ' GLN . 56.8 mt-30 -62.99 -50.35 71.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.223 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.572 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.8 mt -55.09 -36.01 65.2 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.2 -0.938 . . . . 0.0 108.768 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -71.81 -8.98 57.57 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.485 0.659 . . . . 0.0 109.254 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -79.81 -22.5 42.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.422 -0.798 . . . . 0.0 110.958 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.49 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.8 m-85 -100.04 -8.15 24.16 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.069 -1.019 . . . . 0.0 110.209 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 81.6 m -60.39 93.03 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.357 -0.839 . . . . 0.0 109.44 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.284 0 CA-C-O 117.985 -1.453 . . . . 0.0 109.555 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.485 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.744 HG22 ' N ' ' A' ' 3' ' ' ASN . 0.7 OUTLIER 33.1 -94.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 122.125 -0.359 . . . . 0.0 110.659 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.744 ' N ' HG22 ' A' ' 2' ' ' VAL . 0.3 OUTLIER 171.32 88.34 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.014 -1.054 . . . . 0.0 108.853 179.396 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -146.66 165.26 30.11 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.223 -0.923 . . . . 0.0 109.536 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -83.91 129.99 34.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.394 -0.816 . . . . 0.0 109.078 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.402 HD21 ' CB ' ' A' ' 14' ' ' ALA . 5.0 mp -91.86 116.08 28.61 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.26 -0.9 . . . . 0.0 109.793 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.424 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 63.0 m -130.73 124.57 31.77 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.321 -0.862 . . . . 0.0 109.872 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 63.95 -138.1 41.66 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.6 m -41.69 -35.17 0.72 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.715 -0.873 . . . . 0.0 110.764 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.424 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 7.3 t-160 -59.29 -35.68 74.2 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.878 -1.139 . . . . 0.0 108.89 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.721 HD21 HD12 ' A' ' 40' ' ' ILE . 8.4 tp -70.18 -52.73 21.12 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.511 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 64.6 t -58.12 -60.38 2.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.489 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 70.9 mt-10 -44.01 -30.17 0.69 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.818 -0.551 . . . . 0.0 110.022 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.485 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -84.9 -61.15 1.85 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.254 -0.904 . . . . 0.0 109.71 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.498 HD13 ' CD2' ' A' ' 24' ' ' PHE . 13.2 mt -46.1 -36.9 6.22 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.245 -0.909 . . . . 0.0 109.629 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -51.85 -40.43 60.53 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.489 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -78.37 -50.65 11.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 108.761 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.418 ' H ' HG23 ' A' ' 18' ' ' VAL . 19.2 t -50.12 -55.02 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.523 0.678 . . . . 0.0 109.362 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.6 m -77.29 -22.34 52.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.556 -0.715 . . . . 0.0 110.615 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.32 -112.59 2.11 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.571 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 2.6 mp0 -85.32 -25.11 27.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.226 -1.161 . . . . 0.0 109.972 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -54.44 -38.3 66.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.065 -1.022 . . . . 0.0 109.486 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.15 162.71 8.73 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.511 ' HZ ' HG13 ' A' ' 12' ' ' VAL . 9.2 p90 -138.48 173.33 11.71 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.544 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 18.8 p90 -111.96 121.68 45.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 109.643 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.521 ' O ' ' C ' ' A' ' 27' ' ' THR . 13.7 t80 -101.58 108.04 19.48 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.026 -1.046 . . . . 0.0 108.798 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.746 ' O ' HG23 ' A' ' 27' ' ' THR . 9.7 t -18.87 85.6 0.04 OUTLIER Pre-proline 0 N--CA 1.507 2.408 0 C-N-CA 122.474 0.31 . . . . 0.0 111.547 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.559 ' O ' ' N ' ' A' ' 30' ' ' THR . 2.2 Cg_endo -62.9 98.48 0.2 Allowed 'Trans proline' 0 C--N 1.316 -1.18 0 N-CA-C 109.619 -0.954 . . . . 0.0 109.619 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.493 ' O ' ' N ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER 61.42 -36.07 0.1 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.402 0.62 . . . . 0.0 111.715 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.559 ' N ' ' O ' ' A' ' 28' ' ' PRO . 21.5 p -53.89 86.05 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.908 0 O-C-N 121.46 -0.775 . . . . 0.0 110.435 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 29' ' ' ARG . 51.3 mm-40 -94.41 4.91 53.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.253 -0.904 . . . . 0.0 109.038 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -87.56 -23.21 24.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.434 -0.791 . . . . 0.0 109.875 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.14 150.95 0.16 Allowed Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -100.56 -74.23 0.62 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.404 -1.057 . . . . 0.0 109.984 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.439 ' H ' ' HG2' ' A' ' 35' ' ' ARG . 3.2 ptp180 -62.06 -56.98 13.45 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.343 -0.848 . . . . 0.0 109.961 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 38' ' ' ARG . 7.9 mtt-85 -57.01 -163.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.134 -0.979 . . . . 0.0 110.598 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 t 47.71 -87.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.737 -0.602 . . . . 0.0 110.447 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 36' ' ' ARG . 9.9 ptm180 -58.56 -17.18 19.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.036 -1.04 . . . . 0.0 108.814 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.55 -31.01 31.42 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.721 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.13 -52.49 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.706 -0.879 . . . . 0.0 110.137 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.516 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.9 t -68.97 -64.76 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.514 -1.366 . . . . 0.0 111.473 -178.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 46' ' ' ARG . 97.4 mt-10 -58.23 -49.32 77.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.913 -1.117 . . . . 0.0 110.534 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -46.75 -49.47 19.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.82 -1.175 . . . . 0.0 109.899 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.606 ' SG ' HD21 ' A' ' 54' ' ' LEU . 86.4 m -84.16 -51.84 6.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 110.248 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.3 t -61.57 -48.29 81.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.813 -1.179 . . . . 0.0 109.79 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.553 HH21 ' CG ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -66.25 -39.11 89.26 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.99 -1.069 . . . . 0.0 109.703 -179.718 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 44' ' ' CYS . 68.8 m -138.61 152.84 48.48 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.143 -0.973 . . . . 0.0 109.719 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.4 mt -68.53 99.46 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.012 -1.055 . . . . 0.0 109.381 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.3 p -80.87 141.28 34.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 0.0 108.891 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 m -70.39 158.87 35.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -0.951 . . . . 0.0 109.912 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 43.3 mt -53.02 -32.25 45.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.442 -0.786 . . . . 0.0 109.187 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -49.5 -52.09 31.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.257 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.492 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 45.7 mt-30 -62.41 -51.32 68.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 109.326 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.606 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.8 mt -56.5 -33.23 65.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.093 -1.004 . . . . 0.0 108.437 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -74.37 -8.95 58.01 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -79.65 -22.22 43.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.452 -0.78 . . . . 0.0 110.897 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.492 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.4 m-85 -100.27 -8.17 23.78 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.187 -0.946 . . . . 0.0 110.056 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 93.4 m -60.63 96.2 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.59 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 1' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 1' ' ' PHE . 3.6 m -54.49 -171.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.339 -0.85 . . . . 0.0 109.899 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.658 HD22 ' N ' ' A' ' 3' ' ' ASN . 0.3 OUTLIER -95.1 112.53 24.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.57 -0.706 . . . . 0.0 109.097 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.515 ' OE1' ' NE2' ' A' ' 10' ' ' HIS . 2.8 pt20 -151.51 164.99 35.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 109.528 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.82 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 1.4 p80 -72.78 136.32 45.43 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.238 -0.914 . . . . 0.0 109.219 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.407 HD21 ' CB ' ' A' ' 14' ' ' ALA . 4.7 mp -113.27 115.94 28.96 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.684 -0.635 . . . . 0.0 109.295 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.446 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 62.7 m -128.95 124.86 36.19 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.212 -0.93 . . . . 0.0 110.163 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.14 -136.45 45.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -42.01 -35.44 0.89 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.719 -0.871 . . . . 0.0 110.584 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.515 ' NE2' ' OE1' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -59.4 -36.28 75.53 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.9 -1.125 . . . . 0.0 108.751 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.716 HD21 HD12 ' A' ' 40' ' ' ILE . 10.7 tp -70.97 -50.16 37.48 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.9 t -59.36 -60.83 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.498 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.7 mt-10 -44.71 -29.73 0.82 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.919 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.538 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -85.2 -61.11 1.85 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.726 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.529 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.2 mt -46.72 -36.95 7.73 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.142 -0.974 . . . . 0.0 109.706 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -51.37 -40.43 59.18 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.498 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.34 -50.74 11.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 108.759 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.487 ' O ' ' NH1' ' A' ' 22' ' ' ARG . 21.1 t -49.98 -54.94 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.7 m -79.81 -22.39 43.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.62 -0.675 . . . . 0.0 110.113 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.74 -115.69 5.19 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.769 -1.733 . . . . 0.0 108.769 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 8.9 mp0 -84.6 -22.14 30.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.187 -1.184 . . . . 0.0 109.67 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.487 ' NH1' ' O ' ' A' ' 18' ' ' VAL . 78.5 mtm180 -55.02 -37.84 67.15 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.152 -0.968 . . . . 0.0 109.253 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.85 160.14 7.59 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.48 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.529 ' CD2' HD13 ' A' ' 15' ' ' LEU . 8.6 p90 -137.77 172.63 12.66 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.523 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 9.2 p90 -109.86 124.81 51.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 109.335 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -97.55 160.25 14.43 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.045 -1.034 . . . . 0.0 108.703 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.422 ' O ' HG23 ' A' ' 27' ' ' THR . 7.1 t -65.67 134.77 95.42 Favored Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 121.147 -0.971 . . . . 0.0 108.714 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.625 ' O ' ' N ' ' A' ' 30' ' ' THR . 9.2 Cg_endo -66.68 122.67 10.11 Favored 'Trans proline' 0 C--O 1.211 -0.843 0 N-CA-C 109.193 -1.118 . . . . 0.0 109.193 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.475 HH21 ' CB ' ' A' ' 28' ' ' PRO . 4.7 mpt_? 51.68 -79.41 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.437 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.625 ' N ' ' O ' ' A' ' 28' ' ' PRO . 0.3 OUTLIER -168.61 88.15 0.21 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.958 -1.089 . . . . 0.0 109.956 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 33' ' ' GLY . 46.4 mm-40 -78.89 28.55 0.21 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.089 -1.007 . . . . 0.0 108.315 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' A' ' 30' ' ' THR . 75.8 mt-10 -42.77 -25.66 0.1 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.617 -0.677 . . . . 0.0 109.895 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -61.83 -84.6 0.06 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -55.4 -166.48 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.521 -0.988 . . . . 0.0 109.764 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' A' ' 37' ' ' SER . 1.9 ptp180 -90.25 -109.51 0.09 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.449 -0.782 . . . . 0.0 109.628 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.548 ' CG ' HH21 ' A' ' 36' ' ' ARG . 3.5 mtt-85 46.2 -85.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.468 0.651 . . . . 0.0 110.849 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 35' ' ' ARG . 2.7 t -39.03 -49.53 1.74 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.995 -0.441 . . . . 0.0 111.01 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.409 ' HE ' ' HB2' ' A' ' 35' ' ' ARG . 24.8 ptt180 -59.52 -24.8 63.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.839 -1.163 . . . . 0.0 109.678 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 36' ' ' ARG . . . -74.36 -35.74 51.7 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.716 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.12 -51.5 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.244 -1.151 . . . . 0.0 110.467 -179.149 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.487 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 2.5 t -69.56 -64.63 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 120.463 -1.398 . . . . 0.0 111.994 -177.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -55.45 -53.82 51.56 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.849 -1.157 . . . . 0.0 111.028 -177.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.587 HE21 ' C ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -47.19 -49.42 22.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.824 -1.172 . . . . 0.0 109.876 -178.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.61 ' SG ' HD21 ' A' ' 54' ' ' LEU . 95.1 m -81.14 -54.44 5.53 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.931 -1.105 . . . . 0.0 109.897 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.6 t -60.95 -52.06 66.63 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.922 -1.111 . . . . 0.0 110.102 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -68.89 -33.78 74.34 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.218 -0.926 . . . . 0.0 110.402 -179.031 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 44' ' ' CYS . 25.4 m -136.48 147.63 47.27 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.071 -1.018 . . . . 0.0 109.404 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.5 mt -69.14 99.36 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.088 -1.008 . . . . 0.0 109.125 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.1 p -85.41 146.68 26.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.376 -0.827 . . . . 0.0 109.297 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.3 m -77.62 162.94 26.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.891 . . . . 0.0 109.69 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.5 mt -56.09 -31.76 63.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 0.0 108.969 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -46.9 -54.4 10.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 0.0 109.533 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.576 HE22 ' CD ' ' A' ' 43' ' ' GLN . 16.1 mt-30 -62.36 -50.46 71.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.388 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.61 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.3 mt -55.71 -34.14 64.85 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.078 -1.014 . . . . 0.0 108.686 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.487 ' OE2' ' NH2' ' A' ' 22' ' ' ARG . 4.2 tm-20 -74.42 -9.38 58.53 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -79.52 -21.79 44.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.386 -0.822 . . . . 0.0 110.99 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.525 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.9 m-85 -99.17 -7.4 26.63 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.078 -1.014 . . . . 0.0 110.626 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.436 ' O ' ' OXT' ' A' ' 59' ' ' GLY . 78.4 m -59.01 102.17 0.11 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.004 -1.06 . . . . 0.0 109.066 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.492 2.426 0 CA-C-O 117.911 -1.494 . . . . 0.0 109.945 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.558 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.567 HG23 HE21 ' A' ' 4' ' ' GLN . 2.3 m -55.35 -168.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.354 -0.841 . . . . 0.0 109.768 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -102.69 121.06 41.68 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.637 -0.664 . . . . 0.0 109.613 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.567 HE21 HG23 ' A' ' 2' ' ' VAL . 6.2 pt20 -168.08 170.5 10.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.486 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.682 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 0.0 OUTLIER -82.67 122.83 28.65 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.204 -0.935 . . . . 0.0 109.443 -179.326 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.411 HD21 ' CB ' ' A' ' 14' ' ' ALA . 4.3 mp -90.38 117.49 29.14 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.559 -0.713 . . . . 0.0 109.135 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.41 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 58.6 m -130.11 124.99 34.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.177 -0.952 . . . . 0.0 110.516 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.82 -137.27 44.08 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.3 m -43.31 -30.95 0.56 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.54 -0.977 . . . . 0.0 110.419 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.545 ' NE2' ' OE1' ' A' ' 4' ' ' GLN . 2.1 t-80 -63.18 -33.6 75.83 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.97 -1.081 . . . . 0.0 108.811 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.714 HD21 HD12 ' A' ' 40' ' ' ILE . 9.2 tp -72.12 -51.65 20.42 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.517 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 76.5 t -58.12 -60.98 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.49 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 29.2 mt-10 -43.55 -29.35 0.46 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.821 -0.549 . . . . 0.0 109.975 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.558 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -85.77 -61.11 1.83 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.435 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.513 HD13 ' CD2' ' A' ' 24' ' ' PHE . 13.8 mt -46.15 -37.13 6.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.201 -0.937 . . . . 0.0 109.707 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.52 -42.42 61.72 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.407 -0.808 . . . . 0.0 108.842 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.49 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -75.66 -51.23 13.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.281 -0.887 . . . . 0.0 108.763 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.418 ' H ' HG23 ' A' ' 18' ' ' VAL . 19.0 t -50.37 -55.1 6.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-O 121.516 0.674 . . . . 0.0 109.337 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.6 m -78.01 -22.31 49.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.481 -0.762 . . . . 0.0 110.613 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.22 -118.38 13.21 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -85.37 -24.9 27.38 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.135 -1.215 . . . . 0.0 110.329 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.603 HH21 ' CG ' ' A' ' 22' ' ' ARG . 2.8 mtt-85 -54.3 -36.66 63.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.946 -1.096 . . . . 0.0 109.303 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.33 166.84 19.98 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.549 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 7.4 p90 -139.01 172.49 12.76 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.544 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 15.2 p90 -110.19 121.75 46.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.9 . . . . 0.0 109.282 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.465 ' CD2' ' N ' ' A' ' 27' ' ' THR . 15.0 t80 -94.81 172.83 7.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.069 -1.019 . . . . 0.0 109.666 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.698 ' O ' HG23 ' A' ' 27' ' ' THR . 5.5 t -113.14 81.68 4.99 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.796 -0.565 . . . . 0.0 110.021 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 30' ' ' THR . 2.1 Cg_endo -59.26 91.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.319 -0.977 0 C-N-CA 120.698 0.932 . . . . 0.0 109.797 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.461 ' HG3' HH21 ' A' ' 29' ' ' ARG . 0.0 OUTLIER 22.36 37.31 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.451 178.436 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.624 ' N ' ' O ' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -82.95 96.69 8.38 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.412 -0.805 . . . . 0.0 109.234 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.612 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 1.2 pm0 -74.7 9.98 1.59 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.259 -0.9 . . . . 0.0 109.044 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.4 ' H ' ' C ' ' A' ' 30' ' ' THR . 36.1 mt-10 -70.95 -27.59 63.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.279 -0.888 . . . . 0.0 109.444 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.05 162.41 27.35 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.5 t -82.46 -85.07 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -1.136 . . . . 0.0 109.579 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 37' ' ' SER . 3.1 ptt-85 -88.31 -99.86 0.09 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.449 -0.782 . . . . 0.0 109.266 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.615 ' CG ' HH21 ' A' ' 36' ' ' ARG . 0.0 OUTLIER 52.44 -81.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.706 -0.622 . . . . 0.0 111.133 179.232 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 35' ' ' ARG . 1.1 t -44.53 -56.54 4.24 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.353 -0.842 . . . . 0.0 110.795 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -59.12 -9.58 2.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.853 -1.154 . . . . 0.0 109.423 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.44 -37.54 14.29 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.714 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.35 -50.68 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.491 -1.005 . . . . 0.0 109.956 -179.288 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.499 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 4.3 t -69.37 -64.93 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 120.592 -1.317 . . . . 0.0 111.692 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 46' ' ' ARG . 31.3 mm-40 -57.03 -51.87 67.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.804 -1.185 . . . . 0.0 110.262 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.584 ' NE2' HE21 ' A' ' 53' ' ' GLN . 17.5 tt0 -45.6 -48.69 14.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.082 -1.012 . . . . 0.0 110.138 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.629 ' SG ' HD21 ' A' ' 54' ' ' LEU . 86.2 m -84.08 -53.9 5.21 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.199 -0.938 . . . . 0.0 109.992 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 54.0 t -60.82 -51.59 68.68 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.054 -1.029 . . . . 0.0 110.064 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 42' ' ' GLU . 2.9 tmt_? -68.06 -35.67 78.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.135 -0.978 . . . . 0.0 110.003 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 44' ' ' CYS . 23.2 m -136.52 147.73 47.24 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.15 -0.969 . . . . 0.0 109.331 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 63.4 mt -68.49 99.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.022 -1.049 . . . . 0.0 109.312 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.5 p -82.42 138.1 34.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.431 -0.793 . . . . 0.0 108.993 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 m -68.75 158.87 33.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.777 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.8 mt -53.59 -31.72 48.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.351 -0.843 . . . . 0.0 108.964 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -49.01 -51.91 28.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.408 -0.808 . . . . 0.0 109.23 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.584 HE21 ' NE2' ' A' ' 43' ' ' GLN . 24.4 mt-30 -63.32 -49.41 74.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.234 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.629 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.6 mt -56.85 -32.77 66.13 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.015 -1.053 . . . . 0.0 108.249 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -74.55 -9.26 58.41 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -79.76 -22.14 43.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 111.103 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.487 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.5 m-85 -99.5 -4.93 30.2 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.048 -1.033 . . . . 0.0 110.712 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 75.5 m -62.19 102.48 0.3 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.06 -1.025 . . . . 0.0 109.827 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.318 0 CA-C-O 118.026 -1.43 . . . . 0.0 109.557 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 1' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 1' ' ' PHE . 3.6 m -54.45 -168.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.344 -0.848 . . . . 0.0 110.019 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -90.94 120.46 31.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.503 -0.748 . . . . 0.0 109.533 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.525 ' OE1' ' NE2' ' A' ' 10' ' ' HIS . 3.0 pt20 -172.55 148.09 1.93 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.433 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.423 ' CD2' ' N ' ' A' ' 5' ' ' HIS . 9.9 m-70 -70.45 148.87 47.82 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.239 -0.913 . . . . 0.0 109.337 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 mp -113.14 116.38 29.75 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.674 -0.641 . . . . 0.0 109.546 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.421 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 58.1 m -129.21 124.94 35.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.374 -0.829 . . . . 0.0 110.056 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.61 -137.36 44.6 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 m -41.5 -35.61 0.74 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.751 -0.852 . . . . 0.0 110.71 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.525 ' NE2' ' OE1' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -59.45 -35.95 75.01 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.899 -1.125 . . . . 0.0 108.817 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.696 HD21 HD12 ' A' ' 40' ' ' ILE . 10.8 tp -71.05 -50.03 38.43 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -59.6 -61.43 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.497 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 81.7 mt-10 -44.38 -29.9 0.76 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.847 -0.533 . . . . 0.0 110.004 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.529 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -85.34 -60.76 1.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.155 -0.966 . . . . 0.0 109.79 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.538 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.3 mt -47.01 -36.49 7.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.08 -1.012 . . . . 0.0 109.57 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.7 -40.79 60.77 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.497 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.49 -50.75 11.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 0.0 108.992 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -49.89 -53.48 10.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.538 0.685 . . . . 0.0 109.295 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 m -78.79 -22.32 46.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.596 -0.69 . . . . 0.0 110.585 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.24 -114.07 3.45 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 2.2 mp0 -85.28 -24.03 27.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.174 -1.192 . . . . 0.0 109.974 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -54.66 -38.43 66.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.056 -1.028 . . . . 0.0 109.35 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.33 163.39 9.73 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.538 ' CD2' HD13 ' A' ' 15' ' ' LEU . 8.2 p90 -138.37 173.05 12.02 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.529 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 17.6 p90 -111.85 122.61 48.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.29 -0.881 . . . . 0.0 109.54 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -95.0 169.03 10.41 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.088 -1.007 . . . . 0.0 108.396 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.5 t -66.17 141.83 97.58 Favored Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.006 -1.059 . . . . 0.0 109.057 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -74.3 -30.48 8.42 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 N-CA-C 107.905 -1.613 . . . . 0.0 107.905 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.52 ' CG ' ' H ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -140.64 -85.89 0.2 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.521 ' C ' ' H ' ' A' ' 32' ' ' GLU . 82.5 p -149.19 -126.33 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.048 -1.033 . . . . 0.0 111.477 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.661 ' O ' ' N ' ' A' ' 33' ' ' GLY . 32.0 mt-10 -49.74 -9.2 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 109.549 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.521 ' H ' ' C ' ' A' ' 30' ' ' THR . 17.7 mt-10 54.03 -72.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.512 0.673 . . . . 0.0 110.014 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 31' ' ' GLU . . . -164.95 -73.32 0.03 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.7 t -85.57 -127.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.449 -1.03 . . . . 0.0 109.366 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 37' ' ' SER . 2.4 ptp180 -94.56 -100.1 0.15 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.218 -0.926 . . . . 0.0 109.49 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.477 ' O ' ' N ' ' A' ' 39' ' ' GLY . 4.2 mmt-85 53.15 -83.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.713 -0.617 . . . . 0.0 110.611 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -43.98 -62.01 1.27 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.508 -0.745 . . . . 0.0 110.21 -179.232 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -59.39 -9.83 2.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.031 -1.043 . . . . 0.0 109.239 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 36' ' ' ARG . . . -82.49 -33.7 24.61 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.696 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.33 -51.55 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.463 -1.022 . . . . 0.0 110.044 -179.274 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 3.0 t -69.18 -65.1 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 120.485 -1.384 . . . . 0.0 111.525 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' ARG . 78.1 mm-40 -57.55 -49.19 77.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.834 -1.166 . . . . 0.0 110.556 -178.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -47.53 -51.9 19.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.845 -1.159 . . . . 0.0 109.838 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.566 ' SG ' HD21 ' A' ' 54' ' ' LEU . 89.2 m -80.69 -52.02 8.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.26 -0.9 . . . . 0.0 110.09 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.8 t -60.42 -52.06 66.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.805 -1.184 . . . . 0.0 109.827 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.516 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -64.56 -38.09 89.81 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.247 -0.908 . . . . 0.0 110.074 -179.383 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 44' ' ' CYS . 39.4 m -137.3 149.16 46.88 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.144 -0.973 . . . . 0.0 109.552 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.2 mt -68.2 99.31 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.062 -1.024 . . . . 0.0 109.448 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.9 p -81.8 140.92 33.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.396 -0.815 . . . . 0.0 108.956 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.5 m -70.18 159.03 34.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 109.717 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 40.7 mt -52.91 -31.65 41.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.37 -0.832 . . . . 0.0 108.999 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -48.24 -53.78 15.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 109.356 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.517 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 47.0 mt-30 -61.52 -50.62 71.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 109.445 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.566 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.0 mt -56.06 -35.05 66.49 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.126 -0.984 . . . . 0.0 108.605 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -72.61 -9.58 58.77 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -78.5 -22.57 47.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.31 -0.869 . . . . 0.0 111.039 -178.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.517 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.4 m-85 -100.97 -7.03 23.72 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.158 -0.964 . . . . 0.0 110.147 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 96.8 m -62.04 96.34 0.07 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.201 -0.937 . . . . 0.0 109.607 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.33 0 CA-C-O 118.011 -1.438 . . . . 0.0 109.606 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 1' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.412 ' O ' ' O ' ' A' ' 1' ' ' PHE . 3.0 m -55.35 -169.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.344 -0.848 . . . . 0.0 109.699 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.732 ' H ' ' ND2' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -95.0 116.7 29.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.556 -0.715 . . . . 0.0 109.309 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.547 ' CD ' ' HE2' ' A' ' 10' ' ' HIS . 18.2 pt20 -158.79 162.44 37.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -0.91 . . . . 0.0 109.407 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.77 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 0.1 OUTLIER -79.07 122.71 26.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.286 -0.884 . . . . 0.0 109.18 -179.613 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mp -91.03 115.98 28.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.452 -0.78 . . . . 0.0 109.384 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.422 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 62.5 m -129.64 124.97 34.98 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.255 -0.903 . . . . 0.0 109.946 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.5 -138.01 42.71 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.7 m -42.69 -34.89 0.98 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.61 -0.935 . . . . 0.0 110.664 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.547 ' HE2' ' CD ' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -58.56 -34.27 70.84 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.896 -1.128 . . . . 0.0 109.006 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.739 HD21 HD12 ' A' ' 40' ' ' ILE . 9.1 tp -72.33 -53.53 12.12 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.524 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 71.2 t -57.05 -58.95 3.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.499 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 28.9 mt-10 -45.4 -28.81 0.94 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.695 -0.628 . . . . 0.0 109.918 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.514 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -86.62 -61.26 1.77 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.965 . . . . 0.0 109.579 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.512 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.7 mt -46.36 -35.03 5.05 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.21 -0.932 . . . . 0.0 109.409 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -53.19 -40.29 64.3 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.499 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -79.44 -51.01 9.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 108.782 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.403 ' H ' HG23 ' A' ' 18' ' ' VAL . 20.8 t -49.89 -53.14 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.61 0.719 . . . . 0.0 109.187 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.5 m -79.37 -22.15 44.79 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.619 -0.676 . . . . 0.0 110.592 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 51.69 -115.19 3.65 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -84.89 -21.92 29.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.098 -1.237 . . . . 0.0 109.482 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -54.75 -39.07 67.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 109.191 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.6 160.75 7.73 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.524 ' HZ ' HG13 ' A' ' 12' ' ' VAL . 9.9 p90 -138.62 173.52 11.5 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.533 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.1 p90 -112.51 121.64 45.4 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.075 -1.016 . . . . 0.0 110.044 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -103.99 169.43 8.51 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.235 -0.916 . . . . 0.0 109.262 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.8 t -81.28 145.09 55.09 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.37 -75.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 120.817 1.011 . . . . 0.0 109.769 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.417 ' HD2' ' N ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -164.82 -3.16 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 108.779 -179.508 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.416 ' H ' ' H ' ' A' ' 29' ' ' ARG . 7.9 p -41.62 161.63 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.394 0.616 . . . . 0.0 110.349 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -164.92 -21.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.388 -0.82 . . . . 0.0 109.469 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.418 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 4.3 mt-10 -54.9 -38.0 67.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -0.976 . . . . 0.0 108.991 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -157.32 159.74 29.97 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.6 t -127.93 -177.04 3.97 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.259 -1.142 . . . . 0.0 110.542 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.564 ' CG ' HH21 ' A' ' 35' ' ' ARG . 0.0 OUTLIER -165.18 -51.92 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.236 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.474 ' O ' ' N ' ' A' ' 39' ' ' GLY . 9.1 mtp180 -105.37 -47.61 3.9 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.994 0.902 . . . . 0.0 109.076 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 t -41.47 -46.59 3.5 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.461 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.611 ' CG ' HH21 ' A' ' 38' ' ' ARG . 0.0 OUTLIER -63.46 -20.59 65.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.051 -1.031 . . . . 0.0 109.659 -179.621 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 36' ' ' ARG . . . -82.23 -33.61 25.6 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.739 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -100.55 -51.77 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.208 -1.172 . . . . 0.0 110.332 -178.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.51 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 4.4 t -67.54 -64.06 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.662 -1.274 . . . . 0.0 111.709 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 46' ' ' ARG . 53.8 mt-10 -56.93 -54.81 42.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.832 -1.167 . . . . 0.0 110.861 -178.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.693 HE21 ' NE2' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -44.68 -49.74 10.27 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.704 -1.248 . . . . 0.0 110.327 -178.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.582 ' SG ' HD21 ' A' ' 54' ' ' LEU . 99.5 m -79.63 -50.51 10.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.906 -1.121 . . . . 0.0 110.003 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 47.9 t -61.06 -53.02 62.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.073 -1.017 . . . . 0.0 110.512 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 42' ' ' GLU . 13.0 tpt180 -69.56 -38.44 77.43 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.876 -1.14 . . . . 0.0 109.902 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 44' ' ' CYS . 1.6 m -127.09 144.09 51.12 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.249 -0.907 . . . . 0.0 109.469 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.6 mt -69.14 99.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.059 -1.026 . . . . 0.0 108.901 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.7 p -82.9 141.51 32.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.347 -0.846 . . . . 0.0 109.28 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 m -72.13 163.45 27.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.187 -0.946 . . . . 0.0 109.492 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.4 ' CD2' ' CZ ' ' A' ' 1' ' ' PHE . 35.7 mt -56.02 -32.34 63.9 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.312 -0.867 . . . . 0.0 109.074 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -47.31 -56.06 7.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.935 . . . . 0.0 109.476 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.693 ' NE2' HE21 ' A' ' 43' ' ' GLN . 24.1 mt-30 -58.91 -51.27 70.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 109.324 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.582 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.0 mt -55.49 -35.02 65.11 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.099 -1.001 . . . . 0.0 108.779 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -72.63 -9.11 58.22 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.584 0.707 . . . . 0.0 109.106 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -79.98 -22.16 42.86 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.369 -0.832 . . . . 0.0 111.081 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.499 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 7.0 m-85 -99.91 -9.3 22.97 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.105 -0.997 . . . . 0.0 109.98 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 88.9 m -60.02 93.13 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.385 -0.822 . . . . 0.0 109.54 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.253 0 CA-C-O 117.974 -1.459 . . . . 0.0 109.727 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' A' ' 1' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.448 ' CG2' HE21 ' A' ' 4' ' ' GLN . 3.8 m -58.24 -114.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 0.0 110.089 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -160.01 100.19 1.39 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.161 -0.962 . . . . 0.0 109.853 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.448 HE21 ' CG2' ' A' ' 2' ' ' VAL . 28.6 mt-30 -147.15 178.2 8.57 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.224 -0.922 . . . . 0.0 109.303 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.721 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 0.0 OUTLIER -83.99 126.1 32.7 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.485 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.9 mp -93.24 116.19 28.77 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.363 -0.836 . . . . 0.0 110.188 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.416 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 61.9 m -128.96 124.68 35.7 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.321 -0.862 . . . . 0.0 109.985 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.45 -137.0 44.89 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.2 m -42.13 -36.11 1.09 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.723 -0.869 . . . . 0.0 110.6 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.416 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 0.8 OUTLIER -58.22 -35.51 71.79 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.897 -1.127 . . . . 0.0 108.789 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.739 HD21 HD12 ' A' ' 40' ' ' ILE . 11.7 tp -71.56 -50.92 26.54 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.1 t -58.94 -59.75 3.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.503 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 24.9 mt-10 -45.17 -30.04 1.08 Allowed 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.862 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.561 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -85.73 -61.05 1.85 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.928 . . . . 0.0 109.74 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.549 HD13 ' CD2' ' A' ' 24' ' ' PHE . 15.3 mt -46.67 -36.6 7.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.064 -1.023 . . . . 0.0 109.704 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -52.1 -40.49 61.33 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 108.946 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.503 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.52 -50.75 11.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.146 -0.972 . . . . 0.0 108.89 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -49.87 -53.15 11.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 121.556 0.693 . . . . 0.0 109.203 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.0 m -79.95 -22.28 42.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.598 -0.689 . . . . 0.0 110.453 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.73 -115.48 4.96 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -85.02 -23.44 28.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.143 -1.21 . . . . 0.0 109.818 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -54.58 -38.29 66.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.115 -0.99 . . . . 0.0 109.222 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.77 163.02 9.95 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.549 ' CD2' HD13 ' A' ' 15' ' ' LEU . 7.8 p90 -138.53 172.17 13.28 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.54 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 14.8 p90 -111.41 120.59 42.67 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.404 ' CD2' HG22 ' A' ' 27' ' ' THR . 8.4 t80 -82.14 160.26 23.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.894 -1.129 . . . . 0.0 108.847 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.408 ' OG1' ' CB ' ' A' ' 37' ' ' SER . 15.2 t -42.59 145.91 0.78 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.646 -0.659 . . . . 0.0 109.72 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.545 ' C ' ' H ' ' A' ' 30' ' ' THR . 9.1 Cg_exo -47.51 110.11 0.28 Allowed 'Trans proline' 0 C--N 1.321 -0.88 0 N-CA-C 108.867 -1.244 . . . . 0.0 108.867 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.582 ' CD ' ' H ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -72.01 38.77 0.07 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 122.042 0.925 . . . . 0.0 108.692 -179.382 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.545 ' H ' ' C ' ' A' ' 28' ' ' PRO . 11.7 p -131.72 125.5 32.17 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -72.79 45.98 0.15 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.296 -0.877 . . . . 0.0 109.211 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.63 -53.95 23.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.445 -0.784 . . . . 0.0 109.842 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 34' ' ' SER . . . 144.28 -18.2 2.1 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -51.73 -173.28 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.49 -1.006 . . . . 0.0 110.168 -179.422 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.577 ' CG ' HH21 ' A' ' 35' ' ' ARG . 0.0 OUTLIER -115.7 -102.15 0.42 Allowed 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.405 ' H ' ' HG3' ' A' ' 35' ' ' ARG . 28.6 mmt180 60.19 -61.63 0.06 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.048 0.451 . . . . 0.0 111.179 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -43.89 -43.33 6.33 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.589 -179.352 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -59.68 -20.7 57.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.079 -1.013 . . . . 0.0 110.296 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.28 -40.82 8.87 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.235 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.739 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -99.54 -51.39 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.046 -1.267 . . . . 0.0 110.788 -178.123 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.504 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 8.3 t -66.47 -63.61 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.523 -1.36 . . . . 0.0 111.57 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.528 ' N ' ' OE2' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -55.48 -57.07 13.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.935 -1.103 . . . . 0.0 111.106 -178.238 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.722 HE21 HE22 ' A' ' 53' ' ' GLN . 0.1 OUTLIER -43.87 -48.16 8.35 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.934 -1.104 . . . . 0.0 110.515 -178.383 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.589 ' SG ' HD21 ' A' ' 54' ' ' LEU . 95.7 m -81.53 -50.88 8.86 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.974 -1.078 . . . . 0.0 110.034 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.0 t -61.38 -52.91 62.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.202 -0.936 . . . . 0.0 110.584 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 42' ' ' GLU . 4.7 tpt180 -69.07 -38.48 79.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.915 -1.115 . . . . 0.0 109.781 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 44' ' ' CYS . 13.0 m -128.93 145.98 51.08 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.188 -0.945 . . . . 0.0 109.714 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.0 mt -69.02 99.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.231 -0.918 . . . . 0.0 109.315 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.1 p -84.09 140.56 31.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.281 -0.887 . . . . 0.0 109.208 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.3 m -71.54 161.31 31.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.728 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.2 mt -54.15 -31.55 52.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.177 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -48.98 -55.65 11.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 0.0 109.298 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.722 HE22 HE21 ' A' ' 43' ' ' GLN . 28.0 mt-30 -58.79 -51.04 71.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 109.242 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.589 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.0 mt -55.89 -35.08 66.12 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.134 -0.979 . . . . 0.0 108.559 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -72.63 -9.15 58.26 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.558 0.694 . . . . 0.0 109.181 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -79.7 -22.61 43.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.496 -0.752 . . . . 0.0 110.79 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.473 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.5 m-85 -99.86 -6.83 26.16 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.11 -0.994 . . . . 0.0 110.268 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 82.0 m -62.05 96.13 0.07 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.075 -1.016 . . . . 0.0 109.595 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.495 2.573 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.558 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.478 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.1 m -150.75 -166.88 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.378 -0.827 . . . . 0.0 108.793 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -98.06 92.8 5.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.342 -0.848 . . . . 0.0 109.397 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.513 ' OE1' ' NE2' ' A' ' 10' ' ' HIS . 2.6 pt20 -162.95 156.73 20.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.266 -0.896 . . . . 0.0 109.255 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -83.67 147.65 27.56 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.216 -0.927 . . . . 0.0 109.76 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp -106.65 116.34 31.76 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.447 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 60.7 m -129.41 124.98 35.51 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.242 -0.911 . . . . 0.0 110.168 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 61.86 -136.93 46.32 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.1 m -41.64 -34.58 0.62 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.719 -0.871 . . . . 0.0 110.739 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.513 ' NE2' ' OE1' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -61.12 -35.36 76.83 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.912 -1.117 . . . . 0.0 108.905 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.702 HD21 HD12 ' A' ' 40' ' ' ILE . 11.1 tp -71.7 -48.68 45.68 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.7 t -59.82 -61.61 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.493 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 42.6 mt-10 -44.02 -30.28 0.71 Allowed 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.371 -0.531 . . . . 0.0 109.968 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.478 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -84.78 -60.76 1.96 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.181 -0.95 . . . . 0.0 109.989 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.539 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.0 mt -47.48 -36.77 10.66 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.975 -1.078 . . . . 0.0 109.465 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -51.15 -40.08 57.76 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.493 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.3 mp -78.26 -50.92 10.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 108.785 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.406 ' H ' HG23 ' A' ' 18' ' ' VAL . 19.1 t -50.23 -54.36 8.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.585 0.707 . . . . 0.0 109.294 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.2 m -79.38 -22.13 44.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.599 -0.688 . . . . 0.0 110.659 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.45 -116.42 7.0 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -85.29 -25.7 27.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.136 -1.214 . . . . 0.0 110.335 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.412 ' O ' ' O ' ' A' ' 59' ' ' GLY . 61.8 mtt180 -54.44 -36.61 64.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.944 -1.097 . . . . 0.0 109.267 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 75.11 165.91 16.41 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.58 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.539 ' CD2' HD13 ' A' ' 15' ' ' LEU . 9.3 p90 -139.0 172.89 12.18 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.513 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 10.8 p90 -110.23 126.68 54.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.181 -0.949 . . . . 0.0 109.073 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -96.11 167.81 10.99 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.033 -1.042 . . . . 0.0 108.96 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.4 t -68.06 145.6 97.77 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.109 -0.994 . . . . 0.0 108.645 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -69.57 -71.29 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.764 0 N-CA-C 108.882 -1.238 . . . . 0.0 108.882 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.92 -76.54 0.42 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.089 -1.007 . . . . 0.0 108.882 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.515 ' C ' ' H ' ' A' ' 32' ' ' GLU . 7.9 t -164.62 -141.69 0.05 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.329 -0.857 . . . . 0.0 110.313 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.559 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 16.9 mp0 -54.65 -5.0 0.07 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.515 ' H ' ' C ' ' A' ' 30' ' ' THR . 10.2 mt-10 -46.66 -32.41 3.51 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.205 -0.934 . . . . 0.0 109.762 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.63 154.8 7.07 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 t -85.22 -62.15 1.6 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.313 -1.11 . . . . 0.0 109.361 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 36' ' ' ARG . 8.5 ptm180 -101.29 -55.08 2.63 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.678 -0.639 . . . . 0.0 109.446 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.56 ' O ' ' N ' ' A' ' 38' ' ' ARG . 9.4 ptp180 -57.69 -159.86 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.27 -0.894 . . . . 0.0 109.976 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.8 t 53.61 -81.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.598 -0.689 . . . . 0.0 110.06 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' A' ' 36' ' ' ARG . 2.3 ptm180 -58.67 -18.27 29.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.954 -1.091 . . . . 0.0 108.63 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.68 -30.42 32.69 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.702 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.11 -50.96 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.506 -0.997 . . . . 0.0 110.065 -179.382 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.504 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 3.2 t -69.36 -65.13 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.536 -1.353 . . . . 0.0 111.388 -178.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' ARG . 77.7 mt-10 -57.93 -48.86 78.66 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.808 -1.183 . . . . 0.0 110.377 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -46.64 -50.27 17.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.847 -1.158 . . . . 0.0 109.969 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.601 ' SG ' HD21 ' A' ' 54' ' ' LEU . 88.5 m -84.04 -52.71 6.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.268 -0.895 . . . . 0.0 110.208 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.6 t -60.98 -45.36 95.08 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.88 -1.137 . . . . 0.0 110.064 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.564 HH21 ' CG ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -71.13 -37.46 72.31 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.976 -1.078 . . . . 0.0 109.722 -179.522 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 44' ' ' CYS . 14.4 m -137.77 153.62 49.68 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.172 -0.955 . . . . 0.0 110.011 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.7 mt -68.96 99.41 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.122 -0.986 . . . . 0.0 109.441 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.5 p -84.23 140.27 31.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -0.926 . . . . 0.0 108.925 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.8 m -71.41 161.15 31.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.184 -0.948 . . . . 0.0 109.837 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.401 ' CD2' ' CZ ' ' A' ' 1' ' ' PHE . 38.7 mt -54.59 -32.56 58.91 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.328 -0.857 . . . . 0.0 109.183 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -48.15 -52.89 18.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.296 -0.877 . . . . 0.0 109.327 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.529 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 39.7 mt-30 -62.43 -51.27 68.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 109.291 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.601 HD21 ' SG ' ' A' ' 44' ' ' CYS . 97.2 mt -56.15 -32.99 64.79 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.064 -1.023 . . . . 0.0 108.667 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -75.12 -8.83 57.66 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.513 0.673 . . . . 0.0 109.191 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -79.96 -21.93 43.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.453 -0.779 . . . . 0.0 110.874 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.529 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.9 m-85 -99.99 -6.35 26.68 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.17 -0.957 . . . . 0.0 110.458 -178.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 72.3 m -61.18 99.66 0.1 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.081 -1.012 . . . . 0.0 109.542 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.593 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 1.3 t80 . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.402 ' H ' HG22 ' A' ' 2' ' ' VAL . 3.0 m -100.75 -112.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.37 -0.831 . . . . 0.0 109.076 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -84.35 79.31 9.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 109.149 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -141.32 167.72 21.5 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.346 -0.846 . . . . 0.0 109.407 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.726 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 0.1 OUTLIER -93.17 136.64 33.25 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.211 -0.931 . . . . 0.0 109.127 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mp -106.35 117.24 33.51 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.564 -0.71 . . . . 0.0 109.784 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.412 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 67.7 m -129.58 124.98 35.14 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.29 -0.881 . . . . 0.0 110.378 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . 62.85 -137.27 44.0 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.1 m -42.74 -34.91 1.0 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.612 -0.934 . . . . 0.0 110.55 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.412 ' HB3' ' H ' ' A' ' 7' ' ' CYS . 4.0 t-80 -58.94 -34.12 71.38 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.898 -1.126 . . . . 0.0 108.735 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.726 HD21 HD12 ' A' ' 40' ' ' ILE . 9.2 tp -71.95 -53.54 12.75 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.511 HG13 ' HZ ' ' A' ' 24' ' ' PHE . 69.4 t -57.67 -59.93 2.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.485 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 87.5 mt-10 -43.97 -29.77 0.63 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.808 -0.558 . . . . 0.0 109.985 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.593 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -86.22 -60.95 1.86 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.952 . . . . 0.0 109.468 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.505 HD13 ' CD2' ' A' ' 24' ' ' PHE . 14.3 mt -46.43 -36.0 6.11 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.203 -0.936 . . . . 0.0 109.647 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -52.7 -40.03 62.56 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.38 -0.825 . . . . 0.0 108.994 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.485 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 6.2 mp -78.85 -51.55 9.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 108.822 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.2 t -49.76 -53.78 9.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.584 0.707 . . . . 0.0 109.231 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.3 m -78.63 -22.23 47.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.564 -0.71 . . . . 0.0 110.272 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 53.37 -115.54 4.82 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.571 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 4.0 mp0 -84.88 -23.58 28.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -1.162 . . . . 0.0 109.668 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.576 HH21 ' CG ' ' A' ' 22' ' ' ARG . 4.8 mtt-85 -54.31 -38.71 66.27 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.142 -0.974 . . . . 0.0 109.041 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 74.58 162.87 9.52 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.514 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 8.1 p90 -138.46 173.3 11.74 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.554 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 16.3 p90 -110.86 120.13 41.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.179 -0.951 . . . . 0.0 109.882 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.557 ' O ' ' C ' ' A' ' 27' ' ' THR . 9.6 t80 -103.66 106.65 17.23 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.568 ' O ' HG23 ' A' ' 27' ' ' THR . 6.5 t -2.9 76.94 0.03 OUTLIER Pre-proline 0 N--CA 1.513 2.68 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.43 ' N ' ' O ' ' A' ' 26' ' ' TYR . 10.6 Cg_endo -77.14 -19.13 13.86 Favored 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 121.766 1.644 . . . . 0.0 109.755 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.49 ' O ' ' N ' ' A' ' 31' ' ' GLU . 13.7 mmm180 -99.45 -8.73 24.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.541 -0.724 . . . . 0.0 109.266 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 29' ' ' ARG . 5.5 p 49.95 11.48 0.06 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.629 -0.67 . . . . 0.0 109.293 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 29' ' ' ARG . 52.7 mt-10 -73.56 44.19 0.16 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 34' ' ' SER . 32.6 mt-10 -40.52 -64.79 0.48 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.767 -0.583 . . . . 0.0 110.016 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 32' ' ' GLU . . . 37.18 -92.28 0.01 OUTLIER Glycine 0 N--CA 1.499 2.852 0 N-CA-C 110.654 -0.979 . . . . 0.0 110.654 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 32' ' ' GLU . 36.8 t -56.02 -104.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.547 -0.972 . . . . 0.0 109.595 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.617 ' CG ' HH21 ' A' ' 35' ' ' ARG . 0.0 OUTLIER -138.56 -103.53 0.18 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.213 -0.929 . . . . 0.0 109.655 -179.628 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 39' ' ' GLY . 30.6 mtt180 55.2 -80.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.524 0.678 . . . . 0.0 110.303 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 35' ' ' ARG . 2.4 t -44.75 -60.72 1.88 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.67 -0.643 . . . . 0.0 109.881 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.417 HH21 ' HG3' ' A' ' 38' ' ' ARG . 1.8 ptm180 -59.43 -11.6 4.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.991 -1.068 . . . . 0.0 108.42 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 36' ' ' ARG . . . -80.58 -33.32 31.38 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.726 HD12 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -101.2 -51.71 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.432 -1.04 . . . . 0.0 109.439 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.512 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 3.0 t -68.65 -65.0 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 120.622 -1.299 . . . . 0.0 111.466 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 46' ' ' ARG . 57.5 mm-40 -58.85 -45.8 89.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.864 -1.148 . . . . 0.0 110.354 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.635 ' NE2' HE21 ' A' ' 53' ' ' GLN . 24.6 tt0 -48.91 -52.59 23.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.57 -1.331 . . . . 0.0 109.652 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.576 ' SG ' HD21 ' A' ' 54' ' ' LEU . 91.8 m -79.33 -52.42 8.12 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.259 -0.901 . . . . 0.0 109.82 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.6 t -60.16 -52.23 66.23 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.032 -1.042 . . . . 0.0 109.988 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 42' ' ' GLU . 4.2 tmm_? -68.02 -36.04 79.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.283 -0.886 . . . . 0.0 110.066 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 44' ' ' CYS . 9.2 m -135.23 147.65 49.37 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.052 -1.03 . . . . 0.0 109.576 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.5 mt -68.77 99.56 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.155 -0.966 . . . . 0.0 109.494 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 25.3 p -86.21 138.53 31.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.37 -0.831 . . . . 0.0 109.042 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.4 m -69.53 157.32 37.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 110.0 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.9 mt -51.32 -32.67 26.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.397 -0.815 . . . . 0.0 109.211 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -50.13 -53.62 26.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.374 -0.829 . . . . 0.0 109.125 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.635 HE21 ' NE2' ' A' ' 43' ' ' GLN . 19.8 mt-30 -58.75 -49.17 78.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.89 . . . . 0.0 109.002 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.576 HD21 ' SG ' ' A' ' 44' ' ' CYS . 96.2 mt -57.07 -34.16 68.0 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -71.91 -9.41 58.31 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -79.05 -22.78 44.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.408 -0.807 . . . . 0.0 111.086 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.439 ' CE2' ' O ' ' A' ' 53' ' ' GLN . 6.9 m-85 -101.1 -6.9 23.72 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.093 -1.004 . . . . 0.0 110.183 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 86.6 m -61.64 96.06 0.06 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.56 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.907 . . . . . . . . 1 1 . 1 stop_ save_